data_2ro8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ro8 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.429 ' HG1' ' H ' ' A' ' 8' ' ' GLN . 18.7 p . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 121.161 0.505 . . . . 0.0 111.356 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -72.99 -42.89 62.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.875 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -61.77 -44.54 96.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.956 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.558 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 93.2 mt-30 -69.63 -24.73 63.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.53 0.681 . . . . 0.0 109.975 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.8 mt -83.4 -56.18 6.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.243 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.426 ' OG ' ' OE2' ' A' ' 14' ' ' GLU . 11.8 t -58.47 -42.6 87.88 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -63.89 -39.78 94.99 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.558 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.2 m-30 -64.07 -45.71 87.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.771 0.796 . . . . 0.0 109.862 178.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -60.92 -46.78 89.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.729 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -62.26 -39.75 93.93 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.424 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -60.65 -44.67 96.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.435 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.458 ' CE2' ' CG1' ' A' ' 27' ' ' ILE . 35.1 t80 -69.05 -45.63 69.9 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.6 m -65.81 -33.18 75.27 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.738 0.78 . . . . 0.0 109.065 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.37 -40.43 96.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.376 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.424 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 26.6 m-85 -73.87 -14.65 61.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.92 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.532 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 42.4 t0 -89.55 78.91 6.97 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.171 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -40.94 -47.61 3.03 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.736 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.43 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 20.8 p30 -88.11 -1.75 58.19 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.646 0.26 . . . . 0.0 111.683 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 51.12 39.23 41.31 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.051 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.532 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 44.5 p-10 -90.97 -0.05 57.65 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.645 0.26 . . . . 0.0 111.247 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.494 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 81.76 20.66 63.13 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.404 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 6.4 m -143.08 137.28 29.07 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.021 0.439 . . . . 0.0 111.082 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.458 ' CG1' ' CE2' ' A' ' 16' ' ' PHE . 4.9 mm -109.46 122.11 63.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.2 p -100.48 167.13 10.57 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 33' ' ' GLY . 74.7 p -60.4 -28.59 68.36 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.411 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -66.59 -48.34 69.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.592 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -67.47 -45.65 75.34 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.979 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.3 tp -62.1 -41.86 98.64 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -63.78 -42.34 98.57 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.2 m -50.18 -46.22 54.07 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.1 t -69.59 -55.76 13.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 113.389 -1.732 . . . . 0.0 111.296 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 84.5 mmm -57.0 -41.22 78.09 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -58.9 -51.49 69.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.848 0.832 . . . . 0.0 110.622 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.4 t -69.58 -14.19 62.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.687 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.431 ' C ' ' H ' ' A' ' 41' ' ' GLN . 1.7 mm? -97.39 36.7 1.44 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.964 0.412 . . . . 0.0 111.335 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.78 6.33 3.56 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.198 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 39' ' ' LEU . 4.8 tp60 -102.07 151.06 22.6 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -144.05 68.98 16.18 Favored Pre-proline 0 N--CA 1.464 0.253 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.218 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -65.18 152.58 81.73 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.488 2.125 . . . . 0.0 112.185 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.4 m -79.72 159.97 26.43 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -61.41 -48.43 81.23 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.07 -0.652 . . . . 0.0 112.1 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.15 77.06 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -61.07 -45.39 94.93 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.237 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.28 -41.31 98.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.265 0.555 . . . . 0.0 110.774 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -65.24 -45.86 82.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.626 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.92 -42.34 97.42 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.246 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 45.9 tpp -59.13 -45.98 89.54 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.8 mt -63.49 -43.08 98.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.35 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -59.69 -28.97 67.76 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -68.52 -31.31 70.46 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.277 0.56 . . . . 0.0 110.762 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.486 ' C ' ' H ' ' A' ' 57' ' ' ALA . 61.5 t -98.6 -13.36 8.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.541 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 28.8 t0 -72.28 40.89 0.08 Allowed 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.317 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.486 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -40.66 -24.37 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.393 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 4.5 p-10 -89.2 -39.96 13.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.165 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.53 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 92.21 54.76 1.81 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.561 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 47.5 p30 -117.56 -20.77 8.87 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.719 -0.283 . . . . 0.0 110.958 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.561 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 81.2 5.78 89.82 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.8 p -135.76 165.13 26.3 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.8 mt -107.33 126.39 63.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -91.57 -167.42 1.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 175.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -79.67 -50.67 1.24 Allowed Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 118.525 -1.27 . . . . 0.0 111.166 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.72 -33.54 93.01 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.319 1.346 . . . . 0.0 112.011 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -67.01 -30.63 70.79 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -74.81 -30.09 61.3 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.669 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mt -69.74 -33.1 71.99 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -68.09 -45.06 74.79 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.418 1.104 . . . . 0.0 109.357 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.2 tp -60.45 -45.64 92.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.108 -1.86 . . . . 0.0 111.355 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 93.0 mmm -79.29 -26.35 42.32 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.898 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.183 0 CA-C-O 121.221 0.534 . . . . 0.0 110.514 179.715 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.55 ' CG2' ' H ' ' A' ' 6' ' ' ASP . 32.5 m . . . . . 0 N--CA 1.465 0.28 0 CA-C-O 121.109 0.48 . . . . 0.0 111.417 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 9' ' ' ILE . 97.7 m-20 -70.53 -42.02 71.78 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.826 178.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.51 ' CG ' ' N ' ' A' ' 8' ' ' GLN . 7.2 pt-20 -43.98 -41.84 5.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.634 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.534 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 38.1 tp60 -62.94 -23.57 67.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.475 0.655 . . . . 0.0 109.327 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.575 ' N ' ' O ' ' A' ' 6' ' ' ASP . 24.7 mt -81.29 -51.1 15.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.08 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 39.4 t -56.93 -42.8 80.66 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.652 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -63.56 -42.5 98.34 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.6 m-30 -55.1 -46.24 75.51 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -62.59 -40.34 96.58 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.886 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -62.06 -44.86 95.78 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.549 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -57.9 -43.32 86.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.262 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -70.78 -49.38 47.18 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.7 t -59.1 -35.55 73.61 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.8 tp -61.86 -44.52 96.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.281 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.549 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.7 m-30 -59.03 -25.19 63.48 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.965 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -83.27 101.99 11.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.841 0.353 . . . . 0.0 111.432 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -65.44 -30.7 71.53 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.822 0.344 . . . . 0.0 111.725 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -103.21 -10.77 18.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.404 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 61.52 45.77 95.68 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -97.49 18.73 14.69 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.645 0.26 . . . . 0.0 111.256 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.9 7.71 50.42 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 31.5 m -141.77 146.91 36.51 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.991 0.424 . . . . 0.0 110.945 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 92.1 mt -113.17 129.43 68.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 81.5 p -91.47 161.88 14.79 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 33' ' ' GLY . 71.9 p -56.22 -32.75 64.72 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.587 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -64.27 -48.47 75.58 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.229 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.07 -46.21 91.61 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.851 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.1 tp -62.62 -43.31 99.14 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 37' ' ' ARG . . . -59.69 -49.18 81.32 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 178.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.9 m -48.14 -48.28 34.28 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 122.369 1.081 . . . . 0.0 108.607 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.3 t -68.11 -52.71 35.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 113.195 -1.821 . . . . 0.0 111.295 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.401 ' CE ' ' OE1' ' A' ' 41' ' ' GLN . 35.8 mmm -61.86 -42.29 98.88 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.678 0.751 . . . . 0.0 109.756 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 33' ' ' GLY . 29.5 tpt85 -54.37 -51.6 64.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.539 -1.209 . . . . 0.0 110.137 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.448 ' C ' ' H ' ' A' ' 40' ' ' GLY . 47.0 m -62.14 -32.86 73.51 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.98 -1.464 . . . . 0.0 111.702 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.559 ' C ' ' H ' ' A' ' 41' ' ' GLN . 76.2 mt -73.84 33.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.782 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 38' ' ' SER . . . 62.49 -6.71 0.29 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.538 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.559 ' H ' ' C ' ' A' ' 39' ' ' LEU . 42.5 tt0 -81.41 141.73 33.65 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 42' ' ' ASN . 19.1 p-10 -124.88 72.99 63.92 Favored Pre-proline 0 N--CA 1.47 0.529 0 C-N-CA 121.376 -0.13 . . . . 0.0 111.288 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -81.2 142.76 13.66 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.023 1.816 . . . . 0.0 111.845 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.415 ' OG1' ' N ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -87.43 175.11 8.12 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.393 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.415 ' N ' ' OG1' ' A' ' 44' ' ' THR . 52.8 mt-10 -57.2 -46.99 82.38 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.806 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.76 -49.51 72.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.525 0.679 . . . . 0.0 109.594 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -52.53 -47.08 66.94 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.946 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.41 -46.78 78.66 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.195 0.522 . . . . 0.0 111.78 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.448 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 86.6 mt-30 -60.58 -44.54 96.09 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.598 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -67.12 -35.22 79.27 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.436 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.2 tpp -66.64 -50.94 61.33 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.45 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 56' ' ' ASP . 7.9 tt -71.36 -40.69 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.305 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 49' ' ' GLN . 22.9 t-20 -60.03 -39.57 86.34 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -77.43 -13.68 59.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.56 0.695 . . . . 0.0 109.999 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.441 ' O ' ' OE1' ' A' ' 67' ' ' GLU . 38.2 t -103.44 -22.78 4.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.549 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 52' ' ' ILE . 45.9 t0 -76.5 52.71 0.81 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.332 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.67 -27.39 0.1 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.642 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.449 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 37.8 m-20 -80.79 -34.75 33.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.515 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 87.16 10.13 72.08 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 51.3 p-10 -69.64 -27.26 64.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.394 0.14 . . . . 0.0 111.291 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 96.53 -7.25 65.81 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.9 p -129.16 167.08 18.12 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.6 mt -104.0 123.57 57.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.783 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -88.63 -175.86 5.07 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 176.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.402 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 38.2 t80 -67.95 -55.84 12.64 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 117.955 -1.498 . . . . 0.0 112.019 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.1 Cg_endo -56.08 -33.63 90.44 Favored 'Trans proline' 0 N--CA 1.505 2.163 0 C-N-CA 121.517 1.478 . . . . 0.0 112.047 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.449 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 68.7 mm-40 -57.35 -56.04 26.93 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -60.46 -36.49 78.37 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.707 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.94 -48.72 80.53 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.204 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -55.01 -50.04 70.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.591 1.186 . . . . 0.0 109.009 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 tp -53.37 -46.25 69.52 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 112.574 -2.103 . . . . 0.0 110.599 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.2 tpt -67.48 -46.74 72.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.759 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.286 0 CA-C-O 121.129 0.49 . . . . 0.0 109.979 -179.415 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.543 ' CG2' ' H ' ' A' ' 6' ' ' ASP . 27.1 m . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 121.101 0.477 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.543 ' H ' ' CG2' ' A' ' 5' ' ' THR . 1.8 p30 -73.21 -41.96 63.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.165 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.522 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 12.4 pt-20 -64.47 -40.76 96.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.576 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.559 ' O ' ' CD2' ' A' ' 12' ' ' PHE . 95.6 mt-30 -69.8 -35.03 74.51 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.273 0.559 . . . . 0.0 110.498 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.6 mt -72.95 -57.11 7.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.296 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.0 t -57.48 -46.66 83.44 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.089 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -49.27 -46.04 45.77 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 8' ' ' GLN . 20.3 m-30 -66.94 -47.07 72.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.382 0.611 . . . . 0.0 110.101 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -62.54 -45.79 91.35 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.774 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -66.06 -41.97 90.09 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.517 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.37 -45.71 93.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.512 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.42 ' C ' ' CD1' ' A' ' 16' ' ' PHE . 26.3 t80 -67.72 -43.95 78.8 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.3 m -63.88 -35.82 81.89 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 39.0 tp -64.21 -39.74 94.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.445 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.517 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.5 m-30 -66.4 -15.81 63.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.43 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 23' ' ' GLY . 65.7 t0 -92.24 89.59 6.93 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.209 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -50.28 -41.55 50.8 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.787 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -82.94 -27.11 30.79 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.048 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.463 ' H ' ' CG ' ' A' ' 20' ' ' ASP . . . 72.15 31.85 63.57 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.479 ' OD2' ' SG ' ' A' ' 26' ' ' CYS . 35.7 p-10 -81.69 -3.88 54.76 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.23 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.87 3.9 57.99 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.479 ' SG ' ' OD2' ' A' ' 24' ' ' ASP . 15.3 p -141.73 146.38 35.96 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.0 0.429 . . . . 0.0 111.034 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 72.6 mt -108.98 125.11 66.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.0 p -90.0 169.76 10.93 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 p -59.54 -52.24 66.42 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.979 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -53.19 -40.18 64.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -66.21 -43.45 86.67 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.29 -46.6 88.03 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 37' ' ' ARG . . . -60.0 -41.52 97.95 Favored Glycine 0 C--O 1.223 -0.588 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.7 m -48.69 -52.23 24.47 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.2 t -65.74 -49.82 75.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.194 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.7 mmm -65.14 -39.15 92.63 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 33' ' ' GLY . 23.9 tpt180 -55.49 -50.21 70.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.538 0.685 . . . . 0.0 110.2 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.6 t -71.43 -19.51 62.23 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.328 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.91 36.12 0.44 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.717 0.294 . . . . 0.0 111.348 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.74 45.97 94.08 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.496 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -144.75 154.73 43.03 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 25.3 p30 -134.54 73.84 67.12 Favored Pre-proline 0 N--CA 1.467 0.413 0 C-N-CA 121.184 -0.206 . . . . 0.0 110.963 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.26 149.14 24.65 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.963 1.776 . . . . 0.0 111.6 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.8 p -87.91 164.31 15.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -59.54 -42.72 92.97 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.952 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.14 80.68 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.52 -48.12 82.9 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.075 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 52.6 mt -64.64 -42.45 95.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.158 0.504 . . . . 0.0 111.067 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -61.96 -36.59 81.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.899 0.857 . . . . 0.0 109.287 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -75.65 -40.07 56.69 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.006 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 33.9 mtp -63.77 -45.97 87.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.32 0.581 . . . . 0.0 110.048 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.487 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 1.4 tp -65.79 -47.44 85.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.874 -178.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.487 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 18.0 t-20 -69.06 -20.27 64.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.861 -177.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -72.34 -48.74 39.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.182 0.515 . . . . 0.0 110.525 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.561 ' C ' ' H ' ' A' ' 57' ' ' ALA . 12.0 p -86.2 -2.33 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.373 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.459 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 16.6 t70 -64.57 41.89 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.625 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.561 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -50.68 -26.75 5.84 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.862 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 25.8 p30 -71.71 -39.29 70.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.356 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.503 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 91.81 7.39 64.59 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 51.6 p-10 -85.9 -22.53 27.44 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 122.724 -0.28 . . . . 0.0 111.387 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 85.73 3.41 86.04 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.508 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 22.9 p -139.6 151.2 45.83 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.449 HD12 HG22 ' A' ' 63' ' ' ILE . 6.9 mm -85.35 127.6 39.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.333 -0.547 . . . . 0.0 112.359 -176.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -104.71 153.79 20.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.448 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 34.8 t80 -45.89 -55.61 12.46 Favored Pre-proline 0 C--N 1.319 -0.719 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.418 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 11.9 Cg_endo -49.22 -50.31 13.21 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.97 1.78 . . . . 0.0 111.489 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -55.85 -53.38 57.47 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -54.71 -21.36 10.62 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.175 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.04 -44.22 22.64 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.305 0.574 . . . . 0.0 110.219 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -58.23 -42.12 85.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.7 tp -59.71 -64.19 1.03 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 112.785 -2.007 . . . . 0.0 109.456 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.85 -38.11 54.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.645 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.153 0.501 . . . . 0.0 110.254 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 121.242 0.544 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -77.72 -29.41 51.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.385 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.483 ' OE1' ' N ' ' A' ' 7' ' ' GLU . 48.6 mp0 -68.37 -44.21 75.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.197 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.57 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 95.9 mt-30 -65.85 -29.74 70.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.278 0.561 . . . . 0.0 110.194 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.2 mt -77.44 -53.16 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.112 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.7 t -58.16 -46.56 85.48 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.845 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -54.6 -42.97 71.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.596 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.607 ' CE1' ' SD ' ' A' ' 72' ' ' MET . 16.3 m-30 -64.92 -46.73 80.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.163 0.506 . . . . 0.0 110.183 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -65.96 -43.01 89.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.743 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -67.08 -45.24 77.92 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.223 0.535 . . . . 0.0 110.073 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.554 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -62.74 -44.83 95.19 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.534 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -66.72 -43.99 82.77 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.8 m -63.35 -36.64 84.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.2 tp -63.74 -40.29 96.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.473 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.4 m-30 -63.29 -18.01 63.14 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.487 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.541 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 24.2 t0 -98.04 93.89 6.55 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.905 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.406 ' HZ3' ' CG2' ' A' ' 34' ' ' THR . 55.2 mttp -65.74 -19.69 65.99 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.662 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 24' ' ' ASP . 8.8 p30 -109.99 13.16 23.47 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.522 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 35.18 32.08 0.03 OUTLIER Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.541 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 97.5 m-20 -69.84 -8.96 52.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.568 0.223 . . . . 0.0 110.811 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.67 -7.61 65.63 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.8 m -143.64 149.66 37.61 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.748 0.309 . . . . 0.0 111.098 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.8 mt -96.22 125.14 49.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.1 p -84.28 -160.14 0.44 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.7 p -84.79 -58.15 2.83 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.439 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.455 ' O ' ' N ' ' A' ' 34' ' ' THR . 21.7 pttp -54.21 -35.98 62.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.415 . . . . 0.0 109.959 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.438 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 95.6 mt-10 -62.37 -50.84 69.95 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.0 tt -63.34 -42.02 98.9 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.53 -39.34 97.2 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 30' ' ' LYS . 20.0 m -52.77 -49.36 65.69 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.6 t -63.15 -47.86 90.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.807 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 84.6 mmm -63.64 -42.8 98.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.502 0.668 . . . . 0.0 110.416 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -53.26 -49.39 67.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.104 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.3 m -71.45 -27.08 63.01 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.513 -1.221 . . . . 0.0 112.018 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.506 ' C ' ' H ' ' A' ' 41' ' ' GLN . 7.2 mp -84.05 31.56 0.49 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.44 -8.0 1.73 Allowed Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 39' ' ' LEU . 90.4 mm-40 -85.71 146.77 26.66 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.6 p30 -135.79 64.91 58.58 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 121.249 -0.181 . . . . 0.0 111.155 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.27 154.76 41.47 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.441 2.094 . . . . 0.0 111.783 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.9 m -94.32 161.43 14.24 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -54.66 -34.3 62.02 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.706 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.63 -45.15 85.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.465 0.65 . . . . 0.0 109.394 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -63.83 -41.14 97.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.187 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.1 mt -62.28 -45.92 91.12 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.072 0.463 . . . . 0.0 111.091 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -67.27 -45.69 75.89 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.437 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.72 -43.12 99.64 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.288 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.3 ttm -61.39 -41.96 97.96 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 56' ' ' ASP . 34.1 mt -67.94 -44.93 84.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.583 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -58.37 -35.72 72.4 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -69.07 -21.2 64.09 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.121 0.486 . . . . 0.0 110.474 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.612 ' C ' ' H ' ' A' ' 57' ' ' ALA . 83.8 t -106.93 -23.48 4.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.301 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 59' ' ' GLY . 27.5 t0 -63.46 34.23 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.469 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.612 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -36.92 -27.01 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.381 0.61 . . . . 0.0 110.873 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 56' ' ' ASP . 19.3 p-10 -85.96 -37.04 19.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.178 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 87.12 62.41 1.5 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.517 ' H ' ' CG ' ' A' ' 56' ' ' ASP . 55.0 p30 -123.92 -18.17 6.06 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.637 0.219 . . . . 0.0 111.204 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 80.36 2.57 89.46 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.809 -0.516 . . . . 0.0 111.809 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.425 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 64.4 p -136.68 159.61 41.29 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.3 mt -100.05 121.06 50.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -86.99 145.67 26.42 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -46.4 -48.69 45.94 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 118.589 -1.244 . . . . 0.0 111.231 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -52.79 -49.07 18.83 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.24 1.294 . . . . 0.0 111.825 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.406 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 94.4 mt-10 -55.45 -52.83 62.3 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -53.07 -23.92 8.88 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.517 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.91 -46.1 58.87 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.051 0.453 . . . . 0.0 110.55 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -61.52 -42.41 98.76 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 122.427 1.108 . . . . 0.0 108.937 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.5 tp -62.05 -30.65 71.13 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 112.774 -2.012 . . . . 0.0 109.682 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.607 ' SD ' ' CE1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -82.5 -40.37 21.15 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.703 178.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 121.006 0.431 . . . . 0.0 109.983 179.716 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.47 0.573 0 CA-C-O 121.237 0.541 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 6' ' ' ASP . 5.4 p-10 -63.11 -34.47 77.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.406 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.64 -47.72 84.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.724 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.532 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -59.68 -36.02 75.63 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.3 mt -72.17 -55.24 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.977 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.2 t -55.38 -53.49 55.6 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.822 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -54.07 -44.3 71.02 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' A' ' 8' ' ' GLN . 4.7 m-30 -60.74 -51.22 70.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.455 0.645 . . . . 0.0 109.514 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -59.68 -42.7 93.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.5 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -62.33 -46.73 87.4 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.15 78.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.335 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.412 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 34.1 t80 -69.73 -50.94 38.67 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.0 p -57.79 -35.11 70.35 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 46.9 tp -61.27 -45.25 95.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.532 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -61.26 -27.77 68.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.474 ' OD1' ' OD1' ' A' ' 22' ' ' ASP . 27.1 t0 -78.55 90.76 4.52 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.839 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -62.48 -36.02 81.18 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.795 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.474 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 28.8 p30 -96.64 -1.36 46.94 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.481 0.181 . . . . 0.0 111.296 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.31 40.47 37.9 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -88.93 3.93 49.79 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.718 0.294 . . . . 0.0 111.19 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.76 -6.05 84.03 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.4 m -133.1 158.92 41.57 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.836 0.35 . . . . 0.0 110.889 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.0 mt -119.96 126.85 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.5 p -90.4 157.47 17.59 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.554 ' O ' ' N ' ' A' ' 33' ' ' GLY . 66.7 p -55.13 -29.72 58.29 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.349 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.95 -48.83 77.2 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.229 0.538 . . . . 0.0 110.275 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -61.59 -45.11 95.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.842 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 tp -63.42 -38.89 92.9 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 177.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -62.89 -47.62 87.44 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.1 m -47.52 -48.68 27.37 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.8 t -63.72 -51.87 64.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 113.53 -1.668 . . . . 0.0 111.233 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.482 ' SD ' ' OE1' ' A' ' 41' ' ' GLN . 17.3 mmt -63.79 -45.52 89.34 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 33' ' ' GLY . 14.9 tpt180 -47.8 -54.54 12.07 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.313 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.494 ' C ' ' H ' ' A' ' 40' ' ' GLY . 37.5 m -62.06 -37.16 83.92 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.642 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.48 ' C ' ' H ' ' A' ' 41' ' ' GLN . 69.8 mt -69.91 34.78 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.776 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 38' ' ' SER . . . 58.92 3.57 1.75 Allowed Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.482 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 87.0 mt-30 -97.43 149.09 22.53 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -147.54 67.01 10.28 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.269 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -65.52 157.6 57.47 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.288 1.992 . . . . 0.0 111.923 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.478 ' H ' ' HG1' ' A' ' 44' ' ' THR . 6.8 p -82.53 164.83 20.63 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 177.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -57.37 -40.62 78.53 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.436 -0.506 . . . . 0.0 112.051 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.3 -50.08 74.88 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.571 0.7 . . . . 0.0 109.803 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -54.11 -47.19 72.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.268 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.24 -47.33 71.08 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.905 0.384 . . . . 0.0 111.783 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.417 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 94.6 mm-40 -61.05 -40.03 92.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.54 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -74.22 -38.58 63.52 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.774 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 43.4 tpp -62.37 -48.89 77.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.493 0.663 . . . . 0.0 110.548 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.7 tt -71.84 -41.84 69.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.195 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 49' ' ' GLN . 31.3 t30 -64.06 -38.75 92.19 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -60.58 -55.41 33.66 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.456 0.646 . . . . 0.0 110.958 -177.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.414 HG21 HD21 ' A' ' 70' ' ' ASN . 7.1 p -67.67 -6.05 4.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.097 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.595 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.0 t0 -80.07 75.48 6.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.721 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.04 -24.66 1.14 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.259 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 12.0 p-10 -99.43 -44.68 6.1 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.22 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.595 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 93.57 29.11 10.35 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.722 HD21 ' N ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -71.41 -19.84 62.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.441 0.163 . . . . 0.0 111.242 179.493 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.722 ' N ' HD21 ' A' ' 60' ' ' ASN . . . 87.91 -9.45 74.34 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.403 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 68.3 p -132.1 167.27 20.02 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.3 mt -100.13 126.36 53.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.777 -177.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -96.3 -172.25 2.49 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.402 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 55.4 t80 -71.6 -56.01 5.31 Favored Pre-proline 0 C--N 1.319 -0.728 0 C-N-CA 118.114 -1.434 . . . . 0.0 111.865 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 32.5 Cg_endo -57.05 -39.3 92.23 Favored 'Trans proline' 0 N--CA 1.503 2.046 0 C-N-CA 121.488 1.459 . . . . 0.0 111.875 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.432 ' OE2' ' OD1' ' A' ' 58' ' ' ASP . 64.5 mm-40 -55.02 -49.06 72.49 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -57.22 -42.35 81.22 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 114.319 -1.309 . . . . 0.0 110.16 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.3 mt -61.95 -44.77 96.06 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.767 -0.583 . . . . 0.0 110.904 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.414 HD21 HG21 ' A' ' 55' ' ' VAL . 21.8 t30 -57.3 -47.86 80.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 122.533 1.158 . . . . 0.0 109.079 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 32.2 tp -59.5 -50.11 75.17 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 112.823 -1.989 . . . . 0.0 110.102 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.3 tpt -65.48 -42.87 91.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.647 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.206 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.919 -179.769 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.7 p . . . . . 0 N--CA 1.473 0.684 0 CA-C-O 120.814 0.34 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -75.7 -18.12 59.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -66.44 -43.66 84.99 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.049 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.613 ' O ' ' CD2' ' A' ' 12' ' ' PHE . 84.3 mt-30 -67.39 -33.67 75.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.525 0.679 . . . . 0.0 110.383 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.513 ' N ' ' CD1' ' A' ' 9' ' ' ILE . 1.4 mp -74.11 -58.22 5.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.709 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.5 t -56.29 -46.51 79.73 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.72 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -47.11 -50.37 20.21 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.239 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.613 ' CD2' ' O ' ' A' ' 8' ' ' GLN . 17.7 m-85 -62.92 -48.83 77.23 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.491 0.663 . . . . 0.0 110.76 178.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -62.42 -47.33 84.57 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.725 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -62.15 -42.16 98.99 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.0 99.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.396 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 19.6 t80 -70.03 -47.66 61.15 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.8 p -66.21 -30.54 71.02 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.9 tp -61.04 -41.54 96.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.296 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -73.23 -15.18 61.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.821 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.543 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 26.3 t0 -86.8 69.8 10.32 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.269 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -40.08 -46.14 2.1 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.704 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 26.4 p-10 -74.87 -19.78 60.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.443 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 64.72 30.34 77.67 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.543 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 54.9 p-10 -81.58 -3.87 54.49 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.744 0.307 . . . . 0.0 111.151 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.68 5.11 72.03 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.455 ' O ' ' OD1' ' A' ' 20' ' ' ASP . 15.7 m -136.08 150.19 49.04 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.904 0.383 . . . . 0.0 110.817 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.4 ' CD1' ' CD2' ' A' ' 16' ' ' PHE . 82.9 mt -117.36 130.23 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.6 p -104.61 166.49 10.36 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 33' ' ' GLY . 36.0 p -56.45 -24.88 48.46 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.532 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.475 ' O ' ' OG1' ' A' ' 34' ' ' THR . 65.7 tttm -68.08 -50.15 56.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.092 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.25 -49.15 68.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.626 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.2 tp -62.26 -41.85 98.82 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -64.13 -42.68 97.94 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 30' ' ' LYS . 23.6 m -49.19 -46.51 45.7 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 122.275 1.036 . . . . 0.0 108.412 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.1 t -68.94 -55.48 15.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 113.398 -1.728 . . . . 0.0 111.217 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.8 mmt -60.2 -41.05 92.16 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.529 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.465 ' N ' ' O ' ' A' ' 33' ' ' GLY . 71.6 ttp85 -57.56 -50.25 73.71 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.321 178.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -68.38 -18.12 64.39 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.592 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -91.05 38.95 0.97 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.905 0.383 . . . . 0.0 111.476 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.49 26.56 59.74 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.396 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.522 ' OE1' ' N ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -111.97 142.84 43.87 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.522 ' N ' ' OE1' ' A' ' 41' ' ' GLN . 10.9 m120 -128.31 75.11 79.34 Favored Pre-proline 0 N--CA 1.47 0.541 0 C-N-CA 121.288 -0.165 . . . . 0.0 111.361 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -81.11 143.88 14.47 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.254 1.969 . . . . 0.0 111.487 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.11 172.22 9.25 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -63.2 -39.58 95.04 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.901 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.46 94.3 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.392 0.615 . . . . 0.0 109.434 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -56.84 -51.08 70.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.046 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.1 mt -62.62 -42.51 99.63 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.135 0.493 . . . . 0.0 111.11 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -64.64 -37.96 89.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.79 0.805 . . . . 0.0 109.272 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -75.37 -35.32 61.12 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.1 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 32.9 ttm -63.86 -50.76 67.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.451 0.643 . . . . 0.0 110.146 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.415 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 1.3 tt -66.28 -39.5 84.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.635 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -63.71 -30.84 71.89 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.784 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -77.08 -30.31 55.38 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.592 0.711 . . . . 0.0 110.497 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.546 ' C ' ' H ' ' A' ' 57' ' ' ALA . 54.7 t -98.39 -4.71 9.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.474 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 52' ' ' ILE . 16.6 m-20 -64.74 45.01 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.449 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.546 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -45.81 -37.58 6.26 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.286 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 25.0 p-10 -77.65 -43.3 31.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.435 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.476 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 90.36 16.74 54.9 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.497 ' OD1' ' O ' ' A' ' 62' ' ' THR . 52.9 p-10 -94.34 -1.77 53.27 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 122.87 -0.194 . . . . 0.0 111.093 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.77 2.25 50.28 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.532 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.497 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 31.6 p -134.13 150.65 51.14 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.6 mm -91.34 133.3 33.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -101.26 -172.34 2.15 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -76.98 -47.45 2.75 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 118.091 -1.443 . . . . 0.0 111.658 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.96 -37.62 75.35 Favored 'Trans proline' 0 N--CA 1.505 2.176 0 C-N-CA 121.701 1.601 . . . . 0.0 111.934 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -64.22 -35.87 82.21 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -76.44 -23.07 53.93 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.305 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.6 tp -78.3 -32.55 49.45 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.209 0.528 . . . . 0.0 110.652 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -68.43 -42.21 79.22 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.615 1.198 . . . . 0.0 108.641 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.8 tp -62.95 -41.55 99.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 112.527 -2.124 . . . . 0.0 110.416 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.2 mmt -81.02 -22.49 39.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.885 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 121.127 0.489 . . . . 0.0 109.791 -179.617 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.466 0.35 0 CA-C-O 121.082 0.468 . . . . 0.0 111.341 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -68.51 -40.87 80.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.654 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -61.86 -46.67 88.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.949 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.546 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 7.8 mp0 -64.29 -32.08 73.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 78.3 mt -76.45 -55.37 11.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.247 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 42.9 t -56.72 -47.77 79.23 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.032 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -59.98 -40.7 90.05 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.843 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.546 ' CG ' ' O ' ' A' ' 8' ' ' GLN . 3.9 m-30 -61.19 -49.78 75.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.326 0.584 . . . . 0.0 109.835 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -65.57 -39.65 91.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.012 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -61.81 -43.03 99.66 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.531 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.0 -45.92 92.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.576 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 31.7 t80 -66.55 -48.79 68.54 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.9 m -62.91 -35.62 80.68 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.954 0.883 . . . . 0.0 108.8 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.3 tp -60.98 -43.59 98.61 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.311 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 9.7 m-30 -63.15 -19.0 64.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.955 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -85.91 95.27 9.41 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.28 0.363 . . . . 0.0 111.493 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -76.13 -20.58 57.48 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.371 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.2 p30 -110.56 1.09 17.92 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.65 0.262 . . . . 0.0 111.322 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 47.07 40.83 13.69 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 26' ' ' CYS . 34.8 p30 -81.73 -2.65 51.35 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.725 0.298 . . . . 0.0 111.162 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.87 -8.18 78.77 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.449 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.1 m -143.05 139.85 30.7 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.776 0.322 . . . . 0.0 111.074 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.7 mt -96.58 128.4 47.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.5 p -86.23 -159.54 0.48 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 33' ' ' GLY . 22.0 p -86.56 -31.42 21.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.097 0.475 . . . . 0.0 110.806 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -67.12 -46.89 72.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.346 0.593 . . . . 0.0 110.403 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -63.16 -47.02 84.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.92 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.4 tp -63.82 -42.48 97.64 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -60.59 -46.8 93.73 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 178.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.9 m -48.87 -47.91 42.51 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 122.247 1.023 . . . . 0.0 108.292 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.403 HG13 ' CZ ' ' A' ' 19' ' ' PHE . 54.2 t -66.92 -50.32 65.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 113.401 -1.727 . . . . 0.0 111.521 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 75.7 mmm -62.88 -43.0 99.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.783 0.801 . . . . 0.0 109.634 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -55.77 -52.21 64.73 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.452 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.5 t -66.42 -21.19 66.21 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.864 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 36.4 mt -84.43 30.9 0.53 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.583 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.6 45.98 94.74 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.855 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -141.19 151.11 43.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -134.91 68.82 71.21 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-O 120.394 0.14 . . . . 0.0 111.252 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.41 150.33 41.09 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.029 1.819 . . . . 0.0 111.845 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.3 p -87.22 166.96 14.54 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -59.81 -37.21 78.53 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.866 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.37 -47.41 78.95 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.448 0.642 . . . . 0.0 109.354 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -61.08 -46.42 90.73 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.134 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.2 mt -62.69 -49.32 75.58 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.162 0.506 . . . . 0.0 111.513 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -61.71 -39.47 91.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.226 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -72.02 -32.57 67.27 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.56 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.0 mmt -67.1 -45.75 76.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.363 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 4.1 tt -75.57 -41.63 41.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.893 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.41 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 24.4 t-20 -65.42 -41.79 93.19 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -177.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.78 -11.64 61.07 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.002 0.906 . . . . 0.0 109.909 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.559 ' C ' ' H ' ' A' ' 57' ' ' ALA . 42.9 t -110.37 -14.27 10.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.699 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 44.1 t0 -66.04 42.97 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.711 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.559 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -50.29 -28.67 8.2 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.261 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 1.8 p30 -77.87 -37.46 48.11 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.447 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.481 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 89.5 7.54 69.16 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.545 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 57.1 p30 -75.12 -21.52 58.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.416 0.151 . . . . 0.0 111.282 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.545 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 84.78 -5.52 81.8 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.741 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.429 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 54.5 p -133.82 163.71 28.87 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.8 mt -96.02 115.66 35.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.601 -0.439 . . . . 0.0 112.091 -177.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 65' ' ' PHE . 64.8 t0 -82.62 -173.52 4.67 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 176.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.509 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 34.2 t80 -77.68 -48.17 2.28 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 117.954 -1.498 . . . . 0.0 111.738 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.56 -43.57 53.97 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 121.287 1.324 . . . . 0.0 111.606 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.433 ' OE1' ' OD2' ' A' ' 58' ' ' ASP . 76.3 tt0 -56.0 -52.37 64.45 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 122.344 1.069 . . . . 0.0 108.208 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -48.34 -40.78 26.46 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.192 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.0 mt -61.43 -43.52 98.72 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.419 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -58.48 -46.45 86.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 122.379 1.085 . . . . 0.0 109.125 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.1 tp -59.18 -47.43 85.33 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 112.847 -1.979 . . . . 0.0 110.484 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.0 tpt -67.71 -44.35 77.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.346 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.402 0 CA-C-O 121.156 0.503 . . . . 0.0 110.138 -178.719 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.523 HG21 ' H ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.568 0 CA-C-O 121.29 0.566 . . . . 0.0 111.353 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.678 ' O ' ' N ' ' A' ' 9' ' ' ILE . 5.8 p-10 -76.02 -52.7 9.66 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.284 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.43 ' H ' ' CG ' ' A' ' 6' ' ' ASP . 11.6 pt-20 -43.31 -33.82 1.08 Allowed 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.961 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.532 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 84.2 mm-40 -70.53 -22.1 62.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.423 0.63 . . . . 0.0 109.835 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 6' ' ' ASP . 73.4 mt -83.28 -55.62 7.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.518 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -43.45 92.74 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 120.149 -0.621 . . . . 0.0 109.937 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -61.88 -39.64 92.65 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.0 m-30 -63.96 -45.97 86.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.385 0.612 . . . . 0.0 109.675 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -65.7 -43.14 90.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.587 -1.188 . . . . 0.0 111.756 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -62.96 -40.34 97.4 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.521 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -62.75 -43.35 99.03 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.36 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -68.16 -45.29 73.92 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.7 t -63.34 -36.99 85.53 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.4 tp -60.67 -38.39 84.78 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.943 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.521 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.8 m-30 -68.41 -15.39 63.53 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.017 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 65.8 t0 -95.29 77.36 3.43 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -43.02 -36.64 1.64 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.088 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.429 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 46.3 m-20 -83.52 -22.17 32.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.338 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 66.84 30.55 76.32 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.519 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 24.3 p-10 -88.66 0.11 56.74 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.533 0.206 . . . . 0.0 111.157 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.472 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 82.1 18.09 68.03 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.7 m -145.33 130.56 18.53 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 111.007 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 58.4 mt -103.67 141.57 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.2 p -119.72 174.28 6.51 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 33' ' ' GLY . 79.7 p -56.5 -33.48 66.04 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.808 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -67.69 -49.62 61.81 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.309 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.429 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 90.4 mt-10 -69.08 -45.37 70.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.2 tp -60.45 -44.31 95.96 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -63.83 -39.26 97.22 Favored Glycine 0 C--O 1.216 -1.003 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.1 m -50.29 -45.78 54.72 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.292 1.044 . . . . 0.0 108.677 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.71 -54.07 23.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 113.057 -1.883 . . . . 0.0 111.25 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.1 mmt -57.11 -41.6 79.27 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.523 0.678 . . . . 0.0 109.93 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -55.85 -45.39 78.46 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.564 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 61.8 p -79.87 -10.58 59.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.818 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.425 ' C ' ' H ' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -98.75 38.13 1.41 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.549 -178.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.48 5.74 2.82 Favored Glycine 0 N--CA 1.465 0.568 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.502 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.425 ' H ' ' C ' ' A' ' 39' ' ' LEU . 53.7 tp60 -103.71 151.8 22.57 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -138.1 74.04 43.74 Favored Pre-proline 0 N--CA 1.47 0.569 0 O-C-N 122.957 0.161 . . . . 0.0 111.19 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.2 155.35 22.37 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.992 1.794 . . . . 0.0 112.026 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.7 m -94.01 169.75 10.04 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -62.07 -34.0 75.46 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.954 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.48 -44.55 96.88 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.481 0.657 . . . . 0.0 109.963 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.55 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -60.77 -51.54 68.91 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.037 -178.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.3 mt -61.26 -41.38 96.82 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.01 0.433 . . . . 0.0 111.829 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -64.61 -45.61 86.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.746 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -65.81 -37.57 86.6 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.074 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.4 mmm -61.91 -43.22 99.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.437 0.637 . . . . 0.0 109.563 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 22.9 mt -66.68 -43.56 90.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.864 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -64.2 -35.03 79.47 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -70.43 -33.26 71.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.525 0.678 . . . . 0.0 110.324 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.579 ' C ' ' H ' ' A' ' 57' ' ' ALA . 79.8 t -98.1 -4.74 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.095 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 15.8 t70 -65.6 41.59 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.057 0.456 . . . . 0.0 111.023 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.579 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -53.66 -25.97 20.42 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.58 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.434 ' OD1' ' OE1' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -80.31 -43.29 21.49 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.369 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.27 43.55 4.62 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.68 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 46.8 p30 -123.63 -15.27 7.08 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.268 0.099 . . . . 0.0 111.268 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 78.57 5.49 88.1 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.76 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.433 ' O ' ' OE1' ' A' ' 67' ' ' GLU . 72.4 p -135.84 164.5 27.79 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.0 mt -99.57 121.77 50.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.461 ' H ' ' HB3' ' A' ' 67' ' ' GLU . 90.5 m-20 -99.43 157.71 16.23 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 177.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.451 ' C ' ' O ' ' A' ' 64' ' ' ASP . 41.1 t80 -44.45 -53.92 13.43 Favored Pre-proline 0 CA--C 1.556 1.184 0 CA-C-N 120.557 1.526 . . . . 0.0 111.78 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.8 Cg_endo -57.24 -40.45 82.42 Favored 'Trans proline' 0 N--CA 1.505 2.157 0 C-N-CA 121.254 1.303 . . . . 0.0 112.087 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.461 ' HB3' ' H ' ' A' ' 64' ' ' ASP . 77.4 tt0 -63.02 -32.02 73.29 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.444 ' HB3' ' O ' ' A' ' 65' ' ' PHE . 53.5 t80 -71.8 -26.1 62.27 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.764 -1.562 . . . . 0.0 109.7 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.452 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 6.0 mt -76.01 -34.0 59.69 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.401 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -61.47 -42.28 98.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.62 1.2 . . . . 0.0 108.641 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.8 tp -58.17 -63.79 1.14 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 112.317 -2.22 . . . . 0.0 110.285 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 67.1 mmm -63.94 -32.85 74.53 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.187 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 C--O 1.233 0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.439 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.0 p . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 121.257 0.551 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 25.5 p-10 -73.95 -29.01 61.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.469 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.415 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 80.6 mm-40 -61.21 -45.98 92.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.026 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.606 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 53.8 tt0 -66.13 -26.54 67.49 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.408 HD12 HG21 ' A' ' 9' ' ' ILE . 96.0 mt -80.53 -54.6 10.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.086 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.0 t -57.62 -43.82 85.05 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.776 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -64.07 -40.2 95.74 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.606 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 2.7 m-85 -61.24 -47.49 85.81 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.623 0.725 . . . . 0.0 109.377 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -62.73 -44.35 96.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.836 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -61.02 -40.34 93.22 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.53 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.1 -42.0 97.72 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.273 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -68.18 -47.21 68.58 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.9 t -60.19 -36.12 76.91 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.4 tp -61.96 -41.98 98.6 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.444 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.53 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.5 m-30 -62.93 -24.97 68.12 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.315 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.481 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 47.4 t0 -83.21 94.54 7.9 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.346 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -59.67 -33.22 71.28 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.055 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -97.53 -3.03 40.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.609 0.242 . . . . 0.0 111.124 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.46 36.51 30.86 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.481 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 33.2 p-10 -95.46 15.92 18.36 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.672 0.273 . . . . 0.0 111.095 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.44 ' C ' ' SG ' ' A' ' 26' ' ' CYS . . . 69.61 22.24 76.58 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.44 ' SG ' ' C ' ' A' ' 25' ' ' GLY . 3.2 m -149.99 139.18 21.22 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.883 0.373 . . . . 0.0 111.218 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 6.0 mm -108.78 118.87 57.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.6 p -78.66 -162.76 0.39 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.499 ' OG1' ' N ' ' A' ' 30' ' ' LYS . 1.6 p -84.62 -60.11 2.16 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.863 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.499 ' N ' ' OG1' ' A' ' 29' ' ' THR . 20.3 pttp -50.0 -33.2 17.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.112 0.482 . . . . 0.0 110.081 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -67.8 -48.07 67.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.824 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.7 tp -64.52 -42.82 95.56 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 37' ' ' ARG . . . -63.59 -43.26 98.25 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 30' ' ' LYS . 89.1 m -48.65 -47.94 40.08 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.1 t -65.81 -50.16 72.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.648 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.2 mmt -63.5 -40.82 98.07 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.434 ' N ' ' O ' ' A' ' 33' ' ' GLY . 67.0 ttt180 -57.29 -48.86 77.84 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.369 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 86.8 p -69.67 -19.1 63.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.511 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.9 mt -92.13 30.62 1.4 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.469 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.71 43.96 98.56 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.835 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -133.26 144.31 49.66 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -123.34 69.48 41.4 Favored Pre-proline 0 N--CA 1.47 0.574 0 CA-C-O 120.452 0.167 . . . . 0.0 111.385 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -78.8 142.58 17.88 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.044 1.829 . . . . 0.0 111.665 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.2 p -81.26 163.73 22.75 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -57.57 -45.94 84.58 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.957 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.77 -44.75 82.11 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -57.32 -40.97 79.04 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.199 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.4 mt -66.42 -44.52 82.71 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.174 0.511 . . . . 0.0 111.56 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -67.05 -43.88 81.61 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.643 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -61.96 -45.9 91.62 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.04 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 48.9 tpp -57.99 -39.18 77.58 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.449 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 0.6 OUTLIER -68.22 -42.55 84.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.242 179.326 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -58.68 -34.36 71.17 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -73.48 -50.17 22.94 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.88 0.848 . . . . 0.0 111.275 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.482 ' O ' ' OE2' ' A' ' 67' ' ' GLU . 11.3 p -72.59 -18.48 18.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.297 -1.319 . . . . 0.0 111.054 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.2 t0 -79.7 48.71 0.96 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.501 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -44.76 -21.02 0.04 OUTLIER 'General case' 0 C--N 1.34 0.195 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.382 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.439 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 31.3 m-20 -80.5 -35.16 35.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.448 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.53 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 89.27 15.0 59.48 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 62' ' ' THR . 50.4 p-10 -77.32 -28.02 53.05 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.288 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 92.26 -2.73 75.26 Favored Glycine 0 N--CA 1.466 0.649 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.523 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 53.9 p -135.9 163.27 30.64 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.3 mm -95.78 118.64 42.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.855 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -89.31 -168.4 2.15 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.417 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 28.7 t80 -71.78 -55.51 5.46 Favored Pre-proline 0 C--N 1.317 -0.812 0 C-N-CA 118.002 -1.479 . . . . 0.0 111.91 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 38.3 Cg_endo -59.12 -35.11 98.59 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 121.392 1.395 . . . . 0.0 111.698 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.482 ' OE2' ' O ' ' A' ' 55' ' ' VAL . 6.1 tp10 -58.79 -55.25 37.58 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.446 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 42.5 t80 -47.86 -40.52 21.72 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.401 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -57.97 -41.6 83.28 Favored 'General case' 0 C--N 1.313 -1.0 0 O-C-N 121.036 -1.04 . . . . 0.0 110.289 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -60.38 -47.85 84.31 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.703 1.24 . . . . 0.0 108.615 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -46.64 -64.16 0.83 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 112.85 -1.977 . . . . 0.0 110.58 179.357 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 73.0 mmm -62.78 -39.6 94.71 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.294 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.247 0 CA-C-O 121.047 0.451 . . . . 0.0 110.308 -179.609 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 p . . . . . 0 N--CA 1.469 0.505 0 CA-C-O 121.252 0.549 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 19.1 p-10 -78.68 -28.87 45.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.485 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.08 -43.91 97.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.805 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.584 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 99.0 mm-40 -70.31 -26.36 63.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.283 0.563 . . . . 0.0 109.831 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -81.96 -56.78 5.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.094 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.8 m -59.1 -44.24 91.94 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.182 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -61.06 -39.91 91.64 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.601 ' CG ' ' SD ' ' A' ' 72' ' ' MET . 4.3 m-30 -63.67 -46.43 85.63 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.36 0.6 . . . . 0.0 109.779 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.98 -44.23 96.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.652 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.25 -39.89 92.0 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.468 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.27 -45.36 91.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.539 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 34.7 t80 -68.17 -45.41 73.54 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.5 p -67.15 -31.95 72.73 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.5 tp -63.14 -41.87 99.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.564 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.468 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 29.9 m-85 -72.65 -14.26 61.55 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.873 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -91.4 80.83 5.46 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.45 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -49.4 -24.46 1.96 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.313 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -105.47 2.23 28.36 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.528 0.204 . . . . 0.0 111.427 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 40.74 31.09 0.39 Allowed Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.455 ' CG ' ' SG ' ' A' ' 26' ' ' CYS . 29.9 p30 -84.25 1.5 44.41 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.696 0.284 . . . . 0.0 111.133 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.39 24.53 56.57 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.455 ' SG ' ' CG ' ' A' ' 24' ' ' ASP . 17.8 p -153.72 127.78 9.0 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.99 0.424 . . . . 0.0 111.136 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.426 HD13 HG23 ' A' ' 27' ' ' ILE . 79.4 mt -100.45 120.13 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.1 p -90.19 170.16 10.53 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.8 p -65.38 -25.05 67.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.148 0.499 . . . . 0.0 110.562 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -66.54 -49.82 65.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.54 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -62.96 -41.36 99.5 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.92 -42.21 98.84 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.96 -43.41 99.44 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.4 m -50.49 -46.1 56.79 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.9 t -68.98 -54.23 21.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 113.49 -1.686 . . . . 0.0 111.019 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 60.9 mmm -57.21 -44.53 83.8 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.454 0.645 . . . . 0.0 109.444 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -54.96 -51.03 67.42 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.414 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.3 p -70.48 -14.99 62.75 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.707 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.451 ' C ' ' H ' ' A' ' 41' ' ' GLN . 7.3 mp -97.36 38.04 1.3 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.92 0.39 . . . . 0.0 111.587 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.14 5.33 2.24 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.322 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.451 ' H ' ' C ' ' A' ' 39' ' ' LEU . 44.6 tp60 -97.01 147.18 24.27 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.06 72.27 40.05 Favored Pre-proline 0 N--CA 1.47 0.556 0 C-N-CA 121.309 -0.156 . . . . 0.0 111.238 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.92 155.06 30.18 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.199 1.933 . . . . 0.0 111.599 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.442 ' OG1' ' OE2' ' A' ' 47' ' ' GLU . 16.1 p -93.15 169.76 10.15 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 176.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -60.54 -36.92 79.61 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.876 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.15 -45.39 93.24 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.526 0.679 . . . . 0.0 109.458 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.538 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -60.23 -49.08 79.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.172 -178.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.9 mt -64.26 -43.97 93.22 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.268 0.556 . . . . 0.0 111.253 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -60.95 -36.14 78.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.421 -0.808 . . . . 0.0 108.988 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -77.92 -29.28 49.95 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.106 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.443 ' C ' ' SD ' ' A' ' 51' ' ' MET . 1.8 tmm? -67.95 -48.73 65.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.552 0.692 . . . . 0.0 110.016 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 2.2 tp -65.71 -42.69 93.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.368 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.41 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 41.0 t30 -63.02 -39.52 95.01 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.246 -178.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -61.13 -43.66 98.54 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.53 0.681 . . . . 0.0 110.019 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.5 t -104.0 64.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.579 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 58' ' ' ASP . 1.0 OUTLIER -129.14 47.04 2.53 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -178.417 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 56' ' ' ASP . . . -33.52 -32.25 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.96 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 56' ' ' ASP . 6.2 m-20 -94.67 -37.84 11.12 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.497 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 83.41 17.99 65.28 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.2 p30 -80.0 -12.08 59.73 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 121.286 -0.166 . . . . 0.0 111.291 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.58 6.5 77.01 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 71.1 p -138.97 165.43 27.12 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.4 mt -103.69 120.47 53.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.736 -0.386 . . . . 0.0 112.033 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -83.43 -169.09 2.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 176.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.412 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 54.8 t80 -80.24 -43.94 1.41 Allowed Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 120.208 1.367 . . . . 0.0 112.181 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 52.1 Cg_exo -56.97 -37.26 98.88 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 121.54 1.493 . . . . 0.0 112.103 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.449 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 48.1 mt-10 -61.88 -61.9 2.17 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -51.21 -25.7 5.9 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.219 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.3 tp -77.11 -45.55 26.54 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.091 0.472 . . . . 0.0 110.769 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -59.3 -43.2 92.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.38 1.086 . . . . 0.0 108.541 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 tp -55.56 -66.65 0.38 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 112.876 -1.965 . . . . 0.0 109.904 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.601 ' SD ' ' CG ' ' A' ' 12' ' ' PHE . 5.0 ttt -56.93 -36.82 70.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.916 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.054 179.542 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.0 p . . . . . 0 N--CA 1.469 0.487 0 CA-C-O 121.037 0.446 . . . . 0.0 111.558 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -70.32 -38.63 74.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.947 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.462 ' CG ' ' N ' ' A' ' 8' ' ' GLN . 13.0 pt-20 -58.95 -43.14 91.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.761 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.462 ' N ' ' CG ' ' A' ' 7' ' ' GLU . 48.5 tt0 -59.71 -32.17 70.28 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.108 0.48 . . . . 0.0 110.234 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 80.7 mt -71.21 -51.05 37.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.575 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.3 t -55.08 -49.64 71.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.656 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -47.72 -49.08 29.12 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' A' ' 72' ' ' MET . 17.0 m-85 -62.84 -48.26 79.82 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.335 0.588 . . . . 0.0 110.275 178.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -61.62 -43.77 98.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.657 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -63.61 -42.42 98.22 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.26 -44.03 95.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.255 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.445 ' C ' ' CD1' ' A' ' 16' ' ' PHE . 26.3 t80 -68.86 -47.55 65.66 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -178.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.5 m -62.37 -34.06 75.97 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.28 -42.17 99.12 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.77 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -65.57 -20.97 66.54 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.79 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -82.1 94.04 7.14 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.555 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -67.47 -29.98 69.57 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 120.734 0.302 . . . . 0.0 111.703 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -101.01 -0.86 35.71 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 122.335 -0.228 . . . . 0.0 111.422 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 48.57 33.29 11.85 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -73.8 -14.83 61.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.658 0.266 . . . . 0.0 111.29 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.95 -8.25 42.27 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.0 p -140.11 158.39 44.13 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.067 0.461 . . . . 0.0 110.74 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.4 mt -113.89 127.27 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.479 ' HG1' ' CE ' ' A' ' 30' ' ' LYS . 41.3 p -86.69 -162.48 0.78 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 33' ' ' GLY . 70.9 p -85.93 -25.2 26.24 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.625 -0.672 . . . . 0.0 111.104 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.479 ' CE ' ' HG1' ' A' ' 28' ' ' THR . 16.7 pttp -72.97 -46.11 54.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.312 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.97 -50.68 69.82 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.13 -40.39 96.07 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 176.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -58.07 -47.42 89.29 Favored Glycine 0 C--O 1.214 -1.116 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.1 m -55.62 -43.29 75.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.828 0.823 . . . . 0.0 109.082 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.1 t -69.78 -55.24 15.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.185 -1.371 . . . . 0.0 112.78 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.437 ' CG ' ' N ' ' A' ' 37' ' ' ARG . 13.9 ptm -66.29 -42.03 88.97 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.136 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.49 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 60.8 ttm-85 -52.76 -51.3 61.17 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.625 0.726 . . . . 0.0 110.022 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.544 ' C ' ' H ' ' A' ' 40' ' ' GLY . 52.3 m -59.29 -35.85 74.51 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.379 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -66.44 34.78 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.543 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' A' ' 38' ' ' SER . . . 63.99 42.45 98.24 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.886 -0.674 . . . . 0.0 111.793 178.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.405 ' C ' HD21 ' A' ' 42' ' ' ASN . 98.1 mm-40 -136.62 148.91 47.72 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.405 HD21 ' C ' ' A' ' 41' ' ' GLN . 2.6 m-80 -137.3 67.21 53.72 Favored Pre-proline 0 N--CA 1.468 0.433 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.924 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.44 155.21 40.91 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.285 1.99 . . . . 0.0 111.534 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.41 ' CG2' ' H ' ' A' ' 45' ' ' GLU . 45.4 m -88.45 169.82 11.44 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.41 ' H ' ' CG2' ' A' ' 44' ' ' THR . 99.1 mt-10 -60.28 -37.07 79.37 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.908 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.48 -46.72 80.3 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.475 0.655 . . . . 0.0 109.441 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.538 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -60.43 -46.05 91.42 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.233 -179.058 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.05 -47.04 84.68 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.099 0.476 . . . . 0.0 111.224 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -63.64 -39.88 95.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.295 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -75.39 -38.34 60.0 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.945 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.504 ' N ' ' O ' ' A' ' 47' ' ' GLU . 5.7 mmm -62.83 -47.15 84.64 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.604 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.0 tt -72.36 -40.85 65.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.586 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -65.25 -27.74 68.86 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -65.18 -51.46 60.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.45 0.643 . . . . 0.0 111.138 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.511 ' C ' ' H ' ' A' ' 57' ' ' ALA . 9.2 p -80.55 -6.81 10.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.328 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 50.6 t0 -65.94 45.77 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.908 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -47.06 -25.33 0.81 Allowed 'General case' 0 CA--C 1.523 -0.077 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.846 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -80.53 -38.03 30.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.423 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.548 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 86.42 18.15 59.31 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 46.3 p30 -83.51 -26.27 30.33 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 122.812 -0.228 . . . . 0.0 111.36 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.527 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 89.91 -3.69 82.97 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.7 p -130.78 168.88 16.5 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.5 mt -108.97 124.89 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.1 p30 -90.98 -175.99 4.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -77.11 -47.69 2.64 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.568 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.51 -47.3 27.58 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.157 1.238 . . . . 0.0 112.047 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -55.91 -50.33 70.99 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -56.97 -42.99 81.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.703 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.96 -50.62 65.69 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.084 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -56.44 -44.93 80.94 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 122.307 1.051 . . . . 0.0 108.712 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 tt -60.03 -46.56 89.13 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.001 -1.909 . . . . 0.0 110.138 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.424 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . 3.1 mmt -67.52 -45.68 75.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.912 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.213 0 CA-C-O 121.098 0.475 . . . . 0.0 109.844 -178.682 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.629 ' HG1' HE21 ' A' ' 8' ' ' GLN . 70.9 p . . . . . 0 N--CA 1.468 0.475 0 CA-C-O 121.25 0.548 . . . . 0.0 111.589 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 18.6 p-10 -68.33 -25.16 64.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.455 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.74 -46.07 89.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.848 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.629 HE21 ' HG1' ' A' ' 5' ' ' THR . 0.9 OUTLIER -63.44 -31.54 72.73 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 87.5 mt -76.69 -53.66 14.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.956 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.2 t -57.0 -49.78 74.72 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.782 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -54.85 -43.86 73.45 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.544 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 2.9 m-85 -60.72 -48.14 83.15 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -59.99 -45.92 91.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.556 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -63.51 -44.13 95.21 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.55 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -57.68 -47.56 81.99 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.292 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -67.22 -47.57 70.42 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 t -58.47 -37.96 76.56 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.5 tp -61.45 -41.55 97.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.168 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.55 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.3 m-30 -63.69 -29.15 70.41 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.431 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 43.8 t0 -82.73 93.98 7.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.447 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -59.19 -32.25 69.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.174 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -97.08 -10.45 26.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.624 0.249 . . . . 0.0 111.341 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.477 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 58.42 39.82 93.42 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.417 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 37.0 p-10 -99.6 17.41 20.54 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.664 0.268 . . . . 0.0 111.069 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.483 ' O ' ' SG ' ' A' ' 26' ' ' CYS . . . 66.64 25.77 72.87 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 25' ' ' GLY . 39.5 m -154.01 135.02 13.87 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.832 0.348 . . . . 0.0 111.05 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 62.4 mt -107.1 128.46 61.99 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.0 p -94.9 164.21 13.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.557 ' O ' ' N ' ' A' ' 33' ' ' GLY . 68.1 p -54.76 -34.51 62.67 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.508 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.445 ' O ' ' OG1' ' A' ' 34' ' ' THR . 37.2 ttpt -64.99 -47.8 76.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.465 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.27 -46.07 74.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.117 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.3 tt -62.62 -43.48 98.71 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -62.5 -43.35 99.16 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 178.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 30' ' ' LYS . 15.4 m -48.25 -48.09 35.6 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 68.8 t -66.65 -52.73 42.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 113.494 -1.685 . . . . 0.0 111.436 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 68.1 mmm -63.16 -40.45 97.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.317 0.579 . . . . 0.0 109.886 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 33' ' ' GLY . 69.6 ttt180 -57.52 -50.53 72.78 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.197 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.3 t -68.23 -19.99 64.79 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.781 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.401 ' CD2' ' O ' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -85.83 35.98 0.65 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.556 -178.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.13 44.78 94.63 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.644 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -144.51 155.8 43.86 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -145.57 72.84 14.08 Favored Pre-proline 0 N--CA 1.466 0.363 0 C-N-CA 121.112 -0.235 . . . . 0.0 111.29 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -67.08 151.11 82.25 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 122.548 2.165 . . . . 0.0 111.961 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.8 p -83.56 162.94 20.69 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.65 -41.54 86.29 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.491 -0.484 . . . . 0.0 112.071 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.4 -46.88 79.94 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.347 0.594 . . . . 0.0 109.446 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 51' ' ' MET . 81.2 mm-40 -60.1 -46.62 88.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.311 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.9 mt -63.93 -47.89 78.72 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.199 0.524 . . . . 0.0 111.568 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -62.07 -37.58 85.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.09 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -77.85 -38.0 47.14 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.517 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.508 ' N ' ' O ' ' A' ' 47' ' ' GLU . 56.8 tpp -62.4 -48.49 79.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.255 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 9.2 tt -70.41 -42.13 78.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.838 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.426 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 37.6 t30 -67.41 -21.78 65.56 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -73.6 -54.33 8.4 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.574 0.702 . . . . 0.0 110.221 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 57' ' ' ALA . 8.1 p -75.44 -6.83 9.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.469 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 15.9 t0 -65.24 48.98 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.752 -178.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -52.78 -28.82 24.18 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.222 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -75.05 -38.33 61.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.399 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.532 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 85.55 26.85 34.29 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.553 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 45.3 p30 -98.37 -22.6 15.99 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 122.847 -0.208 . . . . 0.0 111.169 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.553 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 90.77 -4.08 81.63 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.463 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 61.3 p -136.74 167.82 20.7 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.457 HG21 HD13 ' A' ' 63' ' ' ILE . 16.8 mm -96.3 118.53 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 C-N-CA 120.681 -0.408 . . . . 0.0 112.076 -177.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -87.88 -172.14 3.71 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.439 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 42.0 t80 -74.1 -54.28 3.52 Favored Pre-proline 0 C--N 1.318 -0.781 0 C-N-CA 118.236 -1.386 . . . . 0.0 112.357 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 23.4 Cg_endo -54.61 -40.39 84.26 Favored 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 121.365 1.377 . . . . 0.0 111.704 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.23 -53.66 55.58 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -48.15 -43.12 31.12 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.698 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.9 mt -63.6 -44.86 92.76 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.741 -0.599 . . . . 0.0 110.579 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -63.55 -45.61 89.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 122.509 1.147 . . . . 0.0 109.027 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 tt -58.01 -58.33 8.9 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 112.731 -2.032 . . . . 0.0 110.267 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 93.1 mmm -64.82 -37.46 87.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.81 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.207 0 CA-C-O 121.214 0.531 . . . . 0.0 110.25 -179.473 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.429 ' OG1' ' OE1' ' A' ' 8' ' ' GLN . 5.2 p . . . . . 0 N--CA 1.469 0.475 0 CA-C-O 121.148 0.499 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -78.92 -33.06 45.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.684 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -62.16 -43.3 99.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.139 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.588 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 1.0 OUTLIER -67.72 -30.93 70.54 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 88.5 mt -80.4 -53.53 12.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.239 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 p -58.8 -46.18 88.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.122 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -59.18 -41.21 87.91 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.59 ' CZ ' ' SD ' ' A' ' 72' ' ' MET . 6.4 m-30 -63.24 -46.59 86.21 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.271 0.558 . . . . 0.0 109.967 178.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.6 tttp -62.52 -43.25 99.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.445 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -62.74 -40.99 98.96 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.471 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -58.9 -48.18 82.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.474 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.412 ' CE1' ' OD2' ' A' ' 20' ' ' ASP . 48.2 t80 -65.78 -45.42 82.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.2 m -65.25 -34.81 79.23 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 62.7 tp -64.0 -43.19 96.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.698 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 30.9 m-85 -66.84 -17.17 64.75 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.706 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.412 ' OD2' ' CE1' ' A' ' 16' ' ' PHE . 43.6 m-20 -90.55 94.12 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.355 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -61.86 -22.48 65.57 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.319 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -110.65 7.4 22.3 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.082 -178.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 35.84 28.78 0.02 OUTLIER Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 22' ' ' ASP . 41.1 p30 -70.31 -14.07 62.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.656 0.265 . . . . 0.0 111.131 -178.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.28 0.25 37.93 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 5.0 p -145.23 139.71 27.35 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.059 0.429 . . . . 0.0 111.117 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 80.6 mt -95.09 122.48 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 77.3 p -86.43 173.39 9.69 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -70.79 -38.62 73.39 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.326 -178.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -54.95 -48.45 73.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.03 0.443 . . . . 0.0 109.832 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.412 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 92.6 mt-10 -62.48 -43.62 98.38 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.4 tp -62.08 -43.64 98.39 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -61.43 -42.26 99.73 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.2 m -50.54 -50.39 53.43 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.1 t -64.85 -49.84 78.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.598 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 58.0 mmm -63.31 -42.19 98.99 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -52.63 -52.13 56.94 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.31 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.8 p -66.47 -26.8 67.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.615 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.556 ' C ' ' H ' ' A' ' 41' ' ' GLN . 68.9 mt -83.11 38.98 0.62 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.734 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.94 -0.76 0.29 Allowed Glycine 0 N--CA 1.465 0.611 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.556 ' H ' ' C ' ' A' ' 39' ' ' LEU . 28.9 tp60 -88.06 146.68 25.34 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -137.21 66.41 52.81 Favored Pre-proline 0 N--CA 1.466 0.373 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.384 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.98 156.91 30.67 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.186 1.924 . . . . 0.0 111.568 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.0 p -91.66 167.18 12.38 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.478 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 55.7 mp0 -61.13 -34.89 75.7 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.563 -0.455 . . . . 0.0 112.002 -178.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.24 -48.32 82.23 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -58.31 -47.29 84.15 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.248 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.19 -44.77 94.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.268 0.556 . . . . 0.0 111.379 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -66.25 -41.67 89.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.219 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.43 ' O ' ' OE2' ' A' ' 54' ' ' GLU . 97.6 m-20 -63.82 -50.22 69.79 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.313 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 39.5 ttm -53.39 -41.77 66.28 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 56' ' ' ASP . 35.2 mt -65.07 -44.56 95.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.338 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -54.63 -33.25 60.26 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.435 ' N ' ' CD ' ' A' ' 54' ' ' GLU . 2.0 mm-40 -76.66 -41.23 46.44 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 121.798 0.808 . . . . 0.0 110.53 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.2 t -81.65 -24.9 9.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.462 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 58' ' ' ASP . 32.4 t70 -82.09 44.01 0.82 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.85 -177.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -39.07 -21.46 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.211 0.529 . . . . 0.0 110.358 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 56' ' ' ASP . 85.4 m-20 -74.0 -36.46 64.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.344 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 85.99 36.88 9.67 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.484 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 8.4 m120 -102.99 -20.18 14.31 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 122.784 -0.245 . . . . 0.0 111.12 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.26 1.31 88.32 Favored Glycine 0 N--CA 1.466 0.695 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.9 p -135.61 162.32 33.04 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.9 mt -96.86 116.85 40.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.868 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -82.17 -166.13 1.18 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 176.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.454 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 71.4 t80 -81.15 -53.1 0.79 Allowed Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.984 178.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 35.4 Cg_endo -56.86 -30.47 85.53 Favored 'Trans proline' 0 N--CA 1.506 2.244 0 C-N-CA 121.832 1.688 . . . . 0.0 111.893 -178.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -65.66 -63.19 1.15 Allowed 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -48.64 -29.43 4.34 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.91 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.4 tp -68.87 -45.68 70.37 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.901 0.381 . . . . 0.0 110.821 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -60.22 -42.74 95.84 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 122.453 1.121 . . . . 0.0 108.809 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.1 tp -62.05 -32.89 73.46 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.431 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.59 ' SD ' ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -78.67 -44.25 24.13 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.9 179.126 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.243 0 CA-C-O 121.147 0.499 . . . . 0.0 110.368 -179.839 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.1 p . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 121.112 0.482 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 17.1 p-10 -70.83 -29.61 65.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.637 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -62.78 -46.96 85.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.925 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.531 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 87.2 mt-30 -65.78 -29.85 70.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.997 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.4 mt -77.49 -57.09 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.197 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.6 m -56.47 -42.24 77.88 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.342 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -65.99 -39.88 90.69 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.631 -0.428 . . . . 0.0 109.955 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.531 ' CG ' ' O ' ' A' ' 8' ' ' GLN . 4.3 m-30 -61.65 -46.84 88.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -58.63 -47.36 84.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.296 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -60.55 -40.95 93.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.539 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -58.8 -48.51 81.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.622 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.412 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 32.9 t80 -67.67 -47.11 70.42 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.7 m -59.83 -36.75 77.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 43.4 tp -62.43 -41.19 98.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.324 178.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.0 m-30 -64.76 -26.59 68.42 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.64 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.413 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 47.7 t0 -82.88 92.64 7.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.195 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -57.38 -34.06 68.47 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.931 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -91.45 -22.81 20.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.521 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.409 ' H ' ' CG ' ' A' ' 20' ' ' ASP . . . 66.68 37.73 92.66 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.413 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 36.4 p-10 -98.05 14.02 28.9 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.549 0.214 . . . . 0.0 111.135 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.35 17.87 80.09 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.0 m -147.59 138.52 23.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.793 0.33 . . . . 0.0 111.115 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.407 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 68.4 mt -112.15 125.2 69.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 47.2 p -88.82 162.15 16.34 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -57.67 -29.99 65.09 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -178.797 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.453 ' O ' ' OG1' ' A' ' 34' ' ' THR . 64.9 tttp -66.42 -47.09 74.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.023 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -67.56 -46.65 72.1 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.263 178.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.3 tt -62.3 -41.08 98.22 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -64.66 -42.93 97.04 Favored Glycine 0 C--O 1.226 -0.393 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 178.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 30' ' ' LYS . 19.7 m -50.07 -48.99 52.76 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 73.3 t -64.17 -51.1 73.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.241 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.1 mmm -64.06 -41.69 97.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.447 0.642 . . . . 0.0 109.643 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 33' ' ' GLY . 45.3 ttm180 -56.21 -45.56 79.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.714 0.769 . . . . 0.0 110.395 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.3 m -71.72 -19.39 62.06 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.855 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -87.5 31.6 0.74 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.897 0.38 . . . . 0.0 111.654 -178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 60.94 42.78 99.84 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.708 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -136.81 149.88 48.01 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -129.43 70.54 81.87 Favored Pre-proline 0 N--CA 1.469 0.491 0 C-N-CA 121.305 -0.158 . . . . 0.0 111.241 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.76 145.52 25.72 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.183 1.922 . . . . 0.0 111.381 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.4 m -86.42 160.05 19.16 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -59.92 -33.31 71.71 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.54 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.9 -47.15 86.02 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.187 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -64.09 -42.76 96.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.764 -179.388 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.49 -46.59 85.44 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.293 0.568 . . . . 0.0 110.788 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -62.85 -46.21 88.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.439 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -64.1 -40.62 96.61 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.664 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.6 ttm -59.82 -43.94 94.29 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.433 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 11.1 mt -64.48 -46.88 91.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.733 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -56.5 -35.89 68.52 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -65.27 -50.97 63.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.218 0.532 . . . . 0.0 111.119 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.425 ' C ' ' H ' ' A' ' 57' ' ' ALA . 6.5 p -74.58 -21.3 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.194 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.553 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.8 t0 -67.79 49.23 0.05 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.797 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -39.98 -26.88 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.267 0.556 . . . . 0.0 110.384 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 56' ' ' ASP . 24.0 m-20 -88.13 -36.24 16.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.08 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 92.47 14.45 55.56 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -66.92 -31.56 72.22 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.819 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.553 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 99.2 -1.1 57.4 Favored Glycine 0 N--CA 1.47 0.922 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 65.9 p -137.23 160.72 38.2 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.443 HG23 HD12 ' A' ' 63' ' ' ILE . 19.4 mm -92.15 122.3 43.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -84.52 -176.3 6.18 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.414 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 43.2 t80 -76.86 -54.91 1.56 Allowed Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 118.336 -1.345 . . . . 0.0 111.868 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.7 Cg_endo -57.67 -41.03 74.92 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.103 1.202 . . . . 0.0 111.513 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.421 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 62.6 mt-10 -55.15 -42.17 72.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.655 0.741 . . . . 0.0 109.179 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -62.12 -38.85 90.5 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.743 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.3 mt -61.48 -42.12 98.3 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.792 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -60.83 -44.91 96.32 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 122.217 1.008 . . . . 0.0 108.75 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.5 tp -63.42 -46.9 84.23 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.29 -1.777 . . . . 0.0 110.733 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.401 ' SD ' ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -67.35 -45.57 75.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.355 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.169 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.66 -179.479 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.611 ' CG2' ' H ' ' A' ' 6' ' ' ASP . 20.4 m . . . . . 0 N--CA 1.469 0.52 0 CA-C-O 121.15 0.5 . . . . 0.0 111.455 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.611 ' H ' ' CG2' ' A' ' 5' ' ' THR . 98.0 m-20 -75.1 -40.73 59.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.444 178.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.411 ' H ' HG22 ' A' ' 5' ' ' THR . 72.7 mm-40 -49.4 -42.51 42.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.617 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.559 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 13.2 mp0 -70.35 -26.23 63.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.292 0.568 . . . . 0.0 109.771 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.405 HD12 HG23 ' A' ' 9' ' ' ILE . 97.4 mt -82.29 -57.19 4.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.059 179.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 t -58.3 -43.76 88.25 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.451 -0.499 . . . . 0.0 109.952 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -62.41 -39.93 94.88 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.559 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.4 m-30 -64.09 -46.07 85.89 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.647 0.737 . . . . 0.0 109.591 178.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -60.03 -47.44 85.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.328 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -62.8 -41.26 99.2 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.72 -47.78 83.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.689 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.465 ' CE1' ' OD2' ' A' ' 20' ' ' ASP . 51.6 t80 -67.82 -45.31 75.06 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.8 m -65.25 -34.09 77.54 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.2 tp -62.9 -40.22 96.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.709 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -73.23 -14.12 61.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.043 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.465 ' OD2' ' CE1' ' A' ' 16' ' ' PHE . 55.5 m-20 -89.28 74.19 7.93 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.396 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -43.26 -43.5 4.87 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.497 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 18.6 p30 -83.42 -22.42 32.67 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.536 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 73.12 28.06 67.16 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.9 p30 -81.1 -4.17 54.42 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.591 0.234 . . . . 0.0 111.229 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.8 12.72 74.02 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 33.6 m -143.16 128.93 19.35 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.856 0.36 . . . . 0.0 110.976 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.422 HD13 HG23 ' A' ' 27' ' ' ILE . 79.9 mt -97.64 123.34 50.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.1 p -97.03 170.14 9.35 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.1 p -61.19 -27.61 68.54 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.742 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -64.46 -48.82 73.85 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.502 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -66.94 -41.86 86.28 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.0 tt -61.1 -43.03 99.5 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.33 -43.99 94.23 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.0 m -49.77 -48.06 50.62 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.1 t -65.28 -51.54 63.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 113.549 -1.659 . . . . 0.0 111.513 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.0 mmt -61.28 -46.02 92.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.513 0.673 . . . . 0.0 109.456 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.9 tpt85 -50.01 -50.95 45.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.947 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.7 t -74.15 -15.51 61.03 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.828 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.0 mp -93.56 37.55 1.06 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.043 0.449 . . . . 0.0 111.754 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.29 4.45 6.44 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.596 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -100.74 149.32 23.93 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -140.72 68.18 29.89 Favored Pre-proline 0 N--CA 1.467 0.401 0 C-N-CA 121.198 -0.201 . . . . 0.0 111.266 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -74.79 158.43 42.99 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.327 2.018 . . . . 0.0 111.566 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.9 p -93.58 166.31 12.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -60.68 -33.21 72.5 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.694 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.53 98.9 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -62.23 -47.54 83.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.141 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.4 mt -64.87 -41.72 95.42 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.148 0.499 . . . . 0.0 111.241 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -61.86 -39.88 93.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.757 0.789 . . . . 0.0 109.196 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -78.32 -24.4 46.61 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.165 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 41.3 ttm -71.22 -46.99 59.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.505 0.669 . . . . 0.0 109.82 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 tp -67.55 -40.52 84.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.269 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -65.3 -37.08 86.05 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.634 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -64.34 -36.65 84.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.407 0.622 . . . . 0.0 109.533 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.45 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 7.2 p -109.39 68.44 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.115 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 58' ' ' ASP . 3.8 t0 -135.29 47.74 2.3 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -34.67 -29.76 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.763 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 42.3 p-10 -97.68 -38.37 9.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.487 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.546 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 91.14 12.67 59.82 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 40.4 p-10 -70.15 -25.23 63.36 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.803 -0.234 . . . . 0.0 111.31 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 90.76 7.84 66.03 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 75.2 p -143.81 157.23 44.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.431 HG22 HD11 ' A' ' 63' ' ' ILE . 8.3 mm -93.84 124.33 46.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -177.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.433 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 85.5 m-20 -90.0 -162.86 0.93 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 176.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.423 ' CZ ' ' CD1' ' A' ' 69' ' ' LEU . 50.4 t80 -76.24 -56.86 1.48 Allowed Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 118.274 -1.371 . . . . 0.0 111.85 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.47 -26.31 62.69 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 CA-C-N 120.37 1.168 . . . . 0.0 111.637 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.459 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 99.3 mt-10 -65.43 -35.07 79.82 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -70.83 -31.14 67.77 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.147 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 73' ' ' ALA . 9.7 mp -70.71 -34.57 72.07 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.588 177.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -64.42 -43.62 93.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 122.41 1.1 . . . . 0.0 108.815 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.8 tp -63.67 -45.92 87.91 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 112.998 -1.91 . . . . 0.0 110.844 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.441 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . 97.5 mmm -78.96 -30.13 44.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.113 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 C--O 1.234 0.253 0 CA-C-O 121.171 0.51 . . . . 0.0 110.094 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.428 ' OG1' ' OE1' ' A' ' 8' ' ' GLN . 77.0 p . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 121.204 0.526 . . . . 0.0 111.302 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 19.3 p-10 -77.41 -30.16 53.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.644 178.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -64.9 -44.79 88.45 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.069 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.532 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 5.1 mp0 -70.53 -25.64 63.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.169 0.509 . . . . 0.0 109.884 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.0 mt -83.97 -56.82 5.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.906 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -58.46 -41.12 84.48 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.258 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -65.6 -38.07 88.41 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.0 m-30 -64.9 -46.88 79.88 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.526 0.679 . . . . 0.0 109.673 178.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -62.23 -45.59 92.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.661 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -59.69 -37.57 79.18 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.495 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.07 -44.42 97.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.353 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.409 ' CE2' ' CG1' ' A' ' 27' ' ' ILE . 52.4 t80 -67.43 -45.95 74.54 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -178.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.4 t -63.45 -35.44 80.45 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.21 -40.64 98.04 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.338 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.495 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 27.1 m-85 -73.55 -19.67 60.84 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.099 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -87.38 80.27 8.2 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 120.904 -0.319 . . . . 0.0 111.583 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -52.59 -26.51 13.62 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.116 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' A' ' 24' ' ' ASP . 36.7 m-20 -103.26 4.46 36.64 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.876 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 38.52 31.59 0.12 Allowed Glycine 0 CA--C 1.529 0.967 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 34.9 p-10 -86.64 -0.85 57.03 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.639 0.257 . . . . 0.0 111.146 -178.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 26' ' ' CYS . . . 82.23 26.79 46.8 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 25' ' ' GLY . 40.4 m -154.09 134.52 13.44 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.907 0.384 . . . . 0.0 111.236 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.409 ' CG1' ' CE2' ' A' ' 16' ' ' PHE . 5.9 mm -102.32 115.54 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.3 p -88.19 163.97 15.89 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.45 -24.42 66.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.18 0.514 . . . . 0.0 110.195 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -69.4 -49.08 58.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.401 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -64.29 -43.52 94.49 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.058 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.7 tp -61.93 -42.81 99.53 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.99 -44.51 97.28 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.6 m -51.23 -46.51 62.32 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.57 -51.8 53.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 113.498 -1.683 . . . . 0.0 111.428 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.501 ' SD ' ' OE1' ' A' ' 41' ' ' GLN . 17.7 mmt -60.17 -42.51 95.12 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 63.3 ttm-85 -54.68 -46.5 74.07 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.591 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.0 m -76.48 -17.08 59.48 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.313 -1.312 . . . . 0.0 111.79 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.517 ' C ' ' H ' ' A' ' 41' ' ' GLN . 55.5 mt -93.26 38.39 1.04 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.723 0.297 . . . . 0.0 111.788 -178.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.1 2.22 0.88 Allowed Glycine 0 N--CA 1.464 0.528 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' A' ' 39' ' ' LEU . 80.2 mt-30 -97.7 150.39 21.25 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -136.54 68.71 60.43 Favored Pre-proline 0 N--CA 1.468 0.468 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.334 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -75.26 153.72 40.75 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.267 1.978 . . . . 0.0 111.725 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.408 ' OG1' ' N ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -92.73 174.74 7.11 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.255 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.408 ' N ' ' OG1' ' A' ' 44' ' ' THR . 97.5 mt-10 -60.34 -40.03 89.21 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.778 -178.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.35 -46.46 90.15 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.508 0.671 . . . . 0.0 109.437 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -54.24 -53.13 57.81 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.016 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.12 -41.97 98.77 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.227 0.537 . . . . 0.0 111.067 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -67.26 -40.73 86.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.586 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -64.29 -41.72 96.74 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.258 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 38.5 ttm -59.15 -41.81 89.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.667 0.746 . . . . 0.0 109.46 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.4 mt -66.27 -40.33 86.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.11 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -60.12 -39.37 85.99 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.354 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.6 -36.7 84.49 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.782 0.801 . . . . 0.0 109.732 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.6 t -110.84 63.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.878 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 58' ' ' ASP . 0.4 OUTLIER -124.37 41.39 3.51 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.356 -178.146 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 56' ' ' ASP . . . -30.64 -36.06 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.159 0.504 . . . . 0.0 111.096 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 48.6 p-10 -99.26 -33.68 10.64 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.741 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.561 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 81.07 22.96 60.07 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.459 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 39.5 p-10 -76.13 -23.68 54.87 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.49 0.182 . . . . 0.0 111.49 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.01 5.72 62.32 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.459 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 59.8 p -138.41 162.78 33.58 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.2 mt -98.91 121.23 49.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.979 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -90.58 -162.72 0.93 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -76.72 -55.0 1.61 Allowed Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 118.347 -1.341 . . . . 0.0 112.027 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -62.02 -26.59 78.61 Favored 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 121.315 1.344 . . . . 0.0 112.189 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.435 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 97.6 mt-10 -70.75 -30.38 66.88 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -76.1 -35.75 59.2 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 113.927 -1.488 . . . . 0.0 110.273 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 73' ' ' ALA . 88.7 mt -67.46 -30.48 70.21 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.405 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -68.18 -45.1 74.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.652 1.215 . . . . 0.0 109.102 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 tp -63.56 -44.17 94.93 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 112.53 -2.123 . . . . 0.0 110.644 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.441 ' CG ' ' CE2' ' A' ' 12' ' ' PHE . 3.3 tpt -77.36 -32.6 55.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.612 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 CA--C 1.518 -0.261 0 CA-C-O 121.038 0.447 . . . . 0.0 109.996 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 p . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 121.083 0.468 . . . . 0.0 111.462 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 23.1 p-10 -73.3 -42.57 62.22 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.566 178.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.492 ' CG ' ' N ' ' A' ' 8' ' ' GLN . 13.6 pt-20 -53.85 -43.64 69.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.575 -179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.613 ' O ' ' CD2' ' A' ' 12' ' ' PHE . 85.4 mt-30 -69.87 -27.1 64.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.332 0.587 . . . . 0.0 109.881 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 77.5 mt -78.53 -58.58 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.405 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.3 t -56.8 -41.69 78.19 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.712 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -59.21 -41.69 89.17 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.613 ' CD2' ' O ' ' A' ' 8' ' ' GLN . 13.0 m-30 -65.72 -49.04 69.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.414 0.626 . . . . 0.0 110.149 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -61.23 -48.46 81.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.376 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -61.64 -40.58 95.39 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.52 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -63.44 -41.72 98.67 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.529 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.433 ' CD2' ' CD1' ' A' ' 27' ' ' ILE . 28.0 t80 -68.61 -47.59 66.28 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 m -64.17 -33.8 76.61 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.46 -40.73 97.57 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.284 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 31.8 m-85 -73.79 -16.33 61.16 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.916 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.543 ' OD2' ' N ' ' A' ' 25' ' ' GLY . 51.1 t0 -84.23 69.68 10.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.744 0.307 . . . . 0.0 111.442 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -43.04 -44.23 4.66 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.136 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -73.56 -23.89 60.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.744 0.307 . . . . 0.0 111.303 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 68.09 28.61 73.31 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 24.7 p-10 -89.93 5.4 46.54 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.764 0.316 . . . . 0.0 111.217 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.543 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 81.45 11.43 83.23 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.2 m -142.27 136.95 30.29 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 122.611 -0.347 . . . . 0.0 111.082 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.433 ' CD1' ' CD2' ' A' ' 16' ' ' PHE . 67.7 mt -101.41 126.9 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.0 p -99.04 160.3 14.36 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.563 ' O ' ' N ' ' A' ' 33' ' ' GLY . 46.8 p -57.0 -25.71 58.99 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.589 -179.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.02 -49.35 72.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.243 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.9 -45.12 87.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.026 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.0 tp -61.84 -42.44 99.04 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -61.42 -44.32 98.19 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 178.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.1 m -49.1 -44.28 42.09 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.416 1.103 . . . . 0.0 108.25 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.1 t -73.83 -59.11 3.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 113.206 -1.816 . . . . 0.0 111.328 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 72.5 mtp -53.63 -44.46 69.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.512 0.672 . . . . 0.0 109.694 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 78.8 ttt-85 -58.83 -45.08 90.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.129 178.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.1 m -79.28 0.65 27.88 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.635 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 mp -106.48 35.47 2.95 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.477 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.5 37.01 91.51 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.702 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -137.74 153.45 49.74 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -136.72 78.66 42.19 Favored Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 121.324 -0.15 . . . . 0.0 111.304 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.72 150.82 21.65 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.234 1.956 . . . . 0.0 111.713 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.1 m -86.17 163.31 17.9 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -64.78 -34.11 77.57 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.832 -178.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.66 -41.31 97.35 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.397 0.618 . . . . 0.0 109.541 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.485 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -62.24 -49.77 74.39 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.258 -179.09 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.6 mt -62.26 -41.24 98.27 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.06 0.457 . . . . 0.0 111.549 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.434 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 55.7 tt0 -65.21 -36.54 84.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.732 0.777 . . . . 0.0 109.429 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -80.17 -35.25 36.72 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.227 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.472 ' C ' ' SD ' ' A' ' 51' ' ' MET . 9.1 tmm? -70.38 -51.3 30.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.093 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 7.6 tp -59.15 -46.54 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.734 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.485 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 96.5 m-20 -69.57 -31.72 70.07 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.4 -36.66 84.88 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.639 0.733 . . . . 0.0 110.497 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 55' ' ' VAL . 14.6 p -98.31 18.25 2.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.8 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.628 ' CG ' ' H ' ' A' ' 59' ' ' GLY . 65.1 t0 -99.32 69.74 1.7 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.889 -177.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -37.74 -25.25 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.651 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 56' ' ' ASP . 17.4 m-20 -94.52 -40.87 9.64 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.615 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.628 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 92.03 7.65 63.98 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.408 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 15.7 m120 -66.99 -28.14 68.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.578 0.228 . . . . 0.0 111.16 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.593 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 99.91 8.26 51.51 Favored Glycine 0 N--CA 1.464 0.52 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 76.7 p -137.87 166.28 24.42 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.8 mt -104.11 125.22 58.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -176.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -97.79 158.09 15.71 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 176.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -49.93 -48.36 78.42 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 118.0 -1.48 . . . . 0.0 111.408 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.35 -44.35 43.63 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 121.219 1.279 . . . . 0.0 112.31 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.432 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 73.3 mt-10 -61.22 -34.49 75.2 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 122.285 1.04 . . . . 0.0 108.297 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -68.42 -25.91 65.26 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.356 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 73' ' ' ALA . 25.2 mt -74.98 -32.71 61.75 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.925 0.393 . . . . 0.0 110.492 177.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -64.2 -42.61 96.55 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 122.745 1.26 . . . . 0.0 108.541 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.2 tp -63.02 -45.67 91.24 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.532 -2.122 . . . . 0.0 110.448 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.546 ' SD ' ' CE1' ' A' ' 12' ' ' PHE . 7.6 mmt -78.48 -28.26 46.41 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.97 178.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 121.145 0.498 . . . . 0.0 110.081 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.2 p . . . . . 0 N--CA 1.468 0.466 0 CA-C-O 121.379 0.609 . . . . 0.0 111.397 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -77.52 -34.45 54.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.587 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 7' ' ' GLU . 57.6 mp0 -65.1 -44.72 87.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.209 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.548 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 38.5 mt-30 -67.35 -24.13 65.68 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.07 0.462 . . . . 0.0 110.199 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 90.0 mt -83.63 -53.58 10.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.192 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.9 t -59.15 -45.12 91.81 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.251 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' A' ' 11' ' ' GLU . 0.3 OUTLIER -62.86 -38.93 92.79 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.293 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.548 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 2.9 m-30 -62.44 -45.2 94.17 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 121.442 0.639 . . . . 0.0 109.861 178.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -63.54 -41.78 98.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.829 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -64.62 -41.78 95.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.54 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -59.39 -49.56 77.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.566 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -66.47 -44.27 83.15 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.1 p -64.8 -35.39 80.95 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 41.2 tp -63.8 -39.43 94.23 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.493 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.54 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.6 m-30 -66.52 -16.27 64.02 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.318 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.463 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 38.6 t0 -94.78 88.21 5.27 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.384 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -47.95 -40.88 23.51 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.537 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.439 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 3.4 p30 -91.98 -24.59 19.19 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.667 -178.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.411 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 76.76 33.12 47.76 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.041 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.463 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 80.0 m-20 -73.45 -7.39 51.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.782 0.325 . . . . 0.0 111.036 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.01 2.69 64.3 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.2 p -143.43 138.01 29.03 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.945 0.402 . . . . 0.0 111.096 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 76.9 mt -96.67 126.65 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.8 p -90.85 170.35 10.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.558 ' O ' ' N ' ' A' ' 33' ' ' GLY . 27.3 p -61.63 -49.29 77.15 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.917 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.509 ' CB ' ' HZ3' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -56.57 -43.03 79.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.152 0.501 . . . . 0.0 110.332 179.557 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.493 ' N ' ' CG ' ' A' ' 30' ' ' LYS . 89.6 mt-10 -61.55 -49.1 78.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.69 178.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.2 tt -63.25 -41.47 99.07 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -61.79 -40.7 99.16 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 30' ' ' LYS . 20.7 m -53.79 -48.62 69.63 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.08 -47.7 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.377 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 17.3 mmt -64.22 -44.28 92.4 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -50.62 -51.29 50.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.634 0.731 . . . . 0.0 110.676 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -68.34 -27.0 65.89 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.705 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.518 ' C ' ' H ' ' A' ' 41' ' ' GLN . 46.6 mt -78.2 37.56 0.26 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -178.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.75 -6.91 0.77 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.138 -0.553 . . . . 0.0 111.75 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.518 ' H ' ' C ' ' A' ' 39' ' ' LEU . 76.6 mt-30 -89.5 149.85 22.72 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -133.95 65.21 69.35 Favored Pre-proline 0 N--CA 1.469 0.476 0 C-N-CA 121.321 -0.151 . . . . 0.0 111.384 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.2 155.6 33.15 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.147 1.898 . . . . 0.0 111.503 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 m -93.38 159.51 15.22 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.53 -33.26 71.16 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.665 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.3 -39.4 82.93 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -69.31 -45.55 69.29 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.103 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.5 mt -63.7 -43.38 96.79 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.144 0.497 . . . . 0.0 110.957 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -60.75 -49.09 78.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.432 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -65.93 -33.22 75.34 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.106 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 34.8 ttm -65.75 -42.41 90.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.722 0.773 . . . . 0.0 109.994 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.427 HG21 ' N ' ' A' ' 53' ' ' ASN . 1.1 tp -65.62 -47.35 86.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.724 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.427 ' N ' HG21 ' A' ' 52' ' ' ILE . 77.7 m-20 -65.48 -28.53 69.28 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 124.009 0.818 . . . . 0.0 112.903 -177.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -68.21 -45.51 73.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.602 0.715 . . . . 0.0 110.969 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.534 ' C ' ' H ' ' A' ' 57' ' ' ALA . 12.4 p -89.03 -3.47 9.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.719 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 37.5 t0 -64.67 41.57 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.233 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.534 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -40.67 -32.57 0.22 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.189 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -74.6 -38.31 62.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.675 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.542 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 91.08 16.57 53.73 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 42.7 p30 -87.64 -25.42 23.55 Favored 'General case' 0 CA--C 1.53 0.173 0 O-C-N 122.685 -0.303 . . . . 0.0 111.334 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.555 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 91.58 5.18 67.12 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.5 p -142.57 168.39 19.83 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.0 mt -97.86 119.62 46.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.307 -0.557 . . . . 0.0 112.194 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -90.62 148.72 22.47 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 176.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -48.03 -52.1 43.18 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 118.145 -1.422 . . . . 0.0 111.464 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.23 -50.61 12.47 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 CA-C-N 119.901 1.0 . . . . 0.0 111.603 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.441 ' OE2' ' O ' ' A' ' 55' ' ' VAL . 32.9 tt0 -55.17 -52.75 62.32 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -47.26 -25.35 0.93 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.941 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.7 mt -79.07 -41.74 28.04 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.781 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -60.96 -41.12 95.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 122.348 1.071 . . . . 0.0 108.466 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.7 tp -57.91 -64.43 0.91 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.821 -1.99 . . . . 0.0 110.318 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.7 mmm -63.45 -36.35 83.45 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.58 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.142 0 CA-C-O 121.116 0.484 . . . . 0.0 110.062 179.619 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.419 ' OG1' ' OE1' ' A' ' 8' ' ' GLN . 16.2 p . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 121.19 0.519 . . . . 0.0 111.392 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 24.9 p-10 -80.03 -26.36 39.82 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.339 177.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.412 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 97.6 mt-10 -63.15 -44.79 94.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.901 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.586 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 5.1 mp0 -69.91 -23.21 63.19 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.522 0.677 . . . . 0.0 110.124 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.415 HG21 HD11 ' A' ' 9' ' ' ILE . 96.6 mt -83.9 -56.55 5.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.429 178.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 61.6 m -58.25 -40.69 82.43 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.151 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -65.73 -37.42 86.33 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.046 0.451 . . . . 0.0 109.873 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.586 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 2.4 m-85 -62.59 -45.28 93.63 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.468 0.652 . . . . 0.0 109.995 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -63.2 -42.21 99.28 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.064 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -63.31 -41.78 98.96 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.85 -46.99 86.43 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.292 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.439 ' CE2' ' CG1' ' A' ' 27' ' ' ILE . 48.1 t80 -67.9 -45.6 73.99 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.3 p -63.71 -33.78 76.41 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.1 tp -62.9 -39.92 95.96 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.242 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -73.97 -18.97 60.8 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.033 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 25' ' ' GLY . 29.2 t0 -86.57 74.1 9.95 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.749 0.309 . . . . 0.0 111.338 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -44.9 -36.55 3.38 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.735 0.303 . . . . 0.0 111.255 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -87.94 -23.86 23.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.708 0.289 . . . . 0.0 111.427 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.51 21.48 76.17 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.0 p-10 -80.13 -1.23 39.32 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.679 0.276 . . . . 0.0 111.11 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.433 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 82.97 26.41 45.08 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 32.2 m -151.03 132.15 14.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.992 0.425 . . . . 0.0 111.057 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.439 ' CG1' ' CE2' ' A' ' 16' ' ' PHE . 4.3 mm -101.64 147.79 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 p -126.94 167.98 15.14 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 33' ' ' GLY . 58.0 p -58.78 -30.49 67.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.959 0.409 . . . . 0.0 110.818 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.465 ' O ' ' OG1' ' A' ' 34' ' ' THR . 38.9 pttt -67.18 -49.47 64.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.79 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.413 ' H ' ' HG3' ' A' ' 30' ' ' LYS . 88.7 mt-10 -67.12 -48.52 67.87 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.189 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.99 -43.7 98.48 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -62.65 -41.21 99.85 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 178.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 30' ' ' LYS . 17.3 m -50.29 -46.04 54.98 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.411 1.101 . . . . 0.0 108.231 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.5 t -69.76 -55.89 13.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 113.345 -1.752 . . . . 0.0 111.424 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 83.0 mmm -54.41 -44.74 72.64 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.868 0.842 . . . . 0.0 109.943 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -54.08 -46.95 72.17 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.461 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.1 t -79.07 -9.39 59.53 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.069 -1.423 . . . . 0.0 111.728 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.405 ' CD2' ' O ' ' A' ' 39' ' ' LEU . 0.9 OUTLIER -94.05 34.62 1.23 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.502 -178.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.37 2.1 6.74 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.548 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.403 ' H ' ' C ' ' A' ' 39' ' ' LEU . 99.2 mm-40 -102.47 152.42 21.16 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -134.61 65.16 66.34 Favored Pre-proline 0 N--CA 1.47 0.531 0 CA-C-O 120.405 0.145 . . . . 0.0 111.271 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.47 156.04 36.43 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.146 1.898 . . . . 0.0 111.629 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.5 p -92.79 168.88 10.89 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -60.02 -31.77 70.27 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.881 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.11 -44.7 96.09 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.585 0.707 . . . . 0.0 109.593 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -60.79 -49.18 78.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.316 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 73.7 mt -62.94 -41.82 99.61 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.954 0.407 . . . . 0.0 111.576 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -66.11 -41.52 90.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.41 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -64.71 -37.26 86.98 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.956 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.6 ttm -61.88 -41.78 98.28 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.2 mt -65.59 -43.24 94.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.292 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -63.72 -39.91 95.46 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -61.85 -37.69 85.43 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 122.028 0.918 . . . . 0.0 110.089 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.0 t -109.18 67.54 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.389 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 58' ' ' ASP . 2.8 t0 -131.9 45.2 2.81 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.128 0.489 . . . . 0.0 109.794 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -38.67 -23.15 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.06 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 56' ' ' ASP . 29.1 p-10 -102.28 -43.09 5.8 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.68 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.457 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 90.88 29.69 12.65 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.436 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 48.1 p30 -87.36 -11.88 48.01 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 111.392 0.145 . . . . 0.0 111.392 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.03 6.13 85.66 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.686 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.8 p -138.85 163.99 30.81 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.6 mt -99.76 122.65 51.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.824 -177.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -91.97 -165.2 1.3 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 176.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -77.48 -47.02 2.52 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 117.823 -1.551 . . . . 0.0 111.841 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -65.26 -31.22 53.72 Favored 'Trans proline' 0 N--CA 1.507 2.319 0 C-N-CA 121.439 1.426 . . . . 0.0 112.06 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -66.59 -31.07 71.53 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 122.808 1.289 . . . . 0.0 108.149 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -75.58 -30.98 59.81 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.456 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 73' ' ' ALA . 4.8 mt -69.7 -34.31 73.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.531 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -65.06 -44.13 89.98 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.47 1.129 . . . . 0.0 109.292 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.6 tp -61.66 -45.84 92.31 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 112.545 -2.116 . . . . 0.0 110.79 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.419 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . 99.5 mmm -80.12 -31.29 39.11 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.102 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.467 0.4 0 CA-C-O 121.31 0.576 . . . . 0.0 109.812 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 121.151 0.501 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -65.3 -33.64 76.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.223 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.94 -45.79 92.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.933 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.543 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -63.84 -36.23 83.23 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.88 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 74.7 mt -74.92 -54.34 14.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.078 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.0 t -55.83 -49.7 72.56 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.004 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -56.55 -41.68 77.27 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.883 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.543 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.0 m-85 -61.73 -48.79 79.13 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -60.78 -44.33 96.93 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.725 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -62.64 -44.94 95.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.39 -49.49 77.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.602 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 38.2 t80 -65.51 -49.15 70.06 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.3 t -60.67 -37.74 82.57 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.7 tp -61.97 -43.92 97.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.064 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -66.26 -24.54 66.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.841 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -86.88 85.24 7.26 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.534 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -67.46 -16.85 64.45 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.207 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 17.4 t0 -96.65 -0.46 48.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.202 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 38.01 53.86 2.02 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 26' ' ' CYS . 31.6 p-10 -111.84 9.15 20.7 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.695 0.283 . . . . 0.0 111.003 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.1 3.15 88.14 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 36.1 m -142.48 146.37 34.68 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.983 0.421 . . . . 0.0 110.887 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.418 HD12 HG22 ' A' ' 27' ' ' ILE . 83.9 mt -110.74 125.76 68.05 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 57.2 p -86.69 160.74 18.76 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 33' ' ' GLY . 34.0 p -58.44 -29.69 66.33 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.311 -178.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -65.04 -48.19 74.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.29 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -60.85 -47.11 87.84 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.3 tp -63.65 -40.6 97.27 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -60.88 -46.67 94.07 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.0 m -48.57 -49.7 35.5 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.75 -51.07 74.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.587 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.2 mmt -62.83 -45.16 93.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 61.6 ttt85 -54.07 -50.24 67.22 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.405 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.3 t -66.85 -21.02 66.03 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.47 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.6 mt -86.83 29.89 0.78 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.73 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.58 39.98 98.56 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.87 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -128.04 142.54 51.19 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -129.64 62.69 64.73 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 121.351 -0.139 . . . . 0.0 111.315 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.35 152.33 34.52 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.222 1.948 . . . . 0.0 111.538 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.8 p -83.85 160.93 21.05 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -60.23 -33.82 72.81 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.849 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.78 -47.15 85.72 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.427 0.632 . . . . 0.0 109.342 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.42 -43.58 83.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.846 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.4 mt -65.19 -45.59 84.17 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.107 0.479 . . . . 0.0 111.632 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.4 ' O ' HG21 ' A' ' 52' ' ' ILE . 58.4 tt0 -66.54 -33.96 76.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 122.203 1.002 . . . . 0.0 109.233 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.467 ' O ' ' OE2' ' A' ' 54' ' ' GLU . 96.2 m-20 -76.37 -39.98 52.33 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.524 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 39.2 ttm -58.66 -45.12 90.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.328 0.585 . . . . 0.0 110.498 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.4 HG21 ' O ' ' A' ' 49' ' ' GLN . 6.6 tt -70.66 -33.22 52.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.399 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -60.46 -39.0 86.02 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.562 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.467 ' OE2' ' O ' ' A' ' 50' ' ' ASP . 4.9 mm-40 -65.28 -16.43 63.55 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.364 0.602 . . . . 0.0 110.833 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 57' ' ' ALA . 3.0 t -110.2 -19.12 7.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.759 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -65.55 48.51 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.043 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -57.7 -23.34 51.19 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.964 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 17.6 p-10 -88.67 -44.88 10.27 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.318 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 93.05 50.31 2.47 Favored Glycine 0 N--CA 1.471 1.006 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.67 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 55.6 p30 -109.88 -21.61 12.27 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.692 -0.299 . . . . 0.0 110.999 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.544 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 84.7 -4.71 84.15 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 51.1 p -131.42 169.43 16.05 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.9 mt -104.14 119.29 52.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -91.54 -175.93 4.35 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 175.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.435 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 75.6 t80 -69.44 -55.61 9.37 Favored Pre-proline 0 C--N 1.318 -0.796 0 C-N-CA 118.63 -1.228 . . . . 0.0 112.242 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 14.3 Cg_endo -50.45 -43.08 46.34 Favored 'Trans proline' 0 N--CA 1.504 2.109 0 C-N-CA 121.885 1.724 . . . . 0.0 111.373 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.401 ' OE2' ' CG ' ' A' ' 58' ' ' ASP . 95.2 mt-10 -58.86 -52.63 64.89 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -57.33 -41.71 80.5 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.648 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.4 tp -61.36 -44.73 96.68 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.163 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -64.24 -52.5 58.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 122.619 1.199 . . . . 0.0 108.953 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.8 tt -51.95 -59.43 4.35 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.078 -1.874 . . . . 0.0 110.62 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.419 ' CG ' ' CE2' ' A' ' 12' ' ' PHE . 1.2 tpt -61.6 -39.29 90.68 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.757 178.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 -0.152 0 CA-C-O 121.197 0.522 . . . . 0.0 110.499 179.472 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 3' ' ' GLN . 88.0 m-20 54.81 42.45 31.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.5 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' A' ' 2' ' ' ASP . 59.2 tt0 58.86 121.42 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.512 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.53 ' N ' ' CD2' ' A' ' 4' ' ' LEU . 3.5 mm? -78.25 145.79 35.25 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.796 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.429 ' HG1' ' H ' ' A' ' 8' ' ' GLN . 18.7 p -94.12 -176.68 4.06 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.161 0.505 . . . . 0.0 111.356 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -72.99 -42.89 62.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.875 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -61.77 -44.54 96.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.956 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.558 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 93.2 mt-30 -69.63 -24.73 63.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.53 0.681 . . . . 0.0 109.975 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.8 mt -83.4 -56.18 6.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.243 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.426 ' OG ' ' OE2' ' A' ' 14' ' ' GLU . 11.8 t -58.47 -42.6 87.88 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -63.89 -39.78 94.99 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.558 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.2 m-30 -64.07 -45.71 87.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.771 0.796 . . . . 0.0 109.862 178.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -60.92 -46.78 89.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.729 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -62.26 -39.75 93.93 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.424 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -60.65 -44.67 96.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.435 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.458 ' CE2' ' CG1' ' A' ' 27' ' ' ILE . 35.1 t80 -69.05 -45.63 69.9 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.6 m -65.81 -33.18 75.27 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.738 0.78 . . . . 0.0 109.065 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.37 -40.43 96.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.376 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.424 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 26.6 m-85 -73.87 -14.65 61.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.92 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.532 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 42.4 t0 -89.55 78.91 6.97 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.171 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -40.94 -47.61 3.03 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.736 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.43 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 20.8 p30 -88.11 -1.75 58.19 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.646 0.26 . . . . 0.0 111.683 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 51.12 39.23 41.31 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.051 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.532 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 44.5 p-10 -90.97 -0.05 57.65 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.645 0.26 . . . . 0.0 111.247 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.494 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 81.76 20.66 63.13 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.404 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 6.4 m -143.08 137.28 29.07 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.021 0.439 . . . . 0.0 111.082 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.458 ' CG1' ' CE2' ' A' ' 16' ' ' PHE . 4.9 mm -109.46 122.11 63.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.2 p -100.48 167.13 10.57 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 33' ' ' GLY . 74.7 p -60.4 -28.59 68.36 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.411 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -66.59 -48.34 69.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.592 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -67.47 -45.65 75.34 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.979 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.3 tp -62.1 -41.86 98.64 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -63.78 -42.34 98.57 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.2 m -50.18 -46.22 54.07 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.1 t -69.59 -55.76 13.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 113.389 -1.732 . . . . 0.0 111.296 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 84.5 mmm -57.0 -41.22 78.09 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -58.9 -51.49 69.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.848 0.832 . . . . 0.0 110.622 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.4 t -69.58 -14.19 62.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.687 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.431 ' C ' ' H ' ' A' ' 41' ' ' GLN . 1.7 mm? -97.39 36.7 1.44 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.964 0.412 . . . . 0.0 111.335 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.78 6.33 3.56 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.198 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 39' ' ' LEU . 4.8 tp60 -102.07 151.06 22.6 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -144.05 68.98 16.18 Favored Pre-proline 0 N--CA 1.464 0.253 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.218 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -65.18 152.58 81.73 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.488 2.125 . . . . 0.0 112.185 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.4 m -79.72 159.97 26.43 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -61.41 -48.43 81.23 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.07 -0.652 . . . . 0.0 112.1 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.15 77.06 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -61.07 -45.39 94.93 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.237 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.28 -41.31 98.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.265 0.555 . . . . 0.0 110.774 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -65.24 -45.86 82.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.626 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.92 -42.34 97.42 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.246 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 45.9 tpp -59.13 -45.98 89.54 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.8 mt -63.49 -43.08 98.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.35 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -59.69 -28.97 67.76 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -68.52 -31.31 70.46 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.277 0.56 . . . . 0.0 110.762 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.486 ' C ' ' H ' ' A' ' 57' ' ' ALA . 61.5 t -98.6 -13.36 8.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.541 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 28.8 t0 -72.28 40.89 0.08 Allowed 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.317 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.486 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -40.66 -24.37 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.393 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 4.5 p-10 -89.2 -39.96 13.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.165 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.53 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 92.21 54.76 1.81 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.561 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 47.5 p30 -117.56 -20.77 8.87 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.719 -0.283 . . . . 0.0 110.958 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.561 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 81.2 5.78 89.82 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.8 p -135.76 165.13 26.3 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.8 mt -107.33 126.39 63.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -91.57 -167.42 1.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 175.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -79.67 -50.67 1.24 Allowed Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 118.525 -1.27 . . . . 0.0 111.166 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.72 -33.54 93.01 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.319 1.346 . . . . 0.0 112.011 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -67.01 -30.63 70.79 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -74.81 -30.09 61.3 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.669 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mt -69.74 -33.1 71.99 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -68.09 -45.06 74.79 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.418 1.104 . . . . 0.0 109.357 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.2 tp -60.45 -45.64 92.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.108 -1.86 . . . . 0.0 111.355 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 93.0 mmm -79.29 -26.35 42.32 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.898 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.45 -37.49 74.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.221 0.534 . . . . 0.0 110.514 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.6 mmm-85 -76.26 -36.82 58.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.62 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.577 ' C ' ' H ' ' A' ' 77' ' ' LYS . 19.5 tptp -63.36 -42.12 98.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.806 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 38.4 mmm -62.92 11.39 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.305 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.577 ' H ' ' C ' ' A' ' 75' ' ' LYS . 64.8 tttm -49.18 -35.86 18.11 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.18 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 77' ' ' LYS . 45.5 t0 -31.32 92.03 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.516 0.51 . . . . 0.0 111.455 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 77' ' ' LYS . 10.2 m . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.652 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.541 ' CG ' ' H ' ' A' ' 3' ' ' GLN . 32.0 t70 58.03 -176.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.789 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.541 ' H ' ' CG ' ' A' ' 2' ' ' ASP . 4.9 tp-100 29.74 82.88 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 O-C-N 122.986 0.179 . . . . 0.0 111.285 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.497 ' CD2' ' H ' ' A' ' 4' ' ' LEU . 4.0 mm? -33.88 146.66 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 O-C-N 122.912 0.132 . . . . 0.0 110.958 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.55 ' CG2' ' H ' ' A' ' 6' ' ' ASP . 32.5 m -82.49 171.68 13.86 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.109 0.48 . . . . 0.0 111.417 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 9' ' ' ILE . 97.7 m-20 -70.53 -42.02 71.78 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.826 178.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.51 ' CG ' ' N ' ' A' ' 8' ' ' GLN . 7.2 pt-20 -43.98 -41.84 5.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.634 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.534 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 38.1 tp60 -62.94 -23.57 67.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.475 0.655 . . . . 0.0 109.327 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.575 ' N ' ' O ' ' A' ' 6' ' ' ASP . 24.7 mt -81.29 -51.1 15.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.08 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 39.4 t -56.93 -42.8 80.66 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.652 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -63.56 -42.5 98.34 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.6 m-30 -55.1 -46.24 75.51 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -62.59 -40.34 96.58 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.886 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -62.06 -44.86 95.78 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.549 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -57.9 -43.32 86.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.262 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -70.78 -49.38 47.18 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.7 t -59.1 -35.55 73.61 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.8 tp -61.86 -44.52 96.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.281 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.549 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.7 m-30 -59.03 -25.19 63.48 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.965 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -83.27 101.99 11.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.841 0.353 . . . . 0.0 111.432 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -65.44 -30.7 71.53 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.822 0.344 . . . . 0.0 111.725 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -103.21 -10.77 18.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.404 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 61.52 45.77 95.68 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -97.49 18.73 14.69 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.645 0.26 . . . . 0.0 111.256 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.9 7.71 50.42 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 31.5 m -141.77 146.91 36.51 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.991 0.424 . . . . 0.0 110.945 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 92.1 mt -113.17 129.43 68.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 81.5 p -91.47 161.88 14.79 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 33' ' ' GLY . 71.9 p -56.22 -32.75 64.72 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.587 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -64.27 -48.47 75.58 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.229 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.07 -46.21 91.61 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.851 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.1 tp -62.62 -43.31 99.14 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 37' ' ' ARG . . . -59.69 -49.18 81.32 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 178.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.9 m -48.14 -48.28 34.28 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 122.369 1.081 . . . . 0.0 108.607 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.3 t -68.11 -52.71 35.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 113.195 -1.821 . . . . 0.0 111.295 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.401 ' CE ' ' OE1' ' A' ' 41' ' ' GLN . 35.8 mmm -61.86 -42.29 98.88 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.678 0.751 . . . . 0.0 109.756 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 33' ' ' GLY . 29.5 tpt85 -54.37 -51.6 64.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.539 -1.209 . . . . 0.0 110.137 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.448 ' C ' ' H ' ' A' ' 40' ' ' GLY . 47.0 m -62.14 -32.86 73.51 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.98 -1.464 . . . . 0.0 111.702 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.559 ' C ' ' H ' ' A' ' 41' ' ' GLN . 76.2 mt -73.84 33.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.782 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 38' ' ' SER . . . 62.49 -6.71 0.29 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.538 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.559 ' H ' ' C ' ' A' ' 39' ' ' LEU . 42.5 tt0 -81.41 141.73 33.65 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 42' ' ' ASN . 19.1 p-10 -124.88 72.99 63.92 Favored Pre-proline 0 N--CA 1.47 0.529 0 C-N-CA 121.376 -0.13 . . . . 0.0 111.288 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -81.2 142.76 13.66 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.023 1.816 . . . . 0.0 111.845 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.415 ' OG1' ' N ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -87.43 175.11 8.12 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.393 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.415 ' N ' ' OG1' ' A' ' 44' ' ' THR . 52.8 mt-10 -57.2 -46.99 82.38 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.806 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.76 -49.51 72.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.525 0.679 . . . . 0.0 109.594 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -52.53 -47.08 66.94 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.946 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.41 -46.78 78.66 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.195 0.522 . . . . 0.0 111.78 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.448 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 86.6 mt-30 -60.58 -44.54 96.09 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.598 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -67.12 -35.22 79.27 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.436 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.2 tpp -66.64 -50.94 61.33 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.45 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 56' ' ' ASP . 7.9 tt -71.36 -40.69 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.305 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 49' ' ' GLN . 22.9 t-20 -60.03 -39.57 86.34 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -77.43 -13.68 59.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.56 0.695 . . . . 0.0 109.999 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.441 ' O ' ' OE1' ' A' ' 67' ' ' GLU . 38.2 t -103.44 -22.78 4.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.549 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 52' ' ' ILE . 45.9 t0 -76.5 52.71 0.81 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.332 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.67 -27.39 0.1 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.642 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.449 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 37.8 m-20 -80.79 -34.75 33.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.515 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 87.16 10.13 72.08 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 51.3 p-10 -69.64 -27.26 64.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.394 0.14 . . . . 0.0 111.291 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 96.53 -7.25 65.81 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.9 p -129.16 167.08 18.12 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.6 mt -104.0 123.57 57.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.783 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -88.63 -175.86 5.07 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 176.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.402 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 38.2 t80 -67.95 -55.84 12.64 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 117.955 -1.498 . . . . 0.0 112.019 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.1 Cg_endo -56.08 -33.63 90.44 Favored 'Trans proline' 0 N--CA 1.505 2.163 0 C-N-CA 121.517 1.478 . . . . 0.0 112.047 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.449 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 68.7 mm-40 -57.35 -56.04 26.93 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -60.46 -36.49 78.37 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.707 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.94 -48.72 80.53 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.204 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -55.01 -50.04 70.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.591 1.186 . . . . 0.0 109.009 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 tp -53.37 -46.25 69.52 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 112.574 -2.103 . . . . 0.0 110.599 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.2 tpt -67.48 -46.74 72.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.759 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.18 -40.12 96.6 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.129 0.49 . . . . 0.0 109.979 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.2 mmt85 -62.38 -44.34 96.7 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.54 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.567 ' C ' ' H ' ' A' ' 77' ' ' LYS . 24.9 mmtp -65.26 -33.38 75.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.38 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.1 ttm -62.4 5.76 0.1 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.328 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.567 ' H ' ' C ' ' A' ' 75' ' ' LYS . 51.6 pttt -58.95 -38.93 80.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.28 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 40.5 p-10 -113.74 13.95 18.64 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.717 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.5 m . . . . . 0 C--O 1.22 -0.5 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.629 -179.733 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 54.63 81.11 0.11 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.413 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -82.45 -5.13 58.49 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.811 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.9 mp -75.55 160.66 29.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.707 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.543 ' CG2' ' H ' ' A' ' 6' ' ' ASP . 27.1 m -104.57 174.42 5.88 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.101 0.477 . . . . 0.0 111.062 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.543 ' H ' ' CG2' ' A' ' 5' ' ' THR . 1.8 p30 -73.21 -41.96 63.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.165 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.522 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 12.4 pt-20 -64.47 -40.76 96.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.576 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.559 ' O ' ' CD2' ' A' ' 12' ' ' PHE . 95.6 mt-30 -69.8 -35.03 74.51 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.273 0.559 . . . . 0.0 110.498 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.6 mt -72.95 -57.11 7.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.296 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.0 t -57.48 -46.66 83.44 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.089 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -49.27 -46.04 45.77 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 8' ' ' GLN . 20.3 m-30 -66.94 -47.07 72.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.382 0.611 . . . . 0.0 110.101 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -62.54 -45.79 91.35 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.774 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -66.06 -41.97 90.09 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.517 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.37 -45.71 93.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.512 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.42 ' C ' ' CD1' ' A' ' 16' ' ' PHE . 26.3 t80 -67.72 -43.95 78.8 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.3 m -63.88 -35.82 81.89 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 39.0 tp -64.21 -39.74 94.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.445 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.517 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.5 m-30 -66.4 -15.81 63.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.43 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 23' ' ' GLY . 65.7 t0 -92.24 89.59 6.93 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.209 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -50.28 -41.55 50.8 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.787 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -82.94 -27.11 30.79 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.048 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.463 ' H ' ' CG ' ' A' ' 20' ' ' ASP . . . 72.15 31.85 63.57 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.479 ' OD2' ' SG ' ' A' ' 26' ' ' CYS . 35.7 p-10 -81.69 -3.88 54.76 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.23 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.87 3.9 57.99 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.479 ' SG ' ' OD2' ' A' ' 24' ' ' ASP . 15.3 p -141.73 146.38 35.96 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.0 0.429 . . . . 0.0 111.034 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 72.6 mt -108.98 125.11 66.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.0 p -90.0 169.76 10.93 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 p -59.54 -52.24 66.42 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.979 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -53.19 -40.18 64.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -66.21 -43.45 86.67 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.29 -46.6 88.03 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 37' ' ' ARG . . . -60.0 -41.52 97.95 Favored Glycine 0 C--O 1.223 -0.588 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.7 m -48.69 -52.23 24.47 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.2 t -65.74 -49.82 75.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.194 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.7 mmm -65.14 -39.15 92.63 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 33' ' ' GLY . 23.9 tpt180 -55.49 -50.21 70.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.538 0.685 . . . . 0.0 110.2 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.6 t -71.43 -19.51 62.23 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.328 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.91 36.12 0.44 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.717 0.294 . . . . 0.0 111.348 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.74 45.97 94.08 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.496 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -144.75 154.73 43.03 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 25.3 p30 -134.54 73.84 67.12 Favored Pre-proline 0 N--CA 1.467 0.413 0 C-N-CA 121.184 -0.206 . . . . 0.0 110.963 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.26 149.14 24.65 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.963 1.776 . . . . 0.0 111.6 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.8 p -87.91 164.31 15.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -59.54 -42.72 92.97 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.952 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.14 80.68 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.52 -48.12 82.9 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.075 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 52.6 mt -64.64 -42.45 95.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.158 0.504 . . . . 0.0 111.067 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -61.96 -36.59 81.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.899 0.857 . . . . 0.0 109.287 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -75.65 -40.07 56.69 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.006 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 33.9 mtp -63.77 -45.97 87.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.32 0.581 . . . . 0.0 110.048 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.487 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 1.4 tp -65.79 -47.44 85.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.874 -178.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.487 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 18.0 t-20 -69.06 -20.27 64.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.861 -177.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -72.34 -48.74 39.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.182 0.515 . . . . 0.0 110.525 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.561 ' C ' ' H ' ' A' ' 57' ' ' ALA . 12.0 p -86.2 -2.33 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.373 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.459 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 16.6 t70 -64.57 41.89 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.625 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.561 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -50.68 -26.75 5.84 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.862 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 25.8 p30 -71.71 -39.29 70.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.356 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.503 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 91.81 7.39 64.59 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 51.6 p-10 -85.9 -22.53 27.44 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 122.724 -0.28 . . . . 0.0 111.387 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 85.73 3.41 86.04 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.508 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 22.9 p -139.6 151.2 45.83 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.449 HD12 HG22 ' A' ' 63' ' ' ILE . 6.9 mm -85.35 127.6 39.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.333 -0.547 . . . . 0.0 112.359 -176.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -104.71 153.79 20.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.448 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 34.8 t80 -45.89 -55.61 12.46 Favored Pre-proline 0 C--N 1.319 -0.719 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.418 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 11.9 Cg_endo -49.22 -50.31 13.21 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.97 1.78 . . . . 0.0 111.489 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -55.85 -53.38 57.47 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -54.71 -21.36 10.62 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.175 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.04 -44.22 22.64 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.305 0.574 . . . . 0.0 110.219 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -58.23 -42.12 85.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.7 tp -59.71 -64.19 1.03 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 112.785 -2.007 . . . . 0.0 109.456 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.85 -38.11 54.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.645 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.38 -41.36 76.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.153 0.501 . . . . 0.0 110.254 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -60.76 -42.3 97.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.276 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.478 ' C ' ' H ' ' A' ' 77' ' ' LYS . 48.7 mtpt -64.05 -39.73 94.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.479 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 26.0 ttm -56.72 -4.78 0.18 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.197 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.478 ' H ' ' C ' ' A' ' 75' ' ' LYS . 3.2 ttmp? -58.32 -46.87 85.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.337 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -100.27 -70.42 0.74 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.693 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.4 t . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.969 -179.869 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.578 ' C ' ' H ' ' A' ' 3' ' ' GLN . . . . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 69.81 -26.12 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.608 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.578 ' H ' ' C ' ' A' ' 1' ' ' ALA . 15.7 mm100 -56.87 135.74 55.78 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.732 0.301 . . . . 0.0 110.558 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 71.9 mt -110.97 159.63 17.56 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.34 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.1 p -104.49 175.17 5.58 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.242 0.544 . . . . 0.0 111.249 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -77.72 -29.41 51.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.385 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.483 ' OE1' ' N ' ' A' ' 7' ' ' GLU . 48.6 mp0 -68.37 -44.21 75.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.197 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.57 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 95.9 mt-30 -65.85 -29.74 70.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.278 0.561 . . . . 0.0 110.194 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.2 mt -77.44 -53.16 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.112 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.7 t -58.16 -46.56 85.48 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.845 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -54.6 -42.97 71.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.596 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.607 ' CE1' ' SD ' ' A' ' 72' ' ' MET . 16.3 m-30 -64.92 -46.73 80.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.163 0.506 . . . . 0.0 110.183 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -65.96 -43.01 89.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.743 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -67.08 -45.24 77.92 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.223 0.535 . . . . 0.0 110.073 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.554 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -62.74 -44.83 95.19 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.534 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -66.72 -43.99 82.77 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.8 m -63.35 -36.64 84.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.2 tp -63.74 -40.29 96.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.473 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.4 m-30 -63.29 -18.01 63.14 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.487 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.541 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 24.2 t0 -98.04 93.89 6.55 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.905 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.406 ' HZ3' ' CG2' ' A' ' 34' ' ' THR . 55.2 mttp -65.74 -19.69 65.99 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.662 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 24' ' ' ASP . 8.8 p30 -109.99 13.16 23.47 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.522 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 35.18 32.08 0.03 OUTLIER Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.541 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 97.5 m-20 -69.84 -8.96 52.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.568 0.223 . . . . 0.0 110.811 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.67 -7.61 65.63 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.8 m -143.64 149.66 37.61 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.748 0.309 . . . . 0.0 111.098 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.8 mt -96.22 125.14 49.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.1 p -84.28 -160.14 0.44 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.7 p -84.79 -58.15 2.83 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.439 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.455 ' O ' ' N ' ' A' ' 34' ' ' THR . 21.7 pttp -54.21 -35.98 62.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.415 . . . . 0.0 109.959 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.438 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 95.6 mt-10 -62.37 -50.84 69.95 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.0 tt -63.34 -42.02 98.9 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.53 -39.34 97.2 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 30' ' ' LYS . 20.0 m -52.77 -49.36 65.69 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.6 t -63.15 -47.86 90.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.807 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 84.6 mmm -63.64 -42.8 98.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.502 0.668 . . . . 0.0 110.416 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -53.26 -49.39 67.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.104 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.3 m -71.45 -27.08 63.01 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.513 -1.221 . . . . 0.0 112.018 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.506 ' C ' ' H ' ' A' ' 41' ' ' GLN . 7.2 mp -84.05 31.56 0.49 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.44 -8.0 1.73 Allowed Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 39' ' ' LEU . 90.4 mm-40 -85.71 146.77 26.66 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.6 p30 -135.79 64.91 58.58 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 121.249 -0.181 . . . . 0.0 111.155 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.27 154.76 41.47 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.441 2.094 . . . . 0.0 111.783 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.9 m -94.32 161.43 14.24 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -54.66 -34.3 62.02 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.706 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.63 -45.15 85.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.465 0.65 . . . . 0.0 109.394 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -63.83 -41.14 97.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.187 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.1 mt -62.28 -45.92 91.12 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.072 0.463 . . . . 0.0 111.091 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -67.27 -45.69 75.89 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.437 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.72 -43.12 99.64 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.288 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.3 ttm -61.39 -41.96 97.96 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 56' ' ' ASP . 34.1 mt -67.94 -44.93 84.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.583 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -58.37 -35.72 72.4 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -69.07 -21.2 64.09 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.121 0.486 . . . . 0.0 110.474 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.612 ' C ' ' H ' ' A' ' 57' ' ' ALA . 83.8 t -106.93 -23.48 4.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.301 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 59' ' ' GLY . 27.5 t0 -63.46 34.23 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.469 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.612 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -36.92 -27.01 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.381 0.61 . . . . 0.0 110.873 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 56' ' ' ASP . 19.3 p-10 -85.96 -37.04 19.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.178 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 87.12 62.41 1.5 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.517 ' H ' ' CG ' ' A' ' 56' ' ' ASP . 55.0 p30 -123.92 -18.17 6.06 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.637 0.219 . . . . 0.0 111.204 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 80.36 2.57 89.46 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.809 -0.516 . . . . 0.0 111.809 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 64.4 p -136.68 159.61 41.29 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.3 mt -100.05 121.06 50.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -86.99 145.67 26.42 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -46.4 -48.69 45.94 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 118.589 -1.244 . . . . 0.0 111.231 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -52.79 -49.07 18.83 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.24 1.294 . . . . 0.0 111.825 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.406 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 94.4 mt-10 -55.45 -52.83 62.3 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -53.07 -23.92 8.88 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.517 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.91 -46.1 58.87 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.051 0.453 . . . . 0.0 110.55 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -61.52 -42.41 98.76 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 122.427 1.108 . . . . 0.0 108.937 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.5 tp -62.05 -30.65 71.13 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 112.774 -2.012 . . . . 0.0 109.682 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.607 ' SD ' ' CE1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -82.5 -40.37 21.15 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.703 178.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.83 -36.54 72.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.006 0.431 . . . . 0.0 109.983 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -66.95 -43.56 82.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.391 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -64.32 -45.93 85.77 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.472 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.3 tpt -69.03 -5.2 20.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.692 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.8 tptt -78.72 -10.48 59.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.202 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.55 ' CG ' ' H ' ' A' ' 79' ' ' THR . 25.3 p-10 -39.89 -65.83 0.36 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.43 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.55 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 10.1 t . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.452 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.471 ' O ' ' O ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 1' ' ' ALA . 87.8 m-20 57.85 144.44 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 O-C-N 123.58 0.55 . . . . 0.0 109.95 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -137.05 16.58 3.02 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 121.186 -0.206 . . . . 0.0 111.41 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.511 ' N ' ' CD2' ' A' ' 4' ' ' LEU . 3.5 mm? -79.68 173.21 12.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.015 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.8 m -114.34 150.7 34.16 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.237 0.541 . . . . 0.0 111.186 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 6' ' ' ASP . 5.4 p-10 -63.11 -34.47 77.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.406 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.64 -47.72 84.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.724 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.532 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -59.68 -36.02 75.63 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.3 mt -72.17 -55.24 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.977 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.2 t -55.38 -53.49 55.6 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.822 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -54.07 -44.3 71.02 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' A' ' 8' ' ' GLN . 4.7 m-30 -60.74 -51.22 70.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.455 0.645 . . . . 0.0 109.514 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -59.68 -42.7 93.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.5 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -62.33 -46.73 87.4 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.15 78.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.335 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.412 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 34.1 t80 -69.73 -50.94 38.67 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.0 p -57.79 -35.11 70.35 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 46.9 tp -61.27 -45.25 95.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.532 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -61.26 -27.77 68.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.474 ' OD1' ' OD1' ' A' ' 22' ' ' ASP . 27.1 t0 -78.55 90.76 4.52 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.839 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -62.48 -36.02 81.18 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.795 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.474 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 28.8 p30 -96.64 -1.36 46.94 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.481 0.181 . . . . 0.0 111.296 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.31 40.47 37.9 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -88.93 3.93 49.79 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.718 0.294 . . . . 0.0 111.19 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.76 -6.05 84.03 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.4 m -133.1 158.92 41.57 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.836 0.35 . . . . 0.0 110.889 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.0 mt -119.96 126.85 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.5 p -90.4 157.47 17.59 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.554 ' O ' ' N ' ' A' ' 33' ' ' GLY . 66.7 p -55.13 -29.72 58.29 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.349 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.95 -48.83 77.2 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.229 0.538 . . . . 0.0 110.275 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -61.59 -45.11 95.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.842 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 tp -63.42 -38.89 92.9 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 177.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -62.89 -47.62 87.44 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.1 m -47.52 -48.68 27.37 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.8 t -63.72 -51.87 64.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 113.53 -1.668 . . . . 0.0 111.233 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.482 ' SD ' ' OE1' ' A' ' 41' ' ' GLN . 17.3 mmt -63.79 -45.52 89.34 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 33' ' ' GLY . 14.9 tpt180 -47.8 -54.54 12.07 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.313 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.494 ' C ' ' H ' ' A' ' 40' ' ' GLY . 37.5 m -62.06 -37.16 83.92 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.642 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.48 ' C ' ' H ' ' A' ' 41' ' ' GLN . 69.8 mt -69.91 34.78 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.776 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 38' ' ' SER . . . 58.92 3.57 1.75 Allowed Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.482 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 87.0 mt-30 -97.43 149.09 22.53 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -147.54 67.01 10.28 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.269 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -65.52 157.6 57.47 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.288 1.992 . . . . 0.0 111.923 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.478 ' H ' ' HG1' ' A' ' 44' ' ' THR . 6.8 p -82.53 164.83 20.63 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 177.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -57.37 -40.62 78.53 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.436 -0.506 . . . . 0.0 112.051 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.3 -50.08 74.88 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.571 0.7 . . . . 0.0 109.803 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -54.11 -47.19 72.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.268 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.24 -47.33 71.08 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.905 0.384 . . . . 0.0 111.783 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.417 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 94.6 mm-40 -61.05 -40.03 92.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.54 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -74.22 -38.58 63.52 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.774 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 43.4 tpp -62.37 -48.89 77.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.493 0.663 . . . . 0.0 110.548 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.7 tt -71.84 -41.84 69.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.195 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 49' ' ' GLN . 31.3 t30 -64.06 -38.75 92.19 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -60.58 -55.41 33.66 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.456 0.646 . . . . 0.0 110.958 -177.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.414 HG21 HD21 ' A' ' 70' ' ' ASN . 7.1 p -67.67 -6.05 4.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.097 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.595 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.0 t0 -80.07 75.48 6.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.721 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.04 -24.66 1.14 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.259 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 12.0 p-10 -99.43 -44.68 6.1 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.22 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.595 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 93.57 29.11 10.35 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.722 HD21 ' N ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -71.41 -19.84 62.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.441 0.163 . . . . 0.0 111.242 179.493 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.722 ' N ' HD21 ' A' ' 60' ' ' ASN . . . 87.91 -9.45 74.34 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.403 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 68.3 p -132.1 167.27 20.02 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.3 mt -100.13 126.36 53.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.777 -177.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -96.3 -172.25 2.49 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.402 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 55.4 t80 -71.6 -56.01 5.31 Favored Pre-proline 0 C--N 1.319 -0.728 0 C-N-CA 118.114 -1.434 . . . . 0.0 111.865 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 32.5 Cg_endo -57.05 -39.3 92.23 Favored 'Trans proline' 0 N--CA 1.503 2.046 0 C-N-CA 121.488 1.459 . . . . 0.0 111.875 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.432 ' OE2' ' OD1' ' A' ' 58' ' ' ASP . 64.5 mm-40 -55.02 -49.06 72.49 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -57.22 -42.35 81.22 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 114.319 -1.309 . . . . 0.0 110.16 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.3 mt -61.95 -44.77 96.06 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.767 -0.583 . . . . 0.0 110.904 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.414 HD21 HG21 ' A' ' 55' ' ' VAL . 21.8 t30 -57.3 -47.86 80.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 122.533 1.158 . . . . 0.0 109.079 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 32.2 tp -59.5 -50.11 75.17 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 112.823 -1.989 . . . . 0.0 110.102 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.3 tpt -65.48 -42.87 91.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.647 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.28 -40.55 94.03 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.919 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.5 ttt180 -57.36 -43.44 83.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.146 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -60.47 -42.52 96.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.287 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 87.2 mmm -69.06 -7.59 37.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.302 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -70.04 -44.53 69.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.621 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.413 ' CG ' ' N ' ' A' ' 79' ' ' THR . 65.9 t0 -150.74 -111.67 0.06 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.816 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.413 ' N ' ' CG ' ' A' ' 78' ' ' ASP . 76.7 p . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.597 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.572 ' C ' ' H ' ' A' ' 4' ' ' LEU . 47.6 p-10 -83.93 174.96 9.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.678 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 67.55 -36.37 0.29 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.973 0.416 . . . . 0.0 111.394 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.572 ' H ' ' C ' ' A' ' 2' ' ' ASP . 32.5 mt -119.17 168.17 11.12 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.003 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.7 p -117.1 161.66 19.07 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.814 0.34 . . . . 0.0 111.114 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -75.7 -18.12 59.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -66.44 -43.66 84.99 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.049 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.613 ' O ' ' CD2' ' A' ' 12' ' ' PHE . 84.3 mt-30 -67.39 -33.67 75.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.525 0.679 . . . . 0.0 110.383 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.513 ' N ' ' CD1' ' A' ' 9' ' ' ILE . 1.4 mp -74.11 -58.22 5.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.709 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.5 t -56.29 -46.51 79.73 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.72 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -47.11 -50.37 20.21 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.239 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.613 ' CD2' ' O ' ' A' ' 8' ' ' GLN . 17.7 m-85 -62.92 -48.83 77.23 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.491 0.663 . . . . 0.0 110.76 178.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -62.42 -47.33 84.57 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.725 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -62.15 -42.16 98.99 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.0 99.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.396 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 19.6 t80 -70.03 -47.66 61.15 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.8 p -66.21 -30.54 71.02 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.9 tp -61.04 -41.54 96.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.296 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -73.23 -15.18 61.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.821 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.543 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 26.3 t0 -86.8 69.8 10.32 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.269 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -40.08 -46.14 2.1 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.704 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 26.4 p-10 -74.87 -19.78 60.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.443 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 64.72 30.34 77.67 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.543 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 54.9 p-10 -81.58 -3.87 54.49 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.744 0.307 . . . . 0.0 111.151 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.68 5.11 72.03 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.455 ' O ' ' OD1' ' A' ' 20' ' ' ASP . 15.7 m -136.08 150.19 49.04 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.904 0.383 . . . . 0.0 110.817 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.4 ' CD1' ' CD2' ' A' ' 16' ' ' PHE . 82.9 mt -117.36 130.23 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.6 p -104.61 166.49 10.36 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 33' ' ' GLY . 36.0 p -56.45 -24.88 48.46 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.532 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.475 ' O ' ' OG1' ' A' ' 34' ' ' THR . 65.7 tttm -68.08 -50.15 56.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.092 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.25 -49.15 68.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.626 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.2 tp -62.26 -41.85 98.82 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -64.13 -42.68 97.94 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 30' ' ' LYS . 23.6 m -49.19 -46.51 45.7 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 122.275 1.036 . . . . 0.0 108.412 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.1 t -68.94 -55.48 15.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 113.398 -1.728 . . . . 0.0 111.217 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.8 mmt -60.2 -41.05 92.16 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.529 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.465 ' N ' ' O ' ' A' ' 33' ' ' GLY . 71.6 ttp85 -57.56 -50.25 73.71 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.321 178.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -68.38 -18.12 64.39 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.592 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -91.05 38.95 0.97 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.905 0.383 . . . . 0.0 111.476 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.49 26.56 59.74 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.396 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.522 ' OE1' ' N ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -111.97 142.84 43.87 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.522 ' N ' ' OE1' ' A' ' 41' ' ' GLN . 10.9 m120 -128.31 75.11 79.34 Favored Pre-proline 0 N--CA 1.47 0.541 0 C-N-CA 121.288 -0.165 . . . . 0.0 111.361 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -81.11 143.88 14.47 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.254 1.969 . . . . 0.0 111.487 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.11 172.22 9.25 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -63.2 -39.58 95.04 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.901 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.46 94.3 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.392 0.615 . . . . 0.0 109.434 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -56.84 -51.08 70.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.046 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.1 mt -62.62 -42.51 99.63 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.135 0.493 . . . . 0.0 111.11 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -64.64 -37.96 89.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.79 0.805 . . . . 0.0 109.272 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -75.37 -35.32 61.12 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.1 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 32.9 ttm -63.86 -50.76 67.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.451 0.643 . . . . 0.0 110.146 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.415 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 1.3 tt -66.28 -39.5 84.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.635 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -63.71 -30.84 71.89 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.784 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -77.08 -30.31 55.38 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.592 0.711 . . . . 0.0 110.497 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.546 ' C ' ' H ' ' A' ' 57' ' ' ALA . 54.7 t -98.39 -4.71 9.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.474 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 52' ' ' ILE . 16.6 m-20 -64.74 45.01 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.449 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.546 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -45.81 -37.58 6.26 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.286 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 25.0 p-10 -77.65 -43.3 31.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.435 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.476 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 90.36 16.74 54.9 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.497 ' OD1' ' O ' ' A' ' 62' ' ' THR . 52.9 p-10 -94.34 -1.77 53.27 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 122.87 -0.194 . . . . 0.0 111.093 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.77 2.25 50.28 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.532 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.497 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 31.6 p -134.13 150.65 51.14 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.6 mm -91.34 133.3 33.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -101.26 -172.34 2.15 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -76.98 -47.45 2.75 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 118.091 -1.443 . . . . 0.0 111.658 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.96 -37.62 75.35 Favored 'Trans proline' 0 N--CA 1.505 2.176 0 C-N-CA 121.701 1.601 . . . . 0.0 111.934 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -64.22 -35.87 82.21 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -76.44 -23.07 53.93 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.305 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.6 tp -78.3 -32.55 49.45 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.209 0.528 . . . . 0.0 110.652 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -68.43 -42.21 79.22 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.615 1.198 . . . . 0.0 108.641 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.8 tp -62.95 -41.55 99.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 112.527 -2.124 . . . . 0.0 110.416 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.2 mmt -81.02 -22.49 39.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.885 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.39 -37.55 27.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.127 0.489 . . . . 0.0 109.791 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -70.47 -42.86 70.88 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.15 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.481 ' C ' ' H ' ' A' ' 77' ' ' LYS . 65.4 tttm -65.68 -47.37 75.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.438 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.513 ' O ' ' SD ' ' A' ' 76' ' ' MET . 0.1 OUTLIER -65.29 4.67 0.47 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.51 -179.416 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 75' ' ' LYS . 88.6 tttt -64.36 -36.23 83.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.221 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -142.59 -84.32 0.17 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.997 0.427 . . . . 0.0 110.743 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.6 m . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.637 -179.757 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -83.16 100.11 10.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.102 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -78.65 138.08 38.14 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.885 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.3 mt -83.54 157.57 22.29 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.933 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.1 m -96.81 165.75 11.96 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.082 0.468 . . . . 0.0 111.341 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -68.51 -40.87 80.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.654 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -61.86 -46.67 88.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.949 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.546 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 7.8 mp0 -64.29 -32.08 73.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 78.3 mt -76.45 -55.37 11.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.247 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 42.9 t -56.72 -47.77 79.23 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.032 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -59.98 -40.7 90.05 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.843 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.546 ' CG ' ' O ' ' A' ' 8' ' ' GLN . 3.9 m-30 -61.19 -49.78 75.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.326 0.584 . . . . 0.0 109.835 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -65.57 -39.65 91.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.012 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -61.81 -43.03 99.66 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.531 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.0 -45.92 92.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.576 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 31.7 t80 -66.55 -48.79 68.54 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.9 m -62.91 -35.62 80.68 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.954 0.883 . . . . 0.0 108.8 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.3 tp -60.98 -43.59 98.61 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.311 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 9.7 m-30 -63.15 -19.0 64.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.955 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -85.91 95.27 9.41 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.28 0.363 . . . . 0.0 111.493 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -76.13 -20.58 57.48 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.371 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.2 p30 -110.56 1.09 17.92 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.65 0.262 . . . . 0.0 111.322 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 47.07 40.83 13.69 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -81.73 -2.65 51.35 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.725 0.298 . . . . 0.0 111.162 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.87 -8.18 78.77 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.1 m -143.05 139.85 30.7 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.776 0.322 . . . . 0.0 111.074 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.7 mt -96.58 128.4 47.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.5 p -86.23 -159.54 0.48 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 33' ' ' GLY . 22.0 p -86.56 -31.42 21.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.097 0.475 . . . . 0.0 110.806 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -67.12 -46.89 72.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.346 0.593 . . . . 0.0 110.403 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -63.16 -47.02 84.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.92 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.4 tp -63.82 -42.48 97.64 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -60.59 -46.8 93.73 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 178.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.9 m -48.87 -47.91 42.51 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 122.247 1.023 . . . . 0.0 108.292 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.403 HG13 ' CZ ' ' A' ' 19' ' ' PHE . 54.2 t -66.92 -50.32 65.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 113.401 -1.727 . . . . 0.0 111.521 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 75.7 mmm -62.88 -43.0 99.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.783 0.801 . . . . 0.0 109.634 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -55.77 -52.21 64.73 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.452 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.5 t -66.42 -21.19 66.21 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.864 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 36.4 mt -84.43 30.9 0.53 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.583 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.6 45.98 94.74 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.855 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -141.19 151.11 43.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -134.91 68.82 71.21 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-O 120.394 0.14 . . . . 0.0 111.252 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.41 150.33 41.09 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.029 1.819 . . . . 0.0 111.845 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.3 p -87.22 166.96 14.54 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -59.81 -37.21 78.53 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.866 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.37 -47.41 78.95 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.448 0.642 . . . . 0.0 109.354 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -61.08 -46.42 90.73 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.134 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.2 mt -62.69 -49.32 75.58 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.162 0.506 . . . . 0.0 111.513 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -61.71 -39.47 91.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.226 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -72.02 -32.57 67.27 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.56 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.0 mmt -67.1 -45.75 76.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.363 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 4.1 tt -75.57 -41.63 41.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.893 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.41 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 24.4 t-20 -65.42 -41.79 93.19 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -177.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.78 -11.64 61.07 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.002 0.906 . . . . 0.0 109.909 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.559 ' C ' ' H ' ' A' ' 57' ' ' ALA . 42.9 t -110.37 -14.27 10.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.699 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 44.1 t0 -66.04 42.97 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.711 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.559 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -50.29 -28.67 8.2 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.261 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 1.8 p30 -77.87 -37.46 48.11 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.447 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.481 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 89.5 7.54 69.16 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.545 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 57.1 p30 -75.12 -21.52 58.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.416 0.151 . . . . 0.0 111.282 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.545 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 84.78 -5.52 81.8 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.741 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.429 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 54.5 p -133.82 163.71 28.87 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.8 mt -96.02 115.66 35.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.601 -0.439 . . . . 0.0 112.091 -177.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 65' ' ' PHE . 64.8 t0 -82.62 -173.52 4.67 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 176.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.509 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 34.2 t80 -77.68 -48.17 2.28 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 117.954 -1.498 . . . . 0.0 111.738 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.56 -43.57 53.97 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 121.287 1.324 . . . . 0.0 111.606 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.433 ' OE1' ' OD2' ' A' ' 58' ' ' ASP . 76.3 tt0 -56.0 -52.37 64.45 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 122.344 1.069 . . . . 0.0 108.208 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -48.34 -40.78 26.46 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.192 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.0 mt -61.43 -43.52 98.72 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.419 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -58.48 -46.45 86.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 122.379 1.085 . . . . 0.0 109.125 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.1 tp -59.18 -47.43 85.33 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 112.847 -1.979 . . . . 0.0 110.484 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.0 tpt -67.71 -44.35 77.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.346 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.65 -39.56 88.77 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.156 0.503 . . . . 0.0 110.138 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.22 -37.46 72.03 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.627 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.566 ' C ' ' H ' ' A' ' 77' ' ' LYS . 65.2 tttm -62.12 -35.35 78.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.365 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 75.8 mmm -64.85 11.69 0.05 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.729 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.566 ' H ' ' C ' ' A' ' 75' ' ' LYS . 88.5 tttt -54.56 -44.38 72.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.04 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -72.55 95.55 1.83 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.095 0.474 . . . . 0.0 110.997 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.5 m . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.745 -179.827 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 54.43 31.09 13.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.808 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -77.11 17.49 0.45 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 121.253 -0.179 . . . . 0.0 111.253 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.2 pp -112.02 154.51 25.23 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.76 0.314 . . . . 0.0 110.626 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.523 HG21 ' H ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -89.76 170.53 10.35 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.29 0.566 . . . . 0.0 111.353 -179.457 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.678 ' O ' ' N ' ' A' ' 9' ' ' ILE . 5.8 p-10 -76.02 -52.7 9.66 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.284 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.43 ' H ' ' CG ' ' A' ' 6' ' ' ASP . 11.6 pt-20 -43.31 -33.82 1.08 Allowed 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.961 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.532 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 84.2 mm-40 -70.53 -22.1 62.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.423 0.63 . . . . 0.0 109.835 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 6' ' ' ASP . 73.4 mt -83.28 -55.62 7.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.518 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -43.45 92.74 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 120.149 -0.621 . . . . 0.0 109.937 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -61.88 -39.64 92.65 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.0 m-30 -63.96 -45.97 86.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.385 0.612 . . . . 0.0 109.675 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -65.7 -43.14 90.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.587 -1.188 . . . . 0.0 111.756 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -62.96 -40.34 97.4 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.521 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -62.75 -43.35 99.03 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.36 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -68.16 -45.29 73.92 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.7 t -63.34 -36.99 85.53 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.4 tp -60.67 -38.39 84.78 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.943 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.521 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.8 m-30 -68.41 -15.39 63.53 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.017 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 65.8 t0 -95.29 77.36 3.43 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -43.02 -36.64 1.64 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.088 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.429 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 46.3 m-20 -83.52 -22.17 32.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.338 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 66.84 30.55 76.32 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.519 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 24.3 p-10 -88.66 0.11 56.74 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.533 0.206 . . . . 0.0 111.157 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.472 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 82.1 18.09 68.03 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.7 m -145.33 130.56 18.53 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 111.007 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 58.4 mt -103.67 141.57 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.2 p -119.72 174.28 6.51 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 33' ' ' GLY . 79.7 p -56.5 -33.48 66.04 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.808 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -67.69 -49.62 61.81 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.309 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.429 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 90.4 mt-10 -69.08 -45.37 70.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.2 tp -60.45 -44.31 95.96 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -63.83 -39.26 97.22 Favored Glycine 0 C--O 1.216 -1.003 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.1 m -50.29 -45.78 54.72 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.292 1.044 . . . . 0.0 108.677 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.71 -54.07 23.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 113.057 -1.883 . . . . 0.0 111.25 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.1 mmt -57.11 -41.6 79.27 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.523 0.678 . . . . 0.0 109.93 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -55.85 -45.39 78.46 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.564 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 61.8 p -79.87 -10.58 59.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.818 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.425 ' C ' ' H ' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -98.75 38.13 1.41 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.549 -178.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.48 5.74 2.82 Favored Glycine 0 N--CA 1.465 0.568 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.502 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.425 ' H ' ' C ' ' A' ' 39' ' ' LEU . 53.7 tp60 -103.71 151.8 22.57 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -138.1 74.04 43.74 Favored Pre-proline 0 N--CA 1.47 0.569 0 O-C-N 122.957 0.161 . . . . 0.0 111.19 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.2 155.35 22.37 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.992 1.794 . . . . 0.0 112.026 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.7 m -94.01 169.75 10.04 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -62.07 -34.0 75.46 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.954 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.48 -44.55 96.88 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.481 0.657 . . . . 0.0 109.963 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.55 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -60.77 -51.54 68.91 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.037 -178.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.3 mt -61.26 -41.38 96.82 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.01 0.433 . . . . 0.0 111.829 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -64.61 -45.61 86.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.746 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -65.81 -37.57 86.6 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.074 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.4 mmm -61.91 -43.22 99.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.437 0.637 . . . . 0.0 109.563 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 22.9 mt -66.68 -43.56 90.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.864 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -64.2 -35.03 79.47 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -70.43 -33.26 71.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.525 0.678 . . . . 0.0 110.324 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.579 ' C ' ' H ' ' A' ' 57' ' ' ALA . 79.8 t -98.1 -4.74 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.095 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 15.8 t70 -65.6 41.59 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.057 0.456 . . . . 0.0 111.023 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.579 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -53.66 -25.97 20.42 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.58 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.434 ' OD1' ' OE1' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -80.31 -43.29 21.49 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.369 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.27 43.55 4.62 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.68 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 46.8 p30 -123.63 -15.27 7.08 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.268 0.099 . . . . 0.0 111.268 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 78.57 5.49 88.1 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.76 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.433 ' O ' ' OE1' ' A' ' 67' ' ' GLU . 72.4 p -135.84 164.5 27.79 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.0 mt -99.57 121.77 50.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.461 ' H ' ' HB3' ' A' ' 67' ' ' GLU . 90.5 m-20 -99.43 157.71 16.23 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 177.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.451 ' C ' ' O ' ' A' ' 64' ' ' ASP . 41.1 t80 -44.45 -53.92 13.43 Favored Pre-proline 0 CA--C 1.556 1.184 0 CA-C-N 120.557 1.526 . . . . 0.0 111.78 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.8 Cg_endo -57.24 -40.45 82.42 Favored 'Trans proline' 0 N--CA 1.505 2.157 0 C-N-CA 121.254 1.303 . . . . 0.0 112.087 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.461 ' HB3' ' H ' ' A' ' 64' ' ' ASP . 77.4 tt0 -63.02 -32.02 73.29 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.444 ' HB3' ' O ' ' A' ' 65' ' ' PHE . 53.5 t80 -71.8 -26.1 62.27 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.764 -1.562 . . . . 0.0 109.7 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.452 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 6.0 mt -76.01 -34.0 59.69 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.401 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -61.47 -42.28 98.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.62 1.2 . . . . 0.0 108.641 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.8 tp -58.17 -63.79 1.14 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 112.317 -2.22 . . . . 0.0 110.285 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 67.1 mmm -63.94 -32.85 74.53 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.187 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -63.46 -48.32 78.18 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.439 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -57.08 -44.19 82.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.244 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -63.51 -42.37 98.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.207 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -70.72 -16.51 62.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.368 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -69.49 -38.9 77.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.607 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -39.45 130.12 1.79 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.208 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.8 p . . . . . 0 C--O 1.222 -0.377 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.683 -179.82 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 3' ' ' GLN . 38.5 p-10 -65.25 -33.99 77.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.379 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.429 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 1.6 pt20 175.18 4.09 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.157 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 77.9 mt -115.14 160.84 19.2 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.596 0.236 . . . . 0.0 110.611 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.0 p -93.66 171.17 9.05 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.257 0.551 . . . . 0.0 111.31 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 25.5 p-10 -73.95 -29.01 61.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.469 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.415 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 80.6 mm-40 -61.21 -45.98 92.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.026 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.606 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 53.8 tt0 -66.13 -26.54 67.49 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.408 HD12 HG21 ' A' ' 9' ' ' ILE . 96.0 mt -80.53 -54.6 10.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.086 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.0 t -57.62 -43.82 85.05 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.776 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -64.07 -40.2 95.74 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.606 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 2.7 m-85 -61.24 -47.49 85.81 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.623 0.725 . . . . 0.0 109.377 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -62.73 -44.35 96.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.836 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -61.02 -40.34 93.22 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.53 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.1 -42.0 97.72 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.273 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -68.18 -47.21 68.58 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.9 t -60.19 -36.12 76.91 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.4 tp -61.96 -41.98 98.6 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.444 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.53 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.5 m-30 -62.93 -24.97 68.12 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.315 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.481 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 47.4 t0 -83.21 94.54 7.9 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.346 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -59.67 -33.22 71.28 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.055 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -97.53 -3.03 40.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.609 0.242 . . . . 0.0 111.124 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.46 36.51 30.86 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.481 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 33.2 p-10 -95.46 15.92 18.36 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.672 0.273 . . . . 0.0 111.095 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.44 ' C ' ' SG ' ' A' ' 26' ' ' CYS . . . 69.61 22.24 76.58 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.44 ' SG ' ' C ' ' A' ' 25' ' ' GLY . 3.2 m -149.99 139.18 21.22 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.883 0.373 . . . . 0.0 111.218 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 6.0 mm -108.78 118.87 57.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.6 p -78.66 -162.76 0.39 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.499 ' OG1' ' N ' ' A' ' 30' ' ' LYS . 1.6 p -84.62 -60.11 2.16 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.863 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.499 ' N ' ' OG1' ' A' ' 29' ' ' THR . 20.3 pttp -50.0 -33.2 17.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.112 0.482 . . . . 0.0 110.081 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -67.8 -48.07 67.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.824 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.7 tp -64.52 -42.82 95.56 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 37' ' ' ARG . . . -63.59 -43.26 98.25 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 30' ' ' LYS . 89.1 m -48.65 -47.94 40.08 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.1 t -65.81 -50.16 72.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.648 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.2 mmt -63.5 -40.82 98.07 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.434 ' N ' ' O ' ' A' ' 33' ' ' GLY . 67.0 ttt180 -57.29 -48.86 77.84 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.369 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 86.8 p -69.67 -19.1 63.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.511 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.9 mt -92.13 30.62 1.4 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.469 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.71 43.96 98.56 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.835 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -133.26 144.31 49.66 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -123.34 69.48 41.4 Favored Pre-proline 0 N--CA 1.47 0.574 0 CA-C-O 120.452 0.167 . . . . 0.0 111.385 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -78.8 142.58 17.88 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.044 1.829 . . . . 0.0 111.665 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.2 p -81.26 163.73 22.75 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -57.57 -45.94 84.58 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.957 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.77 -44.75 82.11 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -57.32 -40.97 79.04 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.199 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.4 mt -66.42 -44.52 82.71 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.174 0.511 . . . . 0.0 111.56 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -67.05 -43.88 81.61 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.643 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -61.96 -45.9 91.62 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.04 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 48.9 tpp -57.99 -39.18 77.58 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.449 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 0.6 OUTLIER -68.22 -42.55 84.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.242 179.326 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -58.68 -34.36 71.17 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.42 ' HB2' HH12 ' A' ' 74' ' ' ARG . 1.1 mt-10 -73.48 -50.17 22.94 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.88 0.848 . . . . 0.0 111.275 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.482 ' O ' ' OE2' ' A' ' 67' ' ' GLU . 11.3 p -72.59 -18.48 18.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.297 -1.319 . . . . 0.0 111.054 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.2 t0 -79.7 48.71 0.96 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.501 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -44.76 -21.02 0.04 OUTLIER 'General case' 0 C--N 1.34 0.195 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.382 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.439 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 31.3 m-20 -80.5 -35.16 35.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.448 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.53 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 89.27 15.0 59.48 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 62' ' ' THR . 50.4 p-10 -77.32 -28.02 53.05 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.288 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 92.26 -2.73 75.26 Favored Glycine 0 N--CA 1.466 0.649 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.523 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 53.9 p -135.9 163.27 30.64 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.3 mm -95.78 118.64 42.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.855 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -89.31 -168.4 2.15 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.417 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 28.7 t80 -71.78 -55.51 5.46 Favored Pre-proline 0 C--N 1.317 -0.812 0 C-N-CA 118.002 -1.479 . . . . 0.0 111.91 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 38.3 Cg_endo -59.12 -35.11 98.59 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 121.392 1.395 . . . . 0.0 111.698 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.482 ' OE2' ' O ' ' A' ' 55' ' ' VAL . 6.1 tp10 -58.79 -55.25 37.58 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.446 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 42.5 t80 -47.86 -40.52 21.72 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.401 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -57.97 -41.6 83.28 Favored 'General case' 0 C--N 1.313 -1.0 0 O-C-N 121.036 -1.04 . . . . 0.0 110.289 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -60.38 -47.85 84.31 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.703 1.24 . . . . 0.0 108.615 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.456 ' CD1' ' NZ ' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -46.64 -64.16 0.83 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 112.85 -1.977 . . . . 0.0 110.58 179.357 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 73.0 mmm -62.78 -39.6 94.71 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.294 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.75 -47.05 77.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.047 0.451 . . . . 0.0 110.308 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.42 HH12 ' HB2' ' A' ' 54' ' ' GLU . 82.5 mtp180 -60.17 -43.45 95.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.272 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.456 ' NZ ' ' CD1' ' A' ' 71' ' ' LEU . 45.6 mttp -65.13 -41.17 95.09 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.45 178.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 89.7 mmm -76.26 -14.2 60.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.477 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -67.65 -46.39 72.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.147 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -165.68 82.79 0.32 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.605 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.7 p . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.796 179.837 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 3' ' ' GLN . 64.5 t0 -69.16 139.53 54.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.826 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.473 ' N ' ' CD ' ' A' ' 3' ' ' GLN . 2.6 pm0 -119.12 172.62 7.44 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.727 0.299 . . . . 0.0 111.01 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.0 mp -80.35 169.7 17.39 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.792 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 p -102.37 176.58 5.14 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.252 0.549 . . . . 0.0 111.347 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 19.1 p-10 -78.68 -28.87 45.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.485 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.08 -43.91 97.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.805 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.584 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 99.0 mm-40 -70.31 -26.36 63.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.283 0.563 . . . . 0.0 109.831 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -81.96 -56.78 5.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.094 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.8 m -59.1 -44.24 91.94 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.182 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -61.06 -39.91 91.64 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.601 ' CG ' ' SD ' ' A' ' 72' ' ' MET . 4.3 m-30 -63.67 -46.43 85.63 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.36 0.6 . . . . 0.0 109.779 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.98 -44.23 96.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.652 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.25 -39.89 92.0 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.468 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.27 -45.36 91.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.539 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 34.7 t80 -68.17 -45.41 73.54 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.5 p -67.15 -31.95 72.73 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.5 tp -63.14 -41.87 99.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.564 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.468 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 29.9 m-85 -72.65 -14.26 61.55 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.873 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -91.4 80.83 5.46 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.45 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -49.4 -24.46 1.96 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.313 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -105.47 2.23 28.36 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.528 0.204 . . . . 0.0 111.427 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 40.74 31.09 0.39 Allowed Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.455 ' CG ' ' SG ' ' A' ' 26' ' ' CYS . 29.9 p30 -84.25 1.5 44.41 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.696 0.284 . . . . 0.0 111.133 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.39 24.53 56.57 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.455 ' SG ' ' CG ' ' A' ' 24' ' ' ASP . 17.8 p -153.72 127.78 9.0 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.99 0.424 . . . . 0.0 111.136 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.426 HD13 HG23 ' A' ' 27' ' ' ILE . 79.4 mt -100.45 120.13 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.1 p -90.19 170.16 10.53 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.8 p -65.38 -25.05 67.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.148 0.499 . . . . 0.0 110.562 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -66.54 -49.82 65.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.54 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -62.96 -41.36 99.5 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.92 -42.21 98.84 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.96 -43.41 99.44 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.4 m -50.49 -46.1 56.79 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.9 t -68.98 -54.23 21.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 113.49 -1.686 . . . . 0.0 111.019 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 60.9 mmm -57.21 -44.53 83.8 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.454 0.645 . . . . 0.0 109.444 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -54.96 -51.03 67.42 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.414 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.3 p -70.48 -14.99 62.75 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.707 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.451 ' C ' ' H ' ' A' ' 41' ' ' GLN . 7.3 mp -97.36 38.04 1.3 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.92 0.39 . . . . 0.0 111.587 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.14 5.33 2.24 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.322 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.451 ' H ' ' C ' ' A' ' 39' ' ' LEU . 44.6 tp60 -97.01 147.18 24.27 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.06 72.27 40.05 Favored Pre-proline 0 N--CA 1.47 0.556 0 C-N-CA 121.309 -0.156 . . . . 0.0 111.238 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.92 155.06 30.18 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.199 1.933 . . . . 0.0 111.599 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.442 ' OG1' ' OE2' ' A' ' 47' ' ' GLU . 16.1 p -93.15 169.76 10.15 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 176.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -60.54 -36.92 79.61 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.876 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.15 -45.39 93.24 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.526 0.679 . . . . 0.0 109.458 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.538 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -60.23 -49.08 79.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.172 -178.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.9 mt -64.26 -43.97 93.22 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.268 0.556 . . . . 0.0 111.253 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -60.95 -36.14 78.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.421 -0.808 . . . . 0.0 108.988 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -77.92 -29.28 49.95 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.106 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.443 ' C ' ' SD ' ' A' ' 51' ' ' MET . 1.8 tmm? -67.95 -48.73 65.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.552 0.692 . . . . 0.0 110.016 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 2.2 tp -65.71 -42.69 93.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.368 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.41 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 41.0 t30 -63.02 -39.52 95.01 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.246 -178.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -61.13 -43.66 98.54 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.53 0.681 . . . . 0.0 110.019 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.5 t -104.0 64.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.579 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 58' ' ' ASP . 1.0 OUTLIER -129.14 47.04 2.53 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -178.417 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 56' ' ' ASP . . . -33.52 -32.25 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.96 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 56' ' ' ASP . 6.2 m-20 -94.67 -37.84 11.12 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.497 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 83.41 17.99 65.28 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.2 p30 -80.0 -12.08 59.73 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 121.286 -0.166 . . . . 0.0 111.291 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.58 6.5 77.01 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 71.1 p -138.97 165.43 27.12 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.4 mt -103.69 120.47 53.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.736 -0.386 . . . . 0.0 112.033 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -83.43 -169.09 2.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 176.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.412 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 54.8 t80 -80.24 -43.94 1.41 Allowed Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 120.208 1.367 . . . . 0.0 112.181 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 52.1 Cg_exo -56.97 -37.26 98.88 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 121.54 1.493 . . . . 0.0 112.103 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.449 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 48.1 mt-10 -61.88 -61.9 2.17 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -51.21 -25.7 5.9 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.219 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.3 tp -77.11 -45.55 26.54 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.091 0.472 . . . . 0.0 110.769 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -59.3 -43.2 92.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.38 1.086 . . . . 0.0 108.541 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 tp -55.56 -66.65 0.38 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 112.876 -1.965 . . . . 0.0 109.904 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.601 ' SD ' ' CG ' ' A' ' 12' ' ' PHE . 5.0 ttt -56.93 -36.82 70.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.916 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.87 -45.47 67.63 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.054 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -55.69 -43.86 76.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.17 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.68 -42.19 98.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.475 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -58.72 -9.58 1.83 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.143 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.4 tttp -62.28 -45.7 92.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.062 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -133.68 -87.71 0.41 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.006 0.431 . . . . 0.0 110.735 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 36.4 p . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.771 -179.542 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 3' ' ' GLN . 51.7 p-10 -84.53 82.6 8.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.015 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.462 ' O ' ' O ' ' A' ' 2' ' ' ASP . 96.3 mm-40 53.51 164.94 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.232 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.98 167.98 16.67 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.329 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.0 p -98.39 167.24 10.96 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.037 0.446 . . . . 0.0 111.558 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -70.32 -38.63 74.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.947 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.462 ' CG ' ' N ' ' A' ' 8' ' ' GLN . 13.0 pt-20 -58.95 -43.14 91.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.761 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.468 HE21 ' CE ' ' A' ' 76' ' ' MET . 48.5 tt0 -59.71 -32.17 70.28 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.108 0.48 . . . . 0.0 110.234 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 80.7 mt -71.21 -51.05 37.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.575 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.3 t -55.08 -49.64 71.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.656 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -47.72 -49.08 29.12 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' A' ' 72' ' ' MET . 17.0 m-85 -62.84 -48.26 79.82 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.335 0.588 . . . . 0.0 110.275 178.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -61.62 -43.77 98.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.657 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -63.61 -42.42 98.22 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.26 -44.03 95.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.255 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.445 ' C ' ' CD1' ' A' ' 16' ' ' PHE . 26.3 t80 -68.86 -47.55 65.66 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -178.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.5 m -62.37 -34.06 75.97 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.28 -42.17 99.12 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.77 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -65.57 -20.97 66.54 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.79 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -82.1 94.04 7.14 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.555 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -67.47 -29.98 69.57 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 120.734 0.302 . . . . 0.0 111.703 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -101.01 -0.86 35.71 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 122.335 -0.228 . . . . 0.0 111.422 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 48.57 33.29 11.85 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -73.8 -14.83 61.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.658 0.266 . . . . 0.0 111.29 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.95 -8.25 42.27 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.0 p -140.11 158.39 44.13 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.067 0.461 . . . . 0.0 110.74 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.4 mt -113.89 127.27 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.479 ' HG1' ' CE ' ' A' ' 30' ' ' LYS . 41.3 p -86.69 -162.48 0.78 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 33' ' ' GLY . 70.9 p -85.93 -25.2 26.24 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.625 -0.672 . . . . 0.0 111.104 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.479 ' CE ' ' HG1' ' A' ' 28' ' ' THR . 16.7 pttp -72.97 -46.11 54.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.312 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.97 -50.68 69.82 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.13 -40.39 96.07 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 176.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -58.07 -47.42 89.29 Favored Glycine 0 C--O 1.214 -1.116 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.1 m -55.62 -43.29 75.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.828 0.823 . . . . 0.0 109.082 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.1 t -69.78 -55.24 15.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.185 -1.371 . . . . 0.0 112.78 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.437 ' CG ' ' N ' ' A' ' 37' ' ' ARG . 13.9 ptm -66.29 -42.03 88.97 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.136 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.49 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 60.8 ttm-85 -52.76 -51.3 61.17 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.625 0.726 . . . . 0.0 110.022 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.544 ' C ' ' H ' ' A' ' 40' ' ' GLY . 52.3 m -59.29 -35.85 74.51 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.379 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -66.44 34.78 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.543 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' A' ' 38' ' ' SER . . . 63.99 42.45 98.24 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.886 -0.674 . . . . 0.0 111.793 178.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.405 ' C ' HD21 ' A' ' 42' ' ' ASN . 98.1 mm-40 -136.62 148.91 47.72 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.405 HD21 ' C ' ' A' ' 41' ' ' GLN . 2.6 m-80 -137.3 67.21 53.72 Favored Pre-proline 0 N--CA 1.468 0.433 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.924 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.44 155.21 40.91 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.285 1.99 . . . . 0.0 111.534 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.41 ' CG2' ' H ' ' A' ' 45' ' ' GLU . 45.4 m -88.45 169.82 11.44 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.41 ' H ' ' CG2' ' A' ' 44' ' ' THR . 99.1 mt-10 -60.28 -37.07 79.37 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.908 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.48 -46.72 80.3 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.475 0.655 . . . . 0.0 109.441 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.538 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -60.43 -46.05 91.42 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.233 -179.058 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.05 -47.04 84.68 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.099 0.476 . . . . 0.0 111.224 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -63.64 -39.88 95.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.295 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -75.39 -38.34 60.0 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.945 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.504 ' N ' ' O ' ' A' ' 47' ' ' GLU . 5.7 mmm -62.83 -47.15 84.64 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.604 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.0 tt -72.36 -40.85 65.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.586 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -65.25 -27.74 68.86 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -65.18 -51.46 60.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.45 0.643 . . . . 0.0 111.138 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.511 ' C ' ' H ' ' A' ' 57' ' ' ALA . 9.2 p -80.55 -6.81 10.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.328 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 50.6 t0 -65.94 45.77 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.908 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -47.06 -25.33 0.81 Allowed 'General case' 0 CA--C 1.523 -0.077 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.846 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -80.53 -38.03 30.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.423 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.548 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 86.42 18.15 59.31 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 46.3 p30 -83.51 -26.27 30.33 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 122.812 -0.228 . . . . 0.0 111.36 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.527 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 89.91 -3.69 82.97 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.7 p -130.78 168.88 16.5 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.5 mt -108.97 124.89 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.1 p30 -90.98 -175.99 4.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -77.11 -47.69 2.64 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.568 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.51 -47.3 27.58 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.157 1.238 . . . . 0.0 112.047 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -55.91 -50.33 70.99 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -56.97 -42.99 81.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.703 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.96 -50.62 65.69 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.084 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -56.44 -44.93 80.94 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 122.307 1.051 . . . . 0.0 108.712 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 tt -60.03 -46.56 89.13 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.001 -1.909 . . . . 0.0 110.138 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.424 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . 3.1 mmt -67.52 -45.68 75.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.912 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.26 -40.79 87.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.098 0.475 . . . . 0.0 109.844 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -46.02 86.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.237 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.548 ' C ' ' H ' ' A' ' 77' ' ' LYS . 21.7 tptp -64.71 -37.79 88.8 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.218 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.468 ' CE ' HE21 ' A' ' 8' ' ' GLN . 16.9 ttt -66.92 12.1 0.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.302 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.548 ' H ' ' C ' ' A' ' 75' ' ' LYS . 87.8 tttt -63.87 -45.24 90.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.363 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -81.83 -75.25 0.3 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.14 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 59.5 p . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.693 -179.547 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.435 ' O ' ' O ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.435 ' O ' ' O ' ' A' ' 1' ' ' ALA . 45.7 t0 59.83 125.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.151 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -96.21 158.58 15.38 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.78 0.324 . . . . 0.0 110.825 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.42 ' CD2' ' H ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -90.55 165.88 13.52 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.314 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.629 ' HG1' HE21 ' A' ' 8' ' ' GLN . 70.9 p -97.79 171.22 8.45 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.25 0.548 . . . . 0.0 111.589 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 18.6 p-10 -68.33 -25.16 64.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.455 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.74 -46.07 89.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.848 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.629 HE21 ' HG1' ' A' ' 5' ' ' THR . 0.9 OUTLIER -63.44 -31.54 72.73 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 87.5 mt -76.69 -53.66 14.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.956 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.2 t -57.0 -49.78 74.72 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.782 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -54.85 -43.86 73.45 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.544 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 2.9 m-85 -60.72 -48.14 83.15 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -59.99 -45.92 91.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.556 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -63.51 -44.13 95.21 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.55 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -57.68 -47.56 81.99 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.292 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -67.22 -47.57 70.42 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 t -58.47 -37.96 76.56 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.5 tp -61.45 -41.55 97.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.168 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.55 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.3 m-30 -63.69 -29.15 70.41 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.431 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 43.8 t0 -82.73 93.98 7.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.447 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -59.19 -32.25 69.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.174 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -97.08 -10.45 26.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.624 0.249 . . . . 0.0 111.341 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.477 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 58.42 39.82 93.42 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.417 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 37.0 p-10 -99.6 17.41 20.54 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.664 0.268 . . . . 0.0 111.069 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.483 ' O ' ' SG ' ' A' ' 26' ' ' CYS . . . 66.64 25.77 72.87 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 25' ' ' GLY . 39.5 m -154.01 135.02 13.87 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.832 0.348 . . . . 0.0 111.05 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 62.4 mt -107.1 128.46 61.99 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.0 p -94.9 164.21 13.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.557 ' O ' ' N ' ' A' ' 33' ' ' GLY . 68.1 p -54.76 -34.51 62.67 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.508 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.445 ' O ' ' OG1' ' A' ' 34' ' ' THR . 37.2 ttpt -64.99 -47.8 76.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.465 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.27 -46.07 74.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.117 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.3 tt -62.62 -43.48 98.71 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -62.5 -43.35 99.16 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 178.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 30' ' ' LYS . 15.4 m -48.25 -48.09 35.6 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 68.8 t -66.65 -52.73 42.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 113.494 -1.685 . . . . 0.0 111.436 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 68.1 mmm -63.16 -40.45 97.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.317 0.579 . . . . 0.0 109.886 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 33' ' ' GLY . 69.6 ttt180 -57.52 -50.53 72.78 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.197 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.3 t -68.23 -19.99 64.79 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.781 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.401 ' CD2' ' O ' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -85.83 35.98 0.65 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.556 -178.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.13 44.78 94.63 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.644 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -144.51 155.8 43.86 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -145.57 72.84 14.08 Favored Pre-proline 0 N--CA 1.466 0.363 0 C-N-CA 121.112 -0.235 . . . . 0.0 111.29 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -67.08 151.11 82.25 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 122.548 2.165 . . . . 0.0 111.961 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.8 p -83.56 162.94 20.69 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.65 -41.54 86.29 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.491 -0.484 . . . . 0.0 112.071 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.4 -46.88 79.94 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.347 0.594 . . . . 0.0 109.446 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 51' ' ' MET . 81.2 mm-40 -60.1 -46.62 88.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.311 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.9 mt -63.93 -47.89 78.72 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.199 0.524 . . . . 0.0 111.568 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -62.07 -37.58 85.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.09 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -77.85 -38.0 47.14 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.517 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.508 ' N ' ' O ' ' A' ' 47' ' ' GLU . 56.8 tpp -62.4 -48.49 79.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.255 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 9.2 tt -70.41 -42.13 78.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.838 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.426 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 37.6 t30 -67.41 -21.78 65.56 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -73.6 -54.33 8.4 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.574 0.702 . . . . 0.0 110.221 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 57' ' ' ALA . 8.1 p -75.44 -6.83 9.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.469 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 15.9 t0 -65.24 48.98 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.752 -178.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -52.78 -28.82 24.18 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.222 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -75.05 -38.33 61.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.399 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.532 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 85.55 26.85 34.29 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.553 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 45.3 p30 -98.37 -22.6 15.99 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 122.847 -0.208 . . . . 0.0 111.169 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.553 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 90.77 -4.08 81.63 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.463 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 61.3 p -136.74 167.82 20.7 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.457 HG21 HD13 ' A' ' 63' ' ' ILE . 16.8 mm -96.3 118.53 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 C-N-CA 120.681 -0.408 . . . . 0.0 112.076 -177.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -87.88 -172.14 3.71 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.439 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 42.0 t80 -74.1 -54.28 3.52 Favored Pre-proline 0 C--N 1.318 -0.781 0 C-N-CA 118.236 -1.386 . . . . 0.0 112.357 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 23.4 Cg_endo -54.61 -40.39 84.26 Favored 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 121.365 1.377 . . . . 0.0 111.704 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.23 -53.66 55.58 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -48.15 -43.12 31.12 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.698 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.9 mt -63.6 -44.86 92.76 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.741 -0.599 . . . . 0.0 110.579 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -63.55 -45.61 89.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 122.509 1.147 . . . . 0.0 109.027 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 tt -58.01 -58.33 8.9 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 112.731 -2.032 . . . . 0.0 110.267 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.52 ' O ' ' N ' ' A' ' 76' ' ' MET . 93.1 mmm -64.82 -37.46 87.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.81 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.23 -40.74 91.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.214 0.531 . . . . 0.0 110.25 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.2 mmt-85 -74.2 -41.87 60.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.948 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -78.26 -6.03 53.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.08 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.52 ' N ' ' O ' ' A' ' 72' ' ' MET . 8.1 ttt -51.25 -47.1 62.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.142 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -56.5 -81.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.359 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 39.4 p-10 -168.01 117.4 0.77 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.705 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.4 ' OXT' ' O ' ' A' ' 78' ' ' ASP . 3.5 m . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.56 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -152.96 -114.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.11 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -134.83 50.69 2.15 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.697 0.284 . . . . 0.0 111.433 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.458 ' N ' ' CD2' ' A' ' 4' ' ' LEU . 3.8 mm? -98.25 172.25 7.69 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.933 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.429 ' OG1' ' OE1' ' A' ' 8' ' ' GLN . 5.2 p -113.58 170.73 8.03 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.148 0.499 . . . . 0.0 111.34 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -78.92 -33.06 45.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.684 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -62.16 -43.3 99.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.139 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.588 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 1.0 OUTLIER -67.72 -30.93 70.54 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 88.5 mt -80.4 -53.53 12.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.239 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 p -58.8 -46.18 88.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.122 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -59.18 -41.21 87.91 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.59 ' CZ ' ' SD ' ' A' ' 72' ' ' MET . 6.4 m-30 -63.24 -46.59 86.21 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.271 0.558 . . . . 0.0 109.967 178.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.6 tttp -62.52 -43.25 99.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.445 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -62.74 -40.99 98.96 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.471 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -58.9 -48.18 82.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.474 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.412 ' CE1' ' OD2' ' A' ' 20' ' ' ASP . 48.2 t80 -65.78 -45.42 82.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.2 m -65.25 -34.81 79.23 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 62.7 tp -64.0 -43.19 96.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.698 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 30.9 m-85 -66.84 -17.17 64.75 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.706 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.412 ' OD2' ' CE1' ' A' ' 16' ' ' PHE . 43.6 m-20 -90.55 94.12 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.355 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -61.86 -22.48 65.57 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.319 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -110.65 7.4 22.3 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.082 -178.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 35.84 28.78 0.02 OUTLIER Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 22' ' ' ASP . 41.1 p30 -70.31 -14.07 62.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.656 0.265 . . . . 0.0 111.131 -178.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.28 0.25 37.93 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 5.0 p -145.23 139.71 27.35 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.059 0.429 . . . . 0.0 111.117 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 80.6 mt -95.09 122.48 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 77.3 p -86.43 173.39 9.69 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -70.79 -38.62 73.39 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.326 -178.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -54.95 -48.45 73.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.03 0.443 . . . . 0.0 109.832 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.412 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 92.6 mt-10 -62.48 -43.62 98.38 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.4 tp -62.08 -43.64 98.39 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -61.43 -42.26 99.73 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.2 m -50.54 -50.39 53.43 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.1 t -64.85 -49.84 78.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.598 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 58.0 mmm -63.31 -42.19 98.99 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -52.63 -52.13 56.94 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.31 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.8 p -66.47 -26.8 67.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.615 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.556 ' C ' ' H ' ' A' ' 41' ' ' GLN . 68.9 mt -83.11 38.98 0.62 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.734 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.94 -0.76 0.29 Allowed Glycine 0 N--CA 1.465 0.611 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.556 ' H ' ' C ' ' A' ' 39' ' ' LEU . 28.9 tp60 -88.06 146.68 25.34 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -137.21 66.41 52.81 Favored Pre-proline 0 N--CA 1.466 0.373 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.384 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.98 156.91 30.67 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.186 1.924 . . . . 0.0 111.568 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.0 p -91.66 167.18 12.38 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.478 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 55.7 mp0 -61.13 -34.89 75.7 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.563 -0.455 . . . . 0.0 112.002 -178.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.24 -48.32 82.23 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -58.31 -47.29 84.15 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.248 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.19 -44.77 94.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.268 0.556 . . . . 0.0 111.379 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -66.25 -41.67 89.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.219 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.43 ' O ' ' OE2' ' A' ' 54' ' ' GLU . 97.6 m-20 -63.82 -50.22 69.79 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.313 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 39.5 ttm -53.39 -41.77 66.28 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 56' ' ' ASP . 35.2 mt -65.07 -44.56 95.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.338 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -54.63 -33.25 60.26 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.435 ' N ' ' CD ' ' A' ' 54' ' ' GLU . 2.0 mm-40 -76.66 -41.23 46.44 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 121.798 0.808 . . . . 0.0 110.53 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.2 t -81.65 -24.9 9.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.462 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 58' ' ' ASP . 32.4 t70 -82.09 44.01 0.82 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.85 -177.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -39.07 -21.46 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.211 0.529 . . . . 0.0 110.358 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 56' ' ' ASP . 85.4 m-20 -74.0 -36.46 64.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.344 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 85.99 36.88 9.67 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.484 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 8.4 m120 -102.99 -20.18 14.31 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 122.784 -0.245 . . . . 0.0 111.12 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.26 1.31 88.32 Favored Glycine 0 N--CA 1.466 0.695 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.9 p -135.61 162.32 33.04 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.9 mt -96.86 116.85 40.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.868 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -82.17 -166.13 1.18 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 176.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.454 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 71.4 t80 -81.15 -53.1 0.79 Allowed Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.984 178.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 35.4 Cg_endo -56.86 -30.47 85.53 Favored 'Trans proline' 0 N--CA 1.506 2.244 0 C-N-CA 121.832 1.688 . . . . 0.0 111.893 -178.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -65.66 -63.19 1.15 Allowed 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -48.64 -29.43 4.34 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.91 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.4 tp -68.87 -45.68 70.37 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.901 0.381 . . . . 0.0 110.821 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -60.22 -42.74 95.84 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 122.453 1.121 . . . . 0.0 108.809 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.1 tp -62.05 -32.89 73.46 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.431 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.59 ' SD ' ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -78.67 -44.25 24.13 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.9 179.126 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.32 -33.04 73.6 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.147 0.499 . . . . 0.0 110.368 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -74.13 -42.5 59.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.891 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -79.96 -10.18 59.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.328 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.7 ttt -51.83 -51.27 57.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.278 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 79' ' ' THR . 17.0 tptm -95.6 -63.6 1.14 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.133 0.492 . . . . 0.0 110.671 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -41.18 91.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.813 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 77' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.654 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 3' ' ' GLN . 87.6 m-20 -73.55 -11.48 60.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.084 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.521 ' O ' ' O ' ' A' ' 2' ' ' ASP . 98.9 mm-40 50.52 119.68 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 O-C-N 123.673 0.608 . . . . 0.0 111.047 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.84 166.79 10.52 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.421 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.1 p -95.2 165.89 12.18 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.112 0.482 . . . . 0.0 111.238 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 17.1 p-10 -70.83 -29.61 65.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.637 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -62.78 -46.96 85.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.925 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.531 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 87.2 mt-30 -65.78 -29.85 70.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.997 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.4 mt -77.49 -57.09 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.197 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.6 m -56.47 -42.24 77.88 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.342 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -65.99 -39.88 90.69 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.631 -0.428 . . . . 0.0 109.955 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.531 ' CG ' ' O ' ' A' ' 8' ' ' GLN . 4.3 m-30 -61.65 -46.84 88.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -58.63 -47.36 84.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.296 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -60.55 -40.95 93.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.539 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -58.8 -48.51 81.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.622 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.412 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 32.9 t80 -67.67 -47.11 70.42 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.7 m -59.83 -36.75 77.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 43.4 tp -62.43 -41.19 98.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.324 178.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.0 m-30 -64.76 -26.59 68.42 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.64 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.413 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 47.7 t0 -82.88 92.64 7.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.195 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -57.38 -34.06 68.47 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.931 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -91.45 -22.81 20.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.521 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.409 ' H ' ' CG ' ' A' ' 20' ' ' ASP . . . 66.68 37.73 92.66 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.413 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 36.4 p-10 -98.05 14.02 28.9 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.549 0.214 . . . . 0.0 111.135 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.35 17.87 80.09 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.0 m -147.59 138.52 23.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.793 0.33 . . . . 0.0 111.115 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.407 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 68.4 mt -112.15 125.2 69.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 47.2 p -88.82 162.15 16.34 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -57.67 -29.99 65.09 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -178.797 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.453 ' O ' ' OG1' ' A' ' 34' ' ' THR . 64.9 tttp -66.42 -47.09 74.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.023 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -67.56 -46.65 72.1 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.263 178.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.3 tt -62.3 -41.08 98.22 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -64.66 -42.93 97.04 Favored Glycine 0 C--O 1.226 -0.393 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 178.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 30' ' ' LYS . 19.7 m -50.07 -48.99 52.76 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 73.3 t -64.17 -51.1 73.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.241 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.1 mmm -64.06 -41.69 97.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.447 0.642 . . . . 0.0 109.643 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 33' ' ' GLY . 45.3 ttm180 -56.21 -45.56 79.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.714 0.769 . . . . 0.0 110.395 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.3 m -71.72 -19.39 62.06 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.855 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -87.5 31.6 0.74 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.897 0.38 . . . . 0.0 111.654 -178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 60.94 42.78 99.84 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.708 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -136.81 149.88 48.01 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -129.43 70.54 81.87 Favored Pre-proline 0 N--CA 1.469 0.491 0 C-N-CA 121.305 -0.158 . . . . 0.0 111.241 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.76 145.52 25.72 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.183 1.922 . . . . 0.0 111.381 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.4 m -86.42 160.05 19.16 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -59.92 -33.31 71.71 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.54 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.9 -47.15 86.02 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.187 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -64.09 -42.76 96.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.764 -179.388 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.49 -46.59 85.44 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.293 0.568 . . . . 0.0 110.788 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -62.85 -46.21 88.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.439 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -64.1 -40.62 96.61 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.664 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.6 ttm -59.82 -43.94 94.29 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.433 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 11.1 mt -64.48 -46.88 91.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.733 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -56.5 -35.89 68.52 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -65.27 -50.97 63.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.218 0.532 . . . . 0.0 111.119 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.425 ' C ' ' H ' ' A' ' 57' ' ' ALA . 6.5 p -74.58 -21.3 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.194 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.553 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.8 t0 -67.79 49.23 0.05 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.797 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -39.98 -26.88 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.267 0.556 . . . . 0.0 110.384 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 56' ' ' ASP . 24.0 m-20 -88.13 -36.24 16.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.08 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 92.47 14.45 55.56 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -66.92 -31.56 72.22 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.819 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.553 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 99.2 -1.1 57.4 Favored Glycine 0 N--CA 1.47 0.922 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 65.9 p -137.23 160.72 38.2 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.443 HG23 HD12 ' A' ' 63' ' ' ILE . 19.4 mm -92.15 122.3 43.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -84.52 -176.3 6.18 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.414 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 43.2 t80 -76.86 -54.91 1.56 Allowed Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 118.336 -1.345 . . . . 0.0 111.868 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.7 Cg_endo -57.67 -41.03 74.92 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.103 1.202 . . . . 0.0 111.513 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.421 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 62.6 mt-10 -55.15 -42.17 72.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.655 0.741 . . . . 0.0 109.179 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -62.12 -38.85 90.5 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.743 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.3 mt -61.48 -42.12 98.3 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.792 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -60.83 -44.91 96.32 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 122.217 1.008 . . . . 0.0 108.75 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.5 tp -63.42 -46.9 84.23 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.29 -1.777 . . . . 0.0 110.733 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.401 ' SD ' ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -67.35 -45.57 75.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.355 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.84 -37.87 89.0 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.66 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -73.11 -46.08 53.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.312 178.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -70.08 -13.61 62.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.446 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.406 ' C ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -54.89 -71.91 0.07 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.3 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -97.38 30.7 2.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.654 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -134.19 88.0 2.42 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.731 0.301 . . . . 0.0 110.463 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.893 -1.051 . . . . 0.0 110.53 179.685 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 53.98 36.02 23.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.37 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -87.44 -5.84 58.66 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.639 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.73 163.84 27.48 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.91 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.611 ' CG2' ' H ' ' A' ' 6' ' ' ASP . 20.4 m -98.2 176.76 5.61 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.15 0.5 . . . . 0.0 111.455 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.611 ' H ' ' CG2' ' A' ' 5' ' ' THR . 98.0 m-20 -75.1 -40.73 59.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.444 178.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.411 ' H ' HG22 ' A' ' 5' ' ' THR . 72.7 mm-40 -49.4 -42.51 42.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.617 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.559 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 13.2 mp0 -70.35 -26.23 63.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.292 0.568 . . . . 0.0 109.771 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.405 HD12 HG23 ' A' ' 9' ' ' ILE . 97.4 mt -82.29 -57.19 4.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.059 179.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 t -58.3 -43.76 88.25 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.451 -0.499 . . . . 0.0 109.952 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -62.41 -39.93 94.88 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.559 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.4 m-30 -64.09 -46.07 85.89 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.647 0.737 . . . . 0.0 109.591 178.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -60.03 -47.44 85.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.328 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -62.8 -41.26 99.2 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.72 -47.78 83.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.689 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.465 ' CE1' ' OD2' ' A' ' 20' ' ' ASP . 51.6 t80 -67.82 -45.31 75.06 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.8 m -65.25 -34.09 77.54 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.2 tp -62.9 -40.22 96.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.709 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -73.23 -14.12 61.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.043 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.465 ' OD2' ' CE1' ' A' ' 16' ' ' PHE . 55.5 m-20 -89.28 74.19 7.93 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.396 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -43.26 -43.5 4.87 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.497 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 18.6 p30 -83.42 -22.42 32.67 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.536 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 73.12 28.06 67.16 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.9 p30 -81.1 -4.17 54.42 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.591 0.234 . . . . 0.0 111.229 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.8 12.72 74.02 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 33.6 m -143.16 128.93 19.35 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.856 0.36 . . . . 0.0 110.976 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.422 HD13 HG23 ' A' ' 27' ' ' ILE . 79.9 mt -97.64 123.34 50.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.1 p -97.03 170.14 9.35 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.1 p -61.19 -27.61 68.54 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.742 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -64.46 -48.82 73.85 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.502 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -66.94 -41.86 86.28 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.0 tt -61.1 -43.03 99.5 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.33 -43.99 94.23 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.0 m -49.77 -48.06 50.62 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.1 t -65.28 -51.54 63.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 113.549 -1.659 . . . . 0.0 111.513 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.0 mmt -61.28 -46.02 92.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.513 0.673 . . . . 0.0 109.456 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.9 tpt85 -50.01 -50.95 45.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.947 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.7 t -74.15 -15.51 61.03 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.828 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.0 mp -93.56 37.55 1.06 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.043 0.449 . . . . 0.0 111.754 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.29 4.45 6.44 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.596 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -100.74 149.32 23.93 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -140.72 68.18 29.89 Favored Pre-proline 0 N--CA 1.467 0.401 0 C-N-CA 121.198 -0.201 . . . . 0.0 111.266 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -74.79 158.43 42.99 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.327 2.018 . . . . 0.0 111.566 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.9 p -93.58 166.31 12.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -60.68 -33.21 72.5 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.694 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.53 98.9 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -62.23 -47.54 83.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.141 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.4 mt -64.87 -41.72 95.42 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.148 0.499 . . . . 0.0 111.241 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -61.86 -39.88 93.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.757 0.789 . . . . 0.0 109.196 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -78.32 -24.4 46.61 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.165 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 41.3 ttm -71.22 -46.99 59.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.505 0.669 . . . . 0.0 109.82 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 tp -67.55 -40.52 84.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.269 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -65.3 -37.08 86.05 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.634 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -64.34 -36.65 84.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.407 0.622 . . . . 0.0 109.533 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.45 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 7.2 p -109.39 68.44 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.115 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 58' ' ' ASP . 3.8 t0 -135.29 47.74 2.3 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -34.67 -29.76 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.763 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 42.3 p-10 -97.68 -38.37 9.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.487 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.546 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 91.14 12.67 59.82 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 40.4 p-10 -70.15 -25.23 63.36 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.803 -0.234 . . . . 0.0 111.31 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 90.76 7.84 66.03 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 75.2 p -143.81 157.23 44.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.431 HG22 HD11 ' A' ' 63' ' ' ILE . 8.3 mm -93.84 124.33 46.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -177.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.433 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 85.5 m-20 -90.0 -162.86 0.93 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 176.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.423 ' CZ ' ' CD1' ' A' ' 69' ' ' LEU . 50.4 t80 -76.24 -56.86 1.48 Allowed Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 118.274 -1.371 . . . . 0.0 111.85 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.47 -26.31 62.69 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 CA-C-N 120.37 1.168 . . . . 0.0 111.637 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.459 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 99.3 mt-10 -65.43 -35.07 79.82 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -70.83 -31.14 67.77 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.147 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 73' ' ' ALA . 9.7 mp -70.71 -34.57 72.07 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.588 177.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -64.42 -43.62 93.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 122.41 1.1 . . . . 0.0 108.815 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.8 tp -63.67 -45.92 87.91 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 112.998 -1.91 . . . . 0.0 110.844 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.441 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . 97.5 mmm -78.96 -30.13 44.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.113 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . -72.2 -41.22 67.18 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.171 0.51 . . . . 0.0 110.094 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.1 tpp85 -65.22 -44.55 87.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -68.03 -42.41 80.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.742 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.519 ' O ' ' SD ' ' A' ' 76' ' ' MET . 13.0 tmm? -71.94 -8.23 53.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.269 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -64.68 -46.01 84.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.148 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -148.92 53.46 0.98 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.748 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.956 179.928 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -157.39 -178.75 7.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.924 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.437 ' CG ' ' H ' ' A' ' 4' ' ' LEU . 25.9 tp60 -120.35 -143.43 0.35 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.736 0.303 . . . . 0.0 110.883 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.437 ' H ' ' CG ' ' A' ' 3' ' ' GLN . 72.2 mt -116.17 154.74 29.5 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.514 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.428 ' OG1' ' OE1' ' A' ' 8' ' ' GLN . 77.0 p -99.06 -177.74 3.72 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.204 0.526 . . . . 0.0 111.302 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 19.3 p-10 -77.41 -30.16 53.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.644 178.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -64.9 -44.79 88.45 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.069 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.532 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 5.1 mp0 -70.53 -25.64 63.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.169 0.509 . . . . 0.0 109.884 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.0 mt -83.97 -56.82 5.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.906 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -58.46 -41.12 84.48 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.258 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -65.6 -38.07 88.41 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.0 m-30 -64.9 -46.88 79.88 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.526 0.679 . . . . 0.0 109.673 178.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -62.23 -45.59 92.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.661 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -59.69 -37.57 79.18 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.495 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.07 -44.42 97.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.353 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.409 ' CE2' ' CG1' ' A' ' 27' ' ' ILE . 52.4 t80 -67.43 -45.95 74.54 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -178.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.4 t -63.45 -35.44 80.45 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.21 -40.64 98.04 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.338 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.495 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 27.1 m-85 -73.55 -19.67 60.84 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.099 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -87.38 80.27 8.2 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 120.904 -0.319 . . . . 0.0 111.583 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -52.59 -26.51 13.62 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.116 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' A' ' 24' ' ' ASP . 36.7 m-20 -103.26 4.46 36.64 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.876 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 38.52 31.59 0.12 Allowed Glycine 0 CA--C 1.529 0.967 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 34.9 p-10 -86.64 -0.85 57.03 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.639 0.257 . . . . 0.0 111.146 -178.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 26' ' ' CYS . . . 82.23 26.79 46.8 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 25' ' ' GLY . 40.4 m -154.09 134.52 13.44 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.907 0.384 . . . . 0.0 111.236 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.409 ' CG1' ' CE2' ' A' ' 16' ' ' PHE . 5.9 mm -102.32 115.54 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.3 p -88.19 163.97 15.89 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.45 -24.42 66.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.18 0.514 . . . . 0.0 110.195 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -69.4 -49.08 58.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.401 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -64.29 -43.52 94.49 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.058 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.7 tp -61.93 -42.81 99.53 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.99 -44.51 97.28 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.6 m -51.23 -46.51 62.32 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.57 -51.8 53.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 113.498 -1.683 . . . . 0.0 111.428 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.501 ' SD ' ' OE1' ' A' ' 41' ' ' GLN . 17.7 mmt -60.17 -42.51 95.12 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 63.3 ttm-85 -54.68 -46.5 74.07 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.591 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.0 m -76.48 -17.08 59.48 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.313 -1.312 . . . . 0.0 111.79 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.517 ' C ' ' H ' ' A' ' 41' ' ' GLN . 55.5 mt -93.26 38.39 1.04 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.723 0.297 . . . . 0.0 111.788 -178.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.1 2.22 0.88 Allowed Glycine 0 N--CA 1.464 0.528 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' A' ' 39' ' ' LEU . 80.2 mt-30 -97.7 150.39 21.25 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -136.54 68.71 60.43 Favored Pre-proline 0 N--CA 1.468 0.468 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.334 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -75.26 153.72 40.75 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.267 1.978 . . . . 0.0 111.725 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.408 ' OG1' ' N ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -92.73 174.74 7.11 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.255 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.408 ' N ' ' OG1' ' A' ' 44' ' ' THR . 97.5 mt-10 -60.34 -40.03 89.21 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.778 -178.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.35 -46.46 90.15 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.508 0.671 . . . . 0.0 109.437 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -54.24 -53.13 57.81 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.016 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.12 -41.97 98.77 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.227 0.537 . . . . 0.0 111.067 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -67.26 -40.73 86.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.586 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -64.29 -41.72 96.74 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.258 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 38.5 ttm -59.15 -41.81 89.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.667 0.746 . . . . 0.0 109.46 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.4 mt -66.27 -40.33 86.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.11 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -60.12 -39.37 85.99 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.354 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.6 -36.7 84.49 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.782 0.801 . . . . 0.0 109.732 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.6 t -110.84 63.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.878 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 58' ' ' ASP . 0.4 OUTLIER -124.37 41.39 3.51 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.356 -178.146 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 56' ' ' ASP . . . -30.64 -36.06 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.159 0.504 . . . . 0.0 111.096 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 48.6 p-10 -99.26 -33.68 10.64 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.741 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.561 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 81.07 22.96 60.07 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.459 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 39.5 p-10 -76.13 -23.68 54.87 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.49 0.182 . . . . 0.0 111.49 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.01 5.72 62.32 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.459 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 59.8 p -138.41 162.78 33.58 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.2 mt -98.91 121.23 49.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.979 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -90.58 -162.72 0.93 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -76.72 -55.0 1.61 Allowed Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 118.347 -1.341 . . . . 0.0 112.027 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -62.02 -26.59 78.61 Favored 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 121.315 1.344 . . . . 0.0 112.189 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.435 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 97.6 mt-10 -70.75 -30.38 66.88 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -76.1 -35.75 59.2 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 113.927 -1.488 . . . . 0.0 110.273 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 73' ' ' ALA . 88.7 mt -67.46 -30.48 70.21 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.405 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -68.18 -45.1 74.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.652 1.215 . . . . 0.0 109.102 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 tp -63.56 -44.17 94.93 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 112.53 -2.123 . . . . 0.0 110.644 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.441 ' CG ' ' CE2' ' A' ' 12' ' ' PHE . 3.3 tpt -77.36 -32.6 55.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.612 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . -67.55 -35.7 79.55 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.038 0.447 . . . . 0.0 109.996 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -77.3 -44.5 29.43 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.584 0.707 . . . . 0.0 109.672 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -67.01 -18.51 65.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.233 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 6.0 ttt -49.5 -75.5 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.09 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -59.12 -74.35 0.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.42 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.43 ' CG ' ' H ' ' A' ' 79' ' ' THR . 37.9 t70 -168.66 172.29 8.11 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.604 -179.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.43 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 84.6 m . . . . . 0 C--N 1.325 -0.495 0 CA-C-O 117.861 -1.066 . . . . 0.0 110.615 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 2' ' ' ASP . 55.8 t0 -66.44 -10.12 40.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.085 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.449 ' HG3' ' H ' ' A' ' 4' ' ' LEU . 28.8 tp60 -112.49 167.08 10.74 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.835 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.449 ' H ' ' HG3' ' A' ' 3' ' ' GLN . 87.6 mt -66.09 149.47 50.23 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.978 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 p -93.15 170.89 9.29 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.083 0.468 . . . . 0.0 111.462 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 23.1 p-10 -73.3 -42.57 62.22 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.566 178.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.492 ' CG ' ' N ' ' A' ' 8' ' ' GLN . 13.6 pt-20 -53.85 -43.64 69.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.575 -179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.613 ' O ' ' CD2' ' A' ' 12' ' ' PHE . 85.4 mt-30 -69.87 -27.1 64.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.332 0.587 . . . . 0.0 109.881 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 77.5 mt -78.53 -58.58 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.405 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.3 t -56.8 -41.69 78.19 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.712 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -59.21 -41.69 89.17 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.613 ' CD2' ' O ' ' A' ' 8' ' ' GLN . 13.0 m-30 -65.72 -49.04 69.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.414 0.626 . . . . 0.0 110.149 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -61.23 -48.46 81.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.376 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -61.64 -40.58 95.39 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.52 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -63.44 -41.72 98.67 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.529 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.433 ' CD2' ' CD1' ' A' ' 27' ' ' ILE . 28.0 t80 -68.61 -47.59 66.28 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 m -64.17 -33.8 76.61 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.46 -40.73 97.57 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.284 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 31.8 m-85 -73.79 -16.33 61.16 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.916 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.543 ' OD2' ' N ' ' A' ' 25' ' ' GLY . 51.1 t0 -84.23 69.68 10.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.744 0.307 . . . . 0.0 111.442 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -43.04 -44.23 4.66 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.136 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -73.56 -23.89 60.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.744 0.307 . . . . 0.0 111.303 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 68.09 28.61 73.31 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 24.7 p-10 -89.93 5.4 46.54 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.764 0.316 . . . . 0.0 111.217 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.543 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 81.45 11.43 83.23 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.2 m -142.27 136.95 30.29 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 122.611 -0.347 . . . . 0.0 111.082 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.433 ' CD1' ' CD2' ' A' ' 16' ' ' PHE . 67.7 mt -101.41 126.9 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.0 p -99.04 160.3 14.36 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.563 ' O ' ' N ' ' A' ' 33' ' ' GLY . 46.8 p -57.0 -25.71 58.99 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.589 -179.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.02 -49.35 72.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.243 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.9 -45.12 87.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.026 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.0 tp -61.84 -42.44 99.04 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -61.42 -44.32 98.19 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 178.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.1 m -49.1 -44.28 42.09 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.416 1.103 . . . . 0.0 108.25 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.1 t -73.83 -59.11 3.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 113.206 -1.816 . . . . 0.0 111.328 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 72.5 mtp -53.63 -44.46 69.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.512 0.672 . . . . 0.0 109.694 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 78.8 ttt-85 -58.83 -45.08 90.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.129 178.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.1 m -79.28 0.65 27.88 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.635 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 mp -106.48 35.47 2.95 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.477 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.5 37.01 91.51 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.702 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -137.74 153.45 49.74 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -136.72 78.66 42.19 Favored Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 121.324 -0.15 . . . . 0.0 111.304 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.72 150.82 21.65 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.234 1.956 . . . . 0.0 111.713 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.1 m -86.17 163.31 17.9 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -64.78 -34.11 77.57 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.832 -178.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.66 -41.31 97.35 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.397 0.618 . . . . 0.0 109.541 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.485 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -62.24 -49.77 74.39 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.258 -179.09 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.6 mt -62.26 -41.24 98.27 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.06 0.457 . . . . 0.0 111.549 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.434 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 55.7 tt0 -65.21 -36.54 84.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.732 0.777 . . . . 0.0 109.429 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -80.17 -35.25 36.72 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.227 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.472 ' C ' ' SD ' ' A' ' 51' ' ' MET . 9.1 tmm? -70.38 -51.3 30.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.093 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 7.6 tp -59.15 -46.54 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.734 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.485 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 96.5 m-20 -69.57 -31.72 70.07 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.4 -36.66 84.88 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.639 0.733 . . . . 0.0 110.497 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 55' ' ' VAL . 14.6 p -98.31 18.25 2.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.8 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.628 ' CG ' ' H ' ' A' ' 59' ' ' GLY . 65.1 t0 -99.32 69.74 1.7 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.889 -177.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -37.74 -25.25 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.651 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 56' ' ' ASP . 17.4 m-20 -94.52 -40.87 9.64 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.615 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.628 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 92.03 7.65 63.98 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.408 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 15.7 m120 -66.99 -28.14 68.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.578 0.228 . . . . 0.0 111.16 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.593 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 99.91 8.26 51.51 Favored Glycine 0 N--CA 1.464 0.52 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 76.7 p -137.87 166.28 24.42 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.8 mt -104.11 125.22 58.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -176.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -97.79 158.09 15.71 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 176.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -49.93 -48.36 78.42 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 118.0 -1.48 . . . . 0.0 111.408 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.35 -44.35 43.63 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 121.219 1.279 . . . . 0.0 112.31 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.432 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 73.3 mt-10 -61.22 -34.49 75.2 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 122.285 1.04 . . . . 0.0 108.297 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -68.42 -25.91 65.26 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.356 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 73' ' ' ALA . 25.2 mt -74.98 -32.71 61.75 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.925 0.393 . . . . 0.0 110.492 177.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -64.2 -42.61 96.55 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 122.745 1.26 . . . . 0.0 108.541 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.2 tp -63.02 -45.67 91.24 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.532 -2.122 . . . . 0.0 110.448 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.546 ' SD ' ' CE1' ' A' ' 12' ' ' PHE . 7.6 mmt -78.48 -28.26 46.41 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.97 178.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . -75.31 -42.95 53.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.145 0.498 . . . . 0.0 110.081 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.8 mmm-85 -66.53 -38.1 86.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.136 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.87 -43.7 98.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.346 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 9.8 mmt -67.43 -1.77 5.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.355 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -63.18 -35.61 80.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.097 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -58.34 -66.43 0.49 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.165 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.621 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -129.5 96.29 4.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -173.66 118.91 0.28 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.99 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.539 ' N ' ' CD2' ' A' ' 4' ' ' LEU . 3.4 mm? -87.55 156.88 19.32 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.868 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.2 p -98.38 175.29 6.1 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.379 0.609 . . . . 0.0 111.397 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -77.52 -34.45 54.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.587 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 7' ' ' GLU . 57.6 mp0 -65.1 -44.72 87.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.209 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.548 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 38.5 mt-30 -67.35 -24.13 65.68 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.07 0.462 . . . . 0.0 110.199 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 90.0 mt -83.63 -53.58 10.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.192 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.9 t -59.15 -45.12 91.81 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.251 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' A' ' 11' ' ' GLU . 0.3 OUTLIER -62.86 -38.93 92.79 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.293 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.548 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 2.9 m-30 -62.44 -45.2 94.17 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 121.442 0.639 . . . . 0.0 109.861 178.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -63.54 -41.78 98.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.829 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -64.62 -41.78 95.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.54 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -59.39 -49.56 77.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.566 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -66.47 -44.27 83.15 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.1 p -64.8 -35.39 80.95 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 41.2 tp -63.8 -39.43 94.23 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.493 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.54 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.6 m-30 -66.52 -16.27 64.02 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.318 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.463 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 38.6 t0 -94.78 88.21 5.27 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.384 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -47.95 -40.88 23.51 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.537 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.439 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 3.4 p30 -91.98 -24.59 19.19 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.667 -178.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.411 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 76.76 33.12 47.76 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.041 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.463 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 80.0 m-20 -73.45 -7.39 51.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.782 0.325 . . . . 0.0 111.036 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.01 2.69 64.3 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.2 p -143.43 138.01 29.03 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.945 0.402 . . . . 0.0 111.096 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 76.9 mt -96.67 126.65 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.8 p -90.85 170.35 10.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.558 ' O ' ' N ' ' A' ' 33' ' ' GLY . 27.3 p -61.63 -49.29 77.15 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.917 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.509 ' CB ' ' HZ3' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -56.57 -43.03 79.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.152 0.501 . . . . 0.0 110.332 179.557 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.493 ' N ' ' CG ' ' A' ' 30' ' ' LYS . 89.6 mt-10 -61.55 -49.1 78.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.69 178.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.2 tt -63.25 -41.47 99.07 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -61.79 -40.7 99.16 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 30' ' ' LYS . 20.7 m -53.79 -48.62 69.63 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.08 -47.7 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.377 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 17.3 mmt -64.22 -44.28 92.4 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -50.62 -51.29 50.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.634 0.731 . . . . 0.0 110.676 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -68.34 -27.0 65.89 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.705 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.518 ' C ' ' H ' ' A' ' 41' ' ' GLN . 46.6 mt -78.2 37.56 0.26 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -178.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.75 -6.91 0.77 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.138 -0.553 . . . . 0.0 111.75 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.518 ' H ' ' C ' ' A' ' 39' ' ' LEU . 76.6 mt-30 -89.5 149.85 22.72 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -133.95 65.21 69.35 Favored Pre-proline 0 N--CA 1.469 0.476 0 C-N-CA 121.321 -0.151 . . . . 0.0 111.384 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.2 155.6 33.15 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.147 1.898 . . . . 0.0 111.503 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 m -93.38 159.51 15.22 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.53 -33.26 71.16 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.665 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.3 -39.4 82.93 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -69.31 -45.55 69.29 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.103 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.5 mt -63.7 -43.38 96.79 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.144 0.497 . . . . 0.0 110.957 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -60.75 -49.09 78.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.432 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -65.93 -33.22 75.34 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.106 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 34.8 ttm -65.75 -42.41 90.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.722 0.773 . . . . 0.0 109.994 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.427 HG21 ' N ' ' A' ' 53' ' ' ASN . 1.1 tp -65.62 -47.35 86.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.724 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.427 ' N ' HG21 ' A' ' 52' ' ' ILE . 77.7 m-20 -65.48 -28.53 69.28 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 124.009 0.818 . . . . 0.0 112.903 -177.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -68.21 -45.51 73.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.602 0.715 . . . . 0.0 110.969 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.534 ' C ' ' H ' ' A' ' 57' ' ' ALA . 12.4 p -89.03 -3.47 9.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.719 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 37.5 t0 -64.67 41.57 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.233 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.534 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -40.67 -32.57 0.22 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.189 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -74.6 -38.31 62.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.675 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.542 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 91.08 16.57 53.73 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 42.7 p30 -87.64 -25.42 23.55 Favored 'General case' 0 CA--C 1.53 0.173 0 O-C-N 122.685 -0.303 . . . . 0.0 111.334 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.555 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 91.58 5.18 67.12 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.5 p -142.57 168.39 19.83 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.0 mt -97.86 119.62 46.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.307 -0.557 . . . . 0.0 112.194 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -90.62 148.72 22.47 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 176.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -48.03 -52.1 43.18 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 118.145 -1.422 . . . . 0.0 111.464 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.23 -50.61 12.47 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 CA-C-N 119.901 1.0 . . . . 0.0 111.603 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.441 ' OE2' ' O ' ' A' ' 55' ' ' VAL . 32.9 tt0 -55.17 -52.75 62.32 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -47.26 -25.35 0.93 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.941 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.7 mt -79.07 -41.74 28.04 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.781 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -60.96 -41.12 95.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 122.348 1.071 . . . . 0.0 108.466 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.7 tp -57.91 -64.43 0.91 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.821 -1.99 . . . . 0.0 110.318 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.7 mmm -63.45 -36.35 83.45 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.58 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.12 -49.08 73.6 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 121.116 0.484 . . . . 0.0 110.062 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -61.33 -43.08 99.47 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.483 ' C ' ' H ' ' A' ' 77' ' ' LYS . 49.8 tttp -65.91 -38.6 89.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.25 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 7.0 ttm -60.78 -1.18 0.36 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.367 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' A' ' 75' ' ' LYS . 61.8 pttt -54.83 -15.48 1.96 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.236 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 40.5 p-10 -74.71 108.16 7.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.086 0.47 . . . . 0.0 111.225 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.0 p . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.61 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.8 t0 52.8 77.88 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.034 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.409 ' HG3' ' H ' ' A' ' 4' ' ' LEU . 0.6 OUTLIER -132.43 179.13 6.31 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.067 -179.212 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.563 ' N ' ' CD2' ' A' ' 4' ' ' LEU . 3.1 mm? -73.71 171.02 14.05 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.211 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.419 ' OG1' ' OE1' ' A' ' 8' ' ' GLN . 16.2 p -98.71 176.99 5.44 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.19 0.519 . . . . 0.0 111.392 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 24.9 p-10 -80.03 -26.36 39.82 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.339 177.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.412 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 97.6 mt-10 -63.15 -44.79 94.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.901 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.586 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 5.1 mp0 -69.91 -23.21 63.19 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.522 0.677 . . . . 0.0 110.124 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.415 HG21 HD11 ' A' ' 9' ' ' ILE . 96.6 mt -83.9 -56.55 5.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.429 178.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 61.6 m -58.25 -40.69 82.43 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.151 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -65.73 -37.42 86.33 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.046 0.451 . . . . 0.0 109.873 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.586 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 2.4 m-85 -62.59 -45.28 93.63 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.468 0.652 . . . . 0.0 109.995 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -63.2 -42.21 99.28 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.064 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -63.31 -41.78 98.96 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.85 -46.99 86.43 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.292 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.439 ' CE2' ' CG1' ' A' ' 27' ' ' ILE . 48.1 t80 -67.9 -45.6 73.99 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.3 p -63.71 -33.78 76.41 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.1 tp -62.9 -39.92 95.96 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.242 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -73.97 -18.97 60.8 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.033 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 25' ' ' GLY . 29.2 t0 -86.57 74.1 9.95 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.749 0.309 . . . . 0.0 111.338 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -44.9 -36.55 3.38 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.735 0.303 . . . . 0.0 111.255 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -87.94 -23.86 23.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.708 0.289 . . . . 0.0 111.427 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.51 21.48 76.17 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.0 p-10 -80.13 -1.23 39.32 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.679 0.276 . . . . 0.0 111.11 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.433 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 82.97 26.41 45.08 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 32.2 m -151.03 132.15 14.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.992 0.425 . . . . 0.0 111.057 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.439 ' CG1' ' CE2' ' A' ' 16' ' ' PHE . 4.3 mm -101.64 147.79 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 p -126.94 167.98 15.14 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 33' ' ' GLY . 58.0 p -58.78 -30.49 67.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.959 0.409 . . . . 0.0 110.818 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.465 ' O ' ' OG1' ' A' ' 34' ' ' THR . 38.9 pttt -67.18 -49.47 64.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.79 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.413 ' H ' ' HG3' ' A' ' 30' ' ' LYS . 88.7 mt-10 -67.12 -48.52 67.87 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.189 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.99 -43.7 98.48 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -62.65 -41.21 99.85 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 178.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 30' ' ' LYS . 17.3 m -50.29 -46.04 54.98 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.411 1.101 . . . . 0.0 108.231 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.5 t -69.76 -55.89 13.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 113.345 -1.752 . . . . 0.0 111.424 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 83.0 mmm -54.41 -44.74 72.64 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.868 0.842 . . . . 0.0 109.943 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -54.08 -46.95 72.17 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.461 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.1 t -79.07 -9.39 59.53 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.069 -1.423 . . . . 0.0 111.728 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.405 ' CD2' ' O ' ' A' ' 39' ' ' LEU . 0.9 OUTLIER -94.05 34.62 1.23 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.502 -178.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.37 2.1 6.74 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.548 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.403 ' H ' ' C ' ' A' ' 39' ' ' LEU . 99.2 mm-40 -102.47 152.42 21.16 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -134.61 65.16 66.34 Favored Pre-proline 0 N--CA 1.47 0.531 0 CA-C-O 120.405 0.145 . . . . 0.0 111.271 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.47 156.04 36.43 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.146 1.898 . . . . 0.0 111.629 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.5 p -92.79 168.88 10.89 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -60.02 -31.77 70.27 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.881 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.11 -44.7 96.09 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.585 0.707 . . . . 0.0 109.593 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -60.79 -49.18 78.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.316 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 73.7 mt -62.94 -41.82 99.61 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.954 0.407 . . . . 0.0 111.576 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -66.11 -41.52 90.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.41 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -64.71 -37.26 86.98 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.956 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.6 ttm -61.88 -41.78 98.28 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.2 mt -65.59 -43.24 94.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.292 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -63.72 -39.91 95.46 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.492 ' OE2' ' CZ ' ' A' ' 74' ' ' ARG . 69.1 tt0 -61.85 -37.69 85.43 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 122.028 0.918 . . . . 0.0 110.089 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.0 t -109.18 67.54 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.389 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 58' ' ' ASP . 2.8 t0 -131.9 45.2 2.81 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.128 0.489 . . . . 0.0 109.794 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -38.67 -23.15 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.06 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 56' ' ' ASP . 29.1 p-10 -102.28 -43.09 5.8 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.68 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.457 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 90.88 29.69 12.65 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.436 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 48.1 p30 -87.36 -11.88 48.01 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 111.392 0.145 . . . . 0.0 111.392 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.03 6.13 85.66 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.686 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.8 p -138.85 163.99 30.81 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.6 mt -99.76 122.65 51.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.824 -177.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -91.97 -165.2 1.3 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 176.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -77.48 -47.02 2.52 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 117.823 -1.551 . . . . 0.0 111.841 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -65.26 -31.22 53.72 Favored 'Trans proline' 0 N--CA 1.507 2.319 0 C-N-CA 121.439 1.426 . . . . 0.0 112.06 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -66.59 -31.07 71.53 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 122.808 1.289 . . . . 0.0 108.149 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -75.58 -30.98 59.81 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.456 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 73' ' ' ALA . 4.8 mt -69.7 -34.31 73.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.531 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -65.06 -44.13 89.98 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.47 1.129 . . . . 0.0 109.292 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.6 tp -61.66 -45.84 92.31 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 112.545 -2.116 . . . . 0.0 110.79 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.419 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . 99.5 mmm -80.12 -31.29 39.11 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.102 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . -72.1 -40.66 68.02 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.31 0.576 . . . . 0.0 109.812 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.492 ' CZ ' ' OE2' ' A' ' 54' ' ' GLU . 63.0 ttt180 -66.45 -42.25 87.89 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.245 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -62.83 -42.67 99.83 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.242 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 82.6 mmm -72.42 -5.28 35.44 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.398 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -63.72 -45.89 87.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.182 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -109.97 -100.0 0.39 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.12 0.486 . . . . 0.0 111.045 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 31.3 p . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.74 -179.617 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.227 -0.656 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -144.73 124.38 13.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.871 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -148.66 -127.3 0.05 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.593 0.235 . . . . 0.0 110.805 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 77.2 mt -99.01 162.76 12.9 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.458 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.6 m -106.15 158.26 16.96 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.151 0.501 . . . . 0.0 111.221 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -65.3 -33.64 76.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.223 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.94 -45.79 92.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.933 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.543 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -63.84 -36.23 83.23 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.88 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 74.7 mt -74.92 -54.34 14.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.078 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.0 t -55.83 -49.7 72.56 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.004 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -56.55 -41.68 77.27 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.883 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.543 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.0 m-85 -61.73 -48.79 79.13 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -60.78 -44.33 96.93 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.725 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -62.64 -44.94 95.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.39 -49.49 77.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.602 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 38.2 t80 -65.51 -49.15 70.06 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.3 t -60.67 -37.74 82.57 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.7 tp -61.97 -43.92 97.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.064 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -66.26 -24.54 66.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.841 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -86.88 85.24 7.26 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.534 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -67.46 -16.85 64.45 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.207 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 17.4 t0 -96.65 -0.46 48.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.202 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 38.01 53.86 2.02 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 26' ' ' CYS . 31.6 p-10 -111.84 9.15 20.7 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.695 0.283 . . . . 0.0 111.003 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.1 3.15 88.14 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 36.1 m -142.48 146.37 34.68 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.983 0.421 . . . . 0.0 110.887 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.418 HD12 HG22 ' A' ' 27' ' ' ILE . 83.9 mt -110.74 125.76 68.05 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 57.2 p -86.69 160.74 18.76 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 33' ' ' GLY . 34.0 p -58.44 -29.69 66.33 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.311 -178.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -65.04 -48.19 74.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.29 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -60.85 -47.11 87.84 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.3 tp -63.65 -40.6 97.27 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -60.88 -46.67 94.07 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.0 m -48.57 -49.7 35.5 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.75 -51.07 74.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.587 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.2 mmt -62.83 -45.16 93.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 61.6 ttt85 -54.07 -50.24 67.22 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.405 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.3 t -66.85 -21.02 66.03 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.47 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.6 mt -86.83 29.89 0.78 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.73 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.58 39.98 98.56 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.87 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -128.04 142.54 51.19 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -129.64 62.69 64.73 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 121.351 -0.139 . . . . 0.0 111.315 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.35 152.33 34.52 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.222 1.948 . . . . 0.0 111.538 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.8 p -83.85 160.93 21.05 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -60.23 -33.82 72.81 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.849 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.78 -47.15 85.72 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.427 0.632 . . . . 0.0 109.342 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.42 -43.58 83.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.846 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.4 mt -65.19 -45.59 84.17 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.107 0.479 . . . . 0.0 111.632 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.4 ' O ' HG21 ' A' ' 52' ' ' ILE . 58.4 tt0 -66.54 -33.96 76.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 122.203 1.002 . . . . 0.0 109.233 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.467 ' O ' ' OE2' ' A' ' 54' ' ' GLU . 96.2 m-20 -76.37 -39.98 52.33 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.524 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 39.2 ttm -58.66 -45.12 90.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.328 0.585 . . . . 0.0 110.498 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.4 HG21 ' O ' ' A' ' 49' ' ' GLN . 6.6 tt -70.66 -33.22 52.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.399 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -60.46 -39.0 86.02 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.562 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.467 ' OE2' ' O ' ' A' ' 50' ' ' ASP . 4.9 mm-40 -65.28 -16.43 63.55 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.364 0.602 . . . . 0.0 110.833 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 57' ' ' ALA . 3.0 t -110.2 -19.12 7.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.759 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -65.55 48.51 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.043 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -57.7 -23.34 51.19 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.964 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 17.6 p-10 -88.67 -44.88 10.27 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.318 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 93.05 50.31 2.47 Favored Glycine 0 N--CA 1.471 1.006 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.67 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 55.6 p30 -109.88 -21.61 12.27 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.692 -0.299 . . . . 0.0 110.999 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.544 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 84.7 -4.71 84.15 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 51.1 p -131.42 169.43 16.05 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.9 mt -104.14 119.29 52.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -91.54 -175.93 4.35 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 175.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.435 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 75.6 t80 -69.44 -55.61 9.37 Favored Pre-proline 0 C--N 1.318 -0.796 0 C-N-CA 118.63 -1.228 . . . . 0.0 112.242 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 14.3 Cg_endo -50.45 -43.08 46.34 Favored 'Trans proline' 0 N--CA 1.504 2.109 0 C-N-CA 121.885 1.724 . . . . 0.0 111.373 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.401 ' OE2' ' CG ' ' A' ' 58' ' ' ASP . 95.2 mt-10 -58.86 -52.63 64.89 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -57.33 -41.71 80.5 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.648 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.4 tp -61.36 -44.73 96.68 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.163 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -64.24 -52.5 58.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 122.619 1.199 . . . . 0.0 108.953 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.8 tt -51.95 -59.43 4.35 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.078 -1.874 . . . . 0.0 110.62 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.465 ' O ' ' N ' ' A' ' 76' ' ' MET . 1.2 tpt -61.6 -39.29 90.68 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.757 178.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.86 -37.54 87.26 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.197 0.522 . . . . 0.0 110.499 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -80.57 -34.97 34.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.593 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -82.79 -7.45 59.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.347 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.465 ' N ' ' O ' ' A' ' 72' ' ' MET . 24.5 tpp -57.84 -47.58 82.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.438 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -54.0 -81.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.954 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 55.76 78.81 0.18 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.068 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.674 -179.958 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 121.161 0.505 . . . . 0.0 111.356 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -72.99 -42.89 62.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.875 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 7' ' ' GLU . 6.7 pt-20 -61.77 -44.54 96.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.956 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.558 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 93.2 mt-30 -69.63 -24.73 63.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.53 0.681 . . . . 0.0 109.975 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.8 mt -83.4 -56.18 6.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.243 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.8 t -58.47 -42.6 87.88 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -63.89 -39.78 94.99 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.558 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.2 m-30 -64.07 -45.71 87.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.771 0.796 . . . . 0.0 109.862 178.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -60.92 -46.78 89.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.729 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -62.26 -39.75 93.93 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.424 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -60.65 -44.67 96.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.435 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.458 ' CE2' ' CG1' ' A' ' 27' ' ' ILE . 35.1 t80 -69.05 -45.63 69.9 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.6 m -65.81 -33.18 75.27 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.738 0.78 . . . . 0.0 109.065 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.37 -40.43 96.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.376 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.549 ' CD1' HG21 ' A' ' 35' ' ' VAL . 26.6 m-85 -73.87 -14.65 61.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.92 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.532 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 42.4 t0 -89.55 78.91 6.97 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.171 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.424 ' NZ ' HG21 ' A' ' 34' ' ' THR . 98.2 mttt -40.94 -47.61 3.03 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.736 -178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.43 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 20.8 p30 -88.11 -1.75 58.19 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.646 0.26 . . . . 0.0 111.683 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.12 39.23 41.31 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.051 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.532 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 44.5 p-10 -90.97 -0.05 57.65 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.645 0.26 . . . . 0.0 111.247 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.494 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 81.76 20.66 63.13 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.404 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 6.4 m -143.08 137.28 29.07 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.021 0.439 . . . . 0.0 111.082 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.458 ' CG1' ' CE2' ' A' ' 16' ' ' PHE . 4.9 mm -109.46 122.11 63.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.2 p -100.48 167.13 10.57 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.656 HG22 HD12 ' A' ' 52' ' ' ILE . 74.7 p -60.4 -28.59 68.36 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.411 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -66.59 -48.34 69.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.592 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -67.47 -45.65 75.34 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.979 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.3 tp -62.1 -41.86 98.64 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -63.78 -42.34 98.57 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.424 HG21 ' NZ ' ' A' ' 21' ' ' LYS . 24.2 m -50.18 -46.22 54.07 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.549 HG21 ' CD1' ' A' ' 19' ' ' PHE . 98.1 t -69.59 -55.76 13.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 113.389 -1.732 . . . . 0.0 111.296 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 84.5 mmm -57.0 -41.22 78.09 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -58.9 -51.49 69.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.848 0.832 . . . . 0.0 110.622 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.4 t -69.58 -14.19 62.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.687 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 41' ' ' GLN . 1.7 mm? -97.39 36.7 1.44 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.964 0.412 . . . . 0.0 111.335 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.78 6.33 3.56 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.198 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' A' ' 39' ' ' LEU . 4.8 tp60 -102.07 151.06 22.6 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -144.05 68.98 16.18 Favored Pre-proline 0 N--CA 1.464 0.253 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.218 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.47 ' HB2' HD21 ' A' ' 48' ' ' LEU . 29.4 Cg_exo -65.18 152.58 81.73 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.488 2.125 . . . . 0.0 112.185 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.4 m -79.72 159.97 26.43 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -61.41 -48.43 81.23 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.07 -0.652 . . . . 0.0 112.1 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.15 77.06 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -61.07 -45.39 94.93 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.237 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 43' ' ' PRO . 85.4 mt -62.28 -41.31 98.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.265 0.555 . . . . 0.0 110.774 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -65.24 -45.86 82.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.626 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.92 -42.34 97.42 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.246 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 45.9 tpp -59.13 -45.98 89.54 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.656 HD12 HG22 ' A' ' 29' ' ' THR . 2.8 mt -63.49 -43.08 98.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.35 178.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -59.69 -28.97 67.76 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -68.52 -31.31 70.46 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.277 0.56 . . . . 0.0 110.762 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.442 ' C ' ' H ' ' A' ' 57' ' ' ALA . 61.5 t -98.6 -13.36 8.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.541 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 28.8 t0 -72.28 40.89 0.08 Allowed 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.317 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.442 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -40.66 -24.37 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.393 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 4.5 p-10 -89.2 -39.96 13.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.165 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.525 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 92.21 54.76 1.81 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.561 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 47.5 p30 -117.56 -20.77 8.87 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.719 -0.283 . . . . 0.0 110.958 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.561 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 81.2 5.78 89.82 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.8 p -135.76 165.13 26.3 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.8 mt -107.33 126.39 63.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -91.57 -167.42 1.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 175.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.566 ' CZ ' HD11 ' A' ' 69' ' ' LEU . 43.4 t80 -79.67 -50.67 1.24 Allowed Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 118.525 -1.27 . . . . 0.0 111.166 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.72 -33.54 93.01 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.319 1.346 . . . . 0.0 112.011 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -67.01 -30.63 70.79 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -74.81 -30.09 61.3 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.669 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.566 HD11 ' CZ ' ' A' ' 65' ' ' PHE . 4.3 mt -69.74 -33.1 71.99 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 177.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -68.09 -45.06 74.79 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.418 1.104 . . . . 0.0 109.357 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.2 tp -60.45 -45.64 92.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.108 -1.86 . . . . 0.0 111.355 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 93.0 mmm -79.29 -26.35 42.32 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.898 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 C--N 1.332 -0.183 0 CA-C-O 121.221 0.534 . . . . 0.0 110.514 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.722 HG22 ' N ' ' A' ' 6' ' ' ASP . 32.5 m . . . . . 0 N--CA 1.465 0.28 0 CA-C-O 121.109 0.48 . . . . 0.0 111.417 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.722 ' N ' HG22 ' A' ' 5' ' ' THR . 97.7 m-20 -70.53 -42.02 71.78 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.826 178.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.51 ' CG ' ' N ' ' A' ' 8' ' ' GLN . 7.2 pt-20 -43.98 -41.84 5.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.634 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.534 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 38.1 tp60 -62.94 -23.57 67.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.475 0.655 . . . . 0.0 109.327 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.559 ' N ' ' O ' ' A' ' 6' ' ' ASP . 24.7 mt -81.29 -51.1 15.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.08 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 39.4 t -56.93 -42.8 80.66 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.652 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -63.56 -42.5 98.34 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.6 m-30 -55.1 -46.24 75.51 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -62.59 -40.34 96.58 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.886 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -62.06 -44.86 95.78 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.549 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -57.9 -43.32 86.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.262 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -70.78 -49.38 47.18 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.7 t -59.1 -35.55 73.61 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.8 tp -61.86 -44.52 96.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.281 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.549 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.7 m-30 -59.03 -25.19 63.48 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.965 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -83.27 101.99 11.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.841 0.353 . . . . 0.0 111.432 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -65.44 -30.7 71.53 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.822 0.344 . . . . 0.0 111.725 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -103.21 -10.77 18.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.404 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 61.52 45.77 95.68 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -97.49 18.73 14.69 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.645 0.26 . . . . 0.0 111.256 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.9 7.71 50.42 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 31.5 m -141.77 146.91 36.51 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.991 0.424 . . . . 0.0 110.945 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 92.1 mt -113.17 129.43 68.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 81.5 p -91.47 161.88 14.79 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 33' ' ' GLY . 71.9 p -56.22 -32.75 64.72 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.587 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -64.27 -48.47 75.58 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.229 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.07 -46.21 91.61 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.851 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.1 tp -62.62 -43.31 99.14 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -59.69 -49.18 81.32 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 178.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.9 m -48.14 -48.28 34.28 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 122.369 1.081 . . . . 0.0 108.607 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.422 HG11 ' CE2' ' A' ' 19' ' ' PHE . 67.3 t -68.11 -52.71 35.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 113.195 -1.821 . . . . 0.0 111.295 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.401 ' CE ' ' OE1' ' A' ' 41' ' ' GLN . 35.8 mmm -61.86 -42.29 98.88 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.678 0.751 . . . . 0.0 109.756 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.5 tpt85 -54.37 -51.6 64.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.539 -1.209 . . . . 0.0 110.137 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.412 ' C ' ' H ' ' A' ' 40' ' ' GLY . 47.0 m -62.14 -32.86 73.51 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.98 -1.464 . . . . 0.0 111.702 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.537 ' C ' ' H ' ' A' ' 41' ' ' GLN . 76.2 mt -73.84 33.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.782 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 38' ' ' SER . . . 62.49 -6.71 0.29 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.538 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.537 ' H ' ' C ' ' A' ' 39' ' ' LEU . 42.5 tt0 -81.41 141.73 33.65 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 42' ' ' ASN . 19.1 p-10 -124.88 72.99 63.92 Favored Pre-proline 0 N--CA 1.47 0.529 0 C-N-CA 121.376 -0.13 . . . . 0.0 111.288 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.407 ' CG ' HD21 ' A' ' 48' ' ' LEU . 94.3 Cg_endo -81.2 142.76 13.66 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.023 1.816 . . . . 0.0 111.845 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.415 ' OG1' ' N ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -87.43 175.11 8.12 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.393 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.415 ' N ' ' OG1' ' A' ' 44' ' ' THR . 52.8 mt-10 -57.2 -46.99 82.38 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.806 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.76 -49.51 72.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.525 0.679 . . . . 0.0 109.594 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -52.53 -47.08 66.94 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.946 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.407 HD21 ' CG ' ' A' ' 43' ' ' PRO . 95.4 mt -65.41 -46.78 78.66 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.195 0.522 . . . . 0.0 111.78 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.448 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 86.6 mt-30 -60.58 -44.54 96.09 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.598 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -67.12 -35.22 79.27 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.436 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.2 tpp -66.64 -50.94 61.33 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.45 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 56' ' ' ASP . 7.9 tt -71.36 -40.69 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.305 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 49' ' ' GLN . 22.9 t-20 -60.03 -39.57 86.34 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -77.43 -13.68 59.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.56 0.695 . . . . 0.0 109.999 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.441 ' O ' ' OE1' ' A' ' 67' ' ' GLU . 38.2 t -103.44 -22.78 4.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.549 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 52' ' ' ILE . 45.9 t0 -76.5 52.71 0.81 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.332 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.67 -27.39 0.1 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.642 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.449 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 37.8 m-20 -80.79 -34.75 33.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.515 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 87.16 10.13 72.08 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 51.3 p-10 -69.64 -27.26 64.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.394 0.14 . . . . 0.0 111.291 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 96.53 -7.25 65.81 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.9 p -129.16 167.08 18.12 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.6 mt -104.0 123.57 57.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.783 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -88.63 -175.86 5.07 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 176.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.417 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 38.2 t80 -67.95 -55.84 12.64 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 117.955 -1.498 . . . . 0.0 112.019 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.1 Cg_endo -56.08 -33.63 90.44 Favored 'Trans proline' 0 N--CA 1.505 2.163 0 C-N-CA 121.517 1.478 . . . . 0.0 112.047 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.449 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 68.7 mm-40 -57.35 -56.04 26.93 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -60.46 -36.49 78.37 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.707 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.48 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -60.94 -48.72 80.53 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.204 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -55.01 -50.04 70.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.591 1.186 . . . . 0.0 109.009 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 tp -53.37 -46.25 69.52 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 112.574 -2.103 . . . . 0.0 110.599 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.2 tpt -67.48 -46.74 72.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.759 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.286 0 CA-C-O 121.129 0.49 . . . . 0.0 109.979 -179.415 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.692 HG22 ' N ' ' A' ' 6' ' ' ASP . 27.1 m . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 121.101 0.477 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.692 ' N ' HG22 ' A' ' 5' ' ' THR . 1.8 p30 -73.21 -41.96 63.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.165 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.522 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 12.4 pt-20 -64.47 -40.76 96.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.576 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.559 ' O ' ' CD2' ' A' ' 12' ' ' PHE . 95.6 mt-30 -69.8 -35.03 74.51 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.273 0.559 . . . . 0.0 110.498 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.6 mt -72.95 -57.11 7.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.296 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.0 t -57.48 -46.66 83.44 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.089 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -49.27 -46.04 45.77 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 8' ' ' GLN . 20.3 m-30 -66.94 -47.07 72.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.382 0.611 . . . . 0.0 110.101 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -62.54 -45.79 91.35 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.774 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -66.06 -41.97 90.09 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.517 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.37 -45.71 93.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.512 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.42 ' C ' ' CD1' ' A' ' 16' ' ' PHE . 26.3 t80 -67.72 -43.95 78.8 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.3 m -63.88 -35.82 81.89 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 39.0 tp -64.21 -39.74 94.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.445 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.517 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.5 m-30 -66.4 -15.81 63.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.43 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.54 ' CG ' ' H ' ' A' ' 23' ' ' GLY . 65.7 t0 -92.24 89.59 6.93 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.209 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -50.28 -41.55 50.8 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.787 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -82.94 -27.11 30.79 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.048 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.54 ' H ' ' CG ' ' A' ' 20' ' ' ASP . . . 72.15 31.85 63.57 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.479 ' OD2' ' SG ' ' A' ' 26' ' ' CYS . 35.7 p-10 -81.69 -3.88 54.76 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.23 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.87 3.9 57.99 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.479 ' SG ' ' OD2' ' A' ' 24' ' ' ASP . 15.3 p -141.73 146.38 35.96 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.0 0.429 . . . . 0.0 111.034 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.4 HD11 ' CD2' ' A' ' 16' ' ' PHE . 72.6 mt -108.98 125.11 66.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.0 p -90.0 169.76 10.93 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.471 ' H ' HG23 ' A' ' 29' ' ' THR . 2.9 p -59.54 -52.24 66.42 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.979 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -53.19 -40.18 64.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -66.21 -43.45 86.67 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.505 HD13 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -62.29 -46.6 88.03 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.294 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 37' ' ' ARG . . . -60.0 -41.52 97.95 Favored Glycine 0 C--O 1.223 -0.588 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.7 m -48.69 -52.23 24.47 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.42 HG11 ' CE2' ' A' ' 19' ' ' PHE . 78.2 t -65.74 -49.82 75.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.194 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.7 mmm -65.14 -39.15 92.63 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 33' ' ' GLY . 23.9 tpt180 -55.49 -50.21 70.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.538 0.685 . . . . 0.0 110.2 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.6 t -71.43 -19.51 62.23 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.328 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.91 36.12 0.44 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.717 0.294 . . . . 0.0 111.348 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.74 45.97 94.08 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.496 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -144.75 154.73 43.03 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 25.3 p30 -134.54 73.84 67.12 Favored Pre-proline 0 N--CA 1.467 0.413 0 C-N-CA 121.184 -0.206 . . . . 0.0 110.963 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.415 ' CG ' HD21 ' A' ' 48' ' ' LEU . 87.1 Cg_endo -78.26 149.14 24.65 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.963 1.776 . . . . 0.0 111.6 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.8 p -87.91 164.31 15.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -59.54 -42.72 92.97 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.952 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.14 80.68 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.52 -48.12 82.9 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.075 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.415 HD21 ' CG ' ' A' ' 43' ' ' PRO . 52.6 mt -64.64 -42.45 95.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.158 0.504 . . . . 0.0 111.067 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -61.96 -36.59 81.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.899 0.857 . . . . 0.0 109.287 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -75.65 -40.07 56.69 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.006 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 33.9 mtp -63.77 -45.97 87.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.32 0.581 . . . . 0.0 110.048 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.487 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 1.4 tp -65.79 -47.44 85.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.874 -178.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.487 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 18.0 t-20 -69.06 -20.27 64.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.861 -177.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -72.34 -48.74 39.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.182 0.515 . . . . 0.0 110.525 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 57' ' ' ALA . 12.0 p -86.2 -2.33 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.373 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.459 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 16.6 t70 -64.57 41.89 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.625 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -50.68 -26.75 5.84 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.862 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 25.8 p30 -71.71 -39.29 70.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.356 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.514 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 91.81 7.39 64.59 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 51.6 p-10 -85.9 -22.53 27.44 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 122.724 -0.28 . . . . 0.0 111.387 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 85.73 3.41 86.04 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.508 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 22.9 p -139.6 151.2 45.83 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.9 mm -85.35 127.6 39.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.333 -0.547 . . . . 0.0 112.359 -176.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -104.71 153.79 20.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.744 ' CZ ' HD23 ' A' ' 69' ' ' LEU . 34.8 t80 -45.89 -55.61 12.46 Favored Pre-proline 0 C--N 1.319 -0.719 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.418 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 11.9 Cg_endo -49.22 -50.31 13.21 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.97 1.78 . . . . 0.0 111.489 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -55.85 -53.38 57.47 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -54.71 -21.36 10.62 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.175 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.744 HD23 ' CZ ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -79.04 -44.22 22.64 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.305 0.574 . . . . 0.0 110.219 179.283 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -58.23 -42.12 85.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.7 tp -59.71 -64.19 1.03 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 112.785 -2.007 . . . . 0.0 109.456 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.85 -38.11 54.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.645 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.153 0.501 . . . . 0.0 110.254 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 121.242 0.544 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -77.72 -29.41 51.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.385 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.442 ' OE1' ' N ' ' A' ' 7' ' ' GLU . 48.6 mp0 -68.37 -44.21 75.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.197 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.57 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 95.9 mt-30 -65.85 -29.74 70.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.278 0.561 . . . . 0.0 110.194 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.2 mt -77.44 -53.16 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.112 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.7 t -58.16 -46.56 85.48 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.845 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -54.6 -42.97 71.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.596 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.607 ' CE1' ' SD ' ' A' ' 72' ' ' MET . 16.3 m-30 -64.92 -46.73 80.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.163 0.506 . . . . 0.0 110.183 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -65.96 -43.01 89.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.743 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -67.08 -45.24 77.92 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.223 0.535 . . . . 0.0 110.073 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.554 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -62.74 -44.83 95.19 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.534 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.429 ' CD2' HD11 ' A' ' 27' ' ' ILE . 54.1 t80 -66.72 -43.99 82.77 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.8 m -63.35 -36.64 84.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.2 tp -63.74 -40.29 96.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.473 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.4 m-30 -63.29 -18.01 63.14 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.487 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.541 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 24.2 t0 -98.04 93.89 6.55 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.905 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.48 ' NZ ' HG21 ' A' ' 34' ' ' THR . 55.2 mttp -65.74 -19.69 65.99 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.662 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 24' ' ' ASP . 8.8 p30 -109.99 13.16 23.47 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.522 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 35.18 32.08 0.03 OUTLIER Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.541 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 97.5 m-20 -69.84 -8.96 52.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.568 0.223 . . . . 0.0 110.811 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.67 -7.61 65.63 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.8 m -143.64 149.66 37.61 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.748 0.309 . . . . 0.0 111.098 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.429 HD11 ' CD2' ' A' ' 16' ' ' PHE . 73.8 mt -96.22 125.14 49.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.1 p -84.28 -160.14 0.44 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.7 p -84.79 -58.15 2.83 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.439 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 34' ' ' THR . 21.7 pttp -54.21 -35.98 62.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.415 . . . . 0.0 109.959 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.438 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 95.6 mt-10 -62.37 -50.84 69.95 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.0 tt -63.34 -42.02 98.9 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.53 -39.34 97.2 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 30' ' ' LYS . 20.0 m -52.77 -49.36 65.69 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.539 ' O ' HD13 ' A' ' 39' ' ' LEU . 96.6 t -63.15 -47.86 90.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.807 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 84.6 mmm -63.64 -42.8 98.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.502 0.668 . . . . 0.0 110.416 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -53.26 -49.39 67.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.104 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.3 m -71.45 -27.08 63.01 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.513 -1.221 . . . . 0.0 112.018 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 35' ' ' VAL . 7.2 mp -84.05 31.56 0.49 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.44 -8.0 1.73 Allowed Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.461 ' H ' ' C ' ' A' ' 39' ' ' LEU . 90.4 mm-40 -85.71 146.77 26.66 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.6 p30 -135.79 64.91 58.58 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 121.249 -0.181 . . . . 0.0 111.155 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.27 154.76 41.47 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.441 2.094 . . . . 0.0 111.783 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.9 m -94.32 161.43 14.24 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.437 ' HG2' ' H ' ' A' ' 45' ' ' GLU . 2.6 pt-20 -54.66 -34.3 62.02 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.706 -178.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.63 -45.15 85.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.465 0.65 . . . . 0.0 109.394 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -63.83 -41.14 97.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.187 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.1 mt -62.28 -45.92 91.12 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.072 0.463 . . . . 0.0 111.091 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -67.27 -45.69 75.89 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.437 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.72 -43.12 99.64 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.288 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.3 ttm -61.39 -41.96 97.96 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 56' ' ' ASP . 34.1 mt -67.94 -44.93 84.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.583 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -58.37 -35.72 72.4 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -69.07 -21.2 64.09 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.121 0.486 . . . . 0.0 110.474 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.577 ' C ' ' H ' ' A' ' 57' ' ' ALA . 83.8 t -106.93 -23.48 4.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.301 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 59' ' ' GLY . 27.5 t0 -63.46 34.23 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.469 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.577 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -36.92 -27.01 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.381 0.61 . . . . 0.0 110.873 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 56' ' ' ASP . 19.3 p-10 -85.96 -37.04 19.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.178 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 87.12 62.41 1.5 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.515 ' H ' ' CG ' ' A' ' 56' ' ' ASP . 55.0 p30 -123.92 -18.17 6.06 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.637 0.219 . . . . 0.0 111.204 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 80.36 2.57 89.46 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.809 -0.516 . . . . 0.0 111.809 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.458 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 64.4 p -136.68 159.61 41.29 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.3 mt -100.05 121.06 50.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -86.99 145.67 26.42 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.422 ' CE2' HD12 ' A' ' 69' ' ' LEU . 34.1 t80 -46.4 -48.69 45.94 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 118.589 -1.244 . . . . 0.0 111.231 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -52.79 -49.07 18.83 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.24 1.294 . . . . 0.0 111.825 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.406 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 94.4 mt-10 -55.45 -52.83 62.3 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -53.07 -23.92 8.88 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.517 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.422 HD12 ' CE2' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -71.91 -46.1 58.87 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.051 0.453 . . . . 0.0 110.55 179.094 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -61.52 -42.41 98.76 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 122.427 1.108 . . . . 0.0 108.937 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.5 tp -62.05 -30.65 71.13 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 112.774 -2.012 . . . . 0.0 109.682 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.607 ' SD ' ' CE1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -82.5 -40.37 21.15 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.703 178.763 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 121.006 0.431 . . . . 0.0 109.983 179.716 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 7' ' ' GLU . 4.8 m . . . . . 0 N--CA 1.47 0.573 0 CA-C-O 121.237 0.541 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 6' ' ' ASP . 5.4 p-10 -63.11 -34.47 77.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.406 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.454 ' H ' HG22 ' A' ' 5' ' ' THR . 97.6 mt-10 -61.64 -47.72 84.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.724 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.532 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -59.68 -36.02 75.63 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.3 mt -72.17 -55.24 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.977 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.2 t -55.38 -53.49 55.6 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.822 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -54.07 -44.3 71.02 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' A' ' 8' ' ' GLN . 4.7 m-30 -60.74 -51.22 70.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.455 0.645 . . . . 0.0 109.514 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -59.68 -42.7 93.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.5 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -62.33 -46.73 87.4 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.15 78.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.335 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.412 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 34.1 t80 -69.73 -50.94 38.67 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.0 p -57.79 -35.11 70.35 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 46.9 tp -61.27 -45.25 95.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.532 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.463 ' CD1' HG21 ' A' ' 35' ' ' VAL . 17.2 m-85 -61.26 -27.77 68.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.474 ' OD1' ' OD1' ' A' ' 22' ' ' ASP . 27.1 t0 -78.55 90.76 4.52 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.839 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -62.48 -36.02 81.18 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.795 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.474 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 28.8 p30 -96.64 -1.36 46.94 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.481 0.181 . . . . 0.0 111.296 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.31 40.47 37.9 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -88.93 3.93 49.79 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.718 0.294 . . . . 0.0 111.19 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.76 -6.05 84.03 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.4 m -133.1 158.92 41.57 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.836 0.35 . . . . 0.0 110.889 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.0 mt -119.96 126.85 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.5 p -90.4 157.47 17.59 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.554 ' O ' ' N ' ' A' ' 33' ' ' GLY . 66.7 p -55.13 -29.72 58.29 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.349 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.95 -48.83 77.2 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.229 0.538 . . . . 0.0 110.275 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -61.59 -45.11 95.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.842 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 tp -63.42 -38.89 92.9 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 177.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -62.89 -47.62 87.44 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.1 m -47.52 -48.68 27.37 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' A' ' 19' ' ' PHE . 56.8 t -63.72 -51.87 64.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 113.53 -1.668 . . . . 0.0 111.233 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.482 ' SD ' ' OE1' ' A' ' 41' ' ' GLN . 17.3 mmt -63.79 -45.52 89.34 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -47.8 -54.54 12.07 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.313 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 40' ' ' GLY . 37.5 m -62.06 -37.16 83.92 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.642 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 41' ' ' GLN . 69.8 mt -69.91 34.78 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.776 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 38' ' ' SER . . . 58.92 3.57 1.75 Allowed Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.482 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 87.0 mt-30 -97.43 149.09 22.53 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -147.54 67.01 10.28 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.269 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -65.52 157.6 57.47 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.288 1.992 . . . . 0.0 111.923 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.8 p -82.53 164.83 20.63 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 177.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -57.37 -40.62 78.53 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.436 -0.506 . . . . 0.0 112.051 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.3 -50.08 74.88 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.571 0.7 . . . . 0.0 109.803 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -54.11 -47.19 72.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.268 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.24 -47.33 71.08 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.905 0.384 . . . . 0.0 111.783 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.417 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 94.6 mm-40 -61.05 -40.03 92.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.54 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -74.22 -38.58 63.52 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.774 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 43.4 tpp -62.37 -48.89 77.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.493 0.663 . . . . 0.0 110.548 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 53' ' ' ASN . 19.7 tt -71.84 -41.84 69.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.195 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 49' ' ' GLN . 31.3 t30 -64.06 -38.75 92.19 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -60.58 -55.41 33.66 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.456 0.646 . . . . 0.0 110.958 -177.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.587 ' O ' HG22 ' A' ' 55' ' ' VAL . 7.1 p -67.67 -6.05 4.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.097 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.595 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.0 t0 -80.07 75.48 6.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.721 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.04 -24.66 1.14 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.259 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 12.0 p-10 -99.43 -44.68 6.1 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.22 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.595 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 93.57 29.11 10.35 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.9 p30 -71.41 -19.84 62.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.441 0.163 . . . . 0.0 111.242 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.91 -9.45 74.34 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.3 p -132.1 167.27 20.02 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.3 mt -100.13 126.36 53.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.777 -177.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -96.3 -172.25 2.49 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.728 ' CE2' HD11 ' A' ' 69' ' ' LEU . 55.4 t80 -71.6 -56.01 5.31 Favored Pre-proline 0 C--N 1.319 -0.728 0 C-N-CA 118.114 -1.434 . . . . 0.0 111.865 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 32.5 Cg_endo -57.05 -39.3 92.23 Favored 'Trans proline' 0 N--CA 1.503 2.046 0 C-N-CA 121.488 1.459 . . . . 0.0 111.875 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.432 ' OE2' ' OD1' ' A' ' 58' ' ' ASP . 64.5 mm-40 -55.02 -49.06 72.49 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -57.22 -42.35 81.22 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 114.319 -1.309 . . . . 0.0 110.16 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.728 HD11 ' CE2' ' A' ' 65' ' ' PHE . 71.3 mt -61.95 -44.77 96.06 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.767 -0.583 . . . . 0.0 110.904 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -57.3 -47.86 80.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 122.533 1.158 . . . . 0.0 109.079 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.424 ' HB2' HG21 ' A' ' 55' ' ' VAL . 32.2 tp -59.5 -50.11 75.17 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 112.823 -1.989 . . . . 0.0 110.102 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.3 tpt -65.48 -42.87 91.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.647 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.206 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.919 -179.769 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.432 ' O ' HD13 ' A' ' 9' ' ' ILE . 43.7 p . . . . . 0 N--CA 1.473 0.684 0 CA-C-O 120.814 0.34 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -75.7 -18.12 59.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -66.44 -43.66 84.99 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.049 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.613 ' O ' ' CD2' ' A' ' 12' ' ' PHE . 84.3 mt-30 -67.39 -33.67 75.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.525 0.679 . . . . 0.0 110.383 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.529 ' N ' HD12 ' A' ' 9' ' ' ILE . 1.4 mp -74.11 -58.22 5.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.709 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.5 t -56.29 -46.51 79.73 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.72 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -47.11 -50.37 20.21 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.239 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.613 ' CD2' ' O ' ' A' ' 8' ' ' GLN . 17.7 m-85 -62.92 -48.83 77.23 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.491 0.663 . . . . 0.0 110.76 178.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -62.42 -47.33 84.57 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.725 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -62.15 -42.16 98.99 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.0 99.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.396 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 19.6 t80 -70.03 -47.66 61.15 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.8 p -66.21 -30.54 71.02 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.9 tp -61.04 -41.54 96.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.296 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.576 ' CD1' HG21 ' A' ' 35' ' ' VAL . 25.9 m-85 -73.23 -15.18 61.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.821 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.543 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 26.3 t0 -86.8 69.8 10.32 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.269 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -40.08 -46.14 2.1 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.704 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.459 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 26.4 p-10 -74.87 -19.78 60.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.443 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 64.72 30.34 77.67 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.543 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 54.9 p-10 -81.58 -3.87 54.49 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.744 0.307 . . . . 0.0 111.151 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.68 5.11 72.03 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.455 ' O ' ' OD1' ' A' ' 20' ' ' ASP . 15.7 m -136.08 150.19 49.04 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.904 0.383 . . . . 0.0 110.817 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.4 ' CD1' ' CD2' ' A' ' 16' ' ' PHE . 82.9 mt -117.36 130.23 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.6 p -104.61 166.49 10.36 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 33' ' ' GLY . 36.0 p -56.45 -24.88 48.46 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.532 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.449 ' O ' ' OG1' ' A' ' 34' ' ' THR . 65.7 tttm -68.08 -50.15 56.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.092 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.25 -49.15 68.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.626 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.2 tp -62.26 -41.85 98.82 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -64.13 -42.68 97.94 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 30' ' ' LYS . 23.6 m -49.19 -46.51 45.7 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 122.275 1.036 . . . . 0.0 108.412 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.576 HG21 ' CD1' ' A' ' 19' ' ' PHE . 74.1 t -68.94 -55.48 15.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 113.398 -1.728 . . . . 0.0 111.217 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.8 mmt -60.2 -41.05 92.16 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.529 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.416 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 71.6 ttp85 -57.56 -50.25 73.71 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.321 178.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -68.38 -18.12 64.39 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.592 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 35' ' ' VAL . 1.8 mm? -91.05 38.95 0.97 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.905 0.383 . . . . 0.0 111.476 -178.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.49 26.56 59.74 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.396 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.522 ' OE1' ' N ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -111.97 142.84 43.87 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.522 ' N ' ' OE1' ' A' ' 41' ' ' GLN . 10.9 m120 -128.31 75.11 79.34 Favored Pre-proline 0 N--CA 1.47 0.541 0 C-N-CA 121.288 -0.165 . . . . 0.0 111.361 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -81.11 143.88 14.47 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.254 1.969 . . . . 0.0 111.487 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.435 HG23 ' H ' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -89.11 172.22 9.25 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.257 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -63.2 -39.58 95.04 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.901 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.46 94.3 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.392 0.615 . . . . 0.0 109.434 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.435 ' H ' HG23 ' A' ' 44' ' ' THR . 51.3 tp10 -56.84 -51.08 70.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.046 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.1 mt -62.62 -42.51 99.63 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.135 0.493 . . . . 0.0 111.11 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -64.64 -37.96 89.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.79 0.805 . . . . 0.0 109.272 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -75.37 -35.32 61.12 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.1 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 32.9 ttm -63.86 -50.76 67.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.451 0.643 . . . . 0.0 110.146 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.415 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 1.3 tt -66.28 -39.5 84.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.635 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -63.71 -30.84 71.89 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.784 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -77.08 -30.31 55.38 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.592 0.711 . . . . 0.0 110.497 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.579 ' O ' ' N ' ' A' ' 57' ' ' ALA . 54.7 t -98.39 -4.71 9.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.474 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 52' ' ' ILE . 16.6 m-20 -64.74 45.01 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.449 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -45.81 -37.58 6.26 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.286 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 25.0 p-10 -77.65 -43.3 31.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.435 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.476 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 90.36 16.74 54.9 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.497 ' OD1' ' O ' ' A' ' 62' ' ' THR . 52.9 p-10 -94.34 -1.77 53.27 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 122.87 -0.194 . . . . 0.0 111.093 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.77 2.25 50.28 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.532 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.497 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 31.6 p -134.13 150.65 51.14 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.6 mm -91.34 133.3 33.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -101.26 -172.34 2.15 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -76.98 -47.45 2.75 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 118.091 -1.443 . . . . 0.0 111.658 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.96 -37.62 75.35 Favored 'Trans proline' 0 N--CA 1.505 2.176 0 C-N-CA 121.701 1.601 . . . . 0.0 111.934 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -64.22 -35.87 82.21 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -76.44 -23.07 53.93 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.305 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.6 tp -78.3 -32.55 49.45 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.209 0.528 . . . . 0.0 110.652 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -68.43 -42.21 79.22 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.615 1.198 . . . . 0.0 108.641 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.8 tp -62.95 -41.55 99.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 112.527 -2.124 . . . . 0.0 110.416 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.404 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . 1.2 mmt -81.02 -22.49 39.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.885 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 121.127 0.489 . . . . 0.0 109.791 -179.617 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.54 HG22 ' N ' ' A' ' 6' ' ' ASP . 7.1 m . . . . . 0 N--CA 1.466 0.35 0 CA-C-O 121.082 0.468 . . . . 0.0 111.341 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.54 ' N ' HG22 ' A' ' 5' ' ' THR . 98.8 m-20 -68.51 -40.87 80.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.654 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -61.86 -46.67 88.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.949 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.546 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 7.8 mp0 -64.29 -32.08 73.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 78.3 mt -76.45 -55.37 11.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.247 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 42.9 t -56.72 -47.77 79.23 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.032 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -59.98 -40.7 90.05 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.843 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.546 ' CG ' ' O ' ' A' ' 8' ' ' GLN . 3.9 m-30 -61.19 -49.78 75.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.326 0.584 . . . . 0.0 109.835 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -65.57 -39.65 91.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.012 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -61.81 -43.03 99.66 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.531 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.0 -45.92 92.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.576 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 31.7 t80 -66.55 -48.79 68.54 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.9 m -62.91 -35.62 80.68 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.954 0.883 . . . . 0.0 108.8 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.3 tp -60.98 -43.59 98.61 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.311 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 9.7 m-30 -63.15 -19.0 64.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.955 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -85.91 95.27 9.41 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.28 0.363 . . . . 0.0 111.493 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -76.13 -20.58 57.48 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.371 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.2 p30 -110.56 1.09 17.92 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.65 0.262 . . . . 0.0 111.322 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 47.07 40.83 13.69 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 26' ' ' CYS . 34.8 p30 -81.73 -2.65 51.35 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.725 0.298 . . . . 0.0 111.162 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.87 -8.18 78.77 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.449 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.1 m -143.05 139.85 30.7 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.776 0.322 . . . . 0.0 111.074 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.7 mt -96.58 128.4 47.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.5 p -86.23 -159.54 0.48 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 33' ' ' GLY . 22.0 p -86.56 -31.42 21.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.097 0.475 . . . . 0.0 110.806 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -67.12 -46.89 72.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.346 0.593 . . . . 0.0 110.403 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -63.16 -47.02 84.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.92 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.4 tp -63.82 -42.48 97.64 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -60.59 -46.8 93.73 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 178.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.9 m -48.87 -47.91 42.51 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 122.247 1.023 . . . . 0.0 108.292 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.92 -50.32 65.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 113.401 -1.727 . . . . 0.0 111.521 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 75.7 mmm -62.88 -43.0 99.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.783 0.801 . . . . 0.0 109.634 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -55.77 -52.21 64.73 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.452 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.5 t -66.42 -21.19 66.21 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.864 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 36.4 mt -84.43 30.9 0.53 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.583 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.6 45.98 94.74 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.855 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -141.19 151.11 43.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -134.91 68.82 71.21 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-O 120.394 0.14 . . . . 0.0 111.252 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.41 150.33 41.09 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.029 1.819 . . . . 0.0 111.845 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.3 p -87.22 166.96 14.54 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -59.81 -37.21 78.53 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.866 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.37 -47.41 78.95 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.448 0.642 . . . . 0.0 109.354 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -61.08 -46.42 90.73 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.134 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.2 mt -62.69 -49.32 75.58 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.162 0.506 . . . . 0.0 111.513 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -61.71 -39.47 91.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.226 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -72.02 -32.57 67.27 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.56 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.0 mmt -67.1 -45.75 76.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.363 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 4.1 tt -75.57 -41.63 41.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.893 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.41 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 24.4 t-20 -65.42 -41.79 93.19 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -177.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.78 -11.64 61.07 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.002 0.906 . . . . 0.0 109.909 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.531 ' C ' ' H ' ' A' ' 57' ' ' ALA . 42.9 t -110.37 -14.27 10.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.699 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 44.1 t0 -66.04 42.97 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.711 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -50.29 -28.67 8.2 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.261 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 1.8 p30 -77.87 -37.46 48.11 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.447 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.481 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 89.5 7.54 69.16 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.545 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 57.1 p30 -75.12 -21.52 58.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.416 0.151 . . . . 0.0 111.282 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.545 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 84.78 -5.52 81.8 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.741 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.429 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 54.5 p -133.82 163.71 28.87 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.8 mt -96.02 115.66 35.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.601 -0.439 . . . . 0.0 112.091 -177.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 65' ' ' PHE . 64.8 t0 -82.62 -173.52 4.67 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 176.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.509 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 34.2 t80 -77.68 -48.17 2.28 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 117.954 -1.498 . . . . 0.0 111.738 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.56 -43.57 53.97 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 121.287 1.324 . . . . 0.0 111.606 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.433 ' OE1' ' OD2' ' A' ' 58' ' ' ASP . 76.3 tt0 -56.0 -52.37 64.45 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 122.344 1.069 . . . . 0.0 108.208 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -48.34 -40.78 26.46 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.192 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.5 HD11 ' CE2' ' A' ' 65' ' ' PHE . 42.0 mt -61.43 -43.52 98.72 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.419 179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -58.48 -46.45 86.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 122.379 1.085 . . . . 0.0 109.125 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.1 tp -59.18 -47.43 85.33 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 112.847 -1.979 . . . . 0.0 110.484 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.0 tpt -67.71 -44.35 77.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.346 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.402 0 CA-C-O 121.156 0.503 . . . . 0.0 110.138 -178.719 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.568 0 CA-C-O 121.29 0.566 . . . . 0.0 111.353 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.678 ' O ' ' N ' ' A' ' 9' ' ' ILE . 5.8 p-10 -76.02 -52.7 9.66 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.284 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -43.31 -33.82 1.08 Allowed 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.961 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.532 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 84.2 mm-40 -70.53 -22.1 62.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.423 0.63 . . . . 0.0 109.835 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 6' ' ' ASP . 73.4 mt -83.28 -55.62 7.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.518 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -43.45 92.74 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 120.149 -0.621 . . . . 0.0 109.937 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -61.88 -39.64 92.65 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.0 m-30 -63.96 -45.97 86.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.385 0.612 . . . . 0.0 109.675 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -65.7 -43.14 90.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.587 -1.188 . . . . 0.0 111.756 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -62.96 -40.34 97.4 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.521 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -62.75 -43.35 99.03 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.36 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.424 ' CD1' HD11 ' A' ' 27' ' ' ILE . 48.1 t80 -68.16 -45.29 73.92 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.7 t -63.34 -36.99 85.53 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.4 tp -60.67 -38.39 84.78 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.943 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.521 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.8 m-30 -68.41 -15.39 63.53 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.017 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 65.8 t0 -95.29 77.36 3.43 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -43.02 -36.64 1.64 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.088 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.429 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 46.3 m-20 -83.52 -22.17 32.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.338 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 66.84 30.55 76.32 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.519 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 24.3 p-10 -88.66 0.11 56.74 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.533 0.206 . . . . 0.0 111.157 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.472 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 82.1 18.09 68.03 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.7 m -145.33 130.56 18.53 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 111.007 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.424 HD11 ' CD1' ' A' ' 16' ' ' PHE . 58.4 mt -103.67 141.57 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.424 ' H ' ' HB2' ' A' ' 31' ' ' GLU . 6.2 p -119.72 174.28 6.51 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.465 ' CG2' HD12 ' A' ' 52' ' ' ILE . 79.7 p -56.5 -33.48 66.04 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.808 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -67.69 -49.62 61.81 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.309 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.429 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 90.4 mt-10 -69.08 -45.37 70.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.2 tp -60.45 -44.31 95.96 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -63.83 -39.26 97.22 Favored Glycine 0 C--O 1.216 -1.003 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.1 m -50.29 -45.78 54.72 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.292 1.044 . . . . 0.0 108.677 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.71 -54.07 23.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 113.057 -1.883 . . . . 0.0 111.25 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.1 mmt -57.11 -41.6 79.27 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.523 0.678 . . . . 0.0 109.93 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -55.85 -45.39 78.46 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.564 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 61.8 p -79.87 -10.58 59.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.818 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.75 38.13 1.41 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.549 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.48 5.74 2.82 Favored Glycine 0 N--CA 1.465 0.568 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.502 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -103.71 151.8 22.57 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -138.1 74.04 43.74 Favored Pre-proline 0 N--CA 1.47 0.569 0 O-C-N 122.957 0.161 . . . . 0.0 111.19 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.445 ' CG ' HD21 ' A' ' 48' ' ' LEU . 97.7 Cg_endo -80.2 155.35 22.37 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.992 1.794 . . . . 0.0 112.026 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.566 HG22 ' N ' ' A' ' 45' ' ' GLU . 26.7 m -94.01 169.75 10.04 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.566 ' N ' HG22 ' A' ' 44' ' ' THR . 98.6 mt-10 -62.07 -34.0 75.46 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.954 -178.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.48 -44.55 96.88 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.481 0.657 . . . . 0.0 109.963 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.55 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -60.77 -51.54 68.91 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.037 -178.812 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.445 HD21 ' CG ' ' A' ' 43' ' ' PRO . 85.3 mt -61.26 -41.38 96.82 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.01 0.433 . . . . 0.0 111.829 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -64.61 -45.61 86.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.746 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -65.81 -37.57 86.6 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.074 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.4 mmm -61.91 -43.22 99.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.437 0.637 . . . . 0.0 109.563 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.465 HD12 ' CG2' ' A' ' 29' ' ' THR . 22.9 mt -66.68 -43.56 90.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.864 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -64.2 -35.03 79.47 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -70.43 -33.26 71.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.525 0.678 . . . . 0.0 110.324 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 55' ' ' VAL . 79.8 t -98.1 -4.74 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.095 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 15.8 t70 -65.6 41.59 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.057 0.456 . . . . 0.0 111.023 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -53.66 -25.97 20.42 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.58 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.434 ' OD1' ' OE1' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -80.31 -43.29 21.49 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.369 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.27 43.55 4.62 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.68 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 46.8 p30 -123.63 -15.27 7.08 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.268 0.099 . . . . 0.0 111.268 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 78.57 5.49 88.1 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.76 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.433 ' O ' ' OE1' ' A' ' 67' ' ' GLU . 72.4 p -135.84 164.5 27.79 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.0 mt -99.57 121.77 50.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.459 ' H ' ' HB3' ' A' ' 67' ' ' GLU . 90.5 m-20 -99.43 157.71 16.23 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 177.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.459 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 41.1 t80 -44.45 -53.92 13.43 Favored Pre-proline 0 CA--C 1.556 1.184 0 CA-C-N 120.557 1.526 . . . . 0.0 111.78 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.8 Cg_endo -57.24 -40.45 82.42 Favored 'Trans proline' 0 N--CA 1.505 2.157 0 C-N-CA 121.254 1.303 . . . . 0.0 112.087 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.459 ' HB3' ' H ' ' A' ' 64' ' ' ASP . 77.4 tt0 -63.02 -32.02 73.29 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.459 ' HB3' ' O ' ' A' ' 65' ' ' PHE . 53.5 t80 -71.8 -26.1 62.27 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.764 -1.562 . . . . 0.0 109.7 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.452 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 6.0 mt -76.01 -34.0 59.69 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.401 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -61.47 -42.28 98.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.62 1.2 . . . . 0.0 108.641 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.8 tp -58.17 -63.79 1.14 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 112.317 -2.22 . . . . 0.0 110.285 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 67.1 mmm -63.94 -32.85 74.53 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.187 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 C--O 1.233 0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.439 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.0 p . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 121.257 0.551 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 25.5 p-10 -73.95 -29.01 61.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.469 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.415 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 80.6 mm-40 -61.21 -45.98 92.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.026 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.606 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 53.8 tt0 -66.13 -26.54 67.49 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.0 mt -80.53 -54.6 10.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.086 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.0 t -57.62 -43.82 85.05 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.776 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -64.07 -40.2 95.74 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.606 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 2.7 m-85 -61.24 -47.49 85.81 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.623 0.725 . . . . 0.0 109.377 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -62.73 -44.35 96.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.836 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -61.02 -40.34 93.22 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.53 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.1 -42.0 97.72 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.273 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -68.18 -47.21 68.58 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.9 t -60.19 -36.12 76.91 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.4 tp -61.96 -41.98 98.6 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.444 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.53 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.5 m-30 -62.93 -24.97 68.12 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.315 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.481 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 47.4 t0 -83.21 94.54 7.9 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.346 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -59.67 -33.22 71.28 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.055 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -97.53 -3.03 40.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.609 0.242 . . . . 0.0 111.124 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.46 36.51 30.86 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.481 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 33.2 p-10 -95.46 15.92 18.36 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.672 0.273 . . . . 0.0 111.095 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.44 ' C ' ' SG ' ' A' ' 26' ' ' CYS . . . 69.61 22.24 76.58 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.44 ' SG ' ' C ' ' A' ' 25' ' ' GLY . 3.2 m -149.99 139.18 21.22 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.883 0.373 . . . . 0.0 111.218 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 6.0 mm -108.78 118.87 57.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.6 p -78.66 -162.76 0.39 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.499 ' OG1' ' N ' ' A' ' 30' ' ' LYS . 1.6 p -84.62 -60.11 2.16 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.863 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.499 ' N ' ' OG1' ' A' ' 29' ' ' THR . 20.3 pttp -50.0 -33.2 17.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.112 0.482 . . . . 0.0 110.081 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -67.8 -48.07 67.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.824 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.7 tp -64.52 -42.82 95.56 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.59 -43.26 98.25 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.1 m -48.65 -47.94 40.08 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.1 t -65.81 -50.16 72.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.648 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.2 mmt -63.5 -40.82 98.07 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -57.29 -48.86 77.84 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.369 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 86.8 p -69.67 -19.1 63.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.511 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.9 mt -92.13 30.62 1.4 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.469 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.71 43.96 98.56 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.835 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -133.26 144.31 49.66 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -123.34 69.48 41.4 Favored Pre-proline 0 N--CA 1.47 0.574 0 CA-C-O 120.452 0.167 . . . . 0.0 111.385 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.431 ' CG ' HD21 ' A' ' 48' ' ' LEU . 86.5 Cg_endo -78.8 142.58 17.88 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.044 1.829 . . . . 0.0 111.665 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.2 p -81.26 163.73 22.75 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -57.57 -45.94 84.58 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.957 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.77 -44.75 82.11 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -57.32 -40.97 79.04 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.199 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.431 HD21 ' CG ' ' A' ' 43' ' ' PRO . 95.4 mt -66.42 -44.52 82.71 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.174 0.511 . . . . 0.0 111.56 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -67.05 -43.88 81.61 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.643 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -61.96 -45.9 91.62 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.04 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 48.9 tpp -57.99 -39.18 77.58 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.449 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 0.6 OUTLIER -68.22 -42.55 84.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.242 179.326 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -58.68 -34.36 71.17 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -73.48 -50.17 22.94 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.88 0.848 . . . . 0.0 111.275 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.549 HG22 ' HG3' ' A' ' 67' ' ' GLU . 11.3 p -72.59 -18.48 18.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.297 -1.319 . . . . 0.0 111.054 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.2 t0 -79.7 48.71 0.96 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.501 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -44.76 -21.02 0.04 OUTLIER 'General case' 0 C--N 1.34 0.195 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.382 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.439 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 31.3 m-20 -80.5 -35.16 35.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.448 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.53 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 89.27 15.0 59.48 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 62' ' ' THR . 50.4 p-10 -77.32 -28.02 53.05 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.288 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 92.26 -2.73 75.26 Favored Glycine 0 N--CA 1.466 0.649 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.523 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 53.9 p -135.9 163.27 30.64 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.3 mm -95.78 118.64 42.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.855 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -89.31 -168.4 2.15 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.435 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 28.7 t80 -71.78 -55.51 5.46 Favored Pre-proline 0 C--N 1.317 -0.812 0 C-N-CA 118.002 -1.479 . . . . 0.0 111.91 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 38.3 Cg_endo -59.12 -35.11 98.59 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 121.392 1.395 . . . . 0.0 111.698 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.549 ' HG3' HG22 ' A' ' 55' ' ' VAL . 6.1 tp10 -58.79 -55.25 37.58 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.48 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 42.5 t80 -47.86 -40.52 21.72 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.401 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -57.97 -41.6 83.28 Favored 'General case' 0 C--N 1.313 -1.0 0 O-C-N 121.036 -1.04 . . . . 0.0 110.289 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -60.38 -47.85 84.31 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.703 1.24 . . . . 0.0 108.615 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.508 HD23 HG21 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -46.64 -64.16 0.83 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 112.85 -1.977 . . . . 0.0 110.58 179.357 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 73.0 mmm -62.78 -39.6 94.71 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.294 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.247 0 CA-C-O 121.047 0.451 . . . . 0.0 110.308 -179.609 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 p . . . . . 0 N--CA 1.469 0.505 0 CA-C-O 121.252 0.549 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 19.1 p-10 -78.68 -28.87 45.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.485 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.08 -43.91 97.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.805 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.584 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 99.0 mm-40 -70.31 -26.36 63.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.283 0.563 . . . . 0.0 109.831 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -81.96 -56.78 5.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.094 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.8 m -59.1 -44.24 91.94 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.182 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -61.06 -39.91 91.64 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.601 ' CG ' ' SD ' ' A' ' 72' ' ' MET . 4.3 m-30 -63.67 -46.43 85.63 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.36 0.6 . . . . 0.0 109.779 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.98 -44.23 96.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.652 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.25 -39.89 92.0 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.468 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.27 -45.36 91.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.539 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 34.7 t80 -68.17 -45.41 73.54 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.5 p -67.15 -31.95 72.73 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.5 tp -63.14 -41.87 99.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.564 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.484 ' CD1' HG21 ' A' ' 35' ' ' VAL . 29.9 m-85 -72.65 -14.26 61.55 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.873 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -91.4 80.83 5.46 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.45 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.506 ' NZ ' HG21 ' A' ' 34' ' ' THR . 97.4 mttt -49.4 -24.46 1.96 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.313 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -105.47 2.23 28.36 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.528 0.204 . . . . 0.0 111.427 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 40.74 31.09 0.39 Allowed Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.455 ' CG ' ' SG ' ' A' ' 26' ' ' CYS . 29.9 p30 -84.25 1.5 44.41 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.696 0.284 . . . . 0.0 111.133 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.39 24.53 56.57 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.455 ' SG ' ' CG ' ' A' ' 24' ' ' ASP . 17.8 p -153.72 127.78 9.0 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.99 0.424 . . . . 0.0 111.136 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.419 HD11 ' CD2' ' A' ' 16' ' ' PHE . 79.4 mt -100.45 120.13 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.1 p -90.19 170.16 10.53 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.8 p -65.38 -25.05 67.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.148 0.499 . . . . 0.0 110.562 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -66.54 -49.82 65.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.54 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -62.96 -41.36 99.5 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.92 -42.21 98.84 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.96 -43.41 99.44 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.506 HG21 ' NZ ' ' A' ' 21' ' ' LYS . 21.4 m -50.49 -46.1 56.79 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.569 ' O ' HD13 ' A' ' 39' ' ' LEU . 70.9 t -68.98 -54.23 21.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 113.49 -1.686 . . . . 0.0 111.019 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 60.9 mmm -57.21 -44.53 83.8 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.454 0.645 . . . . 0.0 109.444 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -54.96 -51.03 67.42 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.414 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.3 p -70.48 -14.99 62.75 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.707 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.569 HD13 ' O ' ' A' ' 35' ' ' VAL . 7.3 mp -97.36 38.04 1.3 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.92 0.39 . . . . 0.0 111.587 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.14 5.33 2.24 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.322 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.43 ' H ' ' C ' ' A' ' 39' ' ' LEU . 44.6 tp60 -97.01 147.18 24.27 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.06 72.27 40.05 Favored Pre-proline 0 N--CA 1.47 0.556 0 C-N-CA 121.309 -0.156 . . . . 0.0 111.238 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.465 ' CG ' HD21 ' A' ' 48' ' ' LEU . 83.2 Cg_endo -77.92 155.06 30.18 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.199 1.933 . . . . 0.0 111.599 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.442 ' OG1' ' OE2' ' A' ' 47' ' ' GLU . 16.1 p -93.15 169.76 10.15 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 176.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -60.54 -36.92 79.61 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.876 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.15 -45.39 93.24 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.526 0.679 . . . . 0.0 109.458 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -60.23 -49.08 79.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.172 -178.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.465 HD21 ' CG ' ' A' ' 43' ' ' PRO . 89.9 mt -64.26 -43.97 93.22 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.268 0.556 . . . . 0.0 111.253 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -60.95 -36.14 78.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.421 -0.808 . . . . 0.0 108.988 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -77.92 -29.28 49.95 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.106 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.443 ' SD ' ' C ' ' A' ' 51' ' ' MET . 1.8 tmm? -67.95 -48.73 65.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.552 0.692 . . . . 0.0 110.016 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 2.2 tp -65.71 -42.69 93.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.368 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.41 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 41.0 t30 -63.02 -39.52 95.01 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.246 -178.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -61.13 -43.66 98.54 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.53 0.681 . . . . 0.0 110.019 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.5 t -104.0 64.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.579 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 58' ' ' ASP . 1.0 OUTLIER -129.14 47.04 2.53 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -178.417 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 56' ' ' ASP . . . -33.52 -32.25 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.96 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 56' ' ' ASP . 6.2 m-20 -94.67 -37.84 11.12 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.497 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 83.41 17.99 65.28 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.2 p30 -80.0 -12.08 59.73 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 121.286 -0.166 . . . . 0.0 111.291 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.58 6.5 77.01 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 71.1 p -138.97 165.43 27.12 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.4 mt -103.69 120.47 53.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.736 -0.386 . . . . 0.0 112.033 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -83.43 -169.09 2.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 176.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.412 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 54.8 t80 -80.24 -43.94 1.41 Allowed Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 120.208 1.367 . . . . 0.0 112.181 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 52.1 Cg_exo -56.97 -37.26 98.88 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 121.54 1.493 . . . . 0.0 112.103 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.449 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 48.1 mt-10 -61.88 -61.9 2.17 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -51.21 -25.7 5.9 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.219 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.3 tp -77.11 -45.55 26.54 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.091 0.472 . . . . 0.0 110.769 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -59.3 -43.2 92.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.38 1.086 . . . . 0.0 108.541 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 tp -55.56 -66.65 0.38 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 112.876 -1.965 . . . . 0.0 109.904 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.601 ' SD ' ' CG ' ' A' ' 12' ' ' PHE . 5.0 ttt -56.93 -36.82 70.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.916 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.054 179.542 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.0 p . . . . . 0 N--CA 1.469 0.487 0 CA-C-O 121.037 0.446 . . . . 0.0 111.558 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -70.32 -38.63 74.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.947 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.462 ' CG ' ' N ' ' A' ' 8' ' ' GLN . 13.0 pt-20 -58.95 -43.14 91.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.761 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.462 ' N ' ' CG ' ' A' ' 7' ' ' GLU . 48.5 tt0 -59.71 -32.17 70.28 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.108 0.48 . . . . 0.0 110.234 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 80.7 mt -71.21 -51.05 37.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.575 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.3 t -55.08 -49.64 71.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.656 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -47.72 -49.08 29.12 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.438 ' CE1' ' HB3' ' A' ' 72' ' ' MET . 17.0 m-85 -62.84 -48.26 79.82 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.335 0.588 . . . . 0.0 110.275 178.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -61.62 -43.77 98.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.657 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -63.61 -42.42 98.22 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.26 -44.03 95.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.255 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.445 ' C ' ' CD1' ' A' ' 16' ' ' PHE . 26.3 t80 -68.86 -47.55 65.66 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.5 m -62.37 -34.06 75.97 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.28 -42.17 99.12 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.77 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.56 ' CD1' HG21 ' A' ' 35' ' ' VAL . 20.5 m-85 -65.57 -20.97 66.54 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.79 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -82.1 94.04 7.14 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.555 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -67.47 -29.98 69.57 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 120.734 0.302 . . . . 0.0 111.703 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -101.01 -0.86 35.71 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 122.335 -0.228 . . . . 0.0 111.422 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 48.57 33.29 11.85 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -73.8 -14.83 61.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.658 0.266 . . . . 0.0 111.29 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.95 -8.25 42.27 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.0 p -140.11 158.39 44.13 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.067 0.461 . . . . 0.0 110.74 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.407 HD12 ' CE2' ' A' ' 16' ' ' PHE . 75.4 mt -113.89 127.27 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.3 p -86.69 -162.48 0.78 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 33' ' ' GLY . 70.9 p -85.93 -25.2 26.24 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.625 -0.672 . . . . 0.0 111.104 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.421 ' HG2' ' H ' ' A' ' 30' ' ' LYS . 16.7 pttp -72.97 -46.11 54.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.312 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.97 -50.68 69.82 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.46 HD23 ' SD ' ' A' ' 36' ' ' MET . 0.4 OUTLIER -64.13 -40.39 96.07 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 176.943 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -58.07 -47.42 89.29 Favored Glycine 0 C--O 1.214 -1.116 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.1 m -55.62 -43.29 75.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.828 0.823 . . . . 0.0 109.082 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.56 HG21 ' CD1' ' A' ' 19' ' ' PHE . 67.1 t -69.78 -55.24 15.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.185 -1.371 . . . . 0.0 112.78 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.46 ' SD ' HD23 ' A' ' 32' ' ' LEU . 13.9 ptm -66.29 -42.03 88.97 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.136 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.49 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 60.8 ttm-85 -52.76 -51.3 61.17 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.625 0.726 . . . . 0.0 110.022 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.512 ' C ' ' H ' ' A' ' 40' ' ' GLY . 52.3 m -59.29 -35.85 74.51 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.379 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.454 HD23 ' O ' ' A' ' 35' ' ' VAL . 1.6 mm? -66.44 34.78 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.543 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 38' ' ' SER . . . 63.99 42.45 98.24 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.886 -0.674 . . . . 0.0 111.793 178.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -136.62 148.91 47.72 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -137.3 67.21 53.72 Favored Pre-proline 0 N--CA 1.468 0.433 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.924 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.44 155.21 40.91 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.285 1.99 . . . . 0.0 111.534 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.593 HG22 ' N ' ' A' ' 45' ' ' GLU . 45.4 m -88.45 169.82 11.44 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.593 ' N ' HG22 ' A' ' 44' ' ' THR . 99.1 mt-10 -60.28 -37.07 79.37 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.908 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.48 -46.72 80.3 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.475 0.655 . . . . 0.0 109.441 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -60.43 -46.05 91.42 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.233 -179.058 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.05 -47.04 84.68 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.099 0.476 . . . . 0.0 111.224 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -63.64 -39.88 95.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.295 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -75.39 -38.34 60.0 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.945 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.439 ' N ' ' O ' ' A' ' 47' ' ' GLU . 5.7 mmm -62.83 -47.15 84.64 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.604 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 52' ' ' ILE . 15.0 tt -72.36 -40.85 65.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.586 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -65.25 -27.74 68.86 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -65.18 -51.46 60.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.45 0.643 . . . . 0.0 111.138 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.54 ' O ' HG22 ' A' ' 55' ' ' VAL . 9.2 p -80.55 -6.81 10.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.328 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 50.6 t0 -65.94 45.77 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.908 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -47.06 -25.33 0.81 Allowed 'General case' 0 CA--C 1.523 -0.077 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.846 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -80.53 -38.03 30.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.423 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.548 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 86.42 18.15 59.31 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 46.3 p30 -83.51 -26.27 30.33 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 122.812 -0.228 . . . . 0.0 111.36 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.527 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 89.91 -3.69 82.97 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.7 p -130.78 168.88 16.5 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.5 mt -108.97 124.89 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.1 p30 -90.98 -175.99 4.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.678 ' CZ ' HD23 ' A' ' 69' ' ' LEU . 32.3 t80 -77.11 -47.69 2.64 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.568 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.51 -47.3 27.58 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.157 1.238 . . . . 0.0 112.047 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -55.91 -50.33 70.99 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -56.97 -42.99 81.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.703 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.678 HD23 ' CZ ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -64.96 -50.62 65.69 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.084 178.817 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -56.44 -44.93 80.94 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 122.307 1.051 . . . . 0.0 108.712 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 tt -60.03 -46.56 89.13 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.001 -1.909 . . . . 0.0 110.138 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.438 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . 3.1 mmt -67.52 -45.68 75.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.912 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.213 0 CA-C-O 121.098 0.475 . . . . 0.0 109.844 -178.682 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.9 p . . . . . 0 N--CA 1.468 0.475 0 CA-C-O 121.25 0.548 . . . . 0.0 111.589 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 18.6 p-10 -68.33 -25.16 64.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.455 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.74 -46.07 89.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.848 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.544 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 5.4 mp0 -63.44 -31.54 72.73 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 87.5 mt -76.69 -53.66 14.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.956 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.2 t -57.0 -49.78 74.72 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.782 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -54.85 -43.86 73.45 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.544 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 2.9 m-85 -60.72 -48.14 83.15 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -59.99 -45.92 91.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.556 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -63.51 -44.13 95.21 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.55 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -57.68 -47.56 81.99 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.292 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.431 ' CD2' HD11 ' A' ' 27' ' ' ILE . 58.6 t80 -67.22 -47.57 70.42 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 t -58.47 -37.96 76.56 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.5 tp -61.45 -41.55 97.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.168 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.55 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.3 m-30 -63.69 -29.15 70.41 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.431 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 43.8 t0 -82.73 93.98 7.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.447 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -59.19 -32.25 69.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.174 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -97.08 -10.45 26.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.624 0.249 . . . . 0.0 111.341 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.477 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 58.42 39.82 93.42 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.417 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 37.0 p-10 -99.6 17.41 20.54 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.664 0.268 . . . . 0.0 111.069 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.483 ' O ' ' SG ' ' A' ' 26' ' ' CYS . . . 66.64 25.77 72.87 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 25' ' ' GLY . 39.5 m -154.01 135.02 13.87 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.832 0.348 . . . . 0.0 111.05 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.431 HD11 ' CD2' ' A' ' 16' ' ' PHE . 62.4 mt -107.1 128.46 61.99 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.0 p -94.9 164.21 13.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.557 ' O ' ' N ' ' A' ' 33' ' ' GLY . 68.1 p -54.76 -34.51 62.67 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.508 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -64.99 -47.8 76.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.465 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.27 -46.07 74.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.117 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.456 HD23 ' C ' ' A' ' 32' ' ' LEU . 8.3 tt -62.62 -43.48 98.71 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -62.5 -43.35 99.16 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 178.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.4 m -48.25 -48.09 35.6 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 68.8 t -66.65 -52.73 42.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 113.494 -1.685 . . . . 0.0 111.436 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 68.1 mmm -63.16 -40.45 97.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.317 0.579 . . . . 0.0 109.886 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -57.52 -50.53 72.78 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.197 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.3 t -68.23 -19.99 64.79 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.781 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.401 ' O ' ' CD2' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -85.83 35.98 0.65 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.556 -178.516 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.13 44.78 94.63 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.644 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -144.51 155.8 43.86 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -145.57 72.84 14.08 Favored Pre-proline 0 N--CA 1.466 0.363 0 C-N-CA 121.112 -0.235 . . . . 0.0 111.29 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.477 ' HB2' HD21 ' A' ' 48' ' ' LEU . 27.6 Cg_exo -67.08 151.11 82.25 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 122.548 2.165 . . . . 0.0 111.961 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.8 p -83.56 162.94 20.69 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.65 -41.54 86.29 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.491 -0.484 . . . . 0.0 112.071 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.4 -46.88 79.94 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.347 0.594 . . . . 0.0 109.446 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 51' ' ' MET . 81.2 mm-40 -60.1 -46.62 88.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.311 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.477 HD21 ' HB2' ' A' ' 43' ' ' PRO . 90.9 mt -63.93 -47.89 78.72 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.199 0.524 . . . . 0.0 111.568 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -62.07 -37.58 85.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.09 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -77.85 -38.0 47.14 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.517 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.489 ' N ' ' O ' ' A' ' 47' ' ' GLU . 56.8 tpp -62.4 -48.49 79.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.255 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 9.2 tt -70.41 -42.13 78.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.838 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.426 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 37.6 t30 -67.41 -21.78 65.56 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -73.6 -54.33 8.4 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.574 0.702 . . . . 0.0 110.221 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.553 ' O ' HG22 ' A' ' 55' ' ' VAL . 8.1 p -75.44 -6.83 9.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.469 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 15.9 t0 -65.24 48.98 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.752 -178.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -52.78 -28.82 24.18 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.222 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -75.05 -38.33 61.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.399 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.532 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 85.55 26.85 34.29 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.553 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 45.3 p30 -98.37 -22.6 15.99 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 122.847 -0.208 . . . . 0.0 111.169 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.553 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 90.77 -4.08 81.63 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.463 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 61.3 p -136.74 167.82 20.7 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.8 mm -96.3 118.53 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 C-N-CA 120.681 -0.408 . . . . 0.0 112.076 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -87.88 -172.14 3.71 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.538 ' CZ ' HD11 ' A' ' 69' ' ' LEU . 42.0 t80 -74.1 -54.28 3.52 Favored Pre-proline 0 C--N 1.318 -0.781 0 C-N-CA 118.236 -1.386 . . . . 0.0 112.357 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 23.4 Cg_endo -54.61 -40.39 84.26 Favored 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 121.365 1.377 . . . . 0.0 111.704 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.23 -53.66 55.58 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -48.15 -43.12 31.12 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.698 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.538 HD11 ' CZ ' ' A' ' 65' ' ' PHE . 9.9 mt -63.6 -44.86 92.76 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.741 -0.599 . . . . 0.0 110.579 177.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -63.55 -45.61 89.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 122.509 1.147 . . . . 0.0 109.027 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.424 HD12 HG11 ' A' ' 55' ' ' VAL . 8.1 tt -58.01 -58.33 8.9 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 112.731 -2.032 . . . . 0.0 110.267 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 93.1 mmm -64.82 -37.46 87.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.81 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 C--N 1.331 -0.207 0 CA-C-O 121.214 0.531 . . . . 0.0 110.25 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.469 0.475 0 CA-C-O 121.148 0.499 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -78.92 -33.06 45.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.684 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -62.16 -43.3 99.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.139 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.588 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 1.0 OUTLIER -67.72 -30.93 70.54 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 88.5 mt -80.4 -53.53 12.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.239 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 p -58.8 -46.18 88.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.122 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -59.18 -41.21 87.91 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.59 ' CZ ' ' SD ' ' A' ' 72' ' ' MET . 6.4 m-30 -63.24 -46.59 86.21 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.271 0.558 . . . . 0.0 109.967 178.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.6 tttp -62.52 -43.25 99.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.445 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -62.74 -40.99 98.96 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.471 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -58.9 -48.18 82.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.474 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.412 ' CE1' ' OD2' ' A' ' 20' ' ' ASP . 48.2 t80 -65.78 -45.42 82.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.2 m -65.25 -34.81 79.23 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 62.7 tp -64.0 -43.19 96.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.698 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 30.9 m-85 -66.84 -17.17 64.75 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.706 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.412 ' OD2' ' CE1' ' A' ' 16' ' ' PHE . 43.6 m-20 -90.55 94.12 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.355 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -61.86 -22.48 65.57 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.319 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -110.65 7.4 22.3 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.082 -178.971 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 35.84 28.78 0.02 OUTLIER Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 22' ' ' ASP . 41.1 p30 -70.31 -14.07 62.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.656 0.265 . . . . 0.0 111.131 -178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.28 0.25 37.93 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 5.0 p -145.23 139.71 27.35 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.059 0.429 . . . . 0.0 111.117 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.401 HD11 ' CD2' ' A' ' 16' ' ' PHE . 80.6 mt -95.09 122.48 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 77.3 p -86.43 173.39 9.69 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -70.79 -38.62 73.39 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.326 -178.521 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -54.95 -48.45 73.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.03 0.443 . . . . 0.0 109.832 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.412 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 92.6 mt-10 -62.48 -43.62 98.38 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.4 tp -62.08 -43.64 98.39 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -61.43 -42.26 99.73 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.2 m -50.54 -50.39 53.43 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.1 t -64.85 -49.84 78.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.598 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 58.0 mmm -63.31 -42.19 98.99 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -52.63 -52.13 56.94 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.31 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.8 p -66.47 -26.8 67.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.615 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.523 ' C ' ' H ' ' A' ' 41' ' ' GLN . 68.9 mt -83.11 38.98 0.62 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.734 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.94 -0.76 0.29 Allowed Glycine 0 N--CA 1.465 0.611 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.523 ' H ' ' C ' ' A' ' 39' ' ' LEU . 28.9 tp60 -88.06 146.68 25.34 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -137.21 66.41 52.81 Favored Pre-proline 0 N--CA 1.466 0.373 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.384 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.452 ' CG ' HD21 ' A' ' 48' ' ' LEU . 87.7 Cg_endo -77.98 156.91 30.67 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.186 1.924 . . . . 0.0 111.568 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.0 p -91.66 167.18 12.38 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.438 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 55.7 mp0 -61.13 -34.89 75.7 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.563 -0.455 . . . . 0.0 112.002 -178.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.24 -48.32 82.23 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -58.31 -47.29 84.15 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.248 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.452 HD21 ' CG ' ' A' ' 43' ' ' PRO . 89.6 mt -63.19 -44.77 94.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.268 0.556 . . . . 0.0 111.379 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -66.25 -41.67 89.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.219 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.43 ' O ' ' OE2' ' A' ' 54' ' ' GLU . 97.6 m-20 -63.82 -50.22 69.79 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.313 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 39.5 ttm -53.39 -41.77 66.28 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 56' ' ' ASP . 35.2 mt -65.07 -44.56 95.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.338 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -54.63 -33.25 60.26 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.435 ' N ' ' CD ' ' A' ' 54' ' ' GLU . 2.0 mm-40 -76.66 -41.23 46.44 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 121.798 0.808 . . . . 0.0 110.53 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.2 t -81.65 -24.9 9.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.462 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 58' ' ' ASP . 32.4 t70 -82.09 44.01 0.82 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.85 -177.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -39.07 -21.46 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.211 0.529 . . . . 0.0 110.358 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 56' ' ' ASP . 85.4 m-20 -74.0 -36.46 64.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.344 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 85.99 36.88 9.67 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.484 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 53.1 m-20 -102.99 -20.18 14.31 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 122.784 -0.245 . . . . 0.0 111.12 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.26 1.31 88.32 Favored Glycine 0 N--CA 1.466 0.695 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.9 p -135.61 162.32 33.04 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.9 mt -96.86 116.85 40.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.868 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -82.17 -166.13 1.18 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 176.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.476 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 71.4 t80 -81.15 -53.1 0.79 Allowed Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.984 178.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 35.4 Cg_endo -56.86 -30.47 85.53 Favored 'Trans proline' 0 N--CA 1.506 2.244 0 C-N-CA 121.832 1.688 . . . . 0.0 111.893 -178.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -65.66 -63.19 1.15 Allowed 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -48.64 -29.43 4.34 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.91 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.4 tp -68.87 -45.68 70.37 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.901 0.381 . . . . 0.0 110.821 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -60.22 -42.74 95.84 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 122.453 1.121 . . . . 0.0 108.809 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.1 tp -62.05 -32.89 73.46 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.431 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.59 ' SD ' ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -78.67 -44.25 24.13 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.9 179.126 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.243 0 CA-C-O 121.147 0.499 . . . . 0.0 110.368 -179.839 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.1 p . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 121.112 0.482 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 17.1 p-10 -70.83 -29.61 65.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.637 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -62.78 -46.96 85.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.925 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.531 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 87.2 mt-30 -65.78 -29.85 70.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.997 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.4 mt -77.49 -57.09 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.197 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.6 m -56.47 -42.24 77.88 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.342 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -65.99 -39.88 90.69 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.631 -0.428 . . . . 0.0 109.955 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.531 ' CG ' ' O ' ' A' ' 8' ' ' GLN . 4.3 m-30 -61.65 -46.84 88.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -58.63 -47.36 84.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.296 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -60.55 -40.95 93.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.539 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -58.8 -48.51 81.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.622 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.415 ' CD2' HD11 ' A' ' 27' ' ' ILE . 32.9 t80 -67.67 -47.11 70.42 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.7 m -59.83 -36.75 77.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 43.4 tp -62.43 -41.19 98.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.324 178.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.0 m-30 -64.76 -26.59 68.42 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.64 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 23' ' ' GLY . 47.7 t0 -82.88 92.64 7.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.195 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -57.38 -34.06 68.47 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.931 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -91.45 -22.81 20.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.521 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.484 ' H ' ' CG ' ' A' ' 20' ' ' ASP . . . 66.68 37.73 92.66 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.413 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 36.4 p-10 -98.05 14.02 28.9 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.549 0.214 . . . . 0.0 111.135 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.35 17.87 80.09 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.0 m -147.59 138.52 23.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.793 0.33 . . . . 0.0 111.115 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.415 HD11 ' CD2' ' A' ' 16' ' ' PHE . 68.4 mt -112.15 125.2 69.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 47.2 p -88.82 162.15 16.34 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -57.67 -29.99 65.09 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -178.797 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -66.42 -47.09 74.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.023 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -67.56 -46.65 72.1 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.263 178.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.3 tt -62.3 -41.08 98.22 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -64.66 -42.93 97.04 Favored Glycine 0 C--O 1.226 -0.393 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 178.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.7 m -50.07 -48.99 52.76 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.417 ' O ' HD23 ' A' ' 39' ' ' LEU . 73.3 t -64.17 -51.1 73.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.241 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.1 mmm -64.06 -41.69 97.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.447 0.642 . . . . 0.0 109.643 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 45.3 ttm180 -56.21 -45.56 79.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.714 0.769 . . . . 0.0 110.395 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.3 m -71.72 -19.39 62.06 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.855 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 35' ' ' VAL . 1.7 mm? -87.5 31.6 0.74 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.897 0.38 . . . . 0.0 111.654 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 60.94 42.78 99.84 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.708 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -136.81 149.88 48.01 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -129.43 70.54 81.87 Favored Pre-proline 0 N--CA 1.469 0.491 0 C-N-CA 121.305 -0.158 . . . . 0.0 111.241 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.76 145.52 25.72 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.183 1.922 . . . . 0.0 111.381 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.4 m -86.42 160.05 19.16 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.438 ' HG2' ' H ' ' A' ' 45' ' ' GLU . 2.0 pt-20 -59.92 -33.31 71.71 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.54 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.9 -47.15 86.02 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.187 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -64.09 -42.76 96.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.764 -179.388 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.49 -46.59 85.44 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.293 0.568 . . . . 0.0 110.788 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -62.85 -46.21 88.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.439 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -64.1 -40.62 96.61 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.664 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.6 ttm -59.82 -43.94 94.29 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.468 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 11.1 mt -64.48 -46.88 91.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.733 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -56.5 -35.89 68.52 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -65.27 -50.97 63.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.218 0.532 . . . . 0.0 111.119 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 57' ' ' ALA . 6.5 p -74.58 -21.3 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.194 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.553 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.8 t0 -67.79 49.23 0.05 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.797 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -39.98 -26.88 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.267 0.556 . . . . 0.0 110.384 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 56' ' ' ASP . 24.0 m-20 -88.13 -36.24 16.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.08 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 92.47 14.45 55.56 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -66.92 -31.56 72.22 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.819 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.553 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 99.2 -1.1 57.4 Favored Glycine 0 N--CA 1.47 0.922 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 65.9 p -137.23 160.72 38.2 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.4 mm -92.15 122.3 43.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -84.52 -176.3 6.18 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.466 ' CE2' HD11 ' A' ' 69' ' ' LEU . 43.2 t80 -76.86 -54.91 1.56 Allowed Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 118.336 -1.345 . . . . 0.0 111.868 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.7 Cg_endo -57.67 -41.03 74.92 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.103 1.202 . . . . 0.0 111.513 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.421 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 62.6 mt-10 -55.15 -42.17 72.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.655 0.741 . . . . 0.0 109.179 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -62.12 -38.85 90.5 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.743 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.466 HD11 ' CE2' ' A' ' 65' ' ' PHE . 74.3 mt -61.48 -42.12 98.3 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.792 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -60.83 -44.91 96.32 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 122.217 1.008 . . . . 0.0 108.75 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.5 tp -63.42 -46.9 84.23 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.29 -1.777 . . . . 0.0 110.733 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.401 ' SD ' ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -67.35 -45.57 75.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.355 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.169 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.66 -179.479 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.747 HG22 ' H ' ' A' ' 6' ' ' ASP . 20.4 m . . . . . 0 N--CA 1.469 0.52 0 CA-C-O 121.15 0.5 . . . . 0.0 111.455 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.747 ' H ' HG22 ' A' ' 5' ' ' THR . 98.0 m-20 -75.1 -40.73 59.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.444 178.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -49.4 -42.51 42.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.617 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.559 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 13.2 mp0 -70.35 -26.23 63.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.292 0.568 . . . . 0.0 109.771 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.4 mt -82.29 -57.19 4.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.059 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 t -58.3 -43.76 88.25 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.451 -0.499 . . . . 0.0 109.952 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -62.41 -39.93 94.88 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.559 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.4 m-30 -64.09 -46.07 85.89 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.647 0.737 . . . . 0.0 109.591 178.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -60.03 -47.44 85.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.328 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -62.8 -41.26 99.2 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.72 -47.78 83.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.689 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.465 ' CE1' ' OD2' ' A' ' 20' ' ' ASP . 51.6 t80 -67.82 -45.31 75.06 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.8 m -65.25 -34.09 77.54 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.2 tp -62.9 -40.22 96.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.709 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.504 ' CD1' HG21 ' A' ' 35' ' ' VAL . 21.9 m-85 -73.23 -14.12 61.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.043 179.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.465 ' OD2' ' CE1' ' A' ' 16' ' ' PHE . 55.5 m-20 -89.28 74.19 7.93 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.396 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -43.26 -43.5 4.87 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.497 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 18.6 p30 -83.42 -22.42 32.67 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.536 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 73.12 28.06 67.16 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.9 p30 -81.1 -4.17 54.42 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.591 0.234 . . . . 0.0 111.229 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.8 12.72 74.02 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 33.6 m -143.16 128.93 19.35 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.856 0.36 . . . . 0.0 110.976 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 79.9 mt -97.64 123.34 50.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.1 p -97.03 170.14 9.35 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.1 p -61.19 -27.61 68.54 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.742 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -64.46 -48.82 73.85 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.502 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.409 ' O ' HG23 ' A' ' 35' ' ' VAL . 94.3 mt-10 -66.94 -41.86 86.28 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.0 tt -61.1 -43.03 99.5 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.33 -43.99 94.23 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.0 m -49.77 -48.06 50.62 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.588 ' O ' HD13 ' A' ' 39' ' ' LEU . 74.1 t -65.28 -51.54 63.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 113.549 -1.659 . . . . 0.0 111.513 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.0 mmt -61.28 -46.02 92.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.513 0.673 . . . . 0.0 109.456 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.9 tpt85 -50.01 -50.95 45.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.947 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.7 t -74.15 -15.51 61.03 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.828 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.588 HD13 ' O ' ' A' ' 35' ' ' VAL . 6.0 mp -93.56 37.55 1.06 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.043 0.449 . . . . 0.0 111.754 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.29 4.45 6.44 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.596 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -100.74 149.32 23.93 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' A' ' 42' ' ' ASN . 2.1 p-10 -140.72 68.18 29.89 Favored Pre-proline 0 N--CA 1.467 0.401 0 C-N-CA 121.198 -0.201 . . . . 0.0 111.266 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.401 ' CG ' HD21 ' A' ' 48' ' ' LEU . 91.4 Cg_endo -74.79 158.43 42.99 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.327 2.018 . . . . 0.0 111.566 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.9 p -93.58 166.31 12.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -60.68 -33.21 72.5 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.694 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.53 98.9 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -62.23 -47.54 83.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.141 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.401 HD21 ' CG ' ' A' ' 43' ' ' PRO . 56.4 mt -64.87 -41.72 95.42 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.148 0.499 . . . . 0.0 111.241 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -61.86 -39.88 93.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.757 0.789 . . . . 0.0 109.196 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -78.32 -24.4 46.61 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.165 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.615 ' O ' HG12 ' A' ' 55' ' ' VAL . 41.3 ttm -71.22 -46.99 59.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.505 0.669 . . . . 0.0 109.82 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 tp -67.55 -40.52 84.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.269 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -65.3 -37.08 86.05 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.634 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -64.34 -36.65 84.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.407 0.622 . . . . 0.0 109.533 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.704 HG13 ' O ' ' A' ' 55' ' ' VAL . 7.2 p -109.39 68.44 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.115 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 58' ' ' ASP . 3.8 t0 -135.29 47.74 2.3 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -34.67 -29.76 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.763 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 42.3 p-10 -97.68 -38.37 9.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.487 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.546 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 91.14 12.67 59.82 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 40.4 p-10 -70.15 -25.23 63.36 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.803 -0.234 . . . . 0.0 111.31 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 90.76 7.84 66.03 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 75.2 p -143.81 157.23 44.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.3 mm -93.84 124.33 46.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.433 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 85.5 m-20 -90.0 -162.86 0.93 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 176.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.672 ' CZ ' HD11 ' A' ' 69' ' ' LEU . 50.4 t80 -76.24 -56.86 1.48 Allowed Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 118.274 -1.371 . . . . 0.0 111.85 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.47 -26.31 62.69 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 CA-C-N 120.37 1.168 . . . . 0.0 111.637 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.459 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 99.3 mt-10 -65.43 -35.07 79.82 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -70.83 -31.14 67.77 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.147 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.672 HD11 ' CZ ' ' A' ' 65' ' ' PHE . 9.7 mp -70.71 -34.57 72.07 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.588 177.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -64.42 -43.62 93.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 122.41 1.1 . . . . 0.0 108.815 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.665 ' HB2' HG21 ' A' ' 55' ' ' VAL . 25.8 tp -63.67 -45.92 87.91 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 112.998 -1.91 . . . . 0.0 110.844 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.485 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . 97.5 mmm -78.96 -30.13 44.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.113 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 C--O 1.234 0.253 0 CA-C-O 121.171 0.51 . . . . 0.0 110.094 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.428 ' OG1' ' OE1' ' A' ' 8' ' ' GLN . 77.0 p . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 121.204 0.526 . . . . 0.0 111.302 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 19.3 p-10 -77.41 -30.16 53.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.644 178.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -64.9 -44.79 88.45 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.069 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.532 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 5.1 mp0 -70.53 -25.64 63.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.169 0.509 . . . . 0.0 109.884 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.0 mt -83.97 -56.82 5.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.906 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -58.46 -41.12 84.48 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.258 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -65.6 -38.07 88.41 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.0 m-30 -64.9 -46.88 79.88 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.526 0.679 . . . . 0.0 109.673 178.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -62.23 -45.59 92.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.661 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -59.69 -37.57 79.18 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.495 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.07 -44.42 97.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.353 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.409 ' CE2' ' CG1' ' A' ' 27' ' ' ILE . 52.4 t80 -67.43 -45.95 74.54 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -178.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.4 t -63.45 -35.44 80.45 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.21 -40.64 98.04 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.338 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.495 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 27.1 m-85 -73.55 -19.67 60.84 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.099 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -87.38 80.27 8.2 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 120.904 -0.319 . . . . 0.0 111.583 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -52.59 -26.51 13.62 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.116 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' A' ' 24' ' ' ASP . 36.7 m-20 -103.26 4.46 36.64 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.876 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 38.52 31.59 0.12 Allowed Glycine 0 CA--C 1.529 0.967 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 34.9 p-10 -86.64 -0.85 57.03 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.639 0.257 . . . . 0.0 111.146 -178.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.425 ' O ' ' SG ' ' A' ' 26' ' ' CYS . . . 82.23 26.79 46.8 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 25' ' ' GLY . 40.4 m -154.09 134.52 13.44 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.907 0.384 . . . . 0.0 111.236 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.409 ' CG1' ' CE2' ' A' ' 16' ' ' PHE . 5.9 mm -102.32 115.54 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.3 p -88.19 163.97 15.89 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.446 HG22 ' CD1' ' A' ' 52' ' ' ILE . 0.6 OUTLIER -61.45 -24.42 66.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.18 0.514 . . . . 0.0 110.195 -178.562 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -69.4 -49.08 58.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.401 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -64.29 -43.52 94.49 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.058 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.7 tp -61.93 -42.81 99.53 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.99 -44.51 97.28 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.6 m -51.23 -46.51 62.32 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.57 -51.8 53.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 113.498 -1.683 . . . . 0.0 111.428 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.501 ' SD ' ' OE1' ' A' ' 41' ' ' GLN . 17.7 mmt -60.17 -42.51 95.12 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 63.3 ttm-85 -54.68 -46.5 74.07 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.591 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.0 m -76.48 -17.08 59.48 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.313 -1.312 . . . . 0.0 111.79 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' A' ' 41' ' ' GLN . 55.5 mt -93.26 38.39 1.04 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.723 0.297 . . . . 0.0 111.788 -178.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.1 2.22 0.88 Allowed Glycine 0 N--CA 1.464 0.528 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.501 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 80.2 mt-30 -97.7 150.39 21.25 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -136.54 68.71 60.43 Favored Pre-proline 0 N--CA 1.468 0.468 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.334 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.542 ' CG ' HD21 ' A' ' 48' ' ' LEU . 93.8 Cg_endo -75.26 153.72 40.75 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.267 1.978 . . . . 0.0 111.725 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -92.73 174.74 7.11 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.255 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.408 ' N ' ' OG1' ' A' ' 44' ' ' THR . 97.5 mt-10 -60.34 -40.03 89.21 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.778 -178.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.35 -46.46 90.15 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.508 0.671 . . . . 0.0 109.437 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.409 ' H ' HG23 ' A' ' 44' ' ' THR . 49.3 tp10 -54.24 -53.13 57.81 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.016 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.542 HD21 ' CG ' ' A' ' 43' ' ' PRO . 90.4 mt -62.12 -41.97 98.77 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.227 0.537 . . . . 0.0 111.067 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -67.26 -40.73 86.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.586 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -64.29 -41.72 96.74 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.258 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 38.5 ttm -59.15 -41.81 89.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.667 0.746 . . . . 0.0 109.46 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.446 ' CD1' HG22 ' A' ' 29' ' ' THR . 78.4 mt -66.27 -40.33 86.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.11 178.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -60.12 -39.37 85.99 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.354 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.6 -36.7 84.49 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.782 0.801 . . . . 0.0 109.732 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.499 HG13 ' OD1' ' A' ' 70' ' ' ASN . 59.6 t -110.84 63.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.878 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 58' ' ' ASP . 0.4 OUTLIER -124.37 41.39 3.51 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.356 -178.146 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 56' ' ' ASP . . . -30.64 -36.06 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.159 0.504 . . . . 0.0 111.096 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 48.6 p-10 -99.26 -33.68 10.64 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.741 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.561 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 81.07 22.96 60.07 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.459 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 39.5 p-10 -76.13 -23.68 54.87 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.49 0.182 . . . . 0.0 111.49 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.01 5.72 62.32 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.459 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 59.8 p -138.41 162.78 33.58 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.2 mt -98.91 121.23 49.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.979 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -90.58 -162.72 0.93 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.723 ' CE2' HD11 ' A' ' 69' ' ' LEU . 57.1 t80 -76.72 -55.0 1.61 Allowed Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 118.347 -1.341 . . . . 0.0 112.027 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 48.8 Cg_endo -62.02 -26.59 78.61 Favored 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 121.315 1.344 . . . . 0.0 112.189 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.435 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 97.6 mt-10 -70.75 -30.38 66.88 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -76.1 -35.75 59.2 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 113.927 -1.488 . . . . 0.0 110.273 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.723 HD11 ' CE2' ' A' ' 65' ' ' PHE . 88.7 mt -67.46 -30.48 70.21 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.405 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.499 ' OD1' HG13 ' A' ' 55' ' ' VAL . 14.0 t-20 -68.18 -45.1 74.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.652 1.215 . . . . 0.0 109.102 178.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 tp -63.56 -44.17 94.93 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 112.53 -2.123 . . . . 0.0 110.644 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.441 ' CG ' ' CE2' ' A' ' 12' ' ' PHE . 3.3 tpt -77.36 -32.6 55.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.612 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 CA--C 1.518 -0.261 0 CA-C-O 121.038 0.447 . . . . 0.0 109.996 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 p . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 121.083 0.468 . . . . 0.0 111.462 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 23.1 p-10 -73.3 -42.57 62.22 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.566 178.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.492 ' CG ' ' N ' ' A' ' 8' ' ' GLN . 13.6 pt-20 -53.85 -43.64 69.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.575 -179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.613 ' O ' ' CD2' ' A' ' 12' ' ' PHE . 85.4 mt-30 -69.87 -27.1 64.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.332 0.587 . . . . 0.0 109.881 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 77.5 mt -78.53 -58.58 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.405 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.3 t -56.8 -41.69 78.19 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.712 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -59.21 -41.69 89.17 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.613 ' CD2' ' O ' ' A' ' 8' ' ' GLN . 13.0 m-30 -65.72 -49.04 69.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.414 0.626 . . . . 0.0 110.149 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -61.23 -48.46 81.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.376 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -61.64 -40.58 95.39 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.52 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -63.44 -41.72 98.67 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.529 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.497 ' CD2' HD11 ' A' ' 27' ' ' ILE . 28.0 t80 -68.61 -47.59 66.28 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 m -64.17 -33.8 76.61 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.46 -40.73 97.57 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.284 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 31.8 m-85 -73.79 -16.33 61.16 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.916 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.542 ' OD2' ' N ' ' A' ' 25' ' ' GLY . 51.1 t0 -84.23 69.68 10.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.744 0.307 . . . . 0.0 111.442 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -43.04 -44.23 4.66 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.136 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -73.56 -23.89 60.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.744 0.307 . . . . 0.0 111.303 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 68.09 28.61 73.31 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 24.7 p-10 -89.93 5.4 46.54 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.764 0.316 . . . . 0.0 111.217 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.542 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 81.45 11.43 83.23 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.2 m -142.27 136.95 30.29 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 122.611 -0.347 . . . . 0.0 111.082 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.497 HD11 ' CD2' ' A' ' 16' ' ' PHE . 67.7 mt -101.41 126.9 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.0 p -99.04 160.3 14.36 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 33' ' ' GLY . 46.8 p -57.0 -25.71 58.99 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.589 -179.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.02 -49.35 72.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.243 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.9 -45.12 87.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.026 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.0 tp -61.84 -42.44 99.04 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -61.42 -44.32 98.19 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 178.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.1 m -49.1 -44.28 42.09 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.416 1.103 . . . . 0.0 108.25 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.1 t -73.83 -59.11 3.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 113.206 -1.816 . . . . 0.0 111.328 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 72.5 mtp -53.63 -44.46 69.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.512 0.672 . . . . 0.0 109.694 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 78.8 ttt-85 -58.83 -45.08 90.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.129 178.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.1 m -79.28 0.65 27.88 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.635 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 mp -106.48 35.47 2.95 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.477 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.5 37.01 91.51 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.702 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -137.74 153.45 49.74 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -136.72 78.66 42.19 Favored Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 121.324 -0.15 . . . . 0.0 111.304 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.72 150.82 21.65 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.234 1.956 . . . . 0.0 111.713 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.1 m -86.17 163.31 17.9 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -64.78 -34.11 77.57 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.832 -178.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.66 -41.31 97.35 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.397 0.618 . . . . 0.0 109.541 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.485 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -62.24 -49.77 74.39 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.258 -179.09 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.6 mt -62.26 -41.24 98.27 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.06 0.457 . . . . 0.0 111.549 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.434 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 55.7 tt0 -65.21 -36.54 84.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.732 0.777 . . . . 0.0 109.429 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -80.17 -35.25 36.72 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.227 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.472 ' SD ' ' C ' ' A' ' 51' ' ' MET . 9.1 tmm? -70.38 -51.3 30.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.093 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 7.6 tp -59.15 -46.54 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.734 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.485 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 96.5 m-20 -69.57 -31.72 70.07 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.4 -36.66 84.88 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.639 0.733 . . . . 0.0 110.497 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.691 ' O ' HG22 ' A' ' 55' ' ' VAL . 14.6 p -98.31 18.25 2.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.8 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.719 ' CG ' ' H ' ' A' ' 59' ' ' GLY . 65.1 t0 -99.32 69.74 1.7 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.889 -177.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -37.74 -25.25 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.651 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 56' ' ' ASP . 17.4 m-20 -94.52 -40.87 9.64 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.615 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.719 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 92.03 7.65 63.98 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.408 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 15.7 m120 -66.99 -28.14 68.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.578 0.228 . . . . 0.0 111.16 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.593 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 99.91 8.26 51.51 Favored Glycine 0 N--CA 1.464 0.52 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 76.7 p -137.87 166.28 24.42 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.428 ' CG1' HD11 ' A' ' 52' ' ' ILE . 4.8 mt -104.11 125.22 58.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -176.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -97.79 158.09 15.71 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 176.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.549 ' CE2' HD11 ' A' ' 69' ' ' LEU . 58.3 t80 -49.93 -48.36 78.42 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 118.0 -1.48 . . . . 0.0 111.408 -178.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.35 -44.35 43.63 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 121.219 1.279 . . . . 0.0 112.31 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.432 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 73.3 mt-10 -61.22 -34.49 75.2 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 122.285 1.04 . . . . 0.0 108.297 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 65' ' ' PHE . 89.5 t80 -68.42 -25.91 65.26 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.356 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.549 HD11 ' CE2' ' A' ' 65' ' ' PHE . 25.2 mt -74.98 -32.71 61.75 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.925 0.393 . . . . 0.0 110.492 177.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -64.2 -42.61 96.55 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 122.745 1.26 . . . . 0.0 108.541 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.423 ' HB2' HG21 ' A' ' 55' ' ' VAL . 43.2 tp -63.02 -45.67 91.24 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.532 -2.122 . . . . 0.0 110.448 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.546 ' SD ' ' CE1' ' A' ' 12' ' ' PHE . 7.6 mmt -78.48 -28.26 46.41 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.97 178.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 121.145 0.498 . . . . 0.0 110.081 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.2 p . . . . . 0 N--CA 1.468 0.466 0 CA-C-O 121.379 0.609 . . . . 0.0 111.397 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -77.52 -34.45 54.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.587 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.472 ' OE1' ' N ' ' A' ' 7' ' ' GLU . 57.6 mp0 -65.1 -44.72 87.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.209 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.548 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 38.5 mt-30 -67.35 -24.13 65.68 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.07 0.462 . . . . 0.0 110.199 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 90.0 mt -83.63 -53.58 10.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.192 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.9 t -59.15 -45.12 91.81 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.251 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 11' ' ' GLU . 0.3 OUTLIER -62.86 -38.93 92.79 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.293 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.548 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 2.9 m-30 -62.44 -45.2 94.17 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 121.442 0.639 . . . . 0.0 109.861 178.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -63.54 -41.78 98.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.829 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -64.62 -41.78 95.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.54 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -59.39 -49.56 77.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.566 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.455 ' CD2' HD11 ' A' ' 27' ' ' ILE . 51.3 t80 -66.47 -44.27 83.15 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.1 p -64.8 -35.39 80.95 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 41.2 tp -63.8 -39.43 94.23 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.493 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.54 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.6 m-30 -66.52 -16.27 64.02 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.318 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.463 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 38.6 t0 -94.78 88.21 5.27 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.384 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -47.95 -40.88 23.51 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.537 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 3.4 p30 -91.98 -24.59 19.19 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.667 -178.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.411 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 76.76 33.12 47.76 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.041 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.463 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 80.0 m-20 -73.45 -7.39 51.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.782 0.325 . . . . 0.0 111.036 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.01 2.69 64.3 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.2 p -143.43 138.01 29.03 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.945 0.402 . . . . 0.0 111.096 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.455 HD11 ' CD2' ' A' ' 16' ' ' PHE . 76.9 mt -96.67 126.65 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.8 p -90.85 170.35 10.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.558 ' O ' ' N ' ' A' ' 33' ' ' GLY . 27.3 p -61.63 -49.29 77.15 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.917 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.493 ' CG ' ' N ' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -56.57 -43.03 79.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.152 0.501 . . . . 0.0 110.332 179.557 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.493 ' N ' ' CG ' ' A' ' 30' ' ' LYS . 89.6 mt-10 -61.55 -49.1 78.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.69 178.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.2 tt -63.25 -41.47 99.07 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -61.79 -40.7 99.16 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 30' ' ' LYS . 20.7 m -53.79 -48.62 69.63 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.08 -47.7 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.377 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 17.3 mmt -64.22 -44.28 92.4 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -50.62 -51.29 50.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.634 0.731 . . . . 0.0 110.676 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -68.34 -27.0 65.89 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.705 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 41' ' ' GLN . 46.6 mt -78.2 37.56 0.26 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -178.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.75 -6.91 0.77 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.138 -0.553 . . . . 0.0 111.75 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.487 ' H ' ' C ' ' A' ' 39' ' ' LEU . 76.6 mt-30 -89.5 149.85 22.72 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -133.95 65.21 69.35 Favored Pre-proline 0 N--CA 1.469 0.476 0 C-N-CA 121.321 -0.151 . . . . 0.0 111.384 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.2 155.6 33.15 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.147 1.898 . . . . 0.0 111.503 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 m -93.38 159.51 15.22 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.431 ' HG2' ' H ' ' A' ' 45' ' ' GLU . 0.8 OUTLIER -59.53 -33.26 71.16 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.665 -178.62 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.3 -39.4 82.93 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -69.31 -45.55 69.29 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.103 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.5 mt -63.7 -43.38 96.79 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.144 0.497 . . . . 0.0 110.957 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -60.75 -49.09 78.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.432 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -65.93 -33.22 75.34 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.106 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 34.8 ttm -65.75 -42.41 90.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.722 0.773 . . . . 0.0 109.994 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 1.1 tp -65.62 -47.35 86.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.724 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.416 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 77.7 m-20 -65.48 -28.53 69.28 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 124.009 0.818 . . . . 0.0 112.903 -177.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -68.21 -45.51 73.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.602 0.715 . . . . 0.0 110.969 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.541 ' O ' HG22 ' A' ' 55' ' ' VAL . 12.4 p -89.03 -3.47 9.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.719 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 37.5 t0 -64.67 41.57 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.233 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -40.67 -32.57 0.22 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.189 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -74.6 -38.31 62.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.675 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.542 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 91.08 16.57 53.73 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 42.7 p30 -87.64 -25.42 23.55 Favored 'General case' 0 CA--C 1.53 0.173 0 O-C-N 122.685 -0.303 . . . . 0.0 111.334 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.555 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 91.58 5.18 67.12 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.5 p -142.57 168.39 19.83 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.0 mt -97.86 119.62 46.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.307 -0.557 . . . . 0.0 112.194 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -90.62 148.72 22.47 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 176.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.565 ' CE2' HD11 ' A' ' 69' ' ' LEU . 46.6 t80 -48.03 -52.1 43.18 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 118.145 -1.422 . . . . 0.0 111.464 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.23 -50.61 12.47 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 CA-C-N 119.901 1.0 . . . . 0.0 111.603 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.441 ' OE2' ' O ' ' A' ' 55' ' ' VAL . 32.9 tt0 -55.17 -52.75 62.32 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -47.26 -25.35 0.93 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.941 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.565 HD11 ' CE2' ' A' ' 65' ' ' PHE . 83.7 mt -79.07 -41.74 28.04 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.781 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -60.96 -41.12 95.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 122.348 1.071 . . . . 0.0 108.466 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.7 tp -57.91 -64.43 0.91 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.821 -1.99 . . . . 0.0 110.318 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.7 mmm -63.45 -36.35 83.45 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.58 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.142 0 CA-C-O 121.116 0.484 . . . . 0.0 110.062 179.619 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.511 ' HG1' ' CD ' ' A' ' 8' ' ' GLN . 16.2 p . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 121.19 0.519 . . . . 0.0 111.392 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.436 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 24.9 p-10 -80.03 -26.36 39.82 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.339 177.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.412 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 97.6 mt-10 -63.15 -44.79 94.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.901 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.586 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 5.1 mp0 -69.91 -23.21 63.19 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.522 0.677 . . . . 0.0 110.124 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -83.9 -56.55 5.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.429 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 61.6 m -58.25 -40.69 82.43 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.151 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -65.73 -37.42 86.33 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.046 0.451 . . . . 0.0 109.873 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.586 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 2.4 m-85 -62.59 -45.28 93.63 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.468 0.652 . . . . 0.0 109.995 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -63.2 -42.21 99.28 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.064 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -63.31 -41.78 98.96 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.85 -46.99 86.43 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.292 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.439 ' CE2' ' CG1' ' A' ' 27' ' ' ILE . 48.1 t80 -67.9 -45.6 73.99 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.3 p -63.71 -33.78 76.41 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.1 tp -62.9 -39.92 95.96 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.242 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.531 ' CD1' HG21 ' A' ' 35' ' ' VAL . 21.2 m-85 -73.97 -18.97 60.8 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.033 179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 25' ' ' GLY . 29.2 t0 -86.57 74.1 9.95 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.749 0.309 . . . . 0.0 111.338 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -44.9 -36.55 3.38 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.735 0.303 . . . . 0.0 111.255 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -87.94 -23.86 23.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.708 0.289 . . . . 0.0 111.427 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.51 21.48 76.17 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.0 p-10 -80.13 -1.23 39.32 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.679 0.276 . . . . 0.0 111.11 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.433 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 82.97 26.41 45.08 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 32.2 m -151.03 132.15 14.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.992 0.425 . . . . 0.0 111.057 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.439 ' CG1' ' CE2' ' A' ' 16' ' ' PHE . 4.3 mm -101.64 147.79 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 p -126.94 167.98 15.14 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 33' ' ' GLY . 58.0 p -58.78 -30.49 67.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.959 0.409 . . . . 0.0 110.818 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HG3' ' H ' ' A' ' 31' ' ' GLU . 38.9 pttt -67.18 -49.47 64.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.79 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.46 ' H ' ' HG3' ' A' ' 30' ' ' LYS . 88.7 mt-10 -67.12 -48.52 67.87 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.189 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.99 -43.7 98.48 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -62.65 -41.21 99.85 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 178.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.3 m -50.29 -46.04 54.98 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.411 1.101 . . . . 0.0 108.231 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.531 HG21 ' CD1' ' A' ' 19' ' ' PHE . 58.5 t -69.76 -55.89 13.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 113.345 -1.752 . . . . 0.0 111.424 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 83.0 mmm -54.41 -44.74 72.64 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.868 0.842 . . . . 0.0 109.943 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -54.08 -46.95 72.17 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.461 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.1 t -79.07 -9.39 59.53 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.069 -1.423 . . . . 0.0 111.728 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.405 ' O ' ' CD2' ' A' ' 39' ' ' LEU . 0.9 OUTLIER -94.05 34.62 1.23 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.502 -178.723 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.37 2.1 6.74 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.548 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -102.47 152.42 21.16 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -134.61 65.16 66.34 Favored Pre-proline 0 N--CA 1.47 0.531 0 CA-C-O 120.405 0.145 . . . . 0.0 111.271 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.403 ' CG ' HD21 ' A' ' 48' ' ' LEU . 85.4 Cg_endo -76.47 156.04 36.43 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.146 1.898 . . . . 0.0 111.629 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.5 p -92.79 168.88 10.89 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -60.02 -31.77 70.27 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.881 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.11 -44.7 96.09 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.585 0.707 . . . . 0.0 109.593 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -60.79 -49.18 78.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.316 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.403 HD21 ' CG ' ' A' ' 43' ' ' PRO . 73.7 mt -62.94 -41.82 99.61 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.954 0.407 . . . . 0.0 111.576 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -66.11 -41.52 90.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.41 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -64.71 -37.26 86.98 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.956 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.6 ttm -61.88 -41.78 98.28 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.479 HD12 ' CG2' ' A' ' 29' ' ' THR . 25.2 mt -65.59 -43.24 94.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.292 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -63.72 -39.91 95.46 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -61.85 -37.69 85.43 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 122.028 0.918 . . . . 0.0 110.089 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.0 t -109.18 67.54 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.389 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 58' ' ' ASP . 2.8 t0 -131.9 45.2 2.81 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.128 0.489 . . . . 0.0 109.794 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -38.67 -23.15 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.06 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 56' ' ' ASP . 29.1 p-10 -102.28 -43.09 5.8 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.68 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.467 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 90.88 29.69 12.65 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.436 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 48.1 p30 -87.36 -11.88 48.01 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 111.392 0.145 . . . . 0.0 111.392 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.03 6.13 85.66 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.686 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.8 p -138.85 163.99 30.81 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.6 mt -99.76 122.65 51.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.824 -177.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -91.97 -165.2 1.3 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 176.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.471 ' CE2' HD11 ' A' ' 69' ' ' LEU . 59.5 t80 -77.48 -47.02 2.52 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 117.823 -1.551 . . . . 0.0 111.841 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -65.26 -31.22 53.72 Favored 'Trans proline' 0 N--CA 1.507 2.319 0 C-N-CA 121.439 1.426 . . . . 0.0 112.06 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -66.59 -31.07 71.53 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 122.808 1.289 . . . . 0.0 108.149 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -75.58 -30.98 59.81 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.456 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 73' ' ' ALA . 4.8 mt -69.7 -34.31 73.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.531 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -65.06 -44.13 89.98 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.47 1.129 . . . . 0.0 109.292 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.6 tp -61.66 -45.84 92.31 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 112.545 -2.116 . . . . 0.0 110.79 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.455 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . 99.5 mmm -80.12 -31.29 39.11 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.102 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.467 0.4 0 CA-C-O 121.31 0.576 . . . . 0.0 109.812 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 121.151 0.501 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -65.3 -33.64 76.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.223 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.94 -45.79 92.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.933 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.543 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -63.84 -36.23 83.23 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.88 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 74.7 mt -74.92 -54.34 14.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.078 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.0 t -55.83 -49.7 72.56 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.004 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -56.55 -41.68 77.27 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.883 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.543 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.0 m-85 -61.73 -48.79 79.13 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -60.78 -44.33 96.93 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.725 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -62.64 -44.94 95.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.39 -49.49 77.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.602 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 38.2 t80 -65.51 -49.15 70.06 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.3 t -60.67 -37.74 82.57 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.7 tp -61.97 -43.92 97.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.064 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.544 ' CD1' HG21 ' A' ' 35' ' ' VAL . 19.5 m-85 -66.26 -24.54 66.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.841 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -86.88 85.24 7.26 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.534 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -67.46 -16.85 64.45 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.207 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 17.4 t0 -96.65 -0.46 48.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.202 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 38.01 53.86 2.02 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 26' ' ' CYS . 31.6 p-10 -111.84 9.15 20.7 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.695 0.283 . . . . 0.0 111.003 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.1 3.15 88.14 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 36.1 m -142.48 146.37 34.68 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.983 0.421 . . . . 0.0 110.887 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.9 mt -110.74 125.76 68.05 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 57.2 p -86.69 160.74 18.76 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 33' ' ' GLY . 34.0 p -58.44 -29.69 66.33 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.311 -178.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -65.04 -48.19 74.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.29 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -60.85 -47.11 87.84 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.3 tp -63.65 -40.6 97.27 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -60.88 -46.67 94.07 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.0 m -48.57 -49.7 35.5 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.544 HG21 ' CD1' ' A' ' 19' ' ' PHE . 53.0 t -63.75 -51.07 74.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.587 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.2 mmt -62.83 -45.16 93.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 61.6 ttt85 -54.07 -50.24 67.22 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.405 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.3 t -66.85 -21.02 66.03 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.47 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.6 mt -86.83 29.89 0.78 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.73 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.58 39.98 98.56 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.87 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -128.04 142.54 51.19 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -129.64 62.69 64.73 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 121.351 -0.139 . . . . 0.0 111.315 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.35 152.33 34.52 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.222 1.948 . . . . 0.0 111.538 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.8 p -83.85 160.93 21.05 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -60.23 -33.82 72.81 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.849 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.78 -47.15 85.72 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.427 0.632 . . . . 0.0 109.342 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.42 -43.58 83.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.846 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.4 mt -65.19 -45.59 84.17 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.107 0.479 . . . . 0.0 111.632 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.441 ' O ' HG22 ' A' ' 52' ' ' ILE . 58.4 tt0 -66.54 -33.96 76.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 122.203 1.002 . . . . 0.0 109.233 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.467 ' O ' ' OE2' ' A' ' 54' ' ' GLU . 96.2 m-20 -76.37 -39.98 52.33 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.524 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 39.2 ttm -58.66 -45.12 90.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.328 0.585 . . . . 0.0 110.498 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.441 HG22 ' O ' ' A' ' 49' ' ' GLN . 6.6 tt -70.66 -33.22 52.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.399 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -60.46 -39.0 86.02 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.562 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.467 ' OE2' ' O ' ' A' ' 50' ' ' ASP . 4.9 mm-40 -65.28 -16.43 63.55 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.364 0.602 . . . . 0.0 110.833 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 57' ' ' ALA . 3.0 t -110.2 -19.12 7.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.759 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -65.55 48.51 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.043 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -57.7 -23.34 51.19 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.964 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 17.6 p-10 -88.67 -44.88 10.27 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.318 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 93.05 50.31 2.47 Favored Glycine 0 N--CA 1.471 1.006 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.67 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 55.6 p30 -109.88 -21.61 12.27 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.692 -0.299 . . . . 0.0 110.999 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.544 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 84.7 -4.71 84.15 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 51.1 p -131.42 169.43 16.05 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.9 mt -104.14 119.29 52.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -91.54 -175.93 4.35 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 175.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.451 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 75.6 t80 -69.44 -55.61 9.37 Favored Pre-proline 0 C--N 1.318 -0.796 0 C-N-CA 118.63 -1.228 . . . . 0.0 112.242 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 14.3 Cg_endo -50.45 -43.08 46.34 Favored 'Trans proline' 0 N--CA 1.504 2.109 0 C-N-CA 121.885 1.724 . . . . 0.0 111.373 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.401 ' OE2' ' CG ' ' A' ' 58' ' ' ASP . 95.2 mt-10 -58.86 -52.63 64.89 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -57.33 -41.71 80.5 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.648 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.4 tp -61.36 -44.73 96.68 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.163 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -64.24 -52.5 58.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 122.619 1.199 . . . . 0.0 108.953 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.8 tt -51.95 -59.43 4.35 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.078 -1.874 . . . . 0.0 110.62 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.419 ' CG ' ' CE2' ' A' ' 12' ' ' PHE . 1.2 tpt -61.6 -39.29 90.68 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.757 178.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 -0.152 0 CA-C-O 121.197 0.522 . . . . 0.0 110.499 179.472 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.431 ' N ' HD21 ' A' ' 4' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 3' ' ' GLN . 88.0 m-20 54.81 42.45 31.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.5 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' A' ' 2' ' ' ASP . 59.2 tt0 58.86 121.42 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.512 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 4' ' ' LEU . 3.5 mm? -78.25 145.79 35.25 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.796 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.7 p -94.12 -176.68 4.06 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.161 0.505 . . . . 0.0 111.356 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -72.99 -42.89 62.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.875 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 7' ' ' GLU . 6.7 pt-20 -61.77 -44.54 96.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.956 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.558 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 93.2 mt-30 -69.63 -24.73 63.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.53 0.681 . . . . 0.0 109.975 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.8 mt -83.4 -56.18 6.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.243 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.8 t -58.47 -42.6 87.88 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -63.89 -39.78 94.99 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.558 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.2 m-30 -64.07 -45.71 87.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.771 0.796 . . . . 0.0 109.862 178.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -60.92 -46.78 89.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.729 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -62.26 -39.75 93.93 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.424 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -60.65 -44.67 96.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.435 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.458 ' CE2' ' CG1' ' A' ' 27' ' ' ILE . 35.1 t80 -69.05 -45.63 69.9 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.6 m -65.81 -33.18 75.27 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.738 0.78 . . . . 0.0 109.065 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.37 -40.43 96.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.376 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.549 ' CD1' HG21 ' A' ' 35' ' ' VAL . 26.6 m-85 -73.87 -14.65 61.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.92 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.532 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 42.4 t0 -89.55 78.91 6.97 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.171 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.424 ' NZ ' HG21 ' A' ' 34' ' ' THR . 98.2 mttt -40.94 -47.61 3.03 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.736 -178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.43 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 20.8 p30 -88.11 -1.75 58.19 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.646 0.26 . . . . 0.0 111.683 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.12 39.23 41.31 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.051 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.532 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 44.5 p-10 -90.97 -0.05 57.65 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.645 0.26 . . . . 0.0 111.247 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.494 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 81.76 20.66 63.13 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.404 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 6.4 m -143.08 137.28 29.07 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.021 0.439 . . . . 0.0 111.082 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.458 ' CG1' ' CE2' ' A' ' 16' ' ' PHE . 4.9 mm -109.46 122.11 63.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.2 p -100.48 167.13 10.57 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.656 HG22 HD12 ' A' ' 52' ' ' ILE . 74.7 p -60.4 -28.59 68.36 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.411 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -66.59 -48.34 69.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.592 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -67.47 -45.65 75.34 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.979 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.3 tp -62.1 -41.86 98.64 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -63.78 -42.34 98.57 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.424 HG21 ' NZ ' ' A' ' 21' ' ' LYS . 24.2 m -50.18 -46.22 54.07 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.549 HG21 ' CD1' ' A' ' 19' ' ' PHE . 98.1 t -69.59 -55.76 13.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 113.389 -1.732 . . . . 0.0 111.296 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 84.5 mmm -57.0 -41.22 78.09 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -58.9 -51.49 69.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.848 0.832 . . . . 0.0 110.622 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.4 t -69.58 -14.19 62.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.687 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 41' ' ' GLN . 1.7 mm? -97.39 36.7 1.44 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.964 0.412 . . . . 0.0 111.335 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.78 6.33 3.56 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.198 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' A' ' 39' ' ' LEU . 4.8 tp60 -102.07 151.06 22.6 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -144.05 68.98 16.18 Favored Pre-proline 0 N--CA 1.464 0.253 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.218 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.47 ' HB2' HD21 ' A' ' 48' ' ' LEU . 29.4 Cg_exo -65.18 152.58 81.73 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.488 2.125 . . . . 0.0 112.185 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.4 m -79.72 159.97 26.43 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -61.41 -48.43 81.23 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.07 -0.652 . . . . 0.0 112.1 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.15 77.06 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -61.07 -45.39 94.93 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.237 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 43' ' ' PRO . 85.4 mt -62.28 -41.31 98.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.265 0.555 . . . . 0.0 110.774 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -65.24 -45.86 82.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.626 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.92 -42.34 97.42 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.246 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 45.9 tpp -59.13 -45.98 89.54 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.656 HD12 HG22 ' A' ' 29' ' ' THR . 2.8 mt -63.49 -43.08 98.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.35 178.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -59.69 -28.97 67.76 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -68.52 -31.31 70.46 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.277 0.56 . . . . 0.0 110.762 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.442 ' C ' ' H ' ' A' ' 57' ' ' ALA . 61.5 t -98.6 -13.36 8.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.541 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 28.8 t0 -72.28 40.89 0.08 Allowed 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.317 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.442 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -40.66 -24.37 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.393 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 4.5 p-10 -89.2 -39.96 13.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.165 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.525 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 92.21 54.76 1.81 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.561 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 47.5 p30 -117.56 -20.77 8.87 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.719 -0.283 . . . . 0.0 110.958 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.561 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 81.2 5.78 89.82 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.8 p -135.76 165.13 26.3 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.8 mt -107.33 126.39 63.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -91.57 -167.42 1.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 175.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.566 ' CZ ' HD11 ' A' ' 69' ' ' LEU . 43.4 t80 -79.67 -50.67 1.24 Allowed Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 118.525 -1.27 . . . . 0.0 111.166 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.72 -33.54 93.01 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.319 1.346 . . . . 0.0 112.011 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -67.01 -30.63 70.79 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -74.81 -30.09 61.3 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.669 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.566 HD11 ' CZ ' ' A' ' 65' ' ' PHE . 4.3 mt -69.74 -33.1 71.99 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 177.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -68.09 -45.06 74.79 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.418 1.104 . . . . 0.0 109.357 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.2 tp -60.45 -45.64 92.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.108 -1.86 . . . . 0.0 111.355 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 93.0 mmm -79.29 -26.35 42.32 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.898 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . -70.45 -37.49 74.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.221 0.534 . . . . 0.0 110.514 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.6 mmm-85 -76.26 -36.82 58.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.62 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.565 ' C ' ' H ' ' A' ' 77' ' ' LYS . 19.5 tptp -63.36 -42.12 98.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.806 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 38.4 mmm -62.92 11.39 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.305 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.565 ' H ' ' C ' ' A' ' 75' ' ' LYS . 64.8 tttm -49.18 -35.86 18.11 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.18 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 77' ' ' LYS . 45.5 t0 -31.32 92.03 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.516 0.51 . . . . 0.0 111.455 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 77' ' ' LYS . 10.2 m . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.652 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.513 ' CG ' ' H ' ' A' ' 3' ' ' GLN . 32.0 t70 58.03 -176.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.789 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.513 ' H ' ' CG ' ' A' ' 2' ' ' ASP . 4.9 tp-100 29.74 82.88 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 O-C-N 122.986 0.179 . . . . 0.0 111.285 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.557 ' H ' ' CD2' ' A' ' 4' ' ' LEU . 4.0 mm? -33.88 146.66 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 O-C-N 122.912 0.132 . . . . 0.0 110.958 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.722 HG22 ' N ' ' A' ' 6' ' ' ASP . 32.5 m -82.49 171.68 13.86 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.109 0.48 . . . . 0.0 111.417 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.722 ' N ' HG22 ' A' ' 5' ' ' THR . 97.7 m-20 -70.53 -42.02 71.78 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.826 178.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.51 ' CG ' ' N ' ' A' ' 8' ' ' GLN . 7.2 pt-20 -43.98 -41.84 5.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.634 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.534 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 38.1 tp60 -62.94 -23.57 67.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.475 0.655 . . . . 0.0 109.327 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.559 ' N ' ' O ' ' A' ' 6' ' ' ASP . 24.7 mt -81.29 -51.1 15.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.08 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 39.4 t -56.93 -42.8 80.66 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.652 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -63.56 -42.5 98.34 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.6 m-30 -55.1 -46.24 75.51 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -62.59 -40.34 96.58 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.886 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -62.06 -44.86 95.78 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.549 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -57.9 -43.32 86.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.262 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -70.78 -49.38 47.18 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.7 t -59.1 -35.55 73.61 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.8 tp -61.86 -44.52 96.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.281 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.549 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.7 m-30 -59.03 -25.19 63.48 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.965 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -83.27 101.99 11.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.841 0.353 . . . . 0.0 111.432 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -65.44 -30.7 71.53 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.822 0.344 . . . . 0.0 111.725 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -103.21 -10.77 18.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.404 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 61.52 45.77 95.68 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -97.49 18.73 14.69 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.645 0.26 . . . . 0.0 111.256 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.9 7.71 50.42 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 31.5 m -141.77 146.91 36.51 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.991 0.424 . . . . 0.0 110.945 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 92.1 mt -113.17 129.43 68.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 81.5 p -91.47 161.88 14.79 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 33' ' ' GLY . 71.9 p -56.22 -32.75 64.72 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.587 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -64.27 -48.47 75.58 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.229 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.07 -46.21 91.61 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.851 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.1 tp -62.62 -43.31 99.14 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -59.69 -49.18 81.32 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 178.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.9 m -48.14 -48.28 34.28 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 122.369 1.081 . . . . 0.0 108.607 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.422 HG11 ' CE2' ' A' ' 19' ' ' PHE . 67.3 t -68.11 -52.71 35.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 113.195 -1.821 . . . . 0.0 111.295 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.401 ' CE ' ' OE1' ' A' ' 41' ' ' GLN . 35.8 mmm -61.86 -42.29 98.88 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.678 0.751 . . . . 0.0 109.756 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.5 tpt85 -54.37 -51.6 64.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.539 -1.209 . . . . 0.0 110.137 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.412 ' C ' ' H ' ' A' ' 40' ' ' GLY . 47.0 m -62.14 -32.86 73.51 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.98 -1.464 . . . . 0.0 111.702 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.537 ' C ' ' H ' ' A' ' 41' ' ' GLN . 76.2 mt -73.84 33.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.782 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 38' ' ' SER . . . 62.49 -6.71 0.29 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.538 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.537 ' H ' ' C ' ' A' ' 39' ' ' LEU . 42.5 tt0 -81.41 141.73 33.65 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 42' ' ' ASN . 19.1 p-10 -124.88 72.99 63.92 Favored Pre-proline 0 N--CA 1.47 0.529 0 C-N-CA 121.376 -0.13 . . . . 0.0 111.288 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.407 ' CG ' HD21 ' A' ' 48' ' ' LEU . 94.3 Cg_endo -81.2 142.76 13.66 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.023 1.816 . . . . 0.0 111.845 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.415 ' OG1' ' N ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -87.43 175.11 8.12 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.393 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.415 ' N ' ' OG1' ' A' ' 44' ' ' THR . 52.8 mt-10 -57.2 -46.99 82.38 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.806 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.76 -49.51 72.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.525 0.679 . . . . 0.0 109.594 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -52.53 -47.08 66.94 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.946 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.407 HD21 ' CG ' ' A' ' 43' ' ' PRO . 95.4 mt -65.41 -46.78 78.66 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.195 0.522 . . . . 0.0 111.78 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.448 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 86.6 mt-30 -60.58 -44.54 96.09 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.598 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -67.12 -35.22 79.27 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.436 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.2 tpp -66.64 -50.94 61.33 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.45 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 56' ' ' ASP . 7.9 tt -71.36 -40.69 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.305 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 49' ' ' GLN . 22.9 t-20 -60.03 -39.57 86.34 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -77.43 -13.68 59.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.56 0.695 . . . . 0.0 109.999 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.441 ' O ' ' OE1' ' A' ' 67' ' ' GLU . 38.2 t -103.44 -22.78 4.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.549 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 52' ' ' ILE . 45.9 t0 -76.5 52.71 0.81 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.332 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.67 -27.39 0.1 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.642 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.449 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 37.8 m-20 -80.79 -34.75 33.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.515 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 87.16 10.13 72.08 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 51.3 p-10 -69.64 -27.26 64.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.394 0.14 . . . . 0.0 111.291 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 96.53 -7.25 65.81 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.9 p -129.16 167.08 18.12 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.6 mt -104.0 123.57 57.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.783 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -88.63 -175.86 5.07 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 176.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.417 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 38.2 t80 -67.95 -55.84 12.64 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 117.955 -1.498 . . . . 0.0 112.019 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.1 Cg_endo -56.08 -33.63 90.44 Favored 'Trans proline' 0 N--CA 1.505 2.163 0 C-N-CA 121.517 1.478 . . . . 0.0 112.047 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.449 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 68.7 mm-40 -57.35 -56.04 26.93 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -60.46 -36.49 78.37 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.707 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.48 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -60.94 -48.72 80.53 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.204 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -55.01 -50.04 70.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.591 1.186 . . . . 0.0 109.009 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 tp -53.37 -46.25 69.52 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 112.574 -2.103 . . . . 0.0 110.599 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.2 tpt -67.48 -46.74 72.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.759 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.18 -40.12 96.6 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.129 0.49 . . . . 0.0 109.979 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.2 mmt85 -62.38 -44.34 96.7 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.54 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.516 ' C ' ' H ' ' A' ' 77' ' ' LYS . 24.9 mmtp -65.26 -33.38 75.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.38 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.1 ttm -62.4 5.76 0.1 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.328 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 75' ' ' LYS . 51.6 pttt -58.95 -38.93 80.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.28 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.5 p-10 -113.74 13.95 18.64 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.717 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.5 m . . . . . 0 C--O 1.22 -0.5 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.629 -179.733 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 54.63 81.11 0.11 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.413 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -82.45 -5.13 58.49 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.811 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.458 HD12 ' N ' ' A' ' 4' ' ' LEU . 7.9 mp -75.55 160.66 29.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.707 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.692 HG22 ' N ' ' A' ' 6' ' ' ASP . 27.1 m -104.57 174.42 5.88 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.101 0.477 . . . . 0.0 111.062 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.692 ' N ' HG22 ' A' ' 5' ' ' THR . 1.8 p30 -73.21 -41.96 63.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.165 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.522 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 12.4 pt-20 -64.47 -40.76 96.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.576 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.559 ' O ' ' CD2' ' A' ' 12' ' ' PHE . 95.6 mt-30 -69.8 -35.03 74.51 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.273 0.559 . . . . 0.0 110.498 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.6 mt -72.95 -57.11 7.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.296 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.0 t -57.48 -46.66 83.44 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.089 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -49.27 -46.04 45.77 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 8' ' ' GLN . 20.3 m-30 -66.94 -47.07 72.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.382 0.611 . . . . 0.0 110.101 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -62.54 -45.79 91.35 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.774 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -66.06 -41.97 90.09 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.517 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.37 -45.71 93.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.512 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.42 ' C ' ' CD1' ' A' ' 16' ' ' PHE . 26.3 t80 -67.72 -43.95 78.8 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.3 m -63.88 -35.82 81.89 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 39.0 tp -64.21 -39.74 94.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.445 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.517 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.5 m-30 -66.4 -15.81 63.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.43 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.54 ' CG ' ' H ' ' A' ' 23' ' ' GLY . 65.7 t0 -92.24 89.59 6.93 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.209 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -50.28 -41.55 50.8 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.787 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -82.94 -27.11 30.79 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.048 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.54 ' H ' ' CG ' ' A' ' 20' ' ' ASP . . . 72.15 31.85 63.57 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.479 ' OD2' ' SG ' ' A' ' 26' ' ' CYS . 35.7 p-10 -81.69 -3.88 54.76 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.23 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.87 3.9 57.99 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.479 ' SG ' ' OD2' ' A' ' 24' ' ' ASP . 15.3 p -141.73 146.38 35.96 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.0 0.429 . . . . 0.0 111.034 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.4 HD11 ' CD2' ' A' ' 16' ' ' PHE . 72.6 mt -108.98 125.11 66.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.0 p -90.0 169.76 10.93 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.471 ' H ' HG23 ' A' ' 29' ' ' THR . 2.9 p -59.54 -52.24 66.42 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.979 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -53.19 -40.18 64.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -66.21 -43.45 86.67 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.505 HD13 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -62.29 -46.6 88.03 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.294 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 37' ' ' ARG . . . -60.0 -41.52 97.95 Favored Glycine 0 C--O 1.223 -0.588 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.7 m -48.69 -52.23 24.47 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.42 HG11 ' CE2' ' A' ' 19' ' ' PHE . 78.2 t -65.74 -49.82 75.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.194 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.7 mmm -65.14 -39.15 92.63 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 33' ' ' GLY . 23.9 tpt180 -55.49 -50.21 70.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.538 0.685 . . . . 0.0 110.2 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.6 t -71.43 -19.51 62.23 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.328 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.91 36.12 0.44 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.717 0.294 . . . . 0.0 111.348 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.74 45.97 94.08 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.496 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -144.75 154.73 43.03 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 25.3 p30 -134.54 73.84 67.12 Favored Pre-proline 0 N--CA 1.467 0.413 0 C-N-CA 121.184 -0.206 . . . . 0.0 110.963 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.415 ' CG ' HD21 ' A' ' 48' ' ' LEU . 87.1 Cg_endo -78.26 149.14 24.65 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.963 1.776 . . . . 0.0 111.6 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.8 p -87.91 164.31 15.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -59.54 -42.72 92.97 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.952 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.14 80.68 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.52 -48.12 82.9 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.075 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.415 HD21 ' CG ' ' A' ' 43' ' ' PRO . 52.6 mt -64.64 -42.45 95.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.158 0.504 . . . . 0.0 111.067 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -61.96 -36.59 81.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.899 0.857 . . . . 0.0 109.287 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -75.65 -40.07 56.69 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.006 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 33.9 mtp -63.77 -45.97 87.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.32 0.581 . . . . 0.0 110.048 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.487 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 1.4 tp -65.79 -47.44 85.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.874 -178.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.487 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 18.0 t-20 -69.06 -20.27 64.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.861 -177.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -72.34 -48.74 39.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.182 0.515 . . . . 0.0 110.525 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 57' ' ' ALA . 12.0 p -86.2 -2.33 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.373 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.459 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 16.6 t70 -64.57 41.89 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.625 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -50.68 -26.75 5.84 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.862 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 25.8 p30 -71.71 -39.29 70.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.356 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.514 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 91.81 7.39 64.59 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 51.6 p-10 -85.9 -22.53 27.44 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 122.724 -0.28 . . . . 0.0 111.387 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 85.73 3.41 86.04 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.508 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 22.9 p -139.6 151.2 45.83 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.9 mm -85.35 127.6 39.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.333 -0.547 . . . . 0.0 112.359 -176.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -104.71 153.79 20.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.744 ' CZ ' HD23 ' A' ' 69' ' ' LEU . 34.8 t80 -45.89 -55.61 12.46 Favored Pre-proline 0 C--N 1.319 -0.719 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.418 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 11.9 Cg_endo -49.22 -50.31 13.21 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.97 1.78 . . . . 0.0 111.489 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -55.85 -53.38 57.47 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -54.71 -21.36 10.62 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.175 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.744 HD23 ' CZ ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -79.04 -44.22 22.64 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.305 0.574 . . . . 0.0 110.219 179.283 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -58.23 -42.12 85.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.7 tp -59.71 -64.19 1.03 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 112.785 -2.007 . . . . 0.0 109.456 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.85 -38.11 54.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.645 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.38 -41.36 76.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.153 0.501 . . . . 0.0 110.254 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -60.76 -42.3 97.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.276 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.441 ' C ' ' H ' ' A' ' 77' ' ' LYS . 48.7 mtpt -64.05 -39.73 94.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.479 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 26.0 ttm -56.72 -4.78 0.18 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.197 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.441 ' H ' ' C ' ' A' ' 75' ' ' LYS . 3.2 ttmp? -58.32 -46.87 85.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.337 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -100.27 -70.42 0.74 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.693 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.4 t . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.969 -179.869 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.547 ' C ' ' H ' ' A' ' 3' ' ' GLN . . . . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 69.81 -26.12 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.608 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.547 ' H ' ' C ' ' A' ' 1' ' ' ALA . 15.7 mm100 -56.87 135.74 55.78 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.732 0.301 . . . . 0.0 110.558 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 71.9 mt -110.97 159.63 17.56 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.34 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.1 p -104.49 175.17 5.58 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.242 0.544 . . . . 0.0 111.249 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -77.72 -29.41 51.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.385 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.442 ' OE1' ' N ' ' A' ' 7' ' ' GLU . 48.6 mp0 -68.37 -44.21 75.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.197 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.57 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 95.9 mt-30 -65.85 -29.74 70.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.278 0.561 . . . . 0.0 110.194 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.2 mt -77.44 -53.16 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.112 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.7 t -58.16 -46.56 85.48 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.845 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -54.6 -42.97 71.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.596 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.607 ' CE1' ' SD ' ' A' ' 72' ' ' MET . 16.3 m-30 -64.92 -46.73 80.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.163 0.506 . . . . 0.0 110.183 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -65.96 -43.01 89.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.743 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -67.08 -45.24 77.92 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.223 0.535 . . . . 0.0 110.073 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.554 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -62.74 -44.83 95.19 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.534 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.429 ' CD2' HD11 ' A' ' 27' ' ' ILE . 54.1 t80 -66.72 -43.99 82.77 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.8 m -63.35 -36.64 84.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.2 tp -63.74 -40.29 96.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.473 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.4 m-30 -63.29 -18.01 63.14 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.487 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.541 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 24.2 t0 -98.04 93.89 6.55 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.905 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.48 ' NZ ' HG21 ' A' ' 34' ' ' THR . 55.2 mttp -65.74 -19.69 65.99 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.662 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 24' ' ' ASP . 8.8 p30 -109.99 13.16 23.47 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.522 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 35.18 32.08 0.03 OUTLIER Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.541 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 97.5 m-20 -69.84 -8.96 52.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.568 0.223 . . . . 0.0 110.811 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.67 -7.61 65.63 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.8 m -143.64 149.66 37.61 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.748 0.309 . . . . 0.0 111.098 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.429 HD11 ' CD2' ' A' ' 16' ' ' PHE . 73.8 mt -96.22 125.14 49.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.1 p -84.28 -160.14 0.44 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.7 p -84.79 -58.15 2.83 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.439 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 34' ' ' THR . 21.7 pttp -54.21 -35.98 62.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.415 . . . . 0.0 109.959 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.438 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 95.6 mt-10 -62.37 -50.84 69.95 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.0 tt -63.34 -42.02 98.9 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.53 -39.34 97.2 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 30' ' ' LYS . 20.0 m -52.77 -49.36 65.69 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.539 ' O ' HD13 ' A' ' 39' ' ' LEU . 96.6 t -63.15 -47.86 90.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.807 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 84.6 mmm -63.64 -42.8 98.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.502 0.668 . . . . 0.0 110.416 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -53.26 -49.39 67.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.104 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.3 m -71.45 -27.08 63.01 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.513 -1.221 . . . . 0.0 112.018 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 35' ' ' VAL . 7.2 mp -84.05 31.56 0.49 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.44 -8.0 1.73 Allowed Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.461 ' H ' ' C ' ' A' ' 39' ' ' LEU . 90.4 mm-40 -85.71 146.77 26.66 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.6 p30 -135.79 64.91 58.58 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 121.249 -0.181 . . . . 0.0 111.155 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.27 154.76 41.47 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.441 2.094 . . . . 0.0 111.783 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.9 m -94.32 161.43 14.24 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.437 ' HG2' ' H ' ' A' ' 45' ' ' GLU . 2.6 pt-20 -54.66 -34.3 62.02 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.706 -178.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.63 -45.15 85.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.465 0.65 . . . . 0.0 109.394 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -63.83 -41.14 97.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.187 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.1 mt -62.28 -45.92 91.12 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.072 0.463 . . . . 0.0 111.091 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -67.27 -45.69 75.89 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.437 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.72 -43.12 99.64 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.288 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.3 ttm -61.39 -41.96 97.96 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 56' ' ' ASP . 34.1 mt -67.94 -44.93 84.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.583 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -58.37 -35.72 72.4 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -69.07 -21.2 64.09 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.121 0.486 . . . . 0.0 110.474 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.577 ' C ' ' H ' ' A' ' 57' ' ' ALA . 83.8 t -106.93 -23.48 4.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.301 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 59' ' ' GLY . 27.5 t0 -63.46 34.23 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.469 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.577 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -36.92 -27.01 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.381 0.61 . . . . 0.0 110.873 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 56' ' ' ASP . 19.3 p-10 -85.96 -37.04 19.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.178 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 87.12 62.41 1.5 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.515 ' H ' ' CG ' ' A' ' 56' ' ' ASP . 55.0 p30 -123.92 -18.17 6.06 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.637 0.219 . . . . 0.0 111.204 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 80.36 2.57 89.46 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.809 -0.516 . . . . 0.0 111.809 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.458 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 64.4 p -136.68 159.61 41.29 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.3 mt -100.05 121.06 50.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -86.99 145.67 26.42 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.422 ' CE2' HD12 ' A' ' 69' ' ' LEU . 34.1 t80 -46.4 -48.69 45.94 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 118.589 -1.244 . . . . 0.0 111.231 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -52.79 -49.07 18.83 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.24 1.294 . . . . 0.0 111.825 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.406 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 94.4 mt-10 -55.45 -52.83 62.3 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -53.07 -23.92 8.88 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.517 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.422 HD12 ' CE2' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -71.91 -46.1 58.87 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.051 0.453 . . . . 0.0 110.55 179.094 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -61.52 -42.41 98.76 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 122.427 1.108 . . . . 0.0 108.937 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.5 tp -62.05 -30.65 71.13 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 112.774 -2.012 . . . . 0.0 109.682 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.607 ' SD ' ' CE1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -82.5 -40.37 21.15 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.703 178.763 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.83 -36.54 72.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.006 0.431 . . . . 0.0 109.983 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -66.95 -43.56 82.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.391 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -64.32 -45.93 85.77 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.472 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.3 tpt -69.03 -5.2 20.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.692 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.8 tptt -78.72 -10.48 59.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.202 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 25.3 p-10 -39.89 -65.83 0.36 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.43 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.5 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 10.1 t . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.452 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.471 ' O ' ' O ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 1' ' ' ALA . 87.8 m-20 57.85 144.44 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 O-C-N 123.58 0.55 . . . . 0.0 109.95 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -137.05 16.58 3.02 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 121.186 -0.206 . . . . 0.0 111.41 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.511 ' N ' ' CD2' ' A' ' 4' ' ' LEU . 3.5 mm? -79.68 173.21 12.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.015 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 7' ' ' GLU . 4.8 m -114.34 150.7 34.16 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.237 0.541 . . . . 0.0 111.186 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 6' ' ' ASP . 5.4 p-10 -63.11 -34.47 77.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.406 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.454 ' H ' HG22 ' A' ' 5' ' ' THR . 97.6 mt-10 -61.64 -47.72 84.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.724 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.532 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -59.68 -36.02 75.63 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.3 mt -72.17 -55.24 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.977 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.2 t -55.38 -53.49 55.6 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.822 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -54.07 -44.3 71.02 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' A' ' 8' ' ' GLN . 4.7 m-30 -60.74 -51.22 70.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.455 0.645 . . . . 0.0 109.514 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -59.68 -42.7 93.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.5 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -62.33 -46.73 87.4 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.15 78.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.335 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.412 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 34.1 t80 -69.73 -50.94 38.67 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.0 p -57.79 -35.11 70.35 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 46.9 tp -61.27 -45.25 95.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.532 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.463 ' CD1' HG21 ' A' ' 35' ' ' VAL . 17.2 m-85 -61.26 -27.77 68.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.474 ' OD1' ' OD1' ' A' ' 22' ' ' ASP . 27.1 t0 -78.55 90.76 4.52 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.839 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -62.48 -36.02 81.18 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.795 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.474 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 28.8 p30 -96.64 -1.36 46.94 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.481 0.181 . . . . 0.0 111.296 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.31 40.47 37.9 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -88.93 3.93 49.79 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.718 0.294 . . . . 0.0 111.19 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.76 -6.05 84.03 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.4 m -133.1 158.92 41.57 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.836 0.35 . . . . 0.0 110.889 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.0 mt -119.96 126.85 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.5 p -90.4 157.47 17.59 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.554 ' O ' ' N ' ' A' ' 33' ' ' GLY . 66.7 p -55.13 -29.72 58.29 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.349 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.95 -48.83 77.2 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.229 0.538 . . . . 0.0 110.275 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -61.59 -45.11 95.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.842 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 tp -63.42 -38.89 92.9 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 177.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -62.89 -47.62 87.44 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.1 m -47.52 -48.68 27.37 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' A' ' 19' ' ' PHE . 56.8 t -63.72 -51.87 64.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 113.53 -1.668 . . . . 0.0 111.233 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.482 ' SD ' ' OE1' ' A' ' 41' ' ' GLN . 17.3 mmt -63.79 -45.52 89.34 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -47.8 -54.54 12.07 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.313 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 40' ' ' GLY . 37.5 m -62.06 -37.16 83.92 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.642 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 41' ' ' GLN . 69.8 mt -69.91 34.78 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.776 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 38' ' ' SER . . . 58.92 3.57 1.75 Allowed Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.482 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 87.0 mt-30 -97.43 149.09 22.53 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -147.54 67.01 10.28 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.269 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -65.52 157.6 57.47 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.288 1.992 . . . . 0.0 111.923 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.8 p -82.53 164.83 20.63 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 177.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -57.37 -40.62 78.53 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.436 -0.506 . . . . 0.0 112.051 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.3 -50.08 74.88 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.571 0.7 . . . . 0.0 109.803 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -54.11 -47.19 72.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.268 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.24 -47.33 71.08 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.905 0.384 . . . . 0.0 111.783 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.417 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 94.6 mm-40 -61.05 -40.03 92.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.54 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -74.22 -38.58 63.52 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.774 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 43.4 tpp -62.37 -48.89 77.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.493 0.663 . . . . 0.0 110.548 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 53' ' ' ASN . 19.7 tt -71.84 -41.84 69.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.195 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 49' ' ' GLN . 31.3 t30 -64.06 -38.75 92.19 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -60.58 -55.41 33.66 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.456 0.646 . . . . 0.0 110.958 -177.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.587 ' O ' HG22 ' A' ' 55' ' ' VAL . 7.1 p -67.67 -6.05 4.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.097 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.595 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.0 t0 -80.07 75.48 6.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.721 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.04 -24.66 1.14 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.259 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 12.0 p-10 -99.43 -44.68 6.1 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.22 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.595 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 93.57 29.11 10.35 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.9 p30 -71.41 -19.84 62.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.441 0.163 . . . . 0.0 111.242 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.91 -9.45 74.34 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.3 p -132.1 167.27 20.02 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.3 mt -100.13 126.36 53.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.777 -177.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -96.3 -172.25 2.49 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.728 ' CE2' HD11 ' A' ' 69' ' ' LEU . 55.4 t80 -71.6 -56.01 5.31 Favored Pre-proline 0 C--N 1.319 -0.728 0 C-N-CA 118.114 -1.434 . . . . 0.0 111.865 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 32.5 Cg_endo -57.05 -39.3 92.23 Favored 'Trans proline' 0 N--CA 1.503 2.046 0 C-N-CA 121.488 1.459 . . . . 0.0 111.875 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.432 ' OE2' ' OD1' ' A' ' 58' ' ' ASP . 64.5 mm-40 -55.02 -49.06 72.49 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -57.22 -42.35 81.22 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 114.319 -1.309 . . . . 0.0 110.16 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.728 HD11 ' CE2' ' A' ' 65' ' ' PHE . 71.3 mt -61.95 -44.77 96.06 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.767 -0.583 . . . . 0.0 110.904 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -57.3 -47.86 80.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 122.533 1.158 . . . . 0.0 109.079 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.424 ' HB2' HG21 ' A' ' 55' ' ' VAL . 32.2 tp -59.5 -50.11 75.17 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 112.823 -1.989 . . . . 0.0 110.102 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.3 tpt -65.48 -42.87 91.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.647 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.28 -40.55 94.03 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.919 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.5 ttt180 -57.36 -43.44 83.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.146 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -60.47 -42.52 96.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.287 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 87.2 mmm -69.06 -7.59 37.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.302 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -70.04 -44.53 69.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.621 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.413 ' CG ' ' N ' ' A' ' 79' ' ' THR . 65.9 t0 -150.74 -111.67 0.06 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.816 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.413 ' N ' ' CG ' ' A' ' 78' ' ' ASP . 76.7 p . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.597 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.544 ' C ' ' H ' ' A' ' 4' ' ' LEU . 47.6 p-10 -83.93 174.96 9.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.678 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 67.55 -36.37 0.29 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.973 0.416 . . . . 0.0 111.394 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.544 ' H ' ' C ' ' A' ' 2' ' ' ASP . 32.5 mt -119.17 168.17 11.12 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.003 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.432 ' O ' HD13 ' A' ' 9' ' ' ILE . 43.7 p -117.1 161.66 19.07 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.814 0.34 . . . . 0.0 111.114 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -75.7 -18.12 59.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -66.44 -43.66 84.99 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.049 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.613 ' O ' ' CD2' ' A' ' 12' ' ' PHE . 84.3 mt-30 -67.39 -33.67 75.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.525 0.679 . . . . 0.0 110.383 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.529 ' N ' HD12 ' A' ' 9' ' ' ILE . 1.4 mp -74.11 -58.22 5.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.709 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.5 t -56.29 -46.51 79.73 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.72 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -47.11 -50.37 20.21 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.239 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.613 ' CD2' ' O ' ' A' ' 8' ' ' GLN . 17.7 m-85 -62.92 -48.83 77.23 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.491 0.663 . . . . 0.0 110.76 178.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -62.42 -47.33 84.57 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.725 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -62.15 -42.16 98.99 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.0 99.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.396 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 19.6 t80 -70.03 -47.66 61.15 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.8 p -66.21 -30.54 71.02 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.9 tp -61.04 -41.54 96.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.296 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.576 ' CD1' HG21 ' A' ' 35' ' ' VAL . 25.9 m-85 -73.23 -15.18 61.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.821 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.543 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 26.3 t0 -86.8 69.8 10.32 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.269 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -40.08 -46.14 2.1 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.704 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.459 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 26.4 p-10 -74.87 -19.78 60.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.443 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 64.72 30.34 77.67 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.543 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 54.9 p-10 -81.58 -3.87 54.49 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.744 0.307 . . . . 0.0 111.151 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.68 5.11 72.03 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.455 ' O ' ' OD1' ' A' ' 20' ' ' ASP . 15.7 m -136.08 150.19 49.04 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.904 0.383 . . . . 0.0 110.817 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.4 ' CD1' ' CD2' ' A' ' 16' ' ' PHE . 82.9 mt -117.36 130.23 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.6 p -104.61 166.49 10.36 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 33' ' ' GLY . 36.0 p -56.45 -24.88 48.46 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.532 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.449 ' O ' ' OG1' ' A' ' 34' ' ' THR . 65.7 tttm -68.08 -50.15 56.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.092 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.25 -49.15 68.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.626 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.2 tp -62.26 -41.85 98.82 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -64.13 -42.68 97.94 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 30' ' ' LYS . 23.6 m -49.19 -46.51 45.7 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 122.275 1.036 . . . . 0.0 108.412 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.576 HG21 ' CD1' ' A' ' 19' ' ' PHE . 74.1 t -68.94 -55.48 15.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 113.398 -1.728 . . . . 0.0 111.217 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.8 mmt -60.2 -41.05 92.16 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.529 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.416 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 71.6 ttp85 -57.56 -50.25 73.71 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.321 178.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -68.38 -18.12 64.39 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.592 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 35' ' ' VAL . 1.8 mm? -91.05 38.95 0.97 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.905 0.383 . . . . 0.0 111.476 -178.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.49 26.56 59.74 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.396 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.522 ' OE1' ' N ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -111.97 142.84 43.87 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.522 ' N ' ' OE1' ' A' ' 41' ' ' GLN . 10.9 m120 -128.31 75.11 79.34 Favored Pre-proline 0 N--CA 1.47 0.541 0 C-N-CA 121.288 -0.165 . . . . 0.0 111.361 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -81.11 143.88 14.47 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.254 1.969 . . . . 0.0 111.487 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.435 HG23 ' H ' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -89.11 172.22 9.25 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.257 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -63.2 -39.58 95.04 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.901 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.46 94.3 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.392 0.615 . . . . 0.0 109.434 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.435 ' H ' HG23 ' A' ' 44' ' ' THR . 51.3 tp10 -56.84 -51.08 70.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.046 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.1 mt -62.62 -42.51 99.63 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.135 0.493 . . . . 0.0 111.11 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -64.64 -37.96 89.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.79 0.805 . . . . 0.0 109.272 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -75.37 -35.32 61.12 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.1 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 32.9 ttm -63.86 -50.76 67.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.451 0.643 . . . . 0.0 110.146 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.415 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 1.3 tt -66.28 -39.5 84.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.635 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -63.71 -30.84 71.89 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.784 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -77.08 -30.31 55.38 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.592 0.711 . . . . 0.0 110.497 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.579 ' O ' ' N ' ' A' ' 57' ' ' ALA . 54.7 t -98.39 -4.71 9.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.474 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 52' ' ' ILE . 16.6 m-20 -64.74 45.01 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.449 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -45.81 -37.58 6.26 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.286 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 25.0 p-10 -77.65 -43.3 31.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.435 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.476 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 90.36 16.74 54.9 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.497 ' OD1' ' O ' ' A' ' 62' ' ' THR . 52.9 p-10 -94.34 -1.77 53.27 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 122.87 -0.194 . . . . 0.0 111.093 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.77 2.25 50.28 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.532 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.497 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 31.6 p -134.13 150.65 51.14 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.6 mm -91.34 133.3 33.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -101.26 -172.34 2.15 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -76.98 -47.45 2.75 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 118.091 -1.443 . . . . 0.0 111.658 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.96 -37.62 75.35 Favored 'Trans proline' 0 N--CA 1.505 2.176 0 C-N-CA 121.701 1.601 . . . . 0.0 111.934 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -64.22 -35.87 82.21 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -76.44 -23.07 53.93 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.305 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.6 tp -78.3 -32.55 49.45 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.209 0.528 . . . . 0.0 110.652 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -68.43 -42.21 79.22 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.615 1.198 . . . . 0.0 108.641 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.8 tp -62.95 -41.55 99.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 112.527 -2.124 . . . . 0.0 110.416 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.404 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . 1.2 mmt -81.02 -22.49 39.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.885 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.39 -37.55 27.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.127 0.489 . . . . 0.0 109.791 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -70.47 -42.86 70.88 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.15 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.445 ' C ' ' H ' ' A' ' 77' ' ' LYS . 65.4 tttm -65.68 -47.37 75.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.438 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.513 ' SD ' ' O ' ' A' ' 76' ' ' MET . 0.1 OUTLIER -65.29 4.67 0.47 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.51 -179.416 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.445 ' H ' ' C ' ' A' ' 75' ' ' LYS . 88.6 tttt -64.36 -36.23 83.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.221 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -142.59 -84.32 0.17 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.997 0.427 . . . . 0.0 110.743 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.6 m . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.637 -179.757 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -83.16 100.11 10.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.102 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -78.65 138.08 38.14 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.885 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.3 mt -83.54 157.57 22.29 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.933 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.54 HG22 ' N ' ' A' ' 6' ' ' ASP . 7.1 m -96.81 165.75 11.96 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.082 0.468 . . . . 0.0 111.341 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.54 ' N ' HG22 ' A' ' 5' ' ' THR . 98.8 m-20 -68.51 -40.87 80.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.654 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -61.86 -46.67 88.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.949 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.546 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 7.8 mp0 -64.29 -32.08 73.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 78.3 mt -76.45 -55.37 11.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.247 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 42.9 t -56.72 -47.77 79.23 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.032 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -59.98 -40.7 90.05 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.843 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.546 ' CG ' ' O ' ' A' ' 8' ' ' GLN . 3.9 m-30 -61.19 -49.78 75.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.326 0.584 . . . . 0.0 109.835 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -65.57 -39.65 91.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.012 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -61.81 -43.03 99.66 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.531 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.0 -45.92 92.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.576 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 31.7 t80 -66.55 -48.79 68.54 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.9 m -62.91 -35.62 80.68 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.954 0.883 . . . . 0.0 108.8 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.3 tp -60.98 -43.59 98.61 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.311 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 9.7 m-30 -63.15 -19.0 64.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.955 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -85.91 95.27 9.41 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.28 0.363 . . . . 0.0 111.493 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -76.13 -20.58 57.48 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.371 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.2 p30 -110.56 1.09 17.92 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.65 0.262 . . . . 0.0 111.322 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 47.07 40.83 13.69 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -81.73 -2.65 51.35 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.725 0.298 . . . . 0.0 111.162 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.87 -8.18 78.77 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.1 m -143.05 139.85 30.7 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.776 0.322 . . . . 0.0 111.074 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.7 mt -96.58 128.4 47.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.5 p -86.23 -159.54 0.48 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 33' ' ' GLY . 22.0 p -86.56 -31.42 21.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.097 0.475 . . . . 0.0 110.806 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -67.12 -46.89 72.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.346 0.593 . . . . 0.0 110.403 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -63.16 -47.02 84.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.92 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.4 tp -63.82 -42.48 97.64 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -60.59 -46.8 93.73 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 178.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.9 m -48.87 -47.91 42.51 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 122.247 1.023 . . . . 0.0 108.292 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.92 -50.32 65.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 113.401 -1.727 . . . . 0.0 111.521 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 75.7 mmm -62.88 -43.0 99.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.783 0.801 . . . . 0.0 109.634 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -55.77 -52.21 64.73 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.452 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.5 t -66.42 -21.19 66.21 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.864 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 36.4 mt -84.43 30.9 0.53 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.583 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.6 45.98 94.74 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.855 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -141.19 151.11 43.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -134.91 68.82 71.21 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-O 120.394 0.14 . . . . 0.0 111.252 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.41 150.33 41.09 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.029 1.819 . . . . 0.0 111.845 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.3 p -87.22 166.96 14.54 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -59.81 -37.21 78.53 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.866 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.37 -47.41 78.95 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.448 0.642 . . . . 0.0 109.354 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -61.08 -46.42 90.73 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.134 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.2 mt -62.69 -49.32 75.58 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.162 0.506 . . . . 0.0 111.513 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -61.71 -39.47 91.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.226 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -72.02 -32.57 67.27 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.56 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.0 mmt -67.1 -45.75 76.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.363 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 4.1 tt -75.57 -41.63 41.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.893 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.41 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 24.4 t-20 -65.42 -41.79 93.19 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -177.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.78 -11.64 61.07 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.002 0.906 . . . . 0.0 109.909 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.531 ' C ' ' H ' ' A' ' 57' ' ' ALA . 42.9 t -110.37 -14.27 10.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.699 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 44.1 t0 -66.04 42.97 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.711 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -50.29 -28.67 8.2 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.261 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 1.8 p30 -77.87 -37.46 48.11 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.447 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.481 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 89.5 7.54 69.16 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.545 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 57.1 p30 -75.12 -21.52 58.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.416 0.151 . . . . 0.0 111.282 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.545 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 84.78 -5.52 81.8 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.741 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.429 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 54.5 p -133.82 163.71 28.87 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.8 mt -96.02 115.66 35.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.601 -0.439 . . . . 0.0 112.091 -177.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 65' ' ' PHE . 64.8 t0 -82.62 -173.52 4.67 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 176.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.509 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 34.2 t80 -77.68 -48.17 2.28 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 117.954 -1.498 . . . . 0.0 111.738 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.56 -43.57 53.97 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 121.287 1.324 . . . . 0.0 111.606 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.433 ' OE1' ' OD2' ' A' ' 58' ' ' ASP . 76.3 tt0 -56.0 -52.37 64.45 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 122.344 1.069 . . . . 0.0 108.208 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -48.34 -40.78 26.46 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.192 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.5 HD11 ' CE2' ' A' ' 65' ' ' PHE . 42.0 mt -61.43 -43.52 98.72 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.419 179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -58.48 -46.45 86.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 122.379 1.085 . . . . 0.0 109.125 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.1 tp -59.18 -47.43 85.33 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 112.847 -1.979 . . . . 0.0 110.484 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.0 tpt -67.71 -44.35 77.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.346 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.65 -39.56 88.77 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.156 0.503 . . . . 0.0 110.138 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.22 -37.46 72.03 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.627 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.535 ' C ' ' H ' ' A' ' 77' ' ' LYS . 65.2 tttm -62.12 -35.35 78.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.365 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 75.8 mmm -64.85 11.69 0.05 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.729 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.535 ' H ' ' C ' ' A' ' 75' ' ' LYS . 88.5 tttt -54.56 -44.38 72.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.04 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -72.55 95.55 1.83 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.095 0.474 . . . . 0.0 110.997 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.5 m . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.745 -179.827 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 54.43 31.09 13.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.808 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -77.11 17.49 0.45 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 121.253 -0.179 . . . . 0.0 111.253 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.2 pp -112.02 154.51 25.23 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.76 0.314 . . . . 0.0 110.626 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -89.76 170.53 10.35 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.29 0.566 . . . . 0.0 111.353 -179.457 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.678 ' O ' ' N ' ' A' ' 9' ' ' ILE . 5.8 p-10 -76.02 -52.7 9.66 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.284 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -43.31 -33.82 1.08 Allowed 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.961 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.532 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 84.2 mm-40 -70.53 -22.1 62.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.423 0.63 . . . . 0.0 109.835 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 6' ' ' ASP . 73.4 mt -83.28 -55.62 7.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.518 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -43.45 92.74 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 120.149 -0.621 . . . . 0.0 109.937 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -61.88 -39.64 92.65 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.0 m-30 -63.96 -45.97 86.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.385 0.612 . . . . 0.0 109.675 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -65.7 -43.14 90.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.587 -1.188 . . . . 0.0 111.756 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -62.96 -40.34 97.4 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.521 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -62.75 -43.35 99.03 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.36 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.424 ' CD1' HD11 ' A' ' 27' ' ' ILE . 48.1 t80 -68.16 -45.29 73.92 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.7 t -63.34 -36.99 85.53 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.4 tp -60.67 -38.39 84.78 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.943 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.521 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.8 m-30 -68.41 -15.39 63.53 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.017 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 65.8 t0 -95.29 77.36 3.43 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -43.02 -36.64 1.64 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.088 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.429 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 46.3 m-20 -83.52 -22.17 32.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.338 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 66.84 30.55 76.32 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.519 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 24.3 p-10 -88.66 0.11 56.74 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.533 0.206 . . . . 0.0 111.157 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.472 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 82.1 18.09 68.03 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.7 m -145.33 130.56 18.53 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 111.007 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.424 HD11 ' CD1' ' A' ' 16' ' ' PHE . 58.4 mt -103.67 141.57 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.424 ' H ' ' HB2' ' A' ' 31' ' ' GLU . 6.2 p -119.72 174.28 6.51 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.465 ' CG2' HD12 ' A' ' 52' ' ' ILE . 79.7 p -56.5 -33.48 66.04 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.808 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -67.69 -49.62 61.81 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.309 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.429 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 90.4 mt-10 -69.08 -45.37 70.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.2 tp -60.45 -44.31 95.96 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -63.83 -39.26 97.22 Favored Glycine 0 C--O 1.216 -1.003 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.1 m -50.29 -45.78 54.72 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.292 1.044 . . . . 0.0 108.677 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.71 -54.07 23.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 113.057 -1.883 . . . . 0.0 111.25 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.1 mmt -57.11 -41.6 79.27 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.523 0.678 . . . . 0.0 109.93 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -55.85 -45.39 78.46 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.564 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 61.8 p -79.87 -10.58 59.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.818 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.75 38.13 1.41 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.549 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.48 5.74 2.82 Favored Glycine 0 N--CA 1.465 0.568 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.502 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -103.71 151.8 22.57 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -138.1 74.04 43.74 Favored Pre-proline 0 N--CA 1.47 0.569 0 O-C-N 122.957 0.161 . . . . 0.0 111.19 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.445 ' CG ' HD21 ' A' ' 48' ' ' LEU . 97.7 Cg_endo -80.2 155.35 22.37 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.992 1.794 . . . . 0.0 112.026 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.566 HG22 ' N ' ' A' ' 45' ' ' GLU . 26.7 m -94.01 169.75 10.04 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.566 ' N ' HG22 ' A' ' 44' ' ' THR . 98.6 mt-10 -62.07 -34.0 75.46 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.954 -178.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.48 -44.55 96.88 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.481 0.657 . . . . 0.0 109.963 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.55 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -60.77 -51.54 68.91 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.037 -178.812 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.445 HD21 ' CG ' ' A' ' 43' ' ' PRO . 85.3 mt -61.26 -41.38 96.82 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.01 0.433 . . . . 0.0 111.829 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -64.61 -45.61 86.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.746 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -65.81 -37.57 86.6 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.074 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.4 mmm -61.91 -43.22 99.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.437 0.637 . . . . 0.0 109.563 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.465 HD12 ' CG2' ' A' ' 29' ' ' THR . 22.9 mt -66.68 -43.56 90.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.864 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -64.2 -35.03 79.47 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -70.43 -33.26 71.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.525 0.678 . . . . 0.0 110.324 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 55' ' ' VAL . 79.8 t -98.1 -4.74 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.095 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 15.8 t70 -65.6 41.59 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.057 0.456 . . . . 0.0 111.023 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -53.66 -25.97 20.42 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.58 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.434 ' OD1' ' OE1' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -80.31 -43.29 21.49 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.369 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.27 43.55 4.62 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.68 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 46.8 p30 -123.63 -15.27 7.08 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.268 0.099 . . . . 0.0 111.268 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 78.57 5.49 88.1 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.76 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.433 ' O ' ' OE1' ' A' ' 67' ' ' GLU . 72.4 p -135.84 164.5 27.79 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.0 mt -99.57 121.77 50.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.459 ' H ' ' HB3' ' A' ' 67' ' ' GLU . 90.5 m-20 -99.43 157.71 16.23 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 177.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.459 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 41.1 t80 -44.45 -53.92 13.43 Favored Pre-proline 0 CA--C 1.556 1.184 0 CA-C-N 120.557 1.526 . . . . 0.0 111.78 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.8 Cg_endo -57.24 -40.45 82.42 Favored 'Trans proline' 0 N--CA 1.505 2.157 0 C-N-CA 121.254 1.303 . . . . 0.0 112.087 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.459 ' HB3' ' H ' ' A' ' 64' ' ' ASP . 77.4 tt0 -63.02 -32.02 73.29 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.459 ' HB3' ' O ' ' A' ' 65' ' ' PHE . 53.5 t80 -71.8 -26.1 62.27 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.764 -1.562 . . . . 0.0 109.7 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.452 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 6.0 mt -76.01 -34.0 59.69 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.401 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -61.47 -42.28 98.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.62 1.2 . . . . 0.0 108.641 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.8 tp -58.17 -63.79 1.14 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 112.317 -2.22 . . . . 0.0 110.285 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 67.1 mmm -63.94 -32.85 74.53 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.187 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -63.46 -48.32 78.18 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.439 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -57.08 -44.19 82.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.244 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -63.51 -42.37 98.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.207 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -70.72 -16.51 62.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.368 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -69.49 -38.9 77.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.607 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -39.45 130.12 1.79 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.208 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.8 p . . . . . 0 C--O 1.222 -0.377 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.683 -179.82 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 3' ' ' GLN . 38.5 p-10 -65.25 -33.99 77.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.379 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.429 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 1.6 pt20 175.18 4.09 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.157 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 77.9 mt -115.14 160.84 19.2 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.596 0.236 . . . . 0.0 110.611 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.0 p -93.66 171.17 9.05 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.257 0.551 . . . . 0.0 111.31 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 25.5 p-10 -73.95 -29.01 61.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.469 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.415 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 80.6 mm-40 -61.21 -45.98 92.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.026 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.606 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 53.8 tt0 -66.13 -26.54 67.49 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.0 mt -80.53 -54.6 10.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.086 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.0 t -57.62 -43.82 85.05 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.776 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -64.07 -40.2 95.74 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.606 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 2.7 m-85 -61.24 -47.49 85.81 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.623 0.725 . . . . 0.0 109.377 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -62.73 -44.35 96.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.836 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -61.02 -40.34 93.22 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.53 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.1 -42.0 97.72 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.273 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -68.18 -47.21 68.58 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.9 t -60.19 -36.12 76.91 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.4 tp -61.96 -41.98 98.6 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.444 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.53 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.5 m-30 -62.93 -24.97 68.12 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.315 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.481 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 47.4 t0 -83.21 94.54 7.9 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.346 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -59.67 -33.22 71.28 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.055 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -97.53 -3.03 40.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.609 0.242 . . . . 0.0 111.124 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.46 36.51 30.86 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.481 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 33.2 p-10 -95.46 15.92 18.36 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.672 0.273 . . . . 0.0 111.095 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.44 ' C ' ' SG ' ' A' ' 26' ' ' CYS . . . 69.61 22.24 76.58 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.44 ' SG ' ' C ' ' A' ' 25' ' ' GLY . 3.2 m -149.99 139.18 21.22 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.883 0.373 . . . . 0.0 111.218 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 6.0 mm -108.78 118.87 57.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.6 p -78.66 -162.76 0.39 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.499 ' OG1' ' N ' ' A' ' 30' ' ' LYS . 1.6 p -84.62 -60.11 2.16 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.863 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.499 ' N ' ' OG1' ' A' ' 29' ' ' THR . 20.3 pttp -50.0 -33.2 17.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.112 0.482 . . . . 0.0 110.081 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -67.8 -48.07 67.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.824 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.7 tp -64.52 -42.82 95.56 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.59 -43.26 98.25 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.1 m -48.65 -47.94 40.08 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.1 t -65.81 -50.16 72.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.648 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.2 mmt -63.5 -40.82 98.07 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -57.29 -48.86 77.84 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.369 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 86.8 p -69.67 -19.1 63.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.511 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.9 mt -92.13 30.62 1.4 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.469 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.71 43.96 98.56 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.835 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -133.26 144.31 49.66 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -123.34 69.48 41.4 Favored Pre-proline 0 N--CA 1.47 0.574 0 CA-C-O 120.452 0.167 . . . . 0.0 111.385 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.431 ' CG ' HD21 ' A' ' 48' ' ' LEU . 86.5 Cg_endo -78.8 142.58 17.88 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.044 1.829 . . . . 0.0 111.665 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.2 p -81.26 163.73 22.75 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -57.57 -45.94 84.58 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.957 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.77 -44.75 82.11 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -57.32 -40.97 79.04 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.199 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.431 HD21 ' CG ' ' A' ' 43' ' ' PRO . 95.4 mt -66.42 -44.52 82.71 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.174 0.511 . . . . 0.0 111.56 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -67.05 -43.88 81.61 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.643 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -61.96 -45.9 91.62 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.04 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 48.9 tpp -57.99 -39.18 77.58 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.449 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 0.6 OUTLIER -68.22 -42.55 84.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.242 179.326 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -58.68 -34.36 71.17 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.467 ' HB2' HH12 ' A' ' 74' ' ' ARG . 1.1 mt-10 -73.48 -50.17 22.94 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.88 0.848 . . . . 0.0 111.275 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.549 HG22 ' HG3' ' A' ' 67' ' ' GLU . 11.3 p -72.59 -18.48 18.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.297 -1.319 . . . . 0.0 111.054 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.2 t0 -79.7 48.71 0.96 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.501 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -44.76 -21.02 0.04 OUTLIER 'General case' 0 C--N 1.34 0.195 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.382 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.439 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 31.3 m-20 -80.5 -35.16 35.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.448 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.53 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 89.27 15.0 59.48 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 62' ' ' THR . 50.4 p-10 -77.32 -28.02 53.05 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.288 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 92.26 -2.73 75.26 Favored Glycine 0 N--CA 1.466 0.649 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.523 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 53.9 p -135.9 163.27 30.64 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.3 mm -95.78 118.64 42.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.855 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -89.31 -168.4 2.15 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.435 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 28.7 t80 -71.78 -55.51 5.46 Favored Pre-proline 0 C--N 1.317 -0.812 0 C-N-CA 118.002 -1.479 . . . . 0.0 111.91 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 38.3 Cg_endo -59.12 -35.11 98.59 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 121.392 1.395 . . . . 0.0 111.698 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.549 ' HG3' HG22 ' A' ' 55' ' ' VAL . 6.1 tp10 -58.79 -55.25 37.58 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.48 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 42.5 t80 -47.86 -40.52 21.72 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.401 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -57.97 -41.6 83.28 Favored 'General case' 0 C--N 1.313 -1.0 0 O-C-N 121.036 -1.04 . . . . 0.0 110.289 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -60.38 -47.85 84.31 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.703 1.24 . . . . 0.0 108.615 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.508 HD23 HG21 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -46.64 -64.16 0.83 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 112.85 -1.977 . . . . 0.0 110.58 179.357 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 73.0 mmm -62.78 -39.6 94.71 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.294 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.75 -47.05 77.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.047 0.451 . . . . 0.0 110.308 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.467 HH12 ' HB2' ' A' ' 54' ' ' GLU . 82.5 mtp180 -60.17 -43.45 95.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.272 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.459 ' HZ3' HD13 ' A' ' 71' ' ' LEU . 45.6 mttp -65.13 -41.17 95.09 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.45 178.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 89.7 mmm -76.26 -14.2 60.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.477 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -67.65 -46.39 72.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.147 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -165.68 82.79 0.32 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.605 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.7 p . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.796 179.837 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 3' ' ' GLN . 64.5 t0 -69.16 139.53 54.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.826 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.473 ' CD ' ' N ' ' A' ' 3' ' ' GLN . 2.6 pm0 -119.12 172.62 7.44 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.727 0.299 . . . . 0.0 111.01 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.517 HD12 ' N ' ' A' ' 4' ' ' LEU . 11.0 mp -80.35 169.7 17.39 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.792 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 p -102.37 176.58 5.14 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.252 0.549 . . . . 0.0 111.347 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 19.1 p-10 -78.68 -28.87 45.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.485 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.08 -43.91 97.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.805 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.584 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 99.0 mm-40 -70.31 -26.36 63.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.283 0.563 . . . . 0.0 109.831 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -81.96 -56.78 5.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.094 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.8 m -59.1 -44.24 91.94 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.182 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -61.06 -39.91 91.64 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.601 ' CG ' ' SD ' ' A' ' 72' ' ' MET . 4.3 m-30 -63.67 -46.43 85.63 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.36 0.6 . . . . 0.0 109.779 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.98 -44.23 96.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.652 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.25 -39.89 92.0 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.468 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.27 -45.36 91.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.539 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 34.7 t80 -68.17 -45.41 73.54 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.5 p -67.15 -31.95 72.73 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.5 tp -63.14 -41.87 99.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.564 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.484 ' CD1' HG21 ' A' ' 35' ' ' VAL . 29.9 m-85 -72.65 -14.26 61.55 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.873 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -91.4 80.83 5.46 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.45 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.506 ' NZ ' HG21 ' A' ' 34' ' ' THR . 97.4 mttt -49.4 -24.46 1.96 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.313 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -105.47 2.23 28.36 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.528 0.204 . . . . 0.0 111.427 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 40.74 31.09 0.39 Allowed Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.455 ' CG ' ' SG ' ' A' ' 26' ' ' CYS . 29.9 p30 -84.25 1.5 44.41 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.696 0.284 . . . . 0.0 111.133 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.39 24.53 56.57 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.455 ' SG ' ' CG ' ' A' ' 24' ' ' ASP . 17.8 p -153.72 127.78 9.0 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.99 0.424 . . . . 0.0 111.136 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.419 HD11 ' CD2' ' A' ' 16' ' ' PHE . 79.4 mt -100.45 120.13 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.1 p -90.19 170.16 10.53 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.8 p -65.38 -25.05 67.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.148 0.499 . . . . 0.0 110.562 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -66.54 -49.82 65.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.54 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -62.96 -41.36 99.5 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.92 -42.21 98.84 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.96 -43.41 99.44 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.506 HG21 ' NZ ' ' A' ' 21' ' ' LYS . 21.4 m -50.49 -46.1 56.79 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.569 ' O ' HD13 ' A' ' 39' ' ' LEU . 70.9 t -68.98 -54.23 21.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 113.49 -1.686 . . . . 0.0 111.019 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 60.9 mmm -57.21 -44.53 83.8 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.454 0.645 . . . . 0.0 109.444 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -54.96 -51.03 67.42 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.414 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.3 p -70.48 -14.99 62.75 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.707 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.569 HD13 ' O ' ' A' ' 35' ' ' VAL . 7.3 mp -97.36 38.04 1.3 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.92 0.39 . . . . 0.0 111.587 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.14 5.33 2.24 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.322 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.43 ' H ' ' C ' ' A' ' 39' ' ' LEU . 44.6 tp60 -97.01 147.18 24.27 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.06 72.27 40.05 Favored Pre-proline 0 N--CA 1.47 0.556 0 C-N-CA 121.309 -0.156 . . . . 0.0 111.238 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.465 ' CG ' HD21 ' A' ' 48' ' ' LEU . 83.2 Cg_endo -77.92 155.06 30.18 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.199 1.933 . . . . 0.0 111.599 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.442 ' OG1' ' OE2' ' A' ' 47' ' ' GLU . 16.1 p -93.15 169.76 10.15 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 176.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -60.54 -36.92 79.61 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.876 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.15 -45.39 93.24 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.526 0.679 . . . . 0.0 109.458 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -60.23 -49.08 79.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.172 -178.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.465 HD21 ' CG ' ' A' ' 43' ' ' PRO . 89.9 mt -64.26 -43.97 93.22 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.268 0.556 . . . . 0.0 111.253 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -60.95 -36.14 78.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.421 -0.808 . . . . 0.0 108.988 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -77.92 -29.28 49.95 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.106 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.443 ' SD ' ' C ' ' A' ' 51' ' ' MET . 1.8 tmm? -67.95 -48.73 65.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.552 0.692 . . . . 0.0 110.016 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 2.2 tp -65.71 -42.69 93.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.368 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.41 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 41.0 t30 -63.02 -39.52 95.01 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.246 -178.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -61.13 -43.66 98.54 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.53 0.681 . . . . 0.0 110.019 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.5 t -104.0 64.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.579 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 58' ' ' ASP . 1.0 OUTLIER -129.14 47.04 2.53 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -178.417 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 56' ' ' ASP . . . -33.52 -32.25 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.96 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 56' ' ' ASP . 6.2 m-20 -94.67 -37.84 11.12 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.497 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 83.41 17.99 65.28 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.2 p30 -80.0 -12.08 59.73 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 121.286 -0.166 . . . . 0.0 111.291 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.58 6.5 77.01 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 71.1 p -138.97 165.43 27.12 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.4 mt -103.69 120.47 53.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.736 -0.386 . . . . 0.0 112.033 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -83.43 -169.09 2.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 176.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.412 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 54.8 t80 -80.24 -43.94 1.41 Allowed Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 120.208 1.367 . . . . 0.0 112.181 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 52.1 Cg_exo -56.97 -37.26 98.88 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 121.54 1.493 . . . . 0.0 112.103 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.449 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 48.1 mt-10 -61.88 -61.9 2.17 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -51.21 -25.7 5.9 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.219 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.3 tp -77.11 -45.55 26.54 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.091 0.472 . . . . 0.0 110.769 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -59.3 -43.2 92.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.38 1.086 . . . . 0.0 108.541 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 tp -55.56 -66.65 0.38 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 112.876 -1.965 . . . . 0.0 109.904 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.601 ' SD ' ' CG ' ' A' ' 12' ' ' PHE . 5.0 ttt -56.93 -36.82 70.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.916 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.87 -45.47 67.63 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.054 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -55.69 -43.86 76.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.17 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.68 -42.19 98.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.475 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -58.72 -9.58 1.83 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.143 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.4 tttp -62.28 -45.7 92.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.062 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -133.68 -87.71 0.41 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.006 0.431 . . . . 0.0 110.735 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 36.4 p . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.771 -179.542 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 3' ' ' GLN . 51.7 p-10 -84.53 82.6 8.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.015 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.462 ' O ' ' O ' ' A' ' 2' ' ' ASP . 96.3 mm-40 53.51 164.94 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.232 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.491 ' HB2' HE21 ' A' ' 8' ' ' GLN . 0.7 OUTLIER -128.98 167.98 16.67 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.329 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.0 p -98.39 167.24 10.96 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.037 0.446 . . . . 0.0 111.558 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -70.32 -38.63 74.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.947 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.462 ' CG ' ' N ' ' A' ' 8' ' ' GLN . 13.0 pt-20 -58.95 -43.14 91.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.761 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.491 HE21 ' HB2' ' A' ' 4' ' ' LEU . 19.9 tt0 -59.71 -32.17 70.28 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.108 0.48 . . . . 0.0 110.234 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 80.7 mt -71.21 -51.05 37.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.575 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.3 t -55.08 -49.64 71.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.656 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -47.72 -49.08 29.12 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.438 ' CE1' ' HB3' ' A' ' 72' ' ' MET . 17.0 m-85 -62.84 -48.26 79.82 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.335 0.588 . . . . 0.0 110.275 178.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -61.62 -43.77 98.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.657 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -63.61 -42.42 98.22 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.26 -44.03 95.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.255 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.445 ' C ' ' CD1' ' A' ' 16' ' ' PHE . 26.3 t80 -68.86 -47.55 65.66 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.5 m -62.37 -34.06 75.97 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.28 -42.17 99.12 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.77 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.56 ' CD1' HG21 ' A' ' 35' ' ' VAL . 20.5 m-85 -65.57 -20.97 66.54 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.79 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -82.1 94.04 7.14 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.555 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -67.47 -29.98 69.57 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 120.734 0.302 . . . . 0.0 111.703 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -101.01 -0.86 35.71 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 122.335 -0.228 . . . . 0.0 111.422 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 48.57 33.29 11.85 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -73.8 -14.83 61.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.658 0.266 . . . . 0.0 111.29 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.95 -8.25 42.27 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.0 p -140.11 158.39 44.13 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.067 0.461 . . . . 0.0 110.74 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.407 HD12 ' CE2' ' A' ' 16' ' ' PHE . 75.4 mt -113.89 127.27 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.3 p -86.69 -162.48 0.78 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 33' ' ' GLY . 70.9 p -85.93 -25.2 26.24 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.625 -0.672 . . . . 0.0 111.104 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.421 ' HG2' ' H ' ' A' ' 30' ' ' LYS . 16.7 pttp -72.97 -46.11 54.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.312 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.97 -50.68 69.82 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.46 HD23 ' SD ' ' A' ' 36' ' ' MET . 0.4 OUTLIER -64.13 -40.39 96.07 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 176.943 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -58.07 -47.42 89.29 Favored Glycine 0 C--O 1.214 -1.116 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.1 m -55.62 -43.29 75.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.828 0.823 . . . . 0.0 109.082 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.56 HG21 ' CD1' ' A' ' 19' ' ' PHE . 67.1 t -69.78 -55.24 15.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.185 -1.371 . . . . 0.0 112.78 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.46 ' SD ' HD23 ' A' ' 32' ' ' LEU . 13.9 ptm -66.29 -42.03 88.97 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.136 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.49 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 60.8 ttm-85 -52.76 -51.3 61.17 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.625 0.726 . . . . 0.0 110.022 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.512 ' C ' ' H ' ' A' ' 40' ' ' GLY . 52.3 m -59.29 -35.85 74.51 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.379 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.454 HD23 ' O ' ' A' ' 35' ' ' VAL . 1.6 mm? -66.44 34.78 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.543 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 38' ' ' SER . . . 63.99 42.45 98.24 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.886 -0.674 . . . . 0.0 111.793 178.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -136.62 148.91 47.72 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -137.3 67.21 53.72 Favored Pre-proline 0 N--CA 1.468 0.433 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.924 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.44 155.21 40.91 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.285 1.99 . . . . 0.0 111.534 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.593 HG22 ' N ' ' A' ' 45' ' ' GLU . 45.4 m -88.45 169.82 11.44 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.593 ' N ' HG22 ' A' ' 44' ' ' THR . 99.1 mt-10 -60.28 -37.07 79.37 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.908 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.48 -46.72 80.3 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.475 0.655 . . . . 0.0 109.441 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -60.43 -46.05 91.42 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.233 -179.058 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.05 -47.04 84.68 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.099 0.476 . . . . 0.0 111.224 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -63.64 -39.88 95.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.295 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -75.39 -38.34 60.0 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.945 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.439 ' N ' ' O ' ' A' ' 47' ' ' GLU . 5.7 mmm -62.83 -47.15 84.64 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.604 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 52' ' ' ILE . 15.0 tt -72.36 -40.85 65.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.586 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -65.25 -27.74 68.86 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -65.18 -51.46 60.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.45 0.643 . . . . 0.0 111.138 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.54 ' O ' HG22 ' A' ' 55' ' ' VAL . 9.2 p -80.55 -6.81 10.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.328 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 50.6 t0 -65.94 45.77 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.908 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -47.06 -25.33 0.81 Allowed 'General case' 0 CA--C 1.523 -0.077 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.846 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -80.53 -38.03 30.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.423 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.548 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 86.42 18.15 59.31 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 46.3 p30 -83.51 -26.27 30.33 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 122.812 -0.228 . . . . 0.0 111.36 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.527 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 89.91 -3.69 82.97 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.7 p -130.78 168.88 16.5 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.5 mt -108.97 124.89 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.1 p30 -90.98 -175.99 4.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.678 ' CZ ' HD23 ' A' ' 69' ' ' LEU . 32.3 t80 -77.11 -47.69 2.64 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.568 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.51 -47.3 27.58 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.157 1.238 . . . . 0.0 112.047 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -55.91 -50.33 70.99 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -56.97 -42.99 81.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.703 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.678 HD23 ' CZ ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -64.96 -50.62 65.69 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.084 178.817 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -56.44 -44.93 80.94 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 122.307 1.051 . . . . 0.0 108.712 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 tt -60.03 -46.56 89.13 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.001 -1.909 . . . . 0.0 110.138 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.438 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . 3.1 mmt -67.52 -45.68 75.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.912 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.26 -40.79 87.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.098 0.475 . . . . 0.0 109.844 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -46.02 86.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.237 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.501 ' C ' ' H ' ' A' ' 77' ' ' LYS . 21.7 tptp -64.71 -37.79 88.8 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.218 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 16.9 ttt -66.92 12.1 0.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.302 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.501 ' H ' ' C ' ' A' ' 75' ' ' LYS . 87.8 tttt -63.87 -45.24 90.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.363 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -81.83 -75.25 0.3 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.14 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 59.5 p . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.693 -179.547 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.435 ' O ' ' O ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.435 ' O ' ' O ' ' A' ' 1' ' ' ALA . 45.7 t0 59.83 125.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.151 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -96.21 158.58 15.38 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.78 0.324 . . . . 0.0 110.825 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.539 ' H ' HD23 ' A' ' 4' ' ' LEU . 0.2 OUTLIER -90.55 165.88 13.52 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.314 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.9 p -97.79 171.22 8.45 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.25 0.548 . . . . 0.0 111.589 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 18.6 p-10 -68.33 -25.16 64.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.455 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.74 -46.07 89.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.848 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.544 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 5.4 mp0 -63.44 -31.54 72.73 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 87.5 mt -76.69 -53.66 14.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.956 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.2 t -57.0 -49.78 74.72 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.782 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -54.85 -43.86 73.45 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.544 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 2.9 m-85 -60.72 -48.14 83.15 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -59.99 -45.92 91.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.556 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -63.51 -44.13 95.21 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.55 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -57.68 -47.56 81.99 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.292 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.431 ' CD2' HD11 ' A' ' 27' ' ' ILE . 58.6 t80 -67.22 -47.57 70.42 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 t -58.47 -37.96 76.56 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.5 tp -61.45 -41.55 97.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.168 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.55 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.3 m-30 -63.69 -29.15 70.41 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.431 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 43.8 t0 -82.73 93.98 7.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.447 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -59.19 -32.25 69.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.174 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -97.08 -10.45 26.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.624 0.249 . . . . 0.0 111.341 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.477 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 58.42 39.82 93.42 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.417 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 37.0 p-10 -99.6 17.41 20.54 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.664 0.268 . . . . 0.0 111.069 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.483 ' O ' ' SG ' ' A' ' 26' ' ' CYS . . . 66.64 25.77 72.87 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 25' ' ' GLY . 39.5 m -154.01 135.02 13.87 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.832 0.348 . . . . 0.0 111.05 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.431 HD11 ' CD2' ' A' ' 16' ' ' PHE . 62.4 mt -107.1 128.46 61.99 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.0 p -94.9 164.21 13.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.557 ' O ' ' N ' ' A' ' 33' ' ' GLY . 68.1 p -54.76 -34.51 62.67 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.508 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -64.99 -47.8 76.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.465 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.27 -46.07 74.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.117 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.456 HD23 ' C ' ' A' ' 32' ' ' LEU . 8.3 tt -62.62 -43.48 98.71 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -62.5 -43.35 99.16 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 178.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.4 m -48.25 -48.09 35.6 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 68.8 t -66.65 -52.73 42.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 113.494 -1.685 . . . . 0.0 111.436 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 68.1 mmm -63.16 -40.45 97.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.317 0.579 . . . . 0.0 109.886 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -57.52 -50.53 72.78 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.197 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.3 t -68.23 -19.99 64.79 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.781 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.401 ' O ' ' CD2' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -85.83 35.98 0.65 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.556 -178.516 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.13 44.78 94.63 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.644 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -144.51 155.8 43.86 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -145.57 72.84 14.08 Favored Pre-proline 0 N--CA 1.466 0.363 0 C-N-CA 121.112 -0.235 . . . . 0.0 111.29 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.477 ' HB2' HD21 ' A' ' 48' ' ' LEU . 27.6 Cg_exo -67.08 151.11 82.25 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 122.548 2.165 . . . . 0.0 111.961 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.8 p -83.56 162.94 20.69 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.65 -41.54 86.29 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.491 -0.484 . . . . 0.0 112.071 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.4 -46.88 79.94 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.347 0.594 . . . . 0.0 109.446 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 51' ' ' MET . 81.2 mm-40 -60.1 -46.62 88.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.311 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.477 HD21 ' HB2' ' A' ' 43' ' ' PRO . 90.9 mt -63.93 -47.89 78.72 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.199 0.524 . . . . 0.0 111.568 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -62.07 -37.58 85.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.09 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -77.85 -38.0 47.14 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.517 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.489 ' N ' ' O ' ' A' ' 47' ' ' GLU . 56.8 tpp -62.4 -48.49 79.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.255 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 9.2 tt -70.41 -42.13 78.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.838 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.426 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 37.6 t30 -67.41 -21.78 65.56 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -73.6 -54.33 8.4 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.574 0.702 . . . . 0.0 110.221 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.553 ' O ' HG22 ' A' ' 55' ' ' VAL . 8.1 p -75.44 -6.83 9.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.469 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 15.9 t0 -65.24 48.98 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.752 -178.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -52.78 -28.82 24.18 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.222 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -75.05 -38.33 61.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.399 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.532 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 85.55 26.85 34.29 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.553 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 45.3 p30 -98.37 -22.6 15.99 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 122.847 -0.208 . . . . 0.0 111.169 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.553 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 90.77 -4.08 81.63 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.463 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 61.3 p -136.74 167.82 20.7 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.8 mm -96.3 118.53 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 C-N-CA 120.681 -0.408 . . . . 0.0 112.076 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -87.88 -172.14 3.71 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.538 ' CZ ' HD11 ' A' ' 69' ' ' LEU . 42.0 t80 -74.1 -54.28 3.52 Favored Pre-proline 0 C--N 1.318 -0.781 0 C-N-CA 118.236 -1.386 . . . . 0.0 112.357 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 23.4 Cg_endo -54.61 -40.39 84.26 Favored 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 121.365 1.377 . . . . 0.0 111.704 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.23 -53.66 55.58 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -48.15 -43.12 31.12 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.698 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.538 HD11 ' CZ ' ' A' ' 65' ' ' PHE . 9.9 mt -63.6 -44.86 92.76 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.741 -0.599 . . . . 0.0 110.579 177.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -63.55 -45.61 89.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 122.509 1.147 . . . . 0.0 109.027 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.424 HD12 HG11 ' A' ' 55' ' ' VAL . 8.1 tt -58.01 -58.33 8.9 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 112.731 -2.032 . . . . 0.0 110.267 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.52 ' O ' ' N ' ' A' ' 76' ' ' MET . 93.1 mmm -64.82 -37.46 87.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.81 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . -60.23 -40.74 91.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.214 0.531 . . . . 0.0 110.25 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.2 mmt-85 -74.2 -41.87 60.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.948 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -78.26 -6.03 53.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.08 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.52 ' N ' ' O ' ' A' ' 72' ' ' MET . 8.1 ttt -51.25 -47.1 62.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.142 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -56.5 -81.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.359 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 39.4 p-10 -168.01 117.4 0.77 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.705 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.4 ' OXT' ' O ' ' A' ' 78' ' ' ASP . 3.5 m . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.56 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -152.96 -114.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.11 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.421 ' C ' HD22 ' A' ' 4' ' ' LEU . 88.3 mt-30 -134.83 50.69 2.15 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.697 0.284 . . . . 0.0 111.433 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.458 ' N ' ' CD2' ' A' ' 4' ' ' LEU . 3.8 mm? -98.25 172.25 7.69 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.933 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 p -113.58 170.73 8.03 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.148 0.499 . . . . 0.0 111.34 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -78.92 -33.06 45.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.684 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -62.16 -43.3 99.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.139 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.588 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 1.0 OUTLIER -67.72 -30.93 70.54 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 88.5 mt -80.4 -53.53 12.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.239 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 p -58.8 -46.18 88.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.122 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -59.18 -41.21 87.91 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.59 ' CZ ' ' SD ' ' A' ' 72' ' ' MET . 6.4 m-30 -63.24 -46.59 86.21 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.271 0.558 . . . . 0.0 109.967 178.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.6 tttp -62.52 -43.25 99.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.445 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -62.74 -40.99 98.96 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.471 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -58.9 -48.18 82.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.474 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.412 ' CE1' ' OD2' ' A' ' 20' ' ' ASP . 48.2 t80 -65.78 -45.42 82.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.2 m -65.25 -34.81 79.23 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 62.7 tp -64.0 -43.19 96.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.698 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 30.9 m-85 -66.84 -17.17 64.75 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.706 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.412 ' OD2' ' CE1' ' A' ' 16' ' ' PHE . 43.6 m-20 -90.55 94.12 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.355 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -61.86 -22.48 65.57 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.319 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -110.65 7.4 22.3 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.082 -178.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 35.84 28.78 0.02 OUTLIER Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 22' ' ' ASP . 41.1 p30 -70.31 -14.07 62.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.656 0.265 . . . . 0.0 111.131 -178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.28 0.25 37.93 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 5.0 p -145.23 139.71 27.35 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.059 0.429 . . . . 0.0 111.117 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.401 HD11 ' CD2' ' A' ' 16' ' ' PHE . 80.6 mt -95.09 122.48 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 77.3 p -86.43 173.39 9.69 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -70.79 -38.62 73.39 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.326 -178.521 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -54.95 -48.45 73.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.03 0.443 . . . . 0.0 109.832 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.412 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 92.6 mt-10 -62.48 -43.62 98.38 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.4 tp -62.08 -43.64 98.39 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -61.43 -42.26 99.73 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.2 m -50.54 -50.39 53.43 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.1 t -64.85 -49.84 78.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.598 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 58.0 mmm -63.31 -42.19 98.99 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -52.63 -52.13 56.94 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.31 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.8 p -66.47 -26.8 67.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.615 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.523 ' C ' ' H ' ' A' ' 41' ' ' GLN . 68.9 mt -83.11 38.98 0.62 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.734 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.94 -0.76 0.29 Allowed Glycine 0 N--CA 1.465 0.611 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.523 ' H ' ' C ' ' A' ' 39' ' ' LEU . 28.9 tp60 -88.06 146.68 25.34 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -137.21 66.41 52.81 Favored Pre-proline 0 N--CA 1.466 0.373 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.384 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.452 ' CG ' HD21 ' A' ' 48' ' ' LEU . 87.7 Cg_endo -77.98 156.91 30.67 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.186 1.924 . . . . 0.0 111.568 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.0 p -91.66 167.18 12.38 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.438 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 55.7 mp0 -61.13 -34.89 75.7 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.563 -0.455 . . . . 0.0 112.002 -178.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.24 -48.32 82.23 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -58.31 -47.29 84.15 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.248 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.452 HD21 ' CG ' ' A' ' 43' ' ' PRO . 89.6 mt -63.19 -44.77 94.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.268 0.556 . . . . 0.0 111.379 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -66.25 -41.67 89.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.219 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.43 ' O ' ' OE2' ' A' ' 54' ' ' GLU . 97.6 m-20 -63.82 -50.22 69.79 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.313 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 39.5 ttm -53.39 -41.77 66.28 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 56' ' ' ASP . 35.2 mt -65.07 -44.56 95.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.338 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -54.63 -33.25 60.26 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.435 ' N ' ' CD ' ' A' ' 54' ' ' GLU . 2.0 mm-40 -76.66 -41.23 46.44 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 121.798 0.808 . . . . 0.0 110.53 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.2 t -81.65 -24.9 9.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.462 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 58' ' ' ASP . 32.4 t70 -82.09 44.01 0.82 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.85 -177.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -39.07 -21.46 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.211 0.529 . . . . 0.0 110.358 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 56' ' ' ASP . 85.4 m-20 -74.0 -36.46 64.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.344 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 85.99 36.88 9.67 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.484 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 53.1 m-20 -102.99 -20.18 14.31 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 122.784 -0.245 . . . . 0.0 111.12 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.26 1.31 88.32 Favored Glycine 0 N--CA 1.466 0.695 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.9 p -135.61 162.32 33.04 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.9 mt -96.86 116.85 40.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.868 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -82.17 -166.13 1.18 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 176.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.476 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 71.4 t80 -81.15 -53.1 0.79 Allowed Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.984 178.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 35.4 Cg_endo -56.86 -30.47 85.53 Favored 'Trans proline' 0 N--CA 1.506 2.244 0 C-N-CA 121.832 1.688 . . . . 0.0 111.893 -178.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -65.66 -63.19 1.15 Allowed 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -48.64 -29.43 4.34 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.91 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.4 tp -68.87 -45.68 70.37 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.901 0.381 . . . . 0.0 110.821 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -60.22 -42.74 95.84 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 122.453 1.121 . . . . 0.0 108.809 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.1 tp -62.05 -32.89 73.46 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.431 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.59 ' SD ' ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -78.67 -44.25 24.13 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.9 179.126 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.32 -33.04 73.6 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.147 0.499 . . . . 0.0 110.368 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -74.13 -42.5 59.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.891 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -79.96 -10.18 59.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.328 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.7 ttt -51.83 -51.27 57.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.278 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 79' ' ' THR . 17.0 tptm -95.6 -63.6 1.14 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.133 0.492 . . . . 0.0 110.671 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -41.18 91.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.813 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 77' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.654 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 3' ' ' GLN . 87.6 m-20 -73.55 -11.48 60.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.084 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.521 ' O ' ' O ' ' A' ' 2' ' ' ASP . 98.9 mm-40 50.52 119.68 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 O-C-N 123.673 0.608 . . . . 0.0 111.047 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.427 HD12 ' N ' ' A' ' 4' ' ' LEU . 11.1 mp -65.84 166.79 10.52 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.421 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.1 p -95.2 165.89 12.18 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.112 0.482 . . . . 0.0 111.238 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 17.1 p-10 -70.83 -29.61 65.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.637 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -62.78 -46.96 85.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.925 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.531 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 87.2 mt-30 -65.78 -29.85 70.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.997 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.4 mt -77.49 -57.09 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.197 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.6 m -56.47 -42.24 77.88 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.342 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -65.99 -39.88 90.69 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.631 -0.428 . . . . 0.0 109.955 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.531 ' CG ' ' O ' ' A' ' 8' ' ' GLN . 4.3 m-30 -61.65 -46.84 88.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -58.63 -47.36 84.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.296 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -60.55 -40.95 93.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.539 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -58.8 -48.51 81.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.622 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.415 ' CD2' HD11 ' A' ' 27' ' ' ILE . 32.9 t80 -67.67 -47.11 70.42 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.7 m -59.83 -36.75 77.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 43.4 tp -62.43 -41.19 98.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.324 178.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.0 m-30 -64.76 -26.59 68.42 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.64 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 23' ' ' GLY . 47.7 t0 -82.88 92.64 7.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.195 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -57.38 -34.06 68.47 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.931 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -91.45 -22.81 20.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.521 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.484 ' H ' ' CG ' ' A' ' 20' ' ' ASP . . . 66.68 37.73 92.66 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.413 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 36.4 p-10 -98.05 14.02 28.9 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.549 0.214 . . . . 0.0 111.135 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.35 17.87 80.09 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.0 m -147.59 138.52 23.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.793 0.33 . . . . 0.0 111.115 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.415 HD11 ' CD2' ' A' ' 16' ' ' PHE . 68.4 mt -112.15 125.2 69.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 47.2 p -88.82 162.15 16.34 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -57.67 -29.99 65.09 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -178.797 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -66.42 -47.09 74.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.023 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -67.56 -46.65 72.1 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.263 178.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.3 tt -62.3 -41.08 98.22 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -64.66 -42.93 97.04 Favored Glycine 0 C--O 1.226 -0.393 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 178.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.7 m -50.07 -48.99 52.76 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.417 ' O ' HD23 ' A' ' 39' ' ' LEU . 73.3 t -64.17 -51.1 73.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.241 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.1 mmm -64.06 -41.69 97.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.447 0.642 . . . . 0.0 109.643 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 45.3 ttm180 -56.21 -45.56 79.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.714 0.769 . . . . 0.0 110.395 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.3 m -71.72 -19.39 62.06 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.855 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 35' ' ' VAL . 1.7 mm? -87.5 31.6 0.74 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.897 0.38 . . . . 0.0 111.654 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 60.94 42.78 99.84 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.708 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -136.81 149.88 48.01 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -129.43 70.54 81.87 Favored Pre-proline 0 N--CA 1.469 0.491 0 C-N-CA 121.305 -0.158 . . . . 0.0 111.241 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.76 145.52 25.72 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.183 1.922 . . . . 0.0 111.381 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.4 m -86.42 160.05 19.16 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.438 ' HG2' ' H ' ' A' ' 45' ' ' GLU . 2.0 pt-20 -59.92 -33.31 71.71 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.54 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.9 -47.15 86.02 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.187 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -64.09 -42.76 96.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.764 -179.388 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.49 -46.59 85.44 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.293 0.568 . . . . 0.0 110.788 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -62.85 -46.21 88.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.439 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -64.1 -40.62 96.61 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.664 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.6 ttm -59.82 -43.94 94.29 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.468 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 11.1 mt -64.48 -46.88 91.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.733 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -56.5 -35.89 68.52 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -65.27 -50.97 63.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.218 0.532 . . . . 0.0 111.119 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 57' ' ' ALA . 6.5 p -74.58 -21.3 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.194 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.553 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.8 t0 -67.79 49.23 0.05 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.797 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -39.98 -26.88 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.267 0.556 . . . . 0.0 110.384 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 56' ' ' ASP . 24.0 m-20 -88.13 -36.24 16.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.08 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 92.47 14.45 55.56 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -66.92 -31.56 72.22 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.819 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.553 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 99.2 -1.1 57.4 Favored Glycine 0 N--CA 1.47 0.922 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 65.9 p -137.23 160.72 38.2 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.4 mm -92.15 122.3 43.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -84.52 -176.3 6.18 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.466 ' CE2' HD11 ' A' ' 69' ' ' LEU . 43.2 t80 -76.86 -54.91 1.56 Allowed Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 118.336 -1.345 . . . . 0.0 111.868 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.7 Cg_endo -57.67 -41.03 74.92 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.103 1.202 . . . . 0.0 111.513 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.421 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 62.6 mt-10 -55.15 -42.17 72.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.655 0.741 . . . . 0.0 109.179 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -62.12 -38.85 90.5 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.743 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.466 HD11 ' CE2' ' A' ' 65' ' ' PHE . 74.3 mt -61.48 -42.12 98.3 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.792 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -60.83 -44.91 96.32 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 122.217 1.008 . . . . 0.0 108.75 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.5 tp -63.42 -46.9 84.23 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.29 -1.777 . . . . 0.0 110.733 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.401 ' SD ' ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -67.35 -45.57 75.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.355 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.84 -37.87 89.0 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.66 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -73.11 -46.08 53.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.312 178.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -70.08 -13.61 62.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.446 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.406 ' SD ' ' C ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -54.89 -71.91 0.07 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.3 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -97.38 30.7 2.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.654 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -134.19 88.0 2.42 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.731 0.301 . . . . 0.0 110.463 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.893 -1.051 . . . . 0.0 110.53 179.685 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 53.98 36.02 23.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.37 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -87.44 -5.84 58.66 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.639 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.424 ' H ' HD23 ' A' ' 4' ' ' LEU . 0.4 OUTLIER -72.73 163.84 27.48 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.91 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.747 HG22 ' H ' ' A' ' 6' ' ' ASP . 20.4 m -98.2 176.76 5.61 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.15 0.5 . . . . 0.0 111.455 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.747 ' H ' HG22 ' A' ' 5' ' ' THR . 98.0 m-20 -75.1 -40.73 59.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.444 178.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -49.4 -42.51 42.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.617 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.559 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 13.2 mp0 -70.35 -26.23 63.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.292 0.568 . . . . 0.0 109.771 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.4 mt -82.29 -57.19 4.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.059 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 t -58.3 -43.76 88.25 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.451 -0.499 . . . . 0.0 109.952 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -62.41 -39.93 94.88 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.559 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.4 m-30 -64.09 -46.07 85.89 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.647 0.737 . . . . 0.0 109.591 178.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -60.03 -47.44 85.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.328 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -62.8 -41.26 99.2 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.72 -47.78 83.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.689 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.465 ' CE1' ' OD2' ' A' ' 20' ' ' ASP . 51.6 t80 -67.82 -45.31 75.06 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.8 m -65.25 -34.09 77.54 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.2 tp -62.9 -40.22 96.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.709 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.504 ' CD1' HG21 ' A' ' 35' ' ' VAL . 21.9 m-85 -73.23 -14.12 61.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.043 179.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.465 ' OD2' ' CE1' ' A' ' 16' ' ' PHE . 55.5 m-20 -89.28 74.19 7.93 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.396 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -43.26 -43.5 4.87 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.497 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 18.6 p30 -83.42 -22.42 32.67 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.536 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 73.12 28.06 67.16 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.9 p30 -81.1 -4.17 54.42 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.591 0.234 . . . . 0.0 111.229 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.8 12.72 74.02 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 33.6 m -143.16 128.93 19.35 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.856 0.36 . . . . 0.0 110.976 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 79.9 mt -97.64 123.34 50.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.1 p -97.03 170.14 9.35 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.1 p -61.19 -27.61 68.54 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.742 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -64.46 -48.82 73.85 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.502 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.409 ' O ' HG23 ' A' ' 35' ' ' VAL . 94.3 mt-10 -66.94 -41.86 86.28 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.0 tt -61.1 -43.03 99.5 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.33 -43.99 94.23 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.0 m -49.77 -48.06 50.62 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.588 ' O ' HD13 ' A' ' 39' ' ' LEU . 74.1 t -65.28 -51.54 63.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 113.549 -1.659 . . . . 0.0 111.513 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.0 mmt -61.28 -46.02 92.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.513 0.673 . . . . 0.0 109.456 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.9 tpt85 -50.01 -50.95 45.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.947 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.7 t -74.15 -15.51 61.03 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.828 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.588 HD13 ' O ' ' A' ' 35' ' ' VAL . 6.0 mp -93.56 37.55 1.06 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.043 0.449 . . . . 0.0 111.754 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.29 4.45 6.44 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.596 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -100.74 149.32 23.93 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' A' ' 42' ' ' ASN . 2.1 p-10 -140.72 68.18 29.89 Favored Pre-proline 0 N--CA 1.467 0.401 0 C-N-CA 121.198 -0.201 . . . . 0.0 111.266 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.401 ' CG ' HD21 ' A' ' 48' ' ' LEU . 91.4 Cg_endo -74.79 158.43 42.99 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.327 2.018 . . . . 0.0 111.566 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.9 p -93.58 166.31 12.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -60.68 -33.21 72.5 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.694 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.53 98.9 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -62.23 -47.54 83.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.141 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.401 HD21 ' CG ' ' A' ' 43' ' ' PRO . 56.4 mt -64.87 -41.72 95.42 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.148 0.499 . . . . 0.0 111.241 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -61.86 -39.88 93.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.757 0.789 . . . . 0.0 109.196 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -78.32 -24.4 46.61 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.165 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.615 ' O ' HG12 ' A' ' 55' ' ' VAL . 41.3 ttm -71.22 -46.99 59.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.505 0.669 . . . . 0.0 109.82 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 tp -67.55 -40.52 84.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.269 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -65.3 -37.08 86.05 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.634 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -64.34 -36.65 84.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.407 0.622 . . . . 0.0 109.533 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.704 HG13 ' O ' ' A' ' 55' ' ' VAL . 7.2 p -109.39 68.44 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.115 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 58' ' ' ASP . 3.8 t0 -135.29 47.74 2.3 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -34.67 -29.76 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.763 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 42.3 p-10 -97.68 -38.37 9.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.487 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.546 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 91.14 12.67 59.82 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 40.4 p-10 -70.15 -25.23 63.36 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.803 -0.234 . . . . 0.0 111.31 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 90.76 7.84 66.03 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 75.2 p -143.81 157.23 44.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.3 mm -93.84 124.33 46.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.433 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 85.5 m-20 -90.0 -162.86 0.93 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 176.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.672 ' CZ ' HD11 ' A' ' 69' ' ' LEU . 50.4 t80 -76.24 -56.86 1.48 Allowed Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 118.274 -1.371 . . . . 0.0 111.85 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.47 -26.31 62.69 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 CA-C-N 120.37 1.168 . . . . 0.0 111.637 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.459 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 99.3 mt-10 -65.43 -35.07 79.82 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -70.83 -31.14 67.77 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.147 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.672 HD11 ' CZ ' ' A' ' 65' ' ' PHE . 9.7 mp -70.71 -34.57 72.07 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.588 177.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -64.42 -43.62 93.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 122.41 1.1 . . . . 0.0 108.815 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.665 ' HB2' HG21 ' A' ' 55' ' ' VAL . 25.8 tp -63.67 -45.92 87.91 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 112.998 -1.91 . . . . 0.0 110.844 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.485 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . 97.5 mmm -78.96 -30.13 44.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.113 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . -72.2 -41.22 67.18 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.171 0.51 . . . . 0.0 110.094 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.1 tpp85 -65.22 -44.55 87.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -68.03 -42.41 80.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.742 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.519 ' SD ' ' O ' ' A' ' 76' ' ' MET . 13.0 tmm? -71.94 -8.23 53.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.269 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -64.68 -46.01 84.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.148 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -148.92 53.46 0.98 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.748 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.956 179.928 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -157.39 -178.75 7.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.924 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.408 ' CG ' ' H ' ' A' ' 4' ' ' LEU . 25.9 tp60 -120.35 -143.43 0.35 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.736 0.303 . . . . 0.0 110.883 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.408 ' H ' ' CG ' ' A' ' 3' ' ' GLN . 72.2 mt -116.17 154.74 29.5 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.514 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.428 ' OG1' ' OE1' ' A' ' 8' ' ' GLN . 77.0 p -99.06 -177.74 3.72 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.204 0.526 . . . . 0.0 111.302 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 19.3 p-10 -77.41 -30.16 53.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.644 178.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -64.9 -44.79 88.45 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.069 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.532 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 5.1 mp0 -70.53 -25.64 63.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.169 0.509 . . . . 0.0 109.884 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.0 mt -83.97 -56.82 5.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.906 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -58.46 -41.12 84.48 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.258 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -65.6 -38.07 88.41 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.0 m-30 -64.9 -46.88 79.88 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.526 0.679 . . . . 0.0 109.673 178.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -62.23 -45.59 92.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.661 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -59.69 -37.57 79.18 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.495 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.07 -44.42 97.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.353 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.409 ' CE2' ' CG1' ' A' ' 27' ' ' ILE . 52.4 t80 -67.43 -45.95 74.54 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -178.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.4 t -63.45 -35.44 80.45 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.21 -40.64 98.04 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.338 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.495 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 27.1 m-85 -73.55 -19.67 60.84 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.099 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -87.38 80.27 8.2 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 120.904 -0.319 . . . . 0.0 111.583 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -52.59 -26.51 13.62 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.116 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' A' ' 24' ' ' ASP . 36.7 m-20 -103.26 4.46 36.64 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.876 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 38.52 31.59 0.12 Allowed Glycine 0 CA--C 1.529 0.967 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 34.9 p-10 -86.64 -0.85 57.03 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.639 0.257 . . . . 0.0 111.146 -178.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.425 ' O ' ' SG ' ' A' ' 26' ' ' CYS . . . 82.23 26.79 46.8 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 25' ' ' GLY . 40.4 m -154.09 134.52 13.44 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.907 0.384 . . . . 0.0 111.236 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.409 ' CG1' ' CE2' ' A' ' 16' ' ' PHE . 5.9 mm -102.32 115.54 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.3 p -88.19 163.97 15.89 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.446 HG22 ' CD1' ' A' ' 52' ' ' ILE . 0.6 OUTLIER -61.45 -24.42 66.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.18 0.514 . . . . 0.0 110.195 -178.562 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -69.4 -49.08 58.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.401 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -64.29 -43.52 94.49 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.058 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.7 tp -61.93 -42.81 99.53 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.99 -44.51 97.28 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.6 m -51.23 -46.51 62.32 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.57 -51.8 53.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 113.498 -1.683 . . . . 0.0 111.428 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.501 ' SD ' ' OE1' ' A' ' 41' ' ' GLN . 17.7 mmt -60.17 -42.51 95.12 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 63.3 ttm-85 -54.68 -46.5 74.07 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.591 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.0 m -76.48 -17.08 59.48 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.313 -1.312 . . . . 0.0 111.79 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' A' ' 41' ' ' GLN . 55.5 mt -93.26 38.39 1.04 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.723 0.297 . . . . 0.0 111.788 -178.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.1 2.22 0.88 Allowed Glycine 0 N--CA 1.464 0.528 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.501 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 80.2 mt-30 -97.7 150.39 21.25 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -136.54 68.71 60.43 Favored Pre-proline 0 N--CA 1.468 0.468 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.334 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.542 ' CG ' HD21 ' A' ' 48' ' ' LEU . 93.8 Cg_endo -75.26 153.72 40.75 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.267 1.978 . . . . 0.0 111.725 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -92.73 174.74 7.11 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.255 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.408 ' N ' ' OG1' ' A' ' 44' ' ' THR . 97.5 mt-10 -60.34 -40.03 89.21 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.778 -178.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.35 -46.46 90.15 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.508 0.671 . . . . 0.0 109.437 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.409 ' H ' HG23 ' A' ' 44' ' ' THR . 49.3 tp10 -54.24 -53.13 57.81 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.016 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.542 HD21 ' CG ' ' A' ' 43' ' ' PRO . 90.4 mt -62.12 -41.97 98.77 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.227 0.537 . . . . 0.0 111.067 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -67.26 -40.73 86.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.586 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -64.29 -41.72 96.74 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.258 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 38.5 ttm -59.15 -41.81 89.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.667 0.746 . . . . 0.0 109.46 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.446 ' CD1' HG22 ' A' ' 29' ' ' THR . 78.4 mt -66.27 -40.33 86.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.11 178.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -60.12 -39.37 85.99 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.354 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.6 -36.7 84.49 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.782 0.801 . . . . 0.0 109.732 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.499 HG13 ' OD1' ' A' ' 70' ' ' ASN . 59.6 t -110.84 63.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.878 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 58' ' ' ASP . 0.4 OUTLIER -124.37 41.39 3.51 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.356 -178.146 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 56' ' ' ASP . . . -30.64 -36.06 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.159 0.504 . . . . 0.0 111.096 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 48.6 p-10 -99.26 -33.68 10.64 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.741 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.561 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 81.07 22.96 60.07 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.459 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 39.5 p-10 -76.13 -23.68 54.87 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.49 0.182 . . . . 0.0 111.49 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.01 5.72 62.32 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.459 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 59.8 p -138.41 162.78 33.58 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.2 mt -98.91 121.23 49.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.979 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -90.58 -162.72 0.93 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.723 ' CE2' HD11 ' A' ' 69' ' ' LEU . 57.1 t80 -76.72 -55.0 1.61 Allowed Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 118.347 -1.341 . . . . 0.0 112.027 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 48.8 Cg_endo -62.02 -26.59 78.61 Favored 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 121.315 1.344 . . . . 0.0 112.189 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.435 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 97.6 mt-10 -70.75 -30.38 66.88 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -76.1 -35.75 59.2 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 113.927 -1.488 . . . . 0.0 110.273 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.723 HD11 ' CE2' ' A' ' 65' ' ' PHE . 88.7 mt -67.46 -30.48 70.21 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.405 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.499 ' OD1' HG13 ' A' ' 55' ' ' VAL . 14.0 t-20 -68.18 -45.1 74.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.652 1.215 . . . . 0.0 109.102 178.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 tp -63.56 -44.17 94.93 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 112.53 -2.123 . . . . 0.0 110.644 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.441 ' CG ' ' CE2' ' A' ' 12' ' ' PHE . 3.3 tpt -77.36 -32.6 55.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.612 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . -67.55 -35.7 79.55 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.038 0.447 . . . . 0.0 109.996 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -77.3 -44.5 29.43 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.584 0.707 . . . . 0.0 109.672 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -67.01 -18.51 65.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.233 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 6.0 ttt -49.5 -75.5 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.09 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -59.12 -74.35 0.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.42 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.412 ' CG ' ' N ' ' A' ' 79' ' ' THR . 37.9 t70 -168.66 172.29 8.11 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.604 -179.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.412 ' N ' ' CG ' ' A' ' 78' ' ' ASP . 84.6 m . . . . . 0 C--N 1.325 -0.495 0 CA-C-O 117.861 -1.066 . . . . 0.0 110.615 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 2' ' ' ASP . 55.8 t0 -66.44 -10.12 40.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.085 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.43 ' HG3' ' H ' ' A' ' 4' ' ' LEU . 28.8 tp60 -112.49 167.08 10.74 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.835 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.43 ' H ' ' HG3' ' A' ' 3' ' ' GLN . 87.6 mt -66.09 149.47 50.23 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.978 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 p -93.15 170.89 9.29 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.083 0.468 . . . . 0.0 111.462 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 23.1 p-10 -73.3 -42.57 62.22 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.566 178.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.492 ' CG ' ' N ' ' A' ' 8' ' ' GLN . 13.6 pt-20 -53.85 -43.64 69.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.575 -179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.613 ' O ' ' CD2' ' A' ' 12' ' ' PHE . 85.4 mt-30 -69.87 -27.1 64.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.332 0.587 . . . . 0.0 109.881 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 77.5 mt -78.53 -58.58 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.405 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.3 t -56.8 -41.69 78.19 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.712 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -59.21 -41.69 89.17 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.613 ' CD2' ' O ' ' A' ' 8' ' ' GLN . 13.0 m-30 -65.72 -49.04 69.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.414 0.626 . . . . 0.0 110.149 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -61.23 -48.46 81.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.376 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -61.64 -40.58 95.39 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.52 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -63.44 -41.72 98.67 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.529 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.497 ' CD2' HD11 ' A' ' 27' ' ' ILE . 28.0 t80 -68.61 -47.59 66.28 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 m -64.17 -33.8 76.61 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.46 -40.73 97.57 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.284 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 31.8 m-85 -73.79 -16.33 61.16 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.916 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.542 ' OD2' ' N ' ' A' ' 25' ' ' GLY . 51.1 t0 -84.23 69.68 10.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.744 0.307 . . . . 0.0 111.442 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -43.04 -44.23 4.66 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.136 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -73.56 -23.89 60.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.744 0.307 . . . . 0.0 111.303 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 68.09 28.61 73.31 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 24.7 p-10 -89.93 5.4 46.54 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.764 0.316 . . . . 0.0 111.217 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.542 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 81.45 11.43 83.23 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.2 m -142.27 136.95 30.29 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 122.611 -0.347 . . . . 0.0 111.082 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.497 HD11 ' CD2' ' A' ' 16' ' ' PHE . 67.7 mt -101.41 126.9 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.0 p -99.04 160.3 14.36 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 33' ' ' GLY . 46.8 p -57.0 -25.71 58.99 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.589 -179.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.02 -49.35 72.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.243 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.9 -45.12 87.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.026 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.0 tp -61.84 -42.44 99.04 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -61.42 -44.32 98.19 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 178.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.1 m -49.1 -44.28 42.09 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.416 1.103 . . . . 0.0 108.25 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.1 t -73.83 -59.11 3.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 113.206 -1.816 . . . . 0.0 111.328 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 72.5 mtp -53.63 -44.46 69.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.512 0.672 . . . . 0.0 109.694 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 78.8 ttt-85 -58.83 -45.08 90.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.129 178.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.1 m -79.28 0.65 27.88 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.635 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 mp -106.48 35.47 2.95 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.477 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.5 37.01 91.51 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.702 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -137.74 153.45 49.74 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -136.72 78.66 42.19 Favored Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 121.324 -0.15 . . . . 0.0 111.304 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.72 150.82 21.65 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.234 1.956 . . . . 0.0 111.713 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.1 m -86.17 163.31 17.9 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -64.78 -34.11 77.57 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.832 -178.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.66 -41.31 97.35 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.397 0.618 . . . . 0.0 109.541 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.485 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -62.24 -49.77 74.39 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.258 -179.09 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.6 mt -62.26 -41.24 98.27 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.06 0.457 . . . . 0.0 111.549 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.434 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 55.7 tt0 -65.21 -36.54 84.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.732 0.777 . . . . 0.0 109.429 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -80.17 -35.25 36.72 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.227 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.472 ' SD ' ' C ' ' A' ' 51' ' ' MET . 9.1 tmm? -70.38 -51.3 30.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.093 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 7.6 tp -59.15 -46.54 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.734 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.485 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 96.5 m-20 -69.57 -31.72 70.07 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.4 -36.66 84.88 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.639 0.733 . . . . 0.0 110.497 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.691 ' O ' HG22 ' A' ' 55' ' ' VAL . 14.6 p -98.31 18.25 2.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.8 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.719 ' CG ' ' H ' ' A' ' 59' ' ' GLY . 65.1 t0 -99.32 69.74 1.7 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.889 -177.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -37.74 -25.25 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.651 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 56' ' ' ASP . 17.4 m-20 -94.52 -40.87 9.64 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.615 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.719 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 92.03 7.65 63.98 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.408 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 15.7 m120 -66.99 -28.14 68.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.578 0.228 . . . . 0.0 111.16 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.593 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 99.91 8.26 51.51 Favored Glycine 0 N--CA 1.464 0.52 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 76.7 p -137.87 166.28 24.42 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.428 ' CG1' HD11 ' A' ' 52' ' ' ILE . 4.8 mt -104.11 125.22 58.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -176.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -97.79 158.09 15.71 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 176.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.549 ' CE2' HD11 ' A' ' 69' ' ' LEU . 58.3 t80 -49.93 -48.36 78.42 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 118.0 -1.48 . . . . 0.0 111.408 -178.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.35 -44.35 43.63 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 121.219 1.279 . . . . 0.0 112.31 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.432 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 73.3 mt-10 -61.22 -34.49 75.2 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 122.285 1.04 . . . . 0.0 108.297 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 65' ' ' PHE . 89.5 t80 -68.42 -25.91 65.26 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.356 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.549 HD11 ' CE2' ' A' ' 65' ' ' PHE . 25.2 mt -74.98 -32.71 61.75 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.925 0.393 . . . . 0.0 110.492 177.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -64.2 -42.61 96.55 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 122.745 1.26 . . . . 0.0 108.541 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.423 ' HB2' HG21 ' A' ' 55' ' ' VAL . 43.2 tp -63.02 -45.67 91.24 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.532 -2.122 . . . . 0.0 110.448 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.546 ' SD ' ' CE1' ' A' ' 12' ' ' PHE . 7.6 mmt -78.48 -28.26 46.41 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.97 178.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . -75.31 -42.95 53.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.145 0.498 . . . . 0.0 110.081 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.8 mmm-85 -66.53 -38.1 86.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.136 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.87 -43.7 98.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.346 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 9.8 mmt -67.43 -1.77 5.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.355 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -63.18 -35.61 80.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.097 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -58.34 -66.43 0.49 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.165 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.621 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -129.5 96.29 4.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -173.66 118.91 0.28 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.99 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.555 HD22 ' N ' ' A' ' 4' ' ' LEU . 3.4 mm? -87.55 156.88 19.32 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.868 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.2 p -98.38 175.29 6.1 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.379 0.609 . . . . 0.0 111.397 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -77.52 -34.45 54.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.587 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.472 ' OE1' ' N ' ' A' ' 7' ' ' GLU . 57.6 mp0 -65.1 -44.72 87.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.209 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.548 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 64.9 mt-30 -67.35 -24.13 65.68 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.07 0.462 . . . . 0.0 110.199 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 90.0 mt -83.63 -53.58 10.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.192 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.9 t -59.15 -45.12 91.81 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.251 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 11' ' ' GLU . 0.3 OUTLIER -62.86 -38.93 92.79 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.293 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.548 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 2.9 m-30 -62.44 -45.2 94.17 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 121.442 0.639 . . . . 0.0 109.861 178.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -63.54 -41.78 98.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.829 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -64.62 -41.78 95.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.54 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -59.39 -49.56 77.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.566 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.455 ' CD2' HD11 ' A' ' 27' ' ' ILE . 51.3 t80 -66.47 -44.27 83.15 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.1 p -64.8 -35.39 80.95 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 41.2 tp -63.8 -39.43 94.23 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.493 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.54 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.6 m-30 -66.52 -16.27 64.02 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.318 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.463 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 38.6 t0 -94.78 88.21 5.27 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.384 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -47.95 -40.88 23.51 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.537 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 3.4 p30 -91.98 -24.59 19.19 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.667 -178.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.411 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 76.76 33.12 47.76 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.041 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.463 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 80.0 m-20 -73.45 -7.39 51.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.782 0.325 . . . . 0.0 111.036 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.01 2.69 64.3 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.2 p -143.43 138.01 29.03 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.945 0.402 . . . . 0.0 111.096 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.455 HD11 ' CD2' ' A' ' 16' ' ' PHE . 76.9 mt -96.67 126.65 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.8 p -90.85 170.35 10.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.558 ' O ' ' N ' ' A' ' 33' ' ' GLY . 27.3 p -61.63 -49.29 77.15 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.917 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.493 ' CG ' ' N ' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -56.57 -43.03 79.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.152 0.501 . . . . 0.0 110.332 179.557 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.493 ' N ' ' CG ' ' A' ' 30' ' ' LYS . 89.6 mt-10 -61.55 -49.1 78.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.69 178.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.2 tt -63.25 -41.47 99.07 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -61.79 -40.7 99.16 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 30' ' ' LYS . 20.7 m -53.79 -48.62 69.63 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.08 -47.7 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.377 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 17.3 mmt -64.22 -44.28 92.4 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -50.62 -51.29 50.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.634 0.731 . . . . 0.0 110.676 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -68.34 -27.0 65.89 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.705 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 41' ' ' GLN . 46.6 mt -78.2 37.56 0.26 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -178.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.75 -6.91 0.77 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.138 -0.553 . . . . 0.0 111.75 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.487 ' H ' ' C ' ' A' ' 39' ' ' LEU . 76.6 mt-30 -89.5 149.85 22.72 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -133.95 65.21 69.35 Favored Pre-proline 0 N--CA 1.469 0.476 0 C-N-CA 121.321 -0.151 . . . . 0.0 111.384 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.2 155.6 33.15 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.147 1.898 . . . . 0.0 111.503 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 m -93.38 159.51 15.22 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.431 ' HG2' ' H ' ' A' ' 45' ' ' GLU . 0.8 OUTLIER -59.53 -33.26 71.16 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.665 -178.62 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.3 -39.4 82.93 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -69.31 -45.55 69.29 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.103 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.5 mt -63.7 -43.38 96.79 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.144 0.497 . . . . 0.0 110.957 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -60.75 -49.09 78.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.432 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -65.93 -33.22 75.34 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.106 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 34.8 ttm -65.75 -42.41 90.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.722 0.773 . . . . 0.0 109.994 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 1.1 tp -65.62 -47.35 86.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.724 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.416 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 77.7 m-20 -65.48 -28.53 69.28 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 124.009 0.818 . . . . 0.0 112.903 -177.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -68.21 -45.51 73.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.602 0.715 . . . . 0.0 110.969 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.541 ' O ' HG22 ' A' ' 55' ' ' VAL . 12.4 p -89.03 -3.47 9.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.719 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 37.5 t0 -64.67 41.57 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.233 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -40.67 -32.57 0.22 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.189 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -74.6 -38.31 62.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.675 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.542 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 91.08 16.57 53.73 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 42.7 p30 -87.64 -25.42 23.55 Favored 'General case' 0 CA--C 1.53 0.173 0 O-C-N 122.685 -0.303 . . . . 0.0 111.334 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.555 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 91.58 5.18 67.12 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.5 p -142.57 168.39 19.83 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.0 mt -97.86 119.62 46.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.307 -0.557 . . . . 0.0 112.194 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -90.62 148.72 22.47 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 176.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.565 ' CE2' HD11 ' A' ' 69' ' ' LEU . 46.6 t80 -48.03 -52.1 43.18 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 118.145 -1.422 . . . . 0.0 111.464 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.23 -50.61 12.47 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 CA-C-N 119.901 1.0 . . . . 0.0 111.603 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.441 ' OE2' ' O ' ' A' ' 55' ' ' VAL . 32.9 tt0 -55.17 -52.75 62.32 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -47.26 -25.35 0.93 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.941 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.565 HD11 ' CE2' ' A' ' 65' ' ' PHE . 83.7 mt -79.07 -41.74 28.04 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.781 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -60.96 -41.12 95.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 122.348 1.071 . . . . 0.0 108.466 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.7 tp -57.91 -64.43 0.91 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.821 -1.99 . . . . 0.0 110.318 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.7 mmm -63.45 -36.35 83.45 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.58 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.12 -49.08 73.6 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 121.116 0.484 . . . . 0.0 110.062 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -61.33 -43.08 99.47 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.442 ' C ' ' H ' ' A' ' 77' ' ' LYS . 49.8 tttp -65.91 -38.6 89.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.25 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 7.0 ttm -60.78 -1.18 0.36 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.367 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.442 ' H ' ' C ' ' A' ' 75' ' ' LYS . 61.8 pttt -54.83 -15.48 1.96 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.236 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 40.5 p-10 -74.71 108.16 7.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.086 0.47 . . . . 0.0 111.225 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.0 p . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.61 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.8 t0 52.8 77.88 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.034 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -132.43 179.13 6.31 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.067 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.591 HD22 ' N ' ' A' ' 4' ' ' LEU . 3.1 mm? -73.71 171.02 14.05 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.211 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.511 ' HG1' ' CD ' ' A' ' 8' ' ' GLN . 16.2 p -98.71 176.99 5.44 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.19 0.519 . . . . 0.0 111.392 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.436 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 24.9 p-10 -80.03 -26.36 39.82 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.339 177.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.412 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 97.6 mt-10 -63.15 -44.79 94.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.901 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.586 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 5.1 mp0 -69.91 -23.21 63.19 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.522 0.677 . . . . 0.0 110.124 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -83.9 -56.55 5.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.429 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 61.6 m -58.25 -40.69 82.43 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.151 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -65.73 -37.42 86.33 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.046 0.451 . . . . 0.0 109.873 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.586 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 2.4 m-85 -62.59 -45.28 93.63 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.468 0.652 . . . . 0.0 109.995 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -63.2 -42.21 99.28 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.064 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -63.31 -41.78 98.96 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.85 -46.99 86.43 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.292 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.439 ' CE2' ' CG1' ' A' ' 27' ' ' ILE . 48.1 t80 -67.9 -45.6 73.99 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.3 p -63.71 -33.78 76.41 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.1 tp -62.9 -39.92 95.96 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.242 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.531 ' CD1' HG21 ' A' ' 35' ' ' VAL . 21.2 m-85 -73.97 -18.97 60.8 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.033 179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 25' ' ' GLY . 29.2 t0 -86.57 74.1 9.95 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.749 0.309 . . . . 0.0 111.338 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -44.9 -36.55 3.38 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.735 0.303 . . . . 0.0 111.255 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -87.94 -23.86 23.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.708 0.289 . . . . 0.0 111.427 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.51 21.48 76.17 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.0 p-10 -80.13 -1.23 39.32 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.679 0.276 . . . . 0.0 111.11 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.433 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 82.97 26.41 45.08 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 32.2 m -151.03 132.15 14.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.992 0.425 . . . . 0.0 111.057 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.439 ' CG1' ' CE2' ' A' ' 16' ' ' PHE . 4.3 mm -101.64 147.79 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 p -126.94 167.98 15.14 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 33' ' ' GLY . 58.0 p -58.78 -30.49 67.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.959 0.409 . . . . 0.0 110.818 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HG3' ' H ' ' A' ' 31' ' ' GLU . 38.9 pttt -67.18 -49.47 64.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.79 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.46 ' H ' ' HG3' ' A' ' 30' ' ' LYS . 88.7 mt-10 -67.12 -48.52 67.87 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.189 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.99 -43.7 98.48 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -62.65 -41.21 99.85 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 178.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.3 m -50.29 -46.04 54.98 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.411 1.101 . . . . 0.0 108.231 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.531 HG21 ' CD1' ' A' ' 19' ' ' PHE . 58.5 t -69.76 -55.89 13.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 113.345 -1.752 . . . . 0.0 111.424 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 83.0 mmm -54.41 -44.74 72.64 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.868 0.842 . . . . 0.0 109.943 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -54.08 -46.95 72.17 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.461 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.1 t -79.07 -9.39 59.53 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.069 -1.423 . . . . 0.0 111.728 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.405 ' O ' ' CD2' ' A' ' 39' ' ' LEU . 0.9 OUTLIER -94.05 34.62 1.23 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.502 -178.723 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.37 2.1 6.74 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.548 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -102.47 152.42 21.16 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -134.61 65.16 66.34 Favored Pre-proline 0 N--CA 1.47 0.531 0 CA-C-O 120.405 0.145 . . . . 0.0 111.271 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.403 ' CG ' HD21 ' A' ' 48' ' ' LEU . 85.4 Cg_endo -76.47 156.04 36.43 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.146 1.898 . . . . 0.0 111.629 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.5 p -92.79 168.88 10.89 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -60.02 -31.77 70.27 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.881 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.11 -44.7 96.09 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.585 0.707 . . . . 0.0 109.593 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -60.79 -49.18 78.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.316 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.403 HD21 ' CG ' ' A' ' 43' ' ' PRO . 73.7 mt -62.94 -41.82 99.61 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.954 0.407 . . . . 0.0 111.576 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -66.11 -41.52 90.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.41 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -64.71 -37.26 86.98 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.956 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.6 ttm -61.88 -41.78 98.28 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.479 HD12 ' CG2' ' A' ' 29' ' ' THR . 25.2 mt -65.59 -43.24 94.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.292 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -63.72 -39.91 95.46 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.492 ' OE2' ' CZ ' ' A' ' 74' ' ' ARG . 69.1 tt0 -61.85 -37.69 85.43 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 122.028 0.918 . . . . 0.0 110.089 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.0 t -109.18 67.54 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.389 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 58' ' ' ASP . 2.8 t0 -131.9 45.2 2.81 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.128 0.489 . . . . 0.0 109.794 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -38.67 -23.15 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.06 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 56' ' ' ASP . 29.1 p-10 -102.28 -43.09 5.8 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.68 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.467 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 90.88 29.69 12.65 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.436 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 48.1 p30 -87.36 -11.88 48.01 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 111.392 0.145 . . . . 0.0 111.392 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.03 6.13 85.66 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.686 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.8 p -138.85 163.99 30.81 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.6 mt -99.76 122.65 51.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.824 -177.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -91.97 -165.2 1.3 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 176.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.471 ' CE2' HD11 ' A' ' 69' ' ' LEU . 59.5 t80 -77.48 -47.02 2.52 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 117.823 -1.551 . . . . 0.0 111.841 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -65.26 -31.22 53.72 Favored 'Trans proline' 0 N--CA 1.507 2.319 0 C-N-CA 121.439 1.426 . . . . 0.0 112.06 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -66.59 -31.07 71.53 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 122.808 1.289 . . . . 0.0 108.149 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -75.58 -30.98 59.81 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.456 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 73' ' ' ALA . 4.8 mt -69.7 -34.31 73.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.531 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -65.06 -44.13 89.98 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.47 1.129 . . . . 0.0 109.292 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.6 tp -61.66 -45.84 92.31 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 112.545 -2.116 . . . . 0.0 110.79 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.455 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . 99.5 mmm -80.12 -31.29 39.11 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.102 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . -72.1 -40.66 68.02 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.31 0.576 . . . . 0.0 109.812 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.492 ' CZ ' ' OE2' ' A' ' 54' ' ' GLU . 63.0 ttt180 -66.45 -42.25 87.89 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.245 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -62.83 -42.67 99.83 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.242 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 82.6 mmm -72.42 -5.28 35.44 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.398 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -63.72 -45.89 87.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.182 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -109.97 -100.0 0.39 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.12 0.486 . . . . 0.0 111.045 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 31.3 p . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.74 -179.617 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.227 -0.656 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -144.73 124.38 13.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.871 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -148.66 -127.3 0.05 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.593 0.235 . . . . 0.0 110.805 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 77.2 mt -99.01 162.76 12.9 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.458 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.6 m -106.15 158.26 16.96 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.151 0.501 . . . . 0.0 111.221 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -65.3 -33.64 76.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.223 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.94 -45.79 92.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.933 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.543 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -63.84 -36.23 83.23 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.88 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 74.7 mt -74.92 -54.34 14.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.078 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.0 t -55.83 -49.7 72.56 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.004 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -56.55 -41.68 77.27 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.883 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.543 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.0 m-85 -61.73 -48.79 79.13 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -60.78 -44.33 96.93 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.725 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -62.64 -44.94 95.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.39 -49.49 77.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.602 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 38.2 t80 -65.51 -49.15 70.06 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.3 t -60.67 -37.74 82.57 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.7 tp -61.97 -43.92 97.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.064 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.544 ' CD1' HG21 ' A' ' 35' ' ' VAL . 19.5 m-85 -66.26 -24.54 66.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.841 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -86.88 85.24 7.26 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.534 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -67.46 -16.85 64.45 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.207 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 17.4 t0 -96.65 -0.46 48.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.202 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 38.01 53.86 2.02 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 26' ' ' CYS . 31.6 p-10 -111.84 9.15 20.7 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.695 0.283 . . . . 0.0 111.003 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.1 3.15 88.14 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 36.1 m -142.48 146.37 34.68 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.983 0.421 . . . . 0.0 110.887 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.9 mt -110.74 125.76 68.05 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 57.2 p -86.69 160.74 18.76 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 33' ' ' GLY . 34.0 p -58.44 -29.69 66.33 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.311 -178.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -65.04 -48.19 74.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.29 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -60.85 -47.11 87.84 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.3 tp -63.65 -40.6 97.27 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -60.88 -46.67 94.07 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.0 m -48.57 -49.7 35.5 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.544 HG21 ' CD1' ' A' ' 19' ' ' PHE . 53.0 t -63.75 -51.07 74.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.587 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.2 mmt -62.83 -45.16 93.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 61.6 ttt85 -54.07 -50.24 67.22 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.405 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.3 t -66.85 -21.02 66.03 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.47 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.6 mt -86.83 29.89 0.78 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.73 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.58 39.98 98.56 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.87 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -128.04 142.54 51.19 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -129.64 62.69 64.73 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 121.351 -0.139 . . . . 0.0 111.315 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.35 152.33 34.52 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.222 1.948 . . . . 0.0 111.538 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.8 p -83.85 160.93 21.05 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -60.23 -33.82 72.81 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.849 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.78 -47.15 85.72 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.427 0.632 . . . . 0.0 109.342 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.42 -43.58 83.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.846 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.4 mt -65.19 -45.59 84.17 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.107 0.479 . . . . 0.0 111.632 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.441 ' O ' HG22 ' A' ' 52' ' ' ILE . 58.4 tt0 -66.54 -33.96 76.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 122.203 1.002 . . . . 0.0 109.233 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.467 ' O ' ' OE2' ' A' ' 54' ' ' GLU . 96.2 m-20 -76.37 -39.98 52.33 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.524 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 39.2 ttm -58.66 -45.12 90.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.328 0.585 . . . . 0.0 110.498 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.441 HG22 ' O ' ' A' ' 49' ' ' GLN . 6.6 tt -70.66 -33.22 52.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.399 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -60.46 -39.0 86.02 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.562 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.467 ' OE2' ' O ' ' A' ' 50' ' ' ASP . 4.9 mm-40 -65.28 -16.43 63.55 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.364 0.602 . . . . 0.0 110.833 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 57' ' ' ALA . 3.0 t -110.2 -19.12 7.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.759 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -65.55 48.51 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.043 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -57.7 -23.34 51.19 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.964 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 17.6 p-10 -88.67 -44.88 10.27 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.318 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 93.05 50.31 2.47 Favored Glycine 0 N--CA 1.471 1.006 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.67 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 55.6 p30 -109.88 -21.61 12.27 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.692 -0.299 . . . . 0.0 110.999 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.544 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 84.7 -4.71 84.15 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 51.1 p -131.42 169.43 16.05 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.9 mt -104.14 119.29 52.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -91.54 -175.93 4.35 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 175.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.451 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 75.6 t80 -69.44 -55.61 9.37 Favored Pre-proline 0 C--N 1.318 -0.796 0 C-N-CA 118.63 -1.228 . . . . 0.0 112.242 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 14.3 Cg_endo -50.45 -43.08 46.34 Favored 'Trans proline' 0 N--CA 1.504 2.109 0 C-N-CA 121.885 1.724 . . . . 0.0 111.373 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.401 ' OE2' ' CG ' ' A' ' 58' ' ' ASP . 95.2 mt-10 -58.86 -52.63 64.89 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -57.33 -41.71 80.5 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.648 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.4 tp -61.36 -44.73 96.68 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.163 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -64.24 -52.5 58.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 122.619 1.199 . . . . 0.0 108.953 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.8 tt -51.95 -59.43 4.35 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.078 -1.874 . . . . 0.0 110.62 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.465 ' O ' ' N ' ' A' ' 76' ' ' MET . 1.2 tpt -61.6 -39.29 90.68 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.757 178.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.86 -37.54 87.26 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.197 0.522 . . . . 0.0 110.499 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -80.57 -34.97 34.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.593 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -82.79 -7.45 59.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.347 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.465 ' N ' ' O ' ' A' ' 72' ' ' MET . 24.5 tpp -57.84 -47.58 82.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.438 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -54.0 -81.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.954 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 55.76 78.81 0.18 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.068 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.674 -179.958 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 121.161 0.505 . . . . 0.0 111.356 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -72.99 -42.89 62.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.875 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 7' ' ' GLU . 6.7 pt-20 -61.77 -44.54 96.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.956 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.558 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 93.2 mt-30 -69.63 -24.73 63.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.53 0.681 . . . . 0.0 109.975 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.8 mt -83.4 -56.18 6.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.243 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.8 t -58.47 -42.6 87.88 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -63.89 -39.78 94.99 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.558 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.2 m-30 -64.07 -45.71 87.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.771 0.796 . . . . 0.0 109.862 178.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -60.92 -46.78 89.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.729 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -62.26 -39.75 93.93 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.424 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -60.65 -44.67 96.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.435 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.458 ' CE2' ' CG1' ' A' ' 27' ' ' ILE . 35.1 t80 -69.05 -45.63 69.9 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.6 m -65.81 -33.18 75.27 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.738 0.78 . . . . 0.0 109.065 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.37 -40.43 96.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.376 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.549 ' CD1' HG21 ' A' ' 35' ' ' VAL . 26.6 m-85 -73.87 -14.65 61.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.92 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.532 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 42.4 t0 -89.55 78.91 6.97 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.171 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.424 ' NZ ' HG21 ' A' ' 34' ' ' THR . 98.2 mttt -40.94 -47.61 3.03 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.736 -178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.43 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 20.8 p30 -88.11 -1.75 58.19 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.646 0.26 . . . . 0.0 111.683 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.12 39.23 41.31 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.051 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.532 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 44.5 p-10 -90.97 -0.05 57.65 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.645 0.26 . . . . 0.0 111.247 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.494 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 81.76 20.66 63.13 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.404 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 6.4 m -143.08 137.28 29.07 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.021 0.439 . . . . 0.0 111.082 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.458 ' CG1' ' CE2' ' A' ' 16' ' ' PHE . 4.9 mm -109.46 122.11 63.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.2 p -100.48 167.13 10.57 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.656 HG22 HD12 ' A' ' 52' ' ' ILE . 74.7 p -60.4 -28.59 68.36 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.411 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -66.59 -48.34 69.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.592 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -67.47 -45.65 75.34 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.979 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.3 tp -62.1 -41.86 98.64 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -63.78 -42.34 98.57 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.424 HG21 ' NZ ' ' A' ' 21' ' ' LYS . 24.2 m -50.18 -46.22 54.07 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.549 HG21 ' CD1' ' A' ' 19' ' ' PHE . 98.1 t -69.59 -55.76 13.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 113.389 -1.732 . . . . 0.0 111.296 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 84.5 mmm -57.0 -41.22 78.09 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -58.9 -51.49 69.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.848 0.832 . . . . 0.0 110.622 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.4 t -69.58 -14.19 62.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.687 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 41' ' ' GLN . 1.7 mm? -97.39 36.7 1.44 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.964 0.412 . . . . 0.0 111.335 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.78 6.33 3.56 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.198 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' A' ' 39' ' ' LEU . 4.8 tp60 -102.07 151.06 22.6 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -144.05 68.98 16.18 Favored Pre-proline 0 N--CA 1.464 0.253 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.218 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.47 ' HB2' HD21 ' A' ' 48' ' ' LEU . 29.4 Cg_exo -65.18 152.58 81.73 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.488 2.125 . . . . 0.0 112.185 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.4 m -79.72 159.97 26.43 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -61.41 -48.43 81.23 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.07 -0.652 . . . . 0.0 112.1 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.15 77.06 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -61.07 -45.39 94.93 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.237 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 43' ' ' PRO . 85.4 mt -62.28 -41.31 98.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.265 0.555 . . . . 0.0 110.774 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -65.24 -45.86 82.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.626 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.92 -42.34 97.42 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.246 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 45.9 tpp -59.13 -45.98 89.54 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.656 HD12 HG22 ' A' ' 29' ' ' THR . 2.8 mt -63.49 -43.08 98.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.35 178.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -59.69 -28.97 67.76 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -68.52 -31.31 70.46 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.277 0.56 . . . . 0.0 110.762 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.442 ' C ' ' H ' ' A' ' 57' ' ' ALA . 61.5 t -98.6 -13.36 8.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.541 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 28.8 t0 -72.28 40.89 0.08 Allowed 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.317 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.442 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -40.66 -24.37 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.393 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 4.5 p-10 -89.2 -39.96 13.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.165 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.525 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 92.21 54.76 1.81 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.561 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 47.5 p30 -117.56 -20.77 8.87 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.719 -0.283 . . . . 0.0 110.958 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.561 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 81.2 5.78 89.82 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.8 p -135.76 165.13 26.3 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.8 mt -107.33 126.39 63.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -91.57 -167.42 1.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 175.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.566 ' CZ ' HD11 ' A' ' 69' ' ' LEU . 43.4 t80 -79.67 -50.67 1.24 Allowed Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 118.525 -1.27 . . . . 0.0 111.166 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.72 -33.54 93.01 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.319 1.346 . . . . 0.0 112.011 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -67.01 -30.63 70.79 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -74.81 -30.09 61.3 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.669 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.566 HD11 ' CZ ' ' A' ' 65' ' ' PHE . 4.3 mt -69.74 -33.1 71.99 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 177.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -68.09 -45.06 74.79 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.418 1.104 . . . . 0.0 109.357 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.2 tp -60.45 -45.64 92.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.108 -1.86 . . . . 0.0 111.355 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 93.0 mmm -79.29 -26.35 42.32 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.898 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 C--N 1.332 -0.183 0 CA-C-O 121.221 0.534 . . . . 0.0 110.514 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.722 HG22 ' N ' ' A' ' 6' ' ' ASP . 32.5 m . . . . . 0 N--CA 1.465 0.28 0 CA-C-O 121.109 0.48 . . . . 0.0 111.417 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.722 ' N ' HG22 ' A' ' 5' ' ' THR . 97.7 m-20 -70.53 -42.02 71.78 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.826 178.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.51 ' CG ' ' N ' ' A' ' 8' ' ' GLN . 7.2 pt-20 -43.98 -41.84 5.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.634 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.534 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 38.1 tp60 -62.94 -23.57 67.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.475 0.655 . . . . 0.0 109.327 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.559 ' N ' ' O ' ' A' ' 6' ' ' ASP . 24.7 mt -81.29 -51.1 15.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.08 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 39.4 t -56.93 -42.8 80.66 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.652 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -63.56 -42.5 98.34 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.6 m-30 -55.1 -46.24 75.51 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -62.59 -40.34 96.58 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.886 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -62.06 -44.86 95.78 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.549 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -57.9 -43.32 86.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.262 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -70.78 -49.38 47.18 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.7 t -59.1 -35.55 73.61 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.8 tp -61.86 -44.52 96.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.281 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.549 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.7 m-30 -59.03 -25.19 63.48 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.965 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -83.27 101.99 11.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.841 0.353 . . . . 0.0 111.432 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -65.44 -30.7 71.53 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.822 0.344 . . . . 0.0 111.725 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -103.21 -10.77 18.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.404 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 61.52 45.77 95.68 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -97.49 18.73 14.69 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.645 0.26 . . . . 0.0 111.256 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.9 7.71 50.42 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 31.5 m -141.77 146.91 36.51 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.991 0.424 . . . . 0.0 110.945 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 92.1 mt -113.17 129.43 68.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 81.5 p -91.47 161.88 14.79 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 33' ' ' GLY . 71.9 p -56.22 -32.75 64.72 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.587 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -64.27 -48.47 75.58 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.229 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.07 -46.21 91.61 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.851 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.1 tp -62.62 -43.31 99.14 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -59.69 -49.18 81.32 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 178.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.9 m -48.14 -48.28 34.28 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 122.369 1.081 . . . . 0.0 108.607 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.422 HG11 ' CE2' ' A' ' 19' ' ' PHE . 67.3 t -68.11 -52.71 35.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 113.195 -1.821 . . . . 0.0 111.295 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.401 ' CE ' ' OE1' ' A' ' 41' ' ' GLN . 35.8 mmm -61.86 -42.29 98.88 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.678 0.751 . . . . 0.0 109.756 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.5 tpt85 -54.37 -51.6 64.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.539 -1.209 . . . . 0.0 110.137 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.412 ' C ' ' H ' ' A' ' 40' ' ' GLY . 47.0 m -62.14 -32.86 73.51 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.98 -1.464 . . . . 0.0 111.702 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.537 ' C ' ' H ' ' A' ' 41' ' ' GLN . 76.2 mt -73.84 33.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.782 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 38' ' ' SER . . . 62.49 -6.71 0.29 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.538 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.537 ' H ' ' C ' ' A' ' 39' ' ' LEU . 42.5 tt0 -81.41 141.73 33.65 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 42' ' ' ASN . 19.1 p-10 -124.88 72.99 63.92 Favored Pre-proline 0 N--CA 1.47 0.529 0 C-N-CA 121.376 -0.13 . . . . 0.0 111.288 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.407 ' CG ' HD21 ' A' ' 48' ' ' LEU . 94.3 Cg_endo -81.2 142.76 13.66 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.023 1.816 . . . . 0.0 111.845 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.415 ' OG1' ' N ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -87.43 175.11 8.12 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.393 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.415 ' N ' ' OG1' ' A' ' 44' ' ' THR . 52.8 mt-10 -57.2 -46.99 82.38 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.806 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.76 -49.51 72.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.525 0.679 . . . . 0.0 109.594 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -52.53 -47.08 66.94 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.946 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.407 HD21 ' CG ' ' A' ' 43' ' ' PRO . 95.4 mt -65.41 -46.78 78.66 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.195 0.522 . . . . 0.0 111.78 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.448 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 86.6 mt-30 -60.58 -44.54 96.09 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.598 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -67.12 -35.22 79.27 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.436 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.2 tpp -66.64 -50.94 61.33 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.45 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 56' ' ' ASP . 7.9 tt -71.36 -40.69 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.305 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 49' ' ' GLN . 22.9 t-20 -60.03 -39.57 86.34 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -77.43 -13.68 59.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.56 0.695 . . . . 0.0 109.999 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.441 ' O ' ' OE1' ' A' ' 67' ' ' GLU . 38.2 t -103.44 -22.78 4.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.549 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 52' ' ' ILE . 45.9 t0 -76.5 52.71 0.81 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.332 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.67 -27.39 0.1 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.642 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.449 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 37.8 m-20 -80.79 -34.75 33.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.515 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 87.16 10.13 72.08 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 51.3 p-10 -69.64 -27.26 64.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.394 0.14 . . . . 0.0 111.291 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 96.53 -7.25 65.81 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.9 p -129.16 167.08 18.12 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.6 mt -104.0 123.57 57.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.783 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -88.63 -175.86 5.07 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 176.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.417 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 38.2 t80 -67.95 -55.84 12.64 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 117.955 -1.498 . . . . 0.0 112.019 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.1 Cg_endo -56.08 -33.63 90.44 Favored 'Trans proline' 0 N--CA 1.505 2.163 0 C-N-CA 121.517 1.478 . . . . 0.0 112.047 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.449 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 68.7 mm-40 -57.35 -56.04 26.93 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -60.46 -36.49 78.37 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.707 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.48 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -60.94 -48.72 80.53 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.204 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -55.01 -50.04 70.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.591 1.186 . . . . 0.0 109.009 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 tp -53.37 -46.25 69.52 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 112.574 -2.103 . . . . 0.0 110.599 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.2 tpt -67.48 -46.74 72.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.759 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.286 0 CA-C-O 121.129 0.49 . . . . 0.0 109.979 -179.415 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.692 HG22 ' N ' ' A' ' 6' ' ' ASP . 27.1 m . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 121.101 0.477 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.692 ' N ' HG22 ' A' ' 5' ' ' THR . 1.8 p30 -73.21 -41.96 63.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.165 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.522 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 12.4 pt-20 -64.47 -40.76 96.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.576 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.559 ' O ' ' CD2' ' A' ' 12' ' ' PHE . 95.6 mt-30 -69.8 -35.03 74.51 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.273 0.559 . . . . 0.0 110.498 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.6 mt -72.95 -57.11 7.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.296 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.0 t -57.48 -46.66 83.44 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.089 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -49.27 -46.04 45.77 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 8' ' ' GLN . 20.3 m-30 -66.94 -47.07 72.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.382 0.611 . . . . 0.0 110.101 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -62.54 -45.79 91.35 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.774 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -66.06 -41.97 90.09 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.517 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.37 -45.71 93.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.512 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.42 ' C ' ' CD1' ' A' ' 16' ' ' PHE . 26.3 t80 -67.72 -43.95 78.8 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.3 m -63.88 -35.82 81.89 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 39.0 tp -64.21 -39.74 94.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.445 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.517 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.5 m-30 -66.4 -15.81 63.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.43 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.54 ' CG ' ' H ' ' A' ' 23' ' ' GLY . 65.7 t0 -92.24 89.59 6.93 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.209 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -50.28 -41.55 50.8 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.787 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -82.94 -27.11 30.79 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.048 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.54 ' H ' ' CG ' ' A' ' 20' ' ' ASP . . . 72.15 31.85 63.57 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.479 ' OD2' ' SG ' ' A' ' 26' ' ' CYS . 35.7 p-10 -81.69 -3.88 54.76 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.23 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.87 3.9 57.99 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.479 ' SG ' ' OD2' ' A' ' 24' ' ' ASP . 15.3 p -141.73 146.38 35.96 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.0 0.429 . . . . 0.0 111.034 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.4 HD11 ' CD2' ' A' ' 16' ' ' PHE . 72.6 mt -108.98 125.11 66.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.0 p -90.0 169.76 10.93 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.471 ' H ' HG23 ' A' ' 29' ' ' THR . 2.9 p -59.54 -52.24 66.42 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.979 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -53.19 -40.18 64.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -66.21 -43.45 86.67 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.505 HD13 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -62.29 -46.6 88.03 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.294 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 37' ' ' ARG . . . -60.0 -41.52 97.95 Favored Glycine 0 C--O 1.223 -0.588 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.7 m -48.69 -52.23 24.47 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.42 HG11 ' CE2' ' A' ' 19' ' ' PHE . 78.2 t -65.74 -49.82 75.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.194 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.7 mmm -65.14 -39.15 92.63 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 33' ' ' GLY . 23.9 tpt180 -55.49 -50.21 70.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.538 0.685 . . . . 0.0 110.2 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.6 t -71.43 -19.51 62.23 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.328 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.91 36.12 0.44 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.717 0.294 . . . . 0.0 111.348 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.74 45.97 94.08 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.496 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -144.75 154.73 43.03 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 25.3 p30 -134.54 73.84 67.12 Favored Pre-proline 0 N--CA 1.467 0.413 0 C-N-CA 121.184 -0.206 . . . . 0.0 110.963 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.415 ' CG ' HD21 ' A' ' 48' ' ' LEU . 87.1 Cg_endo -78.26 149.14 24.65 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.963 1.776 . . . . 0.0 111.6 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.8 p -87.91 164.31 15.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -59.54 -42.72 92.97 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.952 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.14 80.68 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.52 -48.12 82.9 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.075 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.415 HD21 ' CG ' ' A' ' 43' ' ' PRO . 52.6 mt -64.64 -42.45 95.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.158 0.504 . . . . 0.0 111.067 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -61.96 -36.59 81.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.899 0.857 . . . . 0.0 109.287 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -75.65 -40.07 56.69 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.006 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 33.9 mtp -63.77 -45.97 87.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.32 0.581 . . . . 0.0 110.048 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.487 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 1.4 tp -65.79 -47.44 85.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.874 -178.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.487 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 18.0 t-20 -69.06 -20.27 64.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.861 -177.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -72.34 -48.74 39.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.182 0.515 . . . . 0.0 110.525 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 57' ' ' ALA . 12.0 p -86.2 -2.33 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.373 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.459 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 16.6 t70 -64.57 41.89 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.625 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -50.68 -26.75 5.84 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.862 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 25.8 p30 -71.71 -39.29 70.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.356 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.514 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 91.81 7.39 64.59 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 51.6 p-10 -85.9 -22.53 27.44 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 122.724 -0.28 . . . . 0.0 111.387 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 85.73 3.41 86.04 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.508 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 22.9 p -139.6 151.2 45.83 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.9 mm -85.35 127.6 39.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.333 -0.547 . . . . 0.0 112.359 -176.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -104.71 153.79 20.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.744 ' CZ ' HD23 ' A' ' 69' ' ' LEU . 34.8 t80 -45.89 -55.61 12.46 Favored Pre-proline 0 C--N 1.319 -0.719 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.418 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 11.9 Cg_endo -49.22 -50.31 13.21 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.97 1.78 . . . . 0.0 111.489 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -55.85 -53.38 57.47 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -54.71 -21.36 10.62 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.175 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.744 HD23 ' CZ ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -79.04 -44.22 22.64 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.305 0.574 . . . . 0.0 110.219 179.283 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -58.23 -42.12 85.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.7 tp -59.71 -64.19 1.03 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 112.785 -2.007 . . . . 0.0 109.456 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.85 -38.11 54.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.645 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.153 0.501 . . . . 0.0 110.254 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 121.242 0.544 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -77.72 -29.41 51.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.385 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.442 ' OE1' ' N ' ' A' ' 7' ' ' GLU . 48.6 mp0 -68.37 -44.21 75.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.197 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.57 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 95.9 mt-30 -65.85 -29.74 70.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.278 0.561 . . . . 0.0 110.194 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.2 mt -77.44 -53.16 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.112 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.7 t -58.16 -46.56 85.48 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.845 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -54.6 -42.97 71.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.596 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.607 ' CE1' ' SD ' ' A' ' 72' ' ' MET . 16.3 m-30 -64.92 -46.73 80.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.163 0.506 . . . . 0.0 110.183 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -65.96 -43.01 89.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.743 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -67.08 -45.24 77.92 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.223 0.535 . . . . 0.0 110.073 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.554 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -62.74 -44.83 95.19 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.534 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.429 ' CD2' HD11 ' A' ' 27' ' ' ILE . 54.1 t80 -66.72 -43.99 82.77 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.8 m -63.35 -36.64 84.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.2 tp -63.74 -40.29 96.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.473 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.4 m-30 -63.29 -18.01 63.14 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.487 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.541 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 24.2 t0 -98.04 93.89 6.55 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.905 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.48 ' NZ ' HG21 ' A' ' 34' ' ' THR . 55.2 mttp -65.74 -19.69 65.99 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.662 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 24' ' ' ASP . 8.8 p30 -109.99 13.16 23.47 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.522 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 35.18 32.08 0.03 OUTLIER Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.541 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 97.5 m-20 -69.84 -8.96 52.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.568 0.223 . . . . 0.0 110.811 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.67 -7.61 65.63 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.8 m -143.64 149.66 37.61 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.748 0.309 . . . . 0.0 111.098 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.429 HD11 ' CD2' ' A' ' 16' ' ' PHE . 73.8 mt -96.22 125.14 49.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.1 p -84.28 -160.14 0.44 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.7 p -84.79 -58.15 2.83 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.439 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 34' ' ' THR . 21.7 pttp -54.21 -35.98 62.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.415 . . . . 0.0 109.959 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.438 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 95.6 mt-10 -62.37 -50.84 69.95 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.0 tt -63.34 -42.02 98.9 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.53 -39.34 97.2 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 30' ' ' LYS . 20.0 m -52.77 -49.36 65.69 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.539 ' O ' HD13 ' A' ' 39' ' ' LEU . 96.6 t -63.15 -47.86 90.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.807 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 84.6 mmm -63.64 -42.8 98.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.502 0.668 . . . . 0.0 110.416 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -53.26 -49.39 67.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.104 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.3 m -71.45 -27.08 63.01 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.513 -1.221 . . . . 0.0 112.018 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 35' ' ' VAL . 7.2 mp -84.05 31.56 0.49 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.44 -8.0 1.73 Allowed Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.461 ' H ' ' C ' ' A' ' 39' ' ' LEU . 90.4 mm-40 -85.71 146.77 26.66 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.6 p30 -135.79 64.91 58.58 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 121.249 -0.181 . . . . 0.0 111.155 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.27 154.76 41.47 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.441 2.094 . . . . 0.0 111.783 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.9 m -94.32 161.43 14.24 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.437 ' HG2' ' H ' ' A' ' 45' ' ' GLU . 2.6 pt-20 -54.66 -34.3 62.02 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.706 -178.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.63 -45.15 85.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.465 0.65 . . . . 0.0 109.394 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -63.83 -41.14 97.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.187 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.1 mt -62.28 -45.92 91.12 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.072 0.463 . . . . 0.0 111.091 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -67.27 -45.69 75.89 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.437 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.72 -43.12 99.64 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.288 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.3 ttm -61.39 -41.96 97.96 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 56' ' ' ASP . 34.1 mt -67.94 -44.93 84.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.583 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -58.37 -35.72 72.4 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -69.07 -21.2 64.09 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.121 0.486 . . . . 0.0 110.474 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.577 ' C ' ' H ' ' A' ' 57' ' ' ALA . 83.8 t -106.93 -23.48 4.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.301 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 59' ' ' GLY . 27.5 t0 -63.46 34.23 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.469 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.577 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -36.92 -27.01 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.381 0.61 . . . . 0.0 110.873 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 56' ' ' ASP . 19.3 p-10 -85.96 -37.04 19.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.178 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 87.12 62.41 1.5 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.515 ' H ' ' CG ' ' A' ' 56' ' ' ASP . 55.0 p30 -123.92 -18.17 6.06 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.637 0.219 . . . . 0.0 111.204 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 80.36 2.57 89.46 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.809 -0.516 . . . . 0.0 111.809 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.458 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 64.4 p -136.68 159.61 41.29 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.3 mt -100.05 121.06 50.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -86.99 145.67 26.42 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.422 ' CE2' HD12 ' A' ' 69' ' ' LEU . 34.1 t80 -46.4 -48.69 45.94 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 118.589 -1.244 . . . . 0.0 111.231 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -52.79 -49.07 18.83 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.24 1.294 . . . . 0.0 111.825 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.406 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 94.4 mt-10 -55.45 -52.83 62.3 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -53.07 -23.92 8.88 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.517 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.422 HD12 ' CE2' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -71.91 -46.1 58.87 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.051 0.453 . . . . 0.0 110.55 179.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -61.52 -42.41 98.76 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 122.427 1.108 . . . . 0.0 108.937 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.5 tp -62.05 -30.65 71.13 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 112.774 -2.012 . . . . 0.0 109.682 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.607 ' SD ' ' CE1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -82.5 -40.37 21.15 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.703 178.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 121.006 0.431 . . . . 0.0 109.983 179.716 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 7' ' ' GLU . 4.8 m . . . . . 0 N--CA 1.47 0.573 0 CA-C-O 121.237 0.541 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 6' ' ' ASP . 5.4 p-10 -63.11 -34.47 77.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.406 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.454 ' H ' HG22 ' A' ' 5' ' ' THR . 97.6 mt-10 -61.64 -47.72 84.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.724 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.532 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -59.68 -36.02 75.63 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.3 mt -72.17 -55.24 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.977 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.2 t -55.38 -53.49 55.6 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.822 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -54.07 -44.3 71.02 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' A' ' 8' ' ' GLN . 4.7 m-30 -60.74 -51.22 70.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.455 0.645 . . . . 0.0 109.514 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -59.68 -42.7 93.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.5 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -62.33 -46.73 87.4 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.15 78.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.335 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.412 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 34.1 t80 -69.73 -50.94 38.67 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.0 p -57.79 -35.11 70.35 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 46.9 tp -61.27 -45.25 95.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.532 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.463 ' CD1' HG21 ' A' ' 35' ' ' VAL . 17.2 m-85 -61.26 -27.77 68.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.474 ' OD1' ' OD1' ' A' ' 22' ' ' ASP . 27.1 t0 -78.55 90.76 4.52 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.839 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -62.48 -36.02 81.18 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.795 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.474 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 28.8 p30 -96.64 -1.36 46.94 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.481 0.181 . . . . 0.0 111.296 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.31 40.47 37.9 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -88.93 3.93 49.79 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.718 0.294 . . . . 0.0 111.19 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.76 -6.05 84.03 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.4 m -133.1 158.92 41.57 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.836 0.35 . . . . 0.0 110.889 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.0 mt -119.96 126.85 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.5 p -90.4 157.47 17.59 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.554 ' O ' ' N ' ' A' ' 33' ' ' GLY . 66.7 p -55.13 -29.72 58.29 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.349 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.95 -48.83 77.2 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.229 0.538 . . . . 0.0 110.275 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -61.59 -45.11 95.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.842 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 tp -63.42 -38.89 92.9 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 177.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -62.89 -47.62 87.44 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.1 m -47.52 -48.68 27.37 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' A' ' 19' ' ' PHE . 56.8 t -63.72 -51.87 64.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 113.53 -1.668 . . . . 0.0 111.233 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.482 ' SD ' ' OE1' ' A' ' 41' ' ' GLN . 17.3 mmt -63.79 -45.52 89.34 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -47.8 -54.54 12.07 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.313 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 40' ' ' GLY . 37.5 m -62.06 -37.16 83.92 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.642 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 41' ' ' GLN . 69.8 mt -69.91 34.78 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.776 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 38' ' ' SER . . . 58.92 3.57 1.75 Allowed Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.482 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 87.0 mt-30 -97.43 149.09 22.53 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -147.54 67.01 10.28 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.269 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -65.52 157.6 57.47 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.288 1.992 . . . . 0.0 111.923 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.8 p -82.53 164.83 20.63 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 177.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -57.37 -40.62 78.53 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.436 -0.506 . . . . 0.0 112.051 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.3 -50.08 74.88 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.571 0.7 . . . . 0.0 109.803 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -54.11 -47.19 72.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.268 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.24 -47.33 71.08 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.905 0.384 . . . . 0.0 111.783 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.417 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 94.6 mm-40 -61.05 -40.03 92.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.54 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -74.22 -38.58 63.52 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.774 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 43.4 tpp -62.37 -48.89 77.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.493 0.663 . . . . 0.0 110.548 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 53' ' ' ASN . 19.7 tt -71.84 -41.84 69.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.195 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 49' ' ' GLN . 31.3 t30 -64.06 -38.75 92.19 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -60.58 -55.41 33.66 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.456 0.646 . . . . 0.0 110.958 -177.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.587 ' O ' HG22 ' A' ' 55' ' ' VAL . 7.1 p -67.67 -6.05 4.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.097 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.595 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.0 t0 -80.07 75.48 6.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.721 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.04 -24.66 1.14 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.259 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 12.0 p-10 -99.43 -44.68 6.1 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.22 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.595 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 93.57 29.11 10.35 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.76 HD22 ' N ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -71.41 -19.84 62.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.441 0.163 . . . . 0.0 111.242 179.493 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.76 ' N ' HD22 ' A' ' 60' ' ' ASN . . . 87.91 -9.45 74.34 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.403 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 68.3 p -132.1 167.27 20.02 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.3 mt -100.13 126.36 53.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.777 -177.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -96.3 -172.25 2.49 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.728 ' CE2' HD11 ' A' ' 69' ' ' LEU . 55.4 t80 -71.6 -56.01 5.31 Favored Pre-proline 0 C--N 1.319 -0.728 0 C-N-CA 118.114 -1.434 . . . . 0.0 111.865 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 32.5 Cg_endo -57.05 -39.3 92.23 Favored 'Trans proline' 0 N--CA 1.503 2.046 0 C-N-CA 121.488 1.459 . . . . 0.0 111.875 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.432 ' OE2' ' OD1' ' A' ' 58' ' ' ASP . 64.5 mm-40 -55.02 -49.06 72.49 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -57.22 -42.35 81.22 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 114.319 -1.309 . . . . 0.0 110.16 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.728 HD11 ' CE2' ' A' ' 65' ' ' PHE . 71.3 mt -61.95 -44.77 96.06 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.767 -0.583 . . . . 0.0 110.904 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.437 HD22 HG23 ' A' ' 55' ' ' VAL . 21.8 t30 -57.3 -47.86 80.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 122.533 1.158 . . . . 0.0 109.079 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.424 ' HB2' HG21 ' A' ' 55' ' ' VAL . 32.2 tp -59.5 -50.11 75.17 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 112.823 -1.989 . . . . 0.0 110.102 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.3 tpt -65.48 -42.87 91.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.647 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.206 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.919 -179.769 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.432 ' O ' HD13 ' A' ' 9' ' ' ILE . 43.7 p . . . . . 0 N--CA 1.473 0.684 0 CA-C-O 120.814 0.34 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -75.7 -18.12 59.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -66.44 -43.66 84.99 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.049 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.613 ' O ' ' CD2' ' A' ' 12' ' ' PHE . 84.3 mt-30 -67.39 -33.67 75.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.525 0.679 . . . . 0.0 110.383 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.529 ' N ' HD12 ' A' ' 9' ' ' ILE . 1.4 mp -74.11 -58.22 5.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.709 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.5 t -56.29 -46.51 79.73 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.72 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -47.11 -50.37 20.21 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.239 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.613 ' CD2' ' O ' ' A' ' 8' ' ' GLN . 17.7 m-85 -62.92 -48.83 77.23 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.491 0.663 . . . . 0.0 110.76 178.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -62.42 -47.33 84.57 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.725 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -62.15 -42.16 98.99 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.0 99.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.396 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 19.6 t80 -70.03 -47.66 61.15 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.8 p -66.21 -30.54 71.02 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.9 tp -61.04 -41.54 96.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.296 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.576 ' CD1' HG21 ' A' ' 35' ' ' VAL . 25.9 m-85 -73.23 -15.18 61.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.821 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.543 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 26.3 t0 -86.8 69.8 10.32 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.269 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -40.08 -46.14 2.1 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.704 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.459 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 26.4 p-10 -74.87 -19.78 60.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.443 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 64.72 30.34 77.67 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.543 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 54.9 p-10 -81.58 -3.87 54.49 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.744 0.307 . . . . 0.0 111.151 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.68 5.11 72.03 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.455 ' O ' ' OD1' ' A' ' 20' ' ' ASP . 15.7 m -136.08 150.19 49.04 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.904 0.383 . . . . 0.0 110.817 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.4 ' CD1' ' CD2' ' A' ' 16' ' ' PHE . 82.9 mt -117.36 130.23 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.6 p -104.61 166.49 10.36 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 33' ' ' GLY . 36.0 p -56.45 -24.88 48.46 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.532 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.449 ' O ' ' OG1' ' A' ' 34' ' ' THR . 65.7 tttm -68.08 -50.15 56.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.092 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.25 -49.15 68.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.626 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.2 tp -62.26 -41.85 98.82 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -64.13 -42.68 97.94 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 30' ' ' LYS . 23.6 m -49.19 -46.51 45.7 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 122.275 1.036 . . . . 0.0 108.412 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.576 HG21 ' CD1' ' A' ' 19' ' ' PHE . 74.1 t -68.94 -55.48 15.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 113.398 -1.728 . . . . 0.0 111.217 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.8 mmt -60.2 -41.05 92.16 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.529 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.416 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 71.6 ttp85 -57.56 -50.25 73.71 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.321 178.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -68.38 -18.12 64.39 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.592 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 35' ' ' VAL . 1.8 mm? -91.05 38.95 0.97 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.905 0.383 . . . . 0.0 111.476 -178.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.49 26.56 59.74 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.396 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.522 ' OE1' ' N ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -111.97 142.84 43.87 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.522 ' N ' ' OE1' ' A' ' 41' ' ' GLN . 10.9 m120 -128.31 75.11 79.34 Favored Pre-proline 0 N--CA 1.47 0.541 0 C-N-CA 121.288 -0.165 . . . . 0.0 111.361 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -81.11 143.88 14.47 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.254 1.969 . . . . 0.0 111.487 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.435 HG23 ' H ' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -89.11 172.22 9.25 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.257 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -63.2 -39.58 95.04 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.901 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.46 94.3 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.392 0.615 . . . . 0.0 109.434 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.435 ' H ' HG23 ' A' ' 44' ' ' THR . 51.3 tp10 -56.84 -51.08 70.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.046 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.1 mt -62.62 -42.51 99.63 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.135 0.493 . . . . 0.0 111.11 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -64.64 -37.96 89.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.79 0.805 . . . . 0.0 109.272 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -75.37 -35.32 61.12 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.1 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 32.9 ttm -63.86 -50.76 67.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.451 0.643 . . . . 0.0 110.146 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.415 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 1.3 tt -66.28 -39.5 84.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.635 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -63.71 -30.84 71.89 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.784 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -77.08 -30.31 55.38 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.592 0.711 . . . . 0.0 110.497 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.579 ' O ' ' N ' ' A' ' 57' ' ' ALA . 54.7 t -98.39 -4.71 9.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.474 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 52' ' ' ILE . 16.6 m-20 -64.74 45.01 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.449 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -45.81 -37.58 6.26 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.286 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 25.0 p-10 -77.65 -43.3 31.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.435 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.476 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 90.36 16.74 54.9 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.497 ' OD1' ' O ' ' A' ' 62' ' ' THR . 52.9 p-10 -94.34 -1.77 53.27 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 122.87 -0.194 . . . . 0.0 111.093 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.77 2.25 50.28 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.532 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.497 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 31.6 p -134.13 150.65 51.14 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.6 mm -91.34 133.3 33.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -101.26 -172.34 2.15 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -76.98 -47.45 2.75 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 118.091 -1.443 . . . . 0.0 111.658 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.96 -37.62 75.35 Favored 'Trans proline' 0 N--CA 1.505 2.176 0 C-N-CA 121.701 1.601 . . . . 0.0 111.934 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -64.22 -35.87 82.21 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -76.44 -23.07 53.93 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.305 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.6 tp -78.3 -32.55 49.45 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.209 0.528 . . . . 0.0 110.652 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -68.43 -42.21 79.22 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.615 1.198 . . . . 0.0 108.641 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.8 tp -62.95 -41.55 99.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 112.527 -2.124 . . . . 0.0 110.416 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.404 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . 1.2 mmt -81.02 -22.49 39.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.885 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 121.127 0.489 . . . . 0.0 109.791 -179.617 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.54 HG22 ' N ' ' A' ' 6' ' ' ASP . 7.1 m . . . . . 0 N--CA 1.466 0.35 0 CA-C-O 121.082 0.468 . . . . 0.0 111.341 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.54 ' N ' HG22 ' A' ' 5' ' ' THR . 98.8 m-20 -68.51 -40.87 80.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.654 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -61.86 -46.67 88.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.949 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.546 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 7.8 mp0 -64.29 -32.08 73.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 78.3 mt -76.45 -55.37 11.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.247 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 42.9 t -56.72 -47.77 79.23 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.032 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -59.98 -40.7 90.05 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.843 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.546 ' CG ' ' O ' ' A' ' 8' ' ' GLN . 3.9 m-30 -61.19 -49.78 75.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.326 0.584 . . . . 0.0 109.835 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -65.57 -39.65 91.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.012 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -61.81 -43.03 99.66 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.531 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.0 -45.92 92.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.576 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 31.7 t80 -66.55 -48.79 68.54 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.9 m -62.91 -35.62 80.68 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.954 0.883 . . . . 0.0 108.8 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.3 tp -60.98 -43.59 98.61 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.311 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 9.7 m-30 -63.15 -19.0 64.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.955 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -85.91 95.27 9.41 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.28 0.363 . . . . 0.0 111.493 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -76.13 -20.58 57.48 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.371 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.2 p30 -110.56 1.09 17.92 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.65 0.262 . . . . 0.0 111.322 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 47.07 40.83 13.69 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 26' ' ' CYS . 34.8 p30 -81.73 -2.65 51.35 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.725 0.298 . . . . 0.0 111.162 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.87 -8.18 78.77 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.449 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.1 m -143.05 139.85 30.7 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.776 0.322 . . . . 0.0 111.074 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.7 mt -96.58 128.4 47.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.5 p -86.23 -159.54 0.48 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 33' ' ' GLY . 22.0 p -86.56 -31.42 21.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.097 0.475 . . . . 0.0 110.806 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -67.12 -46.89 72.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.346 0.593 . . . . 0.0 110.403 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -63.16 -47.02 84.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.92 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.4 tp -63.82 -42.48 97.64 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -60.59 -46.8 93.73 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 178.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.9 m -48.87 -47.91 42.51 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 122.247 1.023 . . . . 0.0 108.292 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.92 -50.32 65.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 113.401 -1.727 . . . . 0.0 111.521 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 75.7 mmm -62.88 -43.0 99.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.783 0.801 . . . . 0.0 109.634 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -55.77 -52.21 64.73 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.452 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.5 t -66.42 -21.19 66.21 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.864 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 36.4 mt -84.43 30.9 0.53 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.583 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.6 45.98 94.74 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.855 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -141.19 151.11 43.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -134.91 68.82 71.21 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-O 120.394 0.14 . . . . 0.0 111.252 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.41 150.33 41.09 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.029 1.819 . . . . 0.0 111.845 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.3 p -87.22 166.96 14.54 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -59.81 -37.21 78.53 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.866 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.37 -47.41 78.95 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.448 0.642 . . . . 0.0 109.354 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -61.08 -46.42 90.73 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.134 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.2 mt -62.69 -49.32 75.58 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.162 0.506 . . . . 0.0 111.513 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -61.71 -39.47 91.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.226 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -72.02 -32.57 67.27 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.56 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.0 mmt -67.1 -45.75 76.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.363 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 4.1 tt -75.57 -41.63 41.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.893 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.41 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 24.4 t-20 -65.42 -41.79 93.19 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -177.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.78 -11.64 61.07 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.002 0.906 . . . . 0.0 109.909 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.531 ' C ' ' H ' ' A' ' 57' ' ' ALA . 42.9 t -110.37 -14.27 10.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.699 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 44.1 t0 -66.04 42.97 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.711 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -50.29 -28.67 8.2 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.261 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 1.8 p30 -77.87 -37.46 48.11 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.447 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.481 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 89.5 7.54 69.16 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.545 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 57.1 p30 -75.12 -21.52 58.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.416 0.151 . . . . 0.0 111.282 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.545 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 84.78 -5.52 81.8 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.741 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.429 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 54.5 p -133.82 163.71 28.87 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.8 mt -96.02 115.66 35.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.601 -0.439 . . . . 0.0 112.091 -177.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 65' ' ' PHE . 64.8 t0 -82.62 -173.52 4.67 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 176.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.509 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 34.2 t80 -77.68 -48.17 2.28 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 117.954 -1.498 . . . . 0.0 111.738 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.56 -43.57 53.97 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 121.287 1.324 . . . . 0.0 111.606 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.433 ' OE1' ' OD2' ' A' ' 58' ' ' ASP . 76.3 tt0 -56.0 -52.37 64.45 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 122.344 1.069 . . . . 0.0 108.208 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -48.34 -40.78 26.46 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.192 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.5 HD11 ' CE2' ' A' ' 65' ' ' PHE . 42.0 mt -61.43 -43.52 98.72 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.419 179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -58.48 -46.45 86.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 122.379 1.085 . . . . 0.0 109.125 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.1 tp -59.18 -47.43 85.33 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 112.847 -1.979 . . . . 0.0 110.484 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.0 tpt -67.71 -44.35 77.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.346 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.402 0 CA-C-O 121.156 0.503 . . . . 0.0 110.138 -178.719 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.568 0 CA-C-O 121.29 0.566 . . . . 0.0 111.353 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.678 ' O ' ' N ' ' A' ' 9' ' ' ILE . 5.8 p-10 -76.02 -52.7 9.66 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.284 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -43.31 -33.82 1.08 Allowed 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.961 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.532 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 84.2 mm-40 -70.53 -22.1 62.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.423 0.63 . . . . 0.0 109.835 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 6' ' ' ASP . 73.4 mt -83.28 -55.62 7.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.518 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -43.45 92.74 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 120.149 -0.621 . . . . 0.0 109.937 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -61.88 -39.64 92.65 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.0 m-30 -63.96 -45.97 86.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.385 0.612 . . . . 0.0 109.675 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -65.7 -43.14 90.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.587 -1.188 . . . . 0.0 111.756 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -62.96 -40.34 97.4 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.521 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -62.75 -43.35 99.03 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.36 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.424 ' CD1' HD11 ' A' ' 27' ' ' ILE . 48.1 t80 -68.16 -45.29 73.92 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.7 t -63.34 -36.99 85.53 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.4 tp -60.67 -38.39 84.78 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.943 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.521 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.8 m-30 -68.41 -15.39 63.53 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.017 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 65.8 t0 -95.29 77.36 3.43 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -43.02 -36.64 1.64 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.088 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.429 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 46.3 m-20 -83.52 -22.17 32.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.338 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 66.84 30.55 76.32 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.519 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 24.3 p-10 -88.66 0.11 56.74 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.533 0.206 . . . . 0.0 111.157 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.472 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 82.1 18.09 68.03 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.7 m -145.33 130.56 18.53 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 111.007 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.424 HD11 ' CD1' ' A' ' 16' ' ' PHE . 58.4 mt -103.67 141.57 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.424 ' H ' ' HB2' ' A' ' 31' ' ' GLU . 6.2 p -119.72 174.28 6.51 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.465 ' CG2' HD12 ' A' ' 52' ' ' ILE . 79.7 p -56.5 -33.48 66.04 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.808 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -67.69 -49.62 61.81 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.309 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.429 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 90.4 mt-10 -69.08 -45.37 70.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.2 tp -60.45 -44.31 95.96 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -63.83 -39.26 97.22 Favored Glycine 0 C--O 1.216 -1.003 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.1 m -50.29 -45.78 54.72 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.292 1.044 . . . . 0.0 108.677 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.71 -54.07 23.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 113.057 -1.883 . . . . 0.0 111.25 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.1 mmt -57.11 -41.6 79.27 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.523 0.678 . . . . 0.0 109.93 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -55.85 -45.39 78.46 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.564 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 61.8 p -79.87 -10.58 59.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.818 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.75 38.13 1.41 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.549 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.48 5.74 2.82 Favored Glycine 0 N--CA 1.465 0.568 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.502 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -103.71 151.8 22.57 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -138.1 74.04 43.74 Favored Pre-proline 0 N--CA 1.47 0.569 0 O-C-N 122.957 0.161 . . . . 0.0 111.19 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.445 ' CG ' HD21 ' A' ' 48' ' ' LEU . 97.7 Cg_endo -80.2 155.35 22.37 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.992 1.794 . . . . 0.0 112.026 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.566 HG22 ' N ' ' A' ' 45' ' ' GLU . 26.7 m -94.01 169.75 10.04 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.566 ' N ' HG22 ' A' ' 44' ' ' THR . 98.6 mt-10 -62.07 -34.0 75.46 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.954 -178.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.48 -44.55 96.88 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.481 0.657 . . . . 0.0 109.963 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.55 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -60.77 -51.54 68.91 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.037 -178.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.445 HD21 ' CG ' ' A' ' 43' ' ' PRO . 85.3 mt -61.26 -41.38 96.82 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.01 0.433 . . . . 0.0 111.829 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -64.61 -45.61 86.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.746 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -65.81 -37.57 86.6 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.074 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.4 mmm -61.91 -43.22 99.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.437 0.637 . . . . 0.0 109.563 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.465 HD12 ' CG2' ' A' ' 29' ' ' THR . 22.9 mt -66.68 -43.56 90.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.864 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -64.2 -35.03 79.47 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -70.43 -33.26 71.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.525 0.678 . . . . 0.0 110.324 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 55' ' ' VAL . 79.8 t -98.1 -4.74 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.095 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 15.8 t70 -65.6 41.59 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.057 0.456 . . . . 0.0 111.023 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -53.66 -25.97 20.42 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.58 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.434 ' OD1' ' OE1' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -80.31 -43.29 21.49 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.369 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.27 43.55 4.62 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.68 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 46.8 p30 -123.63 -15.27 7.08 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.268 0.099 . . . . 0.0 111.268 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 78.57 5.49 88.1 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.76 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.433 ' O ' ' OE1' ' A' ' 67' ' ' GLU . 72.4 p -135.84 164.5 27.79 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.0 mt -99.57 121.77 50.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.459 ' H ' ' HB3' ' A' ' 67' ' ' GLU . 90.5 m-20 -99.43 157.71 16.23 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 177.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.459 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 41.1 t80 -44.45 -53.92 13.43 Favored Pre-proline 0 CA--C 1.556 1.184 0 CA-C-N 120.557 1.526 . . . . 0.0 111.78 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.8 Cg_endo -57.24 -40.45 82.42 Favored 'Trans proline' 0 N--CA 1.505 2.157 0 C-N-CA 121.254 1.303 . . . . 0.0 112.087 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.459 ' HB3' ' H ' ' A' ' 64' ' ' ASP . 77.4 tt0 -63.02 -32.02 73.29 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.459 ' HB3' ' O ' ' A' ' 65' ' ' PHE . 53.5 t80 -71.8 -26.1 62.27 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.764 -1.562 . . . . 0.0 109.7 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.452 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 6.0 mt -76.01 -34.0 59.69 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.401 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -61.47 -42.28 98.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.62 1.2 . . . . 0.0 108.641 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.8 tp -58.17 -63.79 1.14 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 112.317 -2.22 . . . . 0.0 110.285 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 67.1 mmm -63.94 -32.85 74.53 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.187 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 C--O 1.233 0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.439 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.0 p . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 121.257 0.551 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 25.5 p-10 -73.95 -29.01 61.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.469 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.415 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 80.6 mm-40 -61.21 -45.98 92.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.026 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.606 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 53.8 tt0 -66.13 -26.54 67.49 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.0 mt -80.53 -54.6 10.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.086 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.0 t -57.62 -43.82 85.05 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.776 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -64.07 -40.2 95.74 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.606 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 2.7 m-85 -61.24 -47.49 85.81 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.623 0.725 . . . . 0.0 109.377 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -62.73 -44.35 96.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.836 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -61.02 -40.34 93.22 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.53 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.1 -42.0 97.72 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.273 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -68.18 -47.21 68.58 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.9 t -60.19 -36.12 76.91 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.4 tp -61.96 -41.98 98.6 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.444 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.53 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.5 m-30 -62.93 -24.97 68.12 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.315 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.481 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 47.4 t0 -83.21 94.54 7.9 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.346 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -59.67 -33.22 71.28 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.055 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -97.53 -3.03 40.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.609 0.242 . . . . 0.0 111.124 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.46 36.51 30.86 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.481 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 33.2 p-10 -95.46 15.92 18.36 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.672 0.273 . . . . 0.0 111.095 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.44 ' C ' ' SG ' ' A' ' 26' ' ' CYS . . . 69.61 22.24 76.58 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.44 ' SG ' ' C ' ' A' ' 25' ' ' GLY . 3.2 m -149.99 139.18 21.22 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.883 0.373 . . . . 0.0 111.218 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 6.0 mm -108.78 118.87 57.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.6 p -78.66 -162.76 0.39 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.499 ' OG1' ' N ' ' A' ' 30' ' ' LYS . 1.6 p -84.62 -60.11 2.16 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.863 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.499 ' N ' ' OG1' ' A' ' 29' ' ' THR . 20.3 pttp -50.0 -33.2 17.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.112 0.482 . . . . 0.0 110.081 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -67.8 -48.07 67.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.824 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.7 tp -64.52 -42.82 95.56 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.59 -43.26 98.25 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.1 m -48.65 -47.94 40.08 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.1 t -65.81 -50.16 72.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.648 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.2 mmt -63.5 -40.82 98.07 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -57.29 -48.86 77.84 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.369 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 86.8 p -69.67 -19.1 63.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.511 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.9 mt -92.13 30.62 1.4 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.469 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.71 43.96 98.56 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.835 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -133.26 144.31 49.66 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -123.34 69.48 41.4 Favored Pre-proline 0 N--CA 1.47 0.574 0 CA-C-O 120.452 0.167 . . . . 0.0 111.385 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.431 ' CG ' HD21 ' A' ' 48' ' ' LEU . 86.5 Cg_endo -78.8 142.58 17.88 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.044 1.829 . . . . 0.0 111.665 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.2 p -81.26 163.73 22.75 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -57.57 -45.94 84.58 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.957 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.77 -44.75 82.11 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -57.32 -40.97 79.04 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.199 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.431 HD21 ' CG ' ' A' ' 43' ' ' PRO . 95.4 mt -66.42 -44.52 82.71 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.174 0.511 . . . . 0.0 111.56 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -67.05 -43.88 81.61 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.643 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -61.96 -45.9 91.62 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.04 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 48.9 tpp -57.99 -39.18 77.58 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.449 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 0.6 OUTLIER -68.22 -42.55 84.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.242 179.326 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -58.68 -34.36 71.17 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -73.48 -50.17 22.94 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.88 0.848 . . . . 0.0 111.275 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.549 HG22 ' HG3' ' A' ' 67' ' ' GLU . 11.3 p -72.59 -18.48 18.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.297 -1.319 . . . . 0.0 111.054 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.2 t0 -79.7 48.71 0.96 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.501 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -44.76 -21.02 0.04 OUTLIER 'General case' 0 C--N 1.34 0.195 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.382 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.439 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 31.3 m-20 -80.5 -35.16 35.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.448 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.53 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 89.27 15.0 59.48 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 62' ' ' THR . 50.4 p-10 -77.32 -28.02 53.05 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.288 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 92.26 -2.73 75.26 Favored Glycine 0 N--CA 1.466 0.649 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.523 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 53.9 p -135.9 163.27 30.64 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.3 mm -95.78 118.64 42.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.855 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -89.31 -168.4 2.15 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.435 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 28.7 t80 -71.78 -55.51 5.46 Favored Pre-proline 0 C--N 1.317 -0.812 0 C-N-CA 118.002 -1.479 . . . . 0.0 111.91 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 38.3 Cg_endo -59.12 -35.11 98.59 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 121.392 1.395 . . . . 0.0 111.698 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.549 ' HG3' HG22 ' A' ' 55' ' ' VAL . 6.1 tp10 -58.79 -55.25 37.58 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.48 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 42.5 t80 -47.86 -40.52 21.72 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.401 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -57.97 -41.6 83.28 Favored 'General case' 0 C--N 1.313 -1.0 0 O-C-N 121.036 -1.04 . . . . 0.0 110.289 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -60.38 -47.85 84.31 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.703 1.24 . . . . 0.0 108.615 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.508 HD23 HG21 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -46.64 -64.16 0.83 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 112.85 -1.977 . . . . 0.0 110.58 179.357 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 73.0 mmm -62.78 -39.6 94.71 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.294 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.247 0 CA-C-O 121.047 0.451 . . . . 0.0 110.308 -179.609 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 p . . . . . 0 N--CA 1.469 0.505 0 CA-C-O 121.252 0.549 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 19.1 p-10 -78.68 -28.87 45.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.485 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.08 -43.91 97.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.805 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.584 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 99.0 mm-40 -70.31 -26.36 63.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.283 0.563 . . . . 0.0 109.831 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -81.96 -56.78 5.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.094 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.8 m -59.1 -44.24 91.94 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.182 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -61.06 -39.91 91.64 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.601 ' CG ' ' SD ' ' A' ' 72' ' ' MET . 4.3 m-30 -63.67 -46.43 85.63 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.36 0.6 . . . . 0.0 109.779 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.98 -44.23 96.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.652 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.25 -39.89 92.0 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.468 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.27 -45.36 91.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.539 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 34.7 t80 -68.17 -45.41 73.54 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.5 p -67.15 -31.95 72.73 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.5 tp -63.14 -41.87 99.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.564 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.484 ' CD1' HG21 ' A' ' 35' ' ' VAL . 29.9 m-85 -72.65 -14.26 61.55 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.873 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -91.4 80.83 5.46 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.45 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.506 ' NZ ' HG21 ' A' ' 34' ' ' THR . 97.4 mttt -49.4 -24.46 1.96 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.313 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -105.47 2.23 28.36 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.528 0.204 . . . . 0.0 111.427 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 40.74 31.09 0.39 Allowed Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.455 ' CG ' ' SG ' ' A' ' 26' ' ' CYS . 29.9 p30 -84.25 1.5 44.41 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.696 0.284 . . . . 0.0 111.133 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.39 24.53 56.57 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.455 ' SG ' ' CG ' ' A' ' 24' ' ' ASP . 17.8 p -153.72 127.78 9.0 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.99 0.424 . . . . 0.0 111.136 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.419 HD11 ' CD2' ' A' ' 16' ' ' PHE . 79.4 mt -100.45 120.13 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.1 p -90.19 170.16 10.53 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.8 p -65.38 -25.05 67.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.148 0.499 . . . . 0.0 110.562 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -66.54 -49.82 65.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.54 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -62.96 -41.36 99.5 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.92 -42.21 98.84 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.96 -43.41 99.44 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.506 HG21 ' NZ ' ' A' ' 21' ' ' LYS . 21.4 m -50.49 -46.1 56.79 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.569 ' O ' HD13 ' A' ' 39' ' ' LEU . 70.9 t -68.98 -54.23 21.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 113.49 -1.686 . . . . 0.0 111.019 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 60.9 mmm -57.21 -44.53 83.8 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.454 0.645 . . . . 0.0 109.444 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -54.96 -51.03 67.42 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.414 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.3 p -70.48 -14.99 62.75 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.707 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.569 HD13 ' O ' ' A' ' 35' ' ' VAL . 7.3 mp -97.36 38.04 1.3 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.92 0.39 . . . . 0.0 111.587 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.14 5.33 2.24 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.322 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.43 ' H ' ' C ' ' A' ' 39' ' ' LEU . 44.6 tp60 -97.01 147.18 24.27 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.06 72.27 40.05 Favored Pre-proline 0 N--CA 1.47 0.556 0 C-N-CA 121.309 -0.156 . . . . 0.0 111.238 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.465 ' CG ' HD21 ' A' ' 48' ' ' LEU . 83.2 Cg_endo -77.92 155.06 30.18 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.199 1.933 . . . . 0.0 111.599 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.442 ' OG1' ' OE2' ' A' ' 47' ' ' GLU . 16.1 p -93.15 169.76 10.15 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 176.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -60.54 -36.92 79.61 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.876 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.15 -45.39 93.24 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.526 0.679 . . . . 0.0 109.458 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -60.23 -49.08 79.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.172 -178.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.465 HD21 ' CG ' ' A' ' 43' ' ' PRO . 89.9 mt -64.26 -43.97 93.22 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.268 0.556 . . . . 0.0 111.253 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -60.95 -36.14 78.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.421 -0.808 . . . . 0.0 108.988 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -77.92 -29.28 49.95 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.106 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.443 ' SD ' ' C ' ' A' ' 51' ' ' MET . 1.8 tmm? -67.95 -48.73 65.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.552 0.692 . . . . 0.0 110.016 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 2.2 tp -65.71 -42.69 93.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.368 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.41 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 41.0 t30 -63.02 -39.52 95.01 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.246 -178.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -61.13 -43.66 98.54 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.53 0.681 . . . . 0.0 110.019 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.5 t -104.0 64.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.579 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 58' ' ' ASP . 1.0 OUTLIER -129.14 47.04 2.53 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -178.417 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 56' ' ' ASP . . . -33.52 -32.25 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.96 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 56' ' ' ASP . 6.2 m-20 -94.67 -37.84 11.12 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.497 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 83.41 17.99 65.28 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.2 p30 -80.0 -12.08 59.73 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 121.286 -0.166 . . . . 0.0 111.291 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.58 6.5 77.01 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 71.1 p -138.97 165.43 27.12 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.4 mt -103.69 120.47 53.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.736 -0.386 . . . . 0.0 112.033 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -83.43 -169.09 2.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 176.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.412 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 54.8 t80 -80.24 -43.94 1.41 Allowed Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 120.208 1.367 . . . . 0.0 112.181 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 52.1 Cg_exo -56.97 -37.26 98.88 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 121.54 1.493 . . . . 0.0 112.103 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.449 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 48.1 mt-10 -61.88 -61.9 2.17 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -51.21 -25.7 5.9 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.219 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.3 tp -77.11 -45.55 26.54 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.091 0.472 . . . . 0.0 110.769 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -59.3 -43.2 92.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.38 1.086 . . . . 0.0 108.541 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 tp -55.56 -66.65 0.38 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 112.876 -1.965 . . . . 0.0 109.904 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.601 ' SD ' ' CG ' ' A' ' 12' ' ' PHE . 5.0 ttt -56.93 -36.82 70.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.916 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.054 179.542 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.0 p . . . . . 0 N--CA 1.469 0.487 0 CA-C-O 121.037 0.446 . . . . 0.0 111.558 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -70.32 -38.63 74.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.947 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.462 ' CG ' ' N ' ' A' ' 8' ' ' GLN . 13.0 pt-20 -58.95 -43.14 91.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.761 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.462 ' N ' ' CG ' ' A' ' 7' ' ' GLU . 48.5 tt0 -59.71 -32.17 70.28 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.108 0.48 . . . . 0.0 110.234 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 80.7 mt -71.21 -51.05 37.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.575 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.3 t -55.08 -49.64 71.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.656 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -47.72 -49.08 29.12 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.438 ' CE1' ' HB3' ' A' ' 72' ' ' MET . 17.0 m-85 -62.84 -48.26 79.82 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.335 0.588 . . . . 0.0 110.275 178.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -61.62 -43.77 98.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.657 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -63.61 -42.42 98.22 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.26 -44.03 95.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.255 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.445 ' C ' ' CD1' ' A' ' 16' ' ' PHE . 26.3 t80 -68.86 -47.55 65.66 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -178.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.5 m -62.37 -34.06 75.97 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.28 -42.17 99.12 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.77 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.56 ' CD1' HG21 ' A' ' 35' ' ' VAL . 20.5 m-85 -65.57 -20.97 66.54 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.79 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -82.1 94.04 7.14 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.555 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -67.47 -29.98 69.57 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 120.734 0.302 . . . . 0.0 111.703 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -101.01 -0.86 35.71 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 122.335 -0.228 . . . . 0.0 111.422 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 48.57 33.29 11.85 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -73.8 -14.83 61.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.658 0.266 . . . . 0.0 111.29 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.95 -8.25 42.27 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.0 p -140.11 158.39 44.13 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.067 0.461 . . . . 0.0 110.74 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.407 HD12 ' CE2' ' A' ' 16' ' ' PHE . 75.4 mt -113.89 127.27 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.3 p -86.69 -162.48 0.78 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 33' ' ' GLY . 70.9 p -85.93 -25.2 26.24 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.625 -0.672 . . . . 0.0 111.104 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.421 ' HG2' ' H ' ' A' ' 30' ' ' LYS . 16.7 pttp -72.97 -46.11 54.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.312 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.97 -50.68 69.82 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.46 HD23 ' SD ' ' A' ' 36' ' ' MET . 0.4 OUTLIER -64.13 -40.39 96.07 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 176.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -58.07 -47.42 89.29 Favored Glycine 0 C--O 1.214 -1.116 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.1 m -55.62 -43.29 75.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.828 0.823 . . . . 0.0 109.082 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.56 HG21 ' CD1' ' A' ' 19' ' ' PHE . 67.1 t -69.78 -55.24 15.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.185 -1.371 . . . . 0.0 112.78 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.46 ' SD ' HD23 ' A' ' 32' ' ' LEU . 13.9 ptm -66.29 -42.03 88.97 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.136 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.49 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 60.8 ttm-85 -52.76 -51.3 61.17 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.625 0.726 . . . . 0.0 110.022 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.512 ' C ' ' H ' ' A' ' 40' ' ' GLY . 52.3 m -59.29 -35.85 74.51 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.379 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.454 HD23 ' O ' ' A' ' 35' ' ' VAL . 1.6 mm? -66.44 34.78 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.543 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 38' ' ' SER . . . 63.99 42.45 98.24 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.886 -0.674 . . . . 0.0 111.793 178.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.427 ' C ' HD22 ' A' ' 42' ' ' ASN . 98.1 mm-40 -136.62 148.91 47.72 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.427 HD22 ' C ' ' A' ' 41' ' ' GLN . 2.6 m-80 -137.3 67.21 53.72 Favored Pre-proline 0 N--CA 1.468 0.433 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.924 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.44 155.21 40.91 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.285 1.99 . . . . 0.0 111.534 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.593 HG22 ' N ' ' A' ' 45' ' ' GLU . 45.4 m -88.45 169.82 11.44 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.593 ' N ' HG22 ' A' ' 44' ' ' THR . 99.1 mt-10 -60.28 -37.07 79.37 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.908 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.48 -46.72 80.3 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.475 0.655 . . . . 0.0 109.441 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -60.43 -46.05 91.42 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.233 -179.058 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.05 -47.04 84.68 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.099 0.476 . . . . 0.0 111.224 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -63.64 -39.88 95.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.295 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -75.39 -38.34 60.0 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.945 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.439 ' N ' ' O ' ' A' ' 47' ' ' GLU . 5.7 mmm -62.83 -47.15 84.64 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.604 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 52' ' ' ILE . 15.0 tt -72.36 -40.85 65.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.586 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -65.25 -27.74 68.86 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -65.18 -51.46 60.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.45 0.643 . . . . 0.0 111.138 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.54 ' O ' HG22 ' A' ' 55' ' ' VAL . 9.2 p -80.55 -6.81 10.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.328 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 50.6 t0 -65.94 45.77 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.908 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -47.06 -25.33 0.81 Allowed 'General case' 0 CA--C 1.523 -0.077 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.846 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -80.53 -38.03 30.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.423 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.548 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 86.42 18.15 59.31 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 46.3 p30 -83.51 -26.27 30.33 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 122.812 -0.228 . . . . 0.0 111.36 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.527 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 89.91 -3.69 82.97 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.7 p -130.78 168.88 16.5 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.5 mt -108.97 124.89 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.1 p30 -90.98 -175.99 4.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.678 ' CZ ' HD23 ' A' ' 69' ' ' LEU . 32.3 t80 -77.11 -47.69 2.64 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.568 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.51 -47.3 27.58 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.157 1.238 . . . . 0.0 112.047 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -55.91 -50.33 70.99 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -56.97 -42.99 81.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.703 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.678 HD23 ' CZ ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -64.96 -50.62 65.69 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.084 178.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -56.44 -44.93 80.94 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 122.307 1.051 . . . . 0.0 108.712 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 tt -60.03 -46.56 89.13 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.001 -1.909 . . . . 0.0 110.138 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.438 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . 3.1 mmt -67.52 -45.68 75.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.912 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.213 0 CA-C-O 121.098 0.475 . . . . 0.0 109.844 -178.682 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.541 ' OG1' ' NE2' ' A' ' 8' ' ' GLN . 70.9 p . . . . . 0 N--CA 1.468 0.475 0 CA-C-O 121.25 0.548 . . . . 0.0 111.589 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 18.6 p-10 -68.33 -25.16 64.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.455 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.74 -46.07 89.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.848 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.544 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -63.44 -31.54 72.73 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 87.5 mt -76.69 -53.66 14.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.956 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.2 t -57.0 -49.78 74.72 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.782 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -54.85 -43.86 73.45 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.544 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 2.9 m-85 -60.72 -48.14 83.15 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -59.99 -45.92 91.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.556 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -63.51 -44.13 95.21 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.55 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -57.68 -47.56 81.99 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.292 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.431 ' CD2' HD11 ' A' ' 27' ' ' ILE . 58.6 t80 -67.22 -47.57 70.42 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 t -58.47 -37.96 76.56 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.5 tp -61.45 -41.55 97.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.168 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.55 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.3 m-30 -63.69 -29.15 70.41 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.431 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 43.8 t0 -82.73 93.98 7.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.447 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -59.19 -32.25 69.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.174 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -97.08 -10.45 26.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.624 0.249 . . . . 0.0 111.341 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.477 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 58.42 39.82 93.42 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.417 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 37.0 p-10 -99.6 17.41 20.54 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.664 0.268 . . . . 0.0 111.069 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.483 ' O ' ' SG ' ' A' ' 26' ' ' CYS . . . 66.64 25.77 72.87 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 25' ' ' GLY . 39.5 m -154.01 135.02 13.87 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.832 0.348 . . . . 0.0 111.05 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.431 HD11 ' CD2' ' A' ' 16' ' ' PHE . 62.4 mt -107.1 128.46 61.99 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.0 p -94.9 164.21 13.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.557 ' O ' ' N ' ' A' ' 33' ' ' GLY . 68.1 p -54.76 -34.51 62.67 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.508 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -64.99 -47.8 76.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.465 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.27 -46.07 74.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.117 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.456 HD23 ' C ' ' A' ' 32' ' ' LEU . 8.3 tt -62.62 -43.48 98.71 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -62.5 -43.35 99.16 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 178.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.4 m -48.25 -48.09 35.6 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 68.8 t -66.65 -52.73 42.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 113.494 -1.685 . . . . 0.0 111.436 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 68.1 mmm -63.16 -40.45 97.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.317 0.579 . . . . 0.0 109.886 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -57.52 -50.53 72.78 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.197 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.3 t -68.23 -19.99 64.79 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.781 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.401 ' O ' ' CD2' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -85.83 35.98 0.65 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.556 -178.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.13 44.78 94.63 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.644 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -144.51 155.8 43.86 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -145.57 72.84 14.08 Favored Pre-proline 0 N--CA 1.466 0.363 0 C-N-CA 121.112 -0.235 . . . . 0.0 111.29 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.477 ' HB2' HD21 ' A' ' 48' ' ' LEU . 27.6 Cg_exo -67.08 151.11 82.25 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 122.548 2.165 . . . . 0.0 111.961 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.8 p -83.56 162.94 20.69 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.65 -41.54 86.29 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.491 -0.484 . . . . 0.0 112.071 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.4 -46.88 79.94 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.347 0.594 . . . . 0.0 109.446 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 51' ' ' MET . 81.2 mm-40 -60.1 -46.62 88.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.311 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.477 HD21 ' HB2' ' A' ' 43' ' ' PRO . 90.9 mt -63.93 -47.89 78.72 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.199 0.524 . . . . 0.0 111.568 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -62.07 -37.58 85.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.09 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -77.85 -38.0 47.14 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.517 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.489 ' N ' ' O ' ' A' ' 47' ' ' GLU . 56.8 tpp -62.4 -48.49 79.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.255 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 9.2 tt -70.41 -42.13 78.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.838 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.426 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 37.6 t30 -67.41 -21.78 65.56 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -73.6 -54.33 8.4 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.574 0.702 . . . . 0.0 110.221 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.553 ' O ' HG22 ' A' ' 55' ' ' VAL . 8.1 p -75.44 -6.83 9.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.469 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 15.9 t0 -65.24 48.98 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.752 -178.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -52.78 -28.82 24.18 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.222 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -75.05 -38.33 61.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.399 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.532 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 85.55 26.85 34.29 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.553 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 45.3 p30 -98.37 -22.6 15.99 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 122.847 -0.208 . . . . 0.0 111.169 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.553 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 90.77 -4.08 81.63 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.463 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 61.3 p -136.74 167.82 20.7 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.8 mm -96.3 118.53 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 C-N-CA 120.681 -0.408 . . . . 0.0 112.076 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -87.88 -172.14 3.71 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.538 ' CZ ' HD11 ' A' ' 69' ' ' LEU . 42.0 t80 -74.1 -54.28 3.52 Favored Pre-proline 0 C--N 1.318 -0.781 0 C-N-CA 118.236 -1.386 . . . . 0.0 112.357 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 23.4 Cg_endo -54.61 -40.39 84.26 Favored 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 121.365 1.377 . . . . 0.0 111.704 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.23 -53.66 55.58 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -48.15 -43.12 31.12 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.698 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.538 HD11 ' CZ ' ' A' ' 65' ' ' PHE . 9.9 mt -63.6 -44.86 92.76 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.741 -0.599 . . . . 0.0 110.579 177.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -63.55 -45.61 89.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 122.509 1.147 . . . . 0.0 109.027 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.424 HD12 HG11 ' A' ' 55' ' ' VAL . 8.1 tt -58.01 -58.33 8.9 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 112.731 -2.032 . . . . 0.0 110.267 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 93.1 mmm -64.82 -37.46 87.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.81 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 C--N 1.331 -0.207 0 CA-C-O 121.214 0.531 . . . . 0.0 110.25 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.469 0.475 0 CA-C-O 121.148 0.499 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -78.92 -33.06 45.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.684 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -62.16 -43.3 99.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.139 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.588 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 1.0 OUTLIER -67.72 -30.93 70.54 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 88.5 mt -80.4 -53.53 12.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.239 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 p -58.8 -46.18 88.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.122 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -59.18 -41.21 87.91 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.59 ' CZ ' ' SD ' ' A' ' 72' ' ' MET . 6.4 m-30 -63.24 -46.59 86.21 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.271 0.558 . . . . 0.0 109.967 178.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.6 tttp -62.52 -43.25 99.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.445 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -62.74 -40.99 98.96 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.471 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -58.9 -48.18 82.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.474 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.412 ' CE1' ' OD2' ' A' ' 20' ' ' ASP . 48.2 t80 -65.78 -45.42 82.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.2 m -65.25 -34.81 79.23 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 62.7 tp -64.0 -43.19 96.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.698 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 30.9 m-85 -66.84 -17.17 64.75 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.706 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.412 ' OD2' ' CE1' ' A' ' 16' ' ' PHE . 43.6 m-20 -90.55 94.12 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.355 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -61.86 -22.48 65.57 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.319 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -110.65 7.4 22.3 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.082 -178.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 35.84 28.78 0.02 OUTLIER Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 22' ' ' ASP . 41.1 p30 -70.31 -14.07 62.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.656 0.265 . . . . 0.0 111.131 -178.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.28 0.25 37.93 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 5.0 p -145.23 139.71 27.35 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.059 0.429 . . . . 0.0 111.117 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.401 HD11 ' CD2' ' A' ' 16' ' ' PHE . 80.6 mt -95.09 122.48 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 77.3 p -86.43 173.39 9.69 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -70.79 -38.62 73.39 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.326 -178.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -54.95 -48.45 73.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.03 0.443 . . . . 0.0 109.832 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.412 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 92.6 mt-10 -62.48 -43.62 98.38 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.4 tp -62.08 -43.64 98.39 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -61.43 -42.26 99.73 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.2 m -50.54 -50.39 53.43 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.1 t -64.85 -49.84 78.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.598 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 58.0 mmm -63.31 -42.19 98.99 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -52.63 -52.13 56.94 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.31 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.8 p -66.47 -26.8 67.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.615 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.523 ' C ' ' H ' ' A' ' 41' ' ' GLN . 68.9 mt -83.11 38.98 0.62 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.734 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.94 -0.76 0.29 Allowed Glycine 0 N--CA 1.465 0.611 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.523 ' H ' ' C ' ' A' ' 39' ' ' LEU . 28.9 tp60 -88.06 146.68 25.34 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -137.21 66.41 52.81 Favored Pre-proline 0 N--CA 1.466 0.373 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.384 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.452 ' CG ' HD21 ' A' ' 48' ' ' LEU . 87.7 Cg_endo -77.98 156.91 30.67 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.186 1.924 . . . . 0.0 111.568 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.0 p -91.66 167.18 12.38 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.438 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 55.7 mp0 -61.13 -34.89 75.7 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.563 -0.455 . . . . 0.0 112.002 -178.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.24 -48.32 82.23 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -58.31 -47.29 84.15 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.248 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.452 HD21 ' CG ' ' A' ' 43' ' ' PRO . 89.6 mt -63.19 -44.77 94.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.268 0.556 . . . . 0.0 111.379 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -66.25 -41.67 89.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.219 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.43 ' O ' ' OE2' ' A' ' 54' ' ' GLU . 97.6 m-20 -63.82 -50.22 69.79 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.313 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 39.5 ttm -53.39 -41.77 66.28 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 56' ' ' ASP . 35.2 mt -65.07 -44.56 95.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.338 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -54.63 -33.25 60.26 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.435 ' N ' ' CD ' ' A' ' 54' ' ' GLU . 2.0 mm-40 -76.66 -41.23 46.44 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 121.798 0.808 . . . . 0.0 110.53 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.2 t -81.65 -24.9 9.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.462 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 58' ' ' ASP . 32.4 t70 -82.09 44.01 0.82 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.85 -177.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -39.07 -21.46 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.211 0.529 . . . . 0.0 110.358 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 56' ' ' ASP . 85.4 m-20 -74.0 -36.46 64.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.344 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 85.99 36.88 9.67 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.484 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 8.4 m120 -102.99 -20.18 14.31 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 122.784 -0.245 . . . . 0.0 111.12 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.26 1.31 88.32 Favored Glycine 0 N--CA 1.466 0.695 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.9 p -135.61 162.32 33.04 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.9 mt -96.86 116.85 40.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.868 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -82.17 -166.13 1.18 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 176.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.476 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 71.4 t80 -81.15 -53.1 0.79 Allowed Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.984 178.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 35.4 Cg_endo -56.86 -30.47 85.53 Favored 'Trans proline' 0 N--CA 1.506 2.244 0 C-N-CA 121.832 1.688 . . . . 0.0 111.893 -178.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -65.66 -63.19 1.15 Allowed 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -48.64 -29.43 4.34 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.91 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.4 tp -68.87 -45.68 70.37 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.901 0.381 . . . . 0.0 110.821 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -60.22 -42.74 95.84 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 122.453 1.121 . . . . 0.0 108.809 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.1 tp -62.05 -32.89 73.46 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.431 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.59 ' SD ' ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -78.67 -44.25 24.13 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.9 179.126 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.243 0 CA-C-O 121.147 0.499 . . . . 0.0 110.368 -179.839 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.1 p . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 121.112 0.482 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 17.1 p-10 -70.83 -29.61 65.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.637 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -62.78 -46.96 85.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.925 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.531 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 87.2 mt-30 -65.78 -29.85 70.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.997 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.4 mt -77.49 -57.09 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.197 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.6 m -56.47 -42.24 77.88 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.342 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -65.99 -39.88 90.69 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.631 -0.428 . . . . 0.0 109.955 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.531 ' CG ' ' O ' ' A' ' 8' ' ' GLN . 4.3 m-30 -61.65 -46.84 88.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -58.63 -47.36 84.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.296 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -60.55 -40.95 93.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.539 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -58.8 -48.51 81.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.622 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.415 ' CD2' HD11 ' A' ' 27' ' ' ILE . 32.9 t80 -67.67 -47.11 70.42 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.7 m -59.83 -36.75 77.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 43.4 tp -62.43 -41.19 98.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.324 178.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.0 m-30 -64.76 -26.59 68.42 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.64 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 23' ' ' GLY . 47.7 t0 -82.88 92.64 7.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.195 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -57.38 -34.06 68.47 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.931 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -91.45 -22.81 20.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.521 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.484 ' H ' ' CG ' ' A' ' 20' ' ' ASP . . . 66.68 37.73 92.66 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.413 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 36.4 p-10 -98.05 14.02 28.9 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.549 0.214 . . . . 0.0 111.135 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.35 17.87 80.09 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.0 m -147.59 138.52 23.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.793 0.33 . . . . 0.0 111.115 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.415 HD11 ' CD2' ' A' ' 16' ' ' PHE . 68.4 mt -112.15 125.2 69.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 47.2 p -88.82 162.15 16.34 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -57.67 -29.99 65.09 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -178.797 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -66.42 -47.09 74.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.023 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -67.56 -46.65 72.1 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.263 178.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.3 tt -62.3 -41.08 98.22 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -64.66 -42.93 97.04 Favored Glycine 0 C--O 1.226 -0.393 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 178.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.7 m -50.07 -48.99 52.76 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.417 ' O ' HD23 ' A' ' 39' ' ' LEU . 73.3 t -64.17 -51.1 73.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.241 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.1 mmm -64.06 -41.69 97.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.447 0.642 . . . . 0.0 109.643 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 45.3 ttm180 -56.21 -45.56 79.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.714 0.769 . . . . 0.0 110.395 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.3 m -71.72 -19.39 62.06 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.855 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 35' ' ' VAL . 1.7 mm? -87.5 31.6 0.74 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.897 0.38 . . . . 0.0 111.654 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 60.94 42.78 99.84 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.708 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -136.81 149.88 48.01 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -129.43 70.54 81.87 Favored Pre-proline 0 N--CA 1.469 0.491 0 C-N-CA 121.305 -0.158 . . . . 0.0 111.241 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.76 145.52 25.72 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.183 1.922 . . . . 0.0 111.381 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.4 m -86.42 160.05 19.16 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.438 ' HG2' ' H ' ' A' ' 45' ' ' GLU . 2.0 pt-20 -59.92 -33.31 71.71 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.54 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.9 -47.15 86.02 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.187 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -64.09 -42.76 96.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.764 -179.388 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.49 -46.59 85.44 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.293 0.568 . . . . 0.0 110.788 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -62.85 -46.21 88.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.439 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -64.1 -40.62 96.61 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.664 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.6 ttm -59.82 -43.94 94.29 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.468 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 11.1 mt -64.48 -46.88 91.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.733 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -56.5 -35.89 68.52 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -65.27 -50.97 63.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.218 0.532 . . . . 0.0 111.119 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 57' ' ' ALA . 6.5 p -74.58 -21.3 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.194 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.553 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.8 t0 -67.79 49.23 0.05 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.797 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -39.98 -26.88 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.267 0.556 . . . . 0.0 110.384 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 56' ' ' ASP . 24.0 m-20 -88.13 -36.24 16.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.08 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 92.47 14.45 55.56 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -66.92 -31.56 72.22 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.819 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.553 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 99.2 -1.1 57.4 Favored Glycine 0 N--CA 1.47 0.922 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 65.9 p -137.23 160.72 38.2 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.4 mm -92.15 122.3 43.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -84.52 -176.3 6.18 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.466 ' CE2' HD11 ' A' ' 69' ' ' LEU . 43.2 t80 -76.86 -54.91 1.56 Allowed Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 118.336 -1.345 . . . . 0.0 111.868 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.7 Cg_endo -57.67 -41.03 74.92 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.103 1.202 . . . . 0.0 111.513 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.421 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 62.6 mt-10 -55.15 -42.17 72.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.655 0.741 . . . . 0.0 109.179 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -62.12 -38.85 90.5 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.743 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.466 HD11 ' CE2' ' A' ' 65' ' ' PHE . 74.3 mt -61.48 -42.12 98.3 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.792 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -60.83 -44.91 96.32 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 122.217 1.008 . . . . 0.0 108.75 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.5 tp -63.42 -46.9 84.23 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.29 -1.777 . . . . 0.0 110.733 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.401 ' SD ' ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -67.35 -45.57 75.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.355 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.169 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.66 -179.479 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.747 HG22 ' H ' ' A' ' 6' ' ' ASP . 20.4 m . . . . . 0 N--CA 1.469 0.52 0 CA-C-O 121.15 0.5 . . . . 0.0 111.455 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.747 ' H ' HG22 ' A' ' 5' ' ' THR . 98.0 m-20 -75.1 -40.73 59.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.444 178.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -49.4 -42.51 42.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.617 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.559 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 13.2 mp0 -70.35 -26.23 63.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.292 0.568 . . . . 0.0 109.771 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.4 mt -82.29 -57.19 4.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.059 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 t -58.3 -43.76 88.25 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.451 -0.499 . . . . 0.0 109.952 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -62.41 -39.93 94.88 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.559 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.4 m-30 -64.09 -46.07 85.89 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.647 0.737 . . . . 0.0 109.591 178.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -60.03 -47.44 85.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.328 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -62.8 -41.26 99.2 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.72 -47.78 83.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.689 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.465 ' CE1' ' OD2' ' A' ' 20' ' ' ASP . 51.6 t80 -67.82 -45.31 75.06 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.8 m -65.25 -34.09 77.54 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.2 tp -62.9 -40.22 96.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.709 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.504 ' CD1' HG21 ' A' ' 35' ' ' VAL . 21.9 m-85 -73.23 -14.12 61.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.043 179.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.465 ' OD2' ' CE1' ' A' ' 16' ' ' PHE . 55.5 m-20 -89.28 74.19 7.93 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.396 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -43.26 -43.5 4.87 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.497 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 18.6 p30 -83.42 -22.42 32.67 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.536 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 73.12 28.06 67.16 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.9 p30 -81.1 -4.17 54.42 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.591 0.234 . . . . 0.0 111.229 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.8 12.72 74.02 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 33.6 m -143.16 128.93 19.35 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.856 0.36 . . . . 0.0 110.976 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 79.9 mt -97.64 123.34 50.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.1 p -97.03 170.14 9.35 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.1 p -61.19 -27.61 68.54 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.742 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -64.46 -48.82 73.85 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.502 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.409 ' O ' HG23 ' A' ' 35' ' ' VAL . 94.3 mt-10 -66.94 -41.86 86.28 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.0 tt -61.1 -43.03 99.5 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.33 -43.99 94.23 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.0 m -49.77 -48.06 50.62 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.588 ' O ' HD13 ' A' ' 39' ' ' LEU . 74.1 t -65.28 -51.54 63.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 113.549 -1.659 . . . . 0.0 111.513 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.0 mmt -61.28 -46.02 92.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.513 0.673 . . . . 0.0 109.456 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.9 tpt85 -50.01 -50.95 45.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.947 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.7 t -74.15 -15.51 61.03 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.828 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.588 HD13 ' O ' ' A' ' 35' ' ' VAL . 6.0 mp -93.56 37.55 1.06 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.043 0.449 . . . . 0.0 111.754 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.29 4.45 6.44 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.596 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -100.74 149.32 23.93 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -140.72 68.18 29.89 Favored Pre-proline 0 N--CA 1.467 0.401 0 C-N-CA 121.198 -0.201 . . . . 0.0 111.266 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.401 ' CG ' HD21 ' A' ' 48' ' ' LEU . 91.4 Cg_endo -74.79 158.43 42.99 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.327 2.018 . . . . 0.0 111.566 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.9 p -93.58 166.31 12.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -60.68 -33.21 72.5 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.694 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.53 98.9 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -62.23 -47.54 83.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.141 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.401 HD21 ' CG ' ' A' ' 43' ' ' PRO . 56.4 mt -64.87 -41.72 95.42 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.148 0.499 . . . . 0.0 111.241 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -61.86 -39.88 93.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.757 0.789 . . . . 0.0 109.196 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -78.32 -24.4 46.61 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.165 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.615 ' O ' HG12 ' A' ' 55' ' ' VAL . 41.3 ttm -71.22 -46.99 59.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.505 0.669 . . . . 0.0 109.82 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 tp -67.55 -40.52 84.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.269 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -65.3 -37.08 86.05 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.634 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -64.34 -36.65 84.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.407 0.622 . . . . 0.0 109.533 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.704 HG13 ' O ' ' A' ' 55' ' ' VAL . 7.2 p -109.39 68.44 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.115 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 58' ' ' ASP . 3.8 t0 -135.29 47.74 2.3 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -34.67 -29.76 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.763 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 42.3 p-10 -97.68 -38.37 9.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.487 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.546 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 91.14 12.67 59.82 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 40.4 p-10 -70.15 -25.23 63.36 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.803 -0.234 . . . . 0.0 111.31 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 90.76 7.84 66.03 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 75.2 p -143.81 157.23 44.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.3 mm -93.84 124.33 46.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.433 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 85.5 m-20 -90.0 -162.86 0.93 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 176.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.672 ' CZ ' HD11 ' A' ' 69' ' ' LEU . 50.4 t80 -76.24 -56.86 1.48 Allowed Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 118.274 -1.371 . . . . 0.0 111.85 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.47 -26.31 62.69 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 CA-C-N 120.37 1.168 . . . . 0.0 111.637 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.459 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 99.3 mt-10 -65.43 -35.07 79.82 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -70.83 -31.14 67.77 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.147 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.672 HD11 ' CZ ' ' A' ' 65' ' ' PHE . 9.7 mp -70.71 -34.57 72.07 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.588 177.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -64.42 -43.62 93.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 122.41 1.1 . . . . 0.0 108.815 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.665 ' HB2' HG21 ' A' ' 55' ' ' VAL . 25.8 tp -63.67 -45.92 87.91 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 112.998 -1.91 . . . . 0.0 110.844 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.485 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . 97.5 mmm -78.96 -30.13 44.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.113 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 C--O 1.234 0.253 0 CA-C-O 121.171 0.51 . . . . 0.0 110.094 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.428 ' OG1' ' OE1' ' A' ' 8' ' ' GLN . 77.0 p . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 121.204 0.526 . . . . 0.0 111.302 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 19.3 p-10 -77.41 -30.16 53.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.644 178.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -64.9 -44.79 88.45 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.069 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.532 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 5.1 mp0 -70.53 -25.64 63.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.169 0.509 . . . . 0.0 109.884 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.0 mt -83.97 -56.82 5.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.906 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -58.46 -41.12 84.48 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.258 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -65.6 -38.07 88.41 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.0 m-30 -64.9 -46.88 79.88 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.526 0.679 . . . . 0.0 109.673 178.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -62.23 -45.59 92.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.661 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -59.69 -37.57 79.18 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.495 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.07 -44.42 97.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.353 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.409 ' CE2' ' CG1' ' A' ' 27' ' ' ILE . 52.4 t80 -67.43 -45.95 74.54 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -178.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.4 t -63.45 -35.44 80.45 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.21 -40.64 98.04 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.338 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.495 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 27.1 m-85 -73.55 -19.67 60.84 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.099 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -87.38 80.27 8.2 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 120.904 -0.319 . . . . 0.0 111.583 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -52.59 -26.51 13.62 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.116 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' A' ' 24' ' ' ASP . 36.7 m-20 -103.26 4.46 36.64 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.876 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 38.52 31.59 0.12 Allowed Glycine 0 CA--C 1.529 0.967 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 34.9 p-10 -86.64 -0.85 57.03 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.639 0.257 . . . . 0.0 111.146 -178.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.425 ' O ' ' SG ' ' A' ' 26' ' ' CYS . . . 82.23 26.79 46.8 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 25' ' ' GLY . 40.4 m -154.09 134.52 13.44 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.907 0.384 . . . . 0.0 111.236 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.409 ' CG1' ' CE2' ' A' ' 16' ' ' PHE . 5.9 mm -102.32 115.54 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.3 p -88.19 163.97 15.89 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.446 HG22 ' CD1' ' A' ' 52' ' ' ILE . 0.6 OUTLIER -61.45 -24.42 66.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.18 0.514 . . . . 0.0 110.195 -178.562 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -69.4 -49.08 58.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.401 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -64.29 -43.52 94.49 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.058 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.7 tp -61.93 -42.81 99.53 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.99 -44.51 97.28 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.6 m -51.23 -46.51 62.32 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.57 -51.8 53.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 113.498 -1.683 . . . . 0.0 111.428 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.501 ' SD ' ' OE1' ' A' ' 41' ' ' GLN . 17.7 mmt -60.17 -42.51 95.12 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 63.3 ttm-85 -54.68 -46.5 74.07 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.591 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.0 m -76.48 -17.08 59.48 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.313 -1.312 . . . . 0.0 111.79 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' A' ' 41' ' ' GLN . 55.5 mt -93.26 38.39 1.04 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.723 0.297 . . . . 0.0 111.788 -178.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.1 2.22 0.88 Allowed Glycine 0 N--CA 1.464 0.528 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.501 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 80.2 mt-30 -97.7 150.39 21.25 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -136.54 68.71 60.43 Favored Pre-proline 0 N--CA 1.468 0.468 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.334 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.542 ' CG ' HD21 ' A' ' 48' ' ' LEU . 93.8 Cg_endo -75.26 153.72 40.75 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.267 1.978 . . . . 0.0 111.725 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -92.73 174.74 7.11 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.255 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.408 ' N ' ' OG1' ' A' ' 44' ' ' THR . 97.5 mt-10 -60.34 -40.03 89.21 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.778 -178.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.35 -46.46 90.15 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.508 0.671 . . . . 0.0 109.437 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.409 ' H ' HG23 ' A' ' 44' ' ' THR . 49.3 tp10 -54.24 -53.13 57.81 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.016 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.542 HD21 ' CG ' ' A' ' 43' ' ' PRO . 90.4 mt -62.12 -41.97 98.77 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.227 0.537 . . . . 0.0 111.067 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -67.26 -40.73 86.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.586 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -64.29 -41.72 96.74 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.258 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 38.5 ttm -59.15 -41.81 89.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.667 0.746 . . . . 0.0 109.46 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.446 ' CD1' HG22 ' A' ' 29' ' ' THR . 78.4 mt -66.27 -40.33 86.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.11 178.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -60.12 -39.37 85.99 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.354 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.6 -36.7 84.49 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.782 0.801 . . . . 0.0 109.732 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.499 HG13 ' OD1' ' A' ' 70' ' ' ASN . 59.6 t -110.84 63.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.878 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 58' ' ' ASP . 0.4 OUTLIER -124.37 41.39 3.51 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.356 -178.146 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 56' ' ' ASP . . . -30.64 -36.06 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.159 0.504 . . . . 0.0 111.096 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 48.6 p-10 -99.26 -33.68 10.64 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.741 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.561 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 81.07 22.96 60.07 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.459 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 39.5 p-10 -76.13 -23.68 54.87 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.49 0.182 . . . . 0.0 111.49 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.01 5.72 62.32 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.459 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 59.8 p -138.41 162.78 33.58 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.2 mt -98.91 121.23 49.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.979 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -90.58 -162.72 0.93 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.723 ' CE2' HD11 ' A' ' 69' ' ' LEU . 57.1 t80 -76.72 -55.0 1.61 Allowed Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 118.347 -1.341 . . . . 0.0 112.027 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 48.8 Cg_endo -62.02 -26.59 78.61 Favored 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 121.315 1.344 . . . . 0.0 112.189 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.435 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 97.6 mt-10 -70.75 -30.38 66.88 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -76.1 -35.75 59.2 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 113.927 -1.488 . . . . 0.0 110.273 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.723 HD11 ' CE2' ' A' ' 65' ' ' PHE . 88.7 mt -67.46 -30.48 70.21 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.405 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.499 ' OD1' HG13 ' A' ' 55' ' ' VAL . 14.0 t-20 -68.18 -45.1 74.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.652 1.215 . . . . 0.0 109.102 178.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 tp -63.56 -44.17 94.93 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 112.53 -2.123 . . . . 0.0 110.644 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.441 ' CG ' ' CE2' ' A' ' 12' ' ' PHE . 3.3 tpt -77.36 -32.6 55.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.612 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 CA--C 1.518 -0.261 0 CA-C-O 121.038 0.447 . . . . 0.0 109.996 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 p . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 121.083 0.468 . . . . 0.0 111.462 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 23.1 p-10 -73.3 -42.57 62.22 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.566 178.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.492 ' CG ' ' N ' ' A' ' 8' ' ' GLN . 13.6 pt-20 -53.85 -43.64 69.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.575 -179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.613 ' O ' ' CD2' ' A' ' 12' ' ' PHE . 85.4 mt-30 -69.87 -27.1 64.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.332 0.587 . . . . 0.0 109.881 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 77.5 mt -78.53 -58.58 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.405 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.3 t -56.8 -41.69 78.19 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.712 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -59.21 -41.69 89.17 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.613 ' CD2' ' O ' ' A' ' 8' ' ' GLN . 13.0 m-30 -65.72 -49.04 69.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.414 0.626 . . . . 0.0 110.149 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -61.23 -48.46 81.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.376 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -61.64 -40.58 95.39 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.52 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -63.44 -41.72 98.67 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.529 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.497 ' CD2' HD11 ' A' ' 27' ' ' ILE . 28.0 t80 -68.61 -47.59 66.28 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 m -64.17 -33.8 76.61 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.46 -40.73 97.57 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.284 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 31.8 m-85 -73.79 -16.33 61.16 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.916 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.542 ' OD2' ' N ' ' A' ' 25' ' ' GLY . 51.1 t0 -84.23 69.68 10.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.744 0.307 . . . . 0.0 111.442 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -43.04 -44.23 4.66 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.136 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -73.56 -23.89 60.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.744 0.307 . . . . 0.0 111.303 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 68.09 28.61 73.31 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 24.7 p-10 -89.93 5.4 46.54 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.764 0.316 . . . . 0.0 111.217 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.542 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 81.45 11.43 83.23 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.2 m -142.27 136.95 30.29 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 122.611 -0.347 . . . . 0.0 111.082 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.497 HD11 ' CD2' ' A' ' 16' ' ' PHE . 67.7 mt -101.41 126.9 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.0 p -99.04 160.3 14.36 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 33' ' ' GLY . 46.8 p -57.0 -25.71 58.99 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.589 -179.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.02 -49.35 72.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.243 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.9 -45.12 87.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.026 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.0 tp -61.84 -42.44 99.04 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -61.42 -44.32 98.19 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 178.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.1 m -49.1 -44.28 42.09 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.416 1.103 . . . . 0.0 108.25 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.1 t -73.83 -59.11 3.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 113.206 -1.816 . . . . 0.0 111.328 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 72.5 mtp -53.63 -44.46 69.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.512 0.672 . . . . 0.0 109.694 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 78.8 ttt-85 -58.83 -45.08 90.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.129 178.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.1 m -79.28 0.65 27.88 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.635 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 mp -106.48 35.47 2.95 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.477 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.5 37.01 91.51 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.702 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -137.74 153.45 49.74 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -136.72 78.66 42.19 Favored Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 121.324 -0.15 . . . . 0.0 111.304 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.72 150.82 21.65 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.234 1.956 . . . . 0.0 111.713 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.1 m -86.17 163.31 17.9 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -64.78 -34.11 77.57 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.832 -178.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.66 -41.31 97.35 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.397 0.618 . . . . 0.0 109.541 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.485 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -62.24 -49.77 74.39 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.258 -179.09 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.6 mt -62.26 -41.24 98.27 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.06 0.457 . . . . 0.0 111.549 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.434 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 55.7 tt0 -65.21 -36.54 84.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.732 0.777 . . . . 0.0 109.429 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -80.17 -35.25 36.72 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.227 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.472 ' SD ' ' C ' ' A' ' 51' ' ' MET . 9.1 tmm? -70.38 -51.3 30.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.093 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 7.6 tp -59.15 -46.54 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.734 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.485 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 96.5 m-20 -69.57 -31.72 70.07 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.4 -36.66 84.88 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.639 0.733 . . . . 0.0 110.497 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.691 ' O ' HG22 ' A' ' 55' ' ' VAL . 14.6 p -98.31 18.25 2.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.8 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.719 ' CG ' ' H ' ' A' ' 59' ' ' GLY . 65.1 t0 -99.32 69.74 1.7 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.889 -177.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -37.74 -25.25 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.651 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 56' ' ' ASP . 17.4 m-20 -94.52 -40.87 9.64 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.615 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.719 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 92.03 7.65 63.98 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.408 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 15.7 m120 -66.99 -28.14 68.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.578 0.228 . . . . 0.0 111.16 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.593 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 99.91 8.26 51.51 Favored Glycine 0 N--CA 1.464 0.52 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 76.7 p -137.87 166.28 24.42 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.428 ' CG1' HD11 ' A' ' 52' ' ' ILE . 4.8 mt -104.11 125.22 58.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -176.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -97.79 158.09 15.71 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 176.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.549 ' CE2' HD11 ' A' ' 69' ' ' LEU . 58.3 t80 -49.93 -48.36 78.42 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 118.0 -1.48 . . . . 0.0 111.408 -178.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.35 -44.35 43.63 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 121.219 1.279 . . . . 0.0 112.31 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.432 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 73.3 mt-10 -61.22 -34.49 75.2 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 122.285 1.04 . . . . 0.0 108.297 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 65' ' ' PHE . 89.5 t80 -68.42 -25.91 65.26 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.356 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.549 HD11 ' CE2' ' A' ' 65' ' ' PHE . 25.2 mt -74.98 -32.71 61.75 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.925 0.393 . . . . 0.0 110.492 177.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -64.2 -42.61 96.55 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 122.745 1.26 . . . . 0.0 108.541 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.423 ' HB2' HG21 ' A' ' 55' ' ' VAL . 43.2 tp -63.02 -45.67 91.24 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.532 -2.122 . . . . 0.0 110.448 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.546 ' SD ' ' CE1' ' A' ' 12' ' ' PHE . 7.6 mmt -78.48 -28.26 46.41 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.97 178.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 121.145 0.498 . . . . 0.0 110.081 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.2 p . . . . . 0 N--CA 1.468 0.466 0 CA-C-O 121.379 0.609 . . . . 0.0 111.397 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -77.52 -34.45 54.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.587 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.472 ' OE1' ' N ' ' A' ' 7' ' ' GLU . 57.6 mp0 -65.1 -44.72 87.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.209 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.548 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 38.5 mt-30 -67.35 -24.13 65.68 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.07 0.462 . . . . 0.0 110.199 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 90.0 mt -83.63 -53.58 10.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.192 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.9 t -59.15 -45.12 91.81 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.251 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 11' ' ' GLU . 0.3 OUTLIER -62.86 -38.93 92.79 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.293 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.548 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 2.9 m-30 -62.44 -45.2 94.17 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 121.442 0.639 . . . . 0.0 109.861 178.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -63.54 -41.78 98.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.829 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -64.62 -41.78 95.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.54 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -59.39 -49.56 77.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.566 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.455 ' CD2' HD11 ' A' ' 27' ' ' ILE . 51.3 t80 -66.47 -44.27 83.15 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.1 p -64.8 -35.39 80.95 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 41.2 tp -63.8 -39.43 94.23 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.493 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.54 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.6 m-30 -66.52 -16.27 64.02 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.318 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.463 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 38.6 t0 -94.78 88.21 5.27 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.384 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -47.95 -40.88 23.51 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.537 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 3.4 p30 -91.98 -24.59 19.19 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.667 -178.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.411 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 76.76 33.12 47.76 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.041 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.463 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 80.0 m-20 -73.45 -7.39 51.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.782 0.325 . . . . 0.0 111.036 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.01 2.69 64.3 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.2 p -143.43 138.01 29.03 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.945 0.402 . . . . 0.0 111.096 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.455 HD11 ' CD2' ' A' ' 16' ' ' PHE . 76.9 mt -96.67 126.65 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.8 p -90.85 170.35 10.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.558 ' O ' ' N ' ' A' ' 33' ' ' GLY . 27.3 p -61.63 -49.29 77.15 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.917 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.493 ' CG ' ' N ' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -56.57 -43.03 79.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.152 0.501 . . . . 0.0 110.332 179.557 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.493 ' N ' ' CG ' ' A' ' 30' ' ' LYS . 89.6 mt-10 -61.55 -49.1 78.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.69 178.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.2 tt -63.25 -41.47 99.07 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -61.79 -40.7 99.16 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 30' ' ' LYS . 20.7 m -53.79 -48.62 69.63 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.08 -47.7 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.377 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 17.3 mmt -64.22 -44.28 92.4 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -50.62 -51.29 50.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.634 0.731 . . . . 0.0 110.676 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -68.34 -27.0 65.89 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.705 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 41' ' ' GLN . 46.6 mt -78.2 37.56 0.26 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -178.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.75 -6.91 0.77 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.138 -0.553 . . . . 0.0 111.75 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.487 ' H ' ' C ' ' A' ' 39' ' ' LEU . 76.6 mt-30 -89.5 149.85 22.72 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -133.95 65.21 69.35 Favored Pre-proline 0 N--CA 1.469 0.476 0 C-N-CA 121.321 -0.151 . . . . 0.0 111.384 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.2 155.6 33.15 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.147 1.898 . . . . 0.0 111.503 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 m -93.38 159.51 15.22 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.431 ' HG2' ' H ' ' A' ' 45' ' ' GLU . 0.8 OUTLIER -59.53 -33.26 71.16 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.665 -178.62 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.3 -39.4 82.93 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -69.31 -45.55 69.29 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.103 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.5 mt -63.7 -43.38 96.79 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.144 0.497 . . . . 0.0 110.957 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -60.75 -49.09 78.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.432 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -65.93 -33.22 75.34 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.106 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 34.8 ttm -65.75 -42.41 90.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.722 0.773 . . . . 0.0 109.994 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 1.1 tp -65.62 -47.35 86.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.724 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.416 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 77.7 m-20 -65.48 -28.53 69.28 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 124.009 0.818 . . . . 0.0 112.903 -177.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -68.21 -45.51 73.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.602 0.715 . . . . 0.0 110.969 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.541 ' O ' HG22 ' A' ' 55' ' ' VAL . 12.4 p -89.03 -3.47 9.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.719 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 37.5 t0 -64.67 41.57 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.233 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -40.67 -32.57 0.22 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.189 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -74.6 -38.31 62.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.675 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.542 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 91.08 16.57 53.73 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 42.7 p30 -87.64 -25.42 23.55 Favored 'General case' 0 CA--C 1.53 0.173 0 O-C-N 122.685 -0.303 . . . . 0.0 111.334 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.555 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 91.58 5.18 67.12 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.5 p -142.57 168.39 19.83 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.0 mt -97.86 119.62 46.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.307 -0.557 . . . . 0.0 112.194 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -90.62 148.72 22.47 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 176.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.565 ' CE2' HD11 ' A' ' 69' ' ' LEU . 46.6 t80 -48.03 -52.1 43.18 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 118.145 -1.422 . . . . 0.0 111.464 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.23 -50.61 12.47 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 CA-C-N 119.901 1.0 . . . . 0.0 111.603 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.441 ' OE2' ' O ' ' A' ' 55' ' ' VAL . 32.9 tt0 -55.17 -52.75 62.32 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -47.26 -25.35 0.93 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.941 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.565 HD11 ' CE2' ' A' ' 65' ' ' PHE . 83.7 mt -79.07 -41.74 28.04 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.781 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -60.96 -41.12 95.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 122.348 1.071 . . . . 0.0 108.466 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.7 tp -57.91 -64.43 0.91 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.821 -1.99 . . . . 0.0 110.318 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.7 mmm -63.45 -36.35 83.45 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.58 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.142 0 CA-C-O 121.116 0.484 . . . . 0.0 110.062 179.619 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.511 ' HG1' ' CD ' ' A' ' 8' ' ' GLN . 16.2 p . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 121.19 0.519 . . . . 0.0 111.392 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.436 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 24.9 p-10 -80.03 -26.36 39.82 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.339 177.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.412 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 97.6 mt-10 -63.15 -44.79 94.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.901 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.586 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 5.1 mp0 -69.91 -23.21 63.19 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.522 0.677 . . . . 0.0 110.124 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -83.9 -56.55 5.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.429 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 61.6 m -58.25 -40.69 82.43 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.151 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -65.73 -37.42 86.33 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.046 0.451 . . . . 0.0 109.873 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.586 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 2.4 m-85 -62.59 -45.28 93.63 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.468 0.652 . . . . 0.0 109.995 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -63.2 -42.21 99.28 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.064 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -63.31 -41.78 98.96 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.85 -46.99 86.43 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.292 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.439 ' CE2' ' CG1' ' A' ' 27' ' ' ILE . 48.1 t80 -67.9 -45.6 73.99 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.3 p -63.71 -33.78 76.41 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.1 tp -62.9 -39.92 95.96 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.242 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.531 ' CD1' HG21 ' A' ' 35' ' ' VAL . 21.2 m-85 -73.97 -18.97 60.8 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.033 179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 25' ' ' GLY . 29.2 t0 -86.57 74.1 9.95 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.749 0.309 . . . . 0.0 111.338 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -44.9 -36.55 3.38 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.735 0.303 . . . . 0.0 111.255 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -87.94 -23.86 23.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.708 0.289 . . . . 0.0 111.427 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.51 21.48 76.17 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.0 p-10 -80.13 -1.23 39.32 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.679 0.276 . . . . 0.0 111.11 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.433 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 82.97 26.41 45.08 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 32.2 m -151.03 132.15 14.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.992 0.425 . . . . 0.0 111.057 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.439 ' CG1' ' CE2' ' A' ' 16' ' ' PHE . 4.3 mm -101.64 147.79 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 p -126.94 167.98 15.14 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 33' ' ' GLY . 58.0 p -58.78 -30.49 67.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.959 0.409 . . . . 0.0 110.818 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HG3' ' H ' ' A' ' 31' ' ' GLU . 38.9 pttt -67.18 -49.47 64.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.79 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.46 ' H ' ' HG3' ' A' ' 30' ' ' LYS . 88.7 mt-10 -67.12 -48.52 67.87 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.189 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.99 -43.7 98.48 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -62.65 -41.21 99.85 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 178.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.3 m -50.29 -46.04 54.98 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.411 1.101 . . . . 0.0 108.231 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.531 HG21 ' CD1' ' A' ' 19' ' ' PHE . 58.5 t -69.76 -55.89 13.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 113.345 -1.752 . . . . 0.0 111.424 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 83.0 mmm -54.41 -44.74 72.64 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.868 0.842 . . . . 0.0 109.943 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -54.08 -46.95 72.17 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.461 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.1 t -79.07 -9.39 59.53 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.069 -1.423 . . . . 0.0 111.728 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.405 ' O ' ' CD2' ' A' ' 39' ' ' LEU . 0.9 OUTLIER -94.05 34.62 1.23 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.502 -178.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.37 2.1 6.74 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.548 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -102.47 152.42 21.16 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -134.61 65.16 66.34 Favored Pre-proline 0 N--CA 1.47 0.531 0 CA-C-O 120.405 0.145 . . . . 0.0 111.271 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.403 ' CG ' HD21 ' A' ' 48' ' ' LEU . 85.4 Cg_endo -76.47 156.04 36.43 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.146 1.898 . . . . 0.0 111.629 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.5 p -92.79 168.88 10.89 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -60.02 -31.77 70.27 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.881 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.11 -44.7 96.09 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.585 0.707 . . . . 0.0 109.593 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -60.79 -49.18 78.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.316 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.403 HD21 ' CG ' ' A' ' 43' ' ' PRO . 73.7 mt -62.94 -41.82 99.61 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.954 0.407 . . . . 0.0 111.576 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -66.11 -41.52 90.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.41 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -64.71 -37.26 86.98 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.956 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.6 ttm -61.88 -41.78 98.28 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.479 HD12 ' CG2' ' A' ' 29' ' ' THR . 25.2 mt -65.59 -43.24 94.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.292 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -63.72 -39.91 95.46 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -61.85 -37.69 85.43 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 122.028 0.918 . . . . 0.0 110.089 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.0 t -109.18 67.54 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.389 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 58' ' ' ASP . 2.8 t0 -131.9 45.2 2.81 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.128 0.489 . . . . 0.0 109.794 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -38.67 -23.15 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.06 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 56' ' ' ASP . 29.1 p-10 -102.28 -43.09 5.8 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.68 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.467 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 90.88 29.69 12.65 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.436 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 48.1 p30 -87.36 -11.88 48.01 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 111.392 0.145 . . . . 0.0 111.392 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.03 6.13 85.66 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.686 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.8 p -138.85 163.99 30.81 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.6 mt -99.76 122.65 51.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.824 -177.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -91.97 -165.2 1.3 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 176.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.471 ' CE2' HD11 ' A' ' 69' ' ' LEU . 59.5 t80 -77.48 -47.02 2.52 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 117.823 -1.551 . . . . 0.0 111.841 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -65.26 -31.22 53.72 Favored 'Trans proline' 0 N--CA 1.507 2.319 0 C-N-CA 121.439 1.426 . . . . 0.0 112.06 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -66.59 -31.07 71.53 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 122.808 1.289 . . . . 0.0 108.149 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -75.58 -30.98 59.81 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.456 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 73' ' ' ALA . 4.8 mt -69.7 -34.31 73.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.531 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -65.06 -44.13 89.98 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.47 1.129 . . . . 0.0 109.292 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.6 tp -61.66 -45.84 92.31 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 112.545 -2.116 . . . . 0.0 110.79 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.455 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . 99.5 mmm -80.12 -31.29 39.11 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.102 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.467 0.4 0 CA-C-O 121.31 0.576 . . . . 0.0 109.812 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 121.151 0.501 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -65.3 -33.64 76.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.223 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.94 -45.79 92.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.933 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.543 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -63.84 -36.23 83.23 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.88 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 74.7 mt -74.92 -54.34 14.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.078 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.0 t -55.83 -49.7 72.56 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.004 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -56.55 -41.68 77.27 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.883 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.543 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.0 m-85 -61.73 -48.79 79.13 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -60.78 -44.33 96.93 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.725 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -62.64 -44.94 95.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.39 -49.49 77.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.602 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 38.2 t80 -65.51 -49.15 70.06 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.3 t -60.67 -37.74 82.57 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.7 tp -61.97 -43.92 97.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.064 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.544 ' CD1' HG21 ' A' ' 35' ' ' VAL . 19.5 m-85 -66.26 -24.54 66.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.841 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -86.88 85.24 7.26 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.534 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -67.46 -16.85 64.45 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.207 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 17.4 t0 -96.65 -0.46 48.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.202 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 38.01 53.86 2.02 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 26' ' ' CYS . 31.6 p-10 -111.84 9.15 20.7 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.695 0.283 . . . . 0.0 111.003 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.1 3.15 88.14 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 36.1 m -142.48 146.37 34.68 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.983 0.421 . . . . 0.0 110.887 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.9 mt -110.74 125.76 68.05 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 57.2 p -86.69 160.74 18.76 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 33' ' ' GLY . 34.0 p -58.44 -29.69 66.33 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.311 -178.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -65.04 -48.19 74.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.29 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -60.85 -47.11 87.84 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.3 tp -63.65 -40.6 97.27 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -60.88 -46.67 94.07 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.0 m -48.57 -49.7 35.5 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.544 HG21 ' CD1' ' A' ' 19' ' ' PHE . 53.0 t -63.75 -51.07 74.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.587 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.2 mmt -62.83 -45.16 93.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 61.6 ttt85 -54.07 -50.24 67.22 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.405 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.3 t -66.85 -21.02 66.03 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.47 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.6 mt -86.83 29.89 0.78 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.73 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.58 39.98 98.56 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.87 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -128.04 142.54 51.19 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -129.64 62.69 64.73 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 121.351 -0.139 . . . . 0.0 111.315 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.35 152.33 34.52 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.222 1.948 . . . . 0.0 111.538 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.8 p -83.85 160.93 21.05 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -60.23 -33.82 72.81 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.849 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.78 -47.15 85.72 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.427 0.632 . . . . 0.0 109.342 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.42 -43.58 83.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.846 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.4 mt -65.19 -45.59 84.17 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.107 0.479 . . . . 0.0 111.632 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.441 ' O ' HG22 ' A' ' 52' ' ' ILE . 58.4 tt0 -66.54 -33.96 76.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 122.203 1.002 . . . . 0.0 109.233 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.467 ' O ' ' OE2' ' A' ' 54' ' ' GLU . 96.2 m-20 -76.37 -39.98 52.33 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.524 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 39.2 ttm -58.66 -45.12 90.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.328 0.585 . . . . 0.0 110.498 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.441 HG22 ' O ' ' A' ' 49' ' ' GLN . 6.6 tt -70.66 -33.22 52.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.399 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -60.46 -39.0 86.02 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.562 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.467 ' OE2' ' O ' ' A' ' 50' ' ' ASP . 4.9 mm-40 -65.28 -16.43 63.55 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.364 0.602 . . . . 0.0 110.833 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 57' ' ' ALA . 3.0 t -110.2 -19.12 7.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.759 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -65.55 48.51 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.043 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -57.7 -23.34 51.19 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.964 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 17.6 p-10 -88.67 -44.88 10.27 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.318 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 93.05 50.31 2.47 Favored Glycine 0 N--CA 1.471 1.006 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.67 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 55.6 p30 -109.88 -21.61 12.27 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.692 -0.299 . . . . 0.0 110.999 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.544 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 84.7 -4.71 84.15 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 51.1 p -131.42 169.43 16.05 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.9 mt -104.14 119.29 52.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -91.54 -175.93 4.35 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 175.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.451 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 75.6 t80 -69.44 -55.61 9.37 Favored Pre-proline 0 C--N 1.318 -0.796 0 C-N-CA 118.63 -1.228 . . . . 0.0 112.242 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 14.3 Cg_endo -50.45 -43.08 46.34 Favored 'Trans proline' 0 N--CA 1.504 2.109 0 C-N-CA 121.885 1.724 . . . . 0.0 111.373 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.401 ' OE2' ' CG ' ' A' ' 58' ' ' ASP . 95.2 mt-10 -58.86 -52.63 64.89 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -57.33 -41.71 80.5 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.648 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.4 tp -61.36 -44.73 96.68 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.163 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -64.24 -52.5 58.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 122.619 1.199 . . . . 0.0 108.953 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.8 tt -51.95 -59.43 4.35 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.078 -1.874 . . . . 0.0 110.62 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.419 ' CG ' ' CE2' ' A' ' 12' ' ' PHE . 1.2 tpt -61.6 -39.29 90.68 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.757 178.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 -0.152 0 CA-C-O 121.197 0.522 . . . . 0.0 110.499 179.472 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.431 ' N ' HD21 ' A' ' 4' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 3' ' ' GLN . 88.0 m-20 54.81 42.45 31.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.5 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' A' ' 2' ' ' ASP . 59.2 tt0 58.86 121.42 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.512 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 4' ' ' LEU . 3.5 mm? -78.25 145.79 35.25 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.796 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.7 p -94.12 -176.68 4.06 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.161 0.505 . . . . 0.0 111.356 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -72.99 -42.89 62.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.875 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 7' ' ' GLU . 6.7 pt-20 -61.77 -44.54 96.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.956 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.558 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 93.2 mt-30 -69.63 -24.73 63.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.53 0.681 . . . . 0.0 109.975 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.8 mt -83.4 -56.18 6.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.243 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.8 t -58.47 -42.6 87.88 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -63.89 -39.78 94.99 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.558 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.2 m-30 -64.07 -45.71 87.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.771 0.796 . . . . 0.0 109.862 178.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -60.92 -46.78 89.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.729 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -62.26 -39.75 93.93 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.424 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -60.65 -44.67 96.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.435 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.458 ' CE2' ' CG1' ' A' ' 27' ' ' ILE . 35.1 t80 -69.05 -45.63 69.9 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.6 m -65.81 -33.18 75.27 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.738 0.78 . . . . 0.0 109.065 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.37 -40.43 96.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.376 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.549 ' CD1' HG21 ' A' ' 35' ' ' VAL . 26.6 m-85 -73.87 -14.65 61.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.92 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.532 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 42.4 t0 -89.55 78.91 6.97 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.171 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.424 ' NZ ' HG21 ' A' ' 34' ' ' THR . 98.2 mttt -40.94 -47.61 3.03 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.736 -178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.43 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 20.8 p30 -88.11 -1.75 58.19 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.646 0.26 . . . . 0.0 111.683 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.12 39.23 41.31 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.051 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.532 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 44.5 p-10 -90.97 -0.05 57.65 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.645 0.26 . . . . 0.0 111.247 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.494 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 81.76 20.66 63.13 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.404 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 6.4 m -143.08 137.28 29.07 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.021 0.439 . . . . 0.0 111.082 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.458 ' CG1' ' CE2' ' A' ' 16' ' ' PHE . 4.9 mm -109.46 122.11 63.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.2 p -100.48 167.13 10.57 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.656 HG22 HD12 ' A' ' 52' ' ' ILE . 74.7 p -60.4 -28.59 68.36 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.411 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -66.59 -48.34 69.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.592 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -67.47 -45.65 75.34 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.979 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.3 tp -62.1 -41.86 98.64 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -63.78 -42.34 98.57 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.424 HG21 ' NZ ' ' A' ' 21' ' ' LYS . 24.2 m -50.18 -46.22 54.07 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.549 HG21 ' CD1' ' A' ' 19' ' ' PHE . 98.1 t -69.59 -55.76 13.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 113.389 -1.732 . . . . 0.0 111.296 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 84.5 mmm -57.0 -41.22 78.09 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -58.9 -51.49 69.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.848 0.832 . . . . 0.0 110.622 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.4 t -69.58 -14.19 62.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.687 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 41' ' ' GLN . 1.7 mm? -97.39 36.7 1.44 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.964 0.412 . . . . 0.0 111.335 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.78 6.33 3.56 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.198 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' A' ' 39' ' ' LEU . 4.8 tp60 -102.07 151.06 22.6 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -144.05 68.98 16.18 Favored Pre-proline 0 N--CA 1.464 0.253 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.218 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.47 ' HB2' HD21 ' A' ' 48' ' ' LEU . 29.4 Cg_exo -65.18 152.58 81.73 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.488 2.125 . . . . 0.0 112.185 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.4 m -79.72 159.97 26.43 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -61.41 -48.43 81.23 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.07 -0.652 . . . . 0.0 112.1 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.15 77.06 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -61.07 -45.39 94.93 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.237 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 43' ' ' PRO . 85.4 mt -62.28 -41.31 98.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.265 0.555 . . . . 0.0 110.774 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -65.24 -45.86 82.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.626 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.92 -42.34 97.42 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.246 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 45.9 tpp -59.13 -45.98 89.54 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.656 HD12 HG22 ' A' ' 29' ' ' THR . 2.8 mt -63.49 -43.08 98.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.35 178.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -59.69 -28.97 67.76 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -68.52 -31.31 70.46 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.277 0.56 . . . . 0.0 110.762 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.442 ' C ' ' H ' ' A' ' 57' ' ' ALA . 61.5 t -98.6 -13.36 8.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.541 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 28.8 t0 -72.28 40.89 0.08 Allowed 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.317 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.442 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -40.66 -24.37 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.393 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 4.5 p-10 -89.2 -39.96 13.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.165 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.525 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 92.21 54.76 1.81 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.561 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 47.5 p30 -117.56 -20.77 8.87 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.719 -0.283 . . . . 0.0 110.958 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.561 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 81.2 5.78 89.82 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.8 p -135.76 165.13 26.3 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.8 mt -107.33 126.39 63.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -91.57 -167.42 1.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 175.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.566 ' CZ ' HD11 ' A' ' 69' ' ' LEU . 43.4 t80 -79.67 -50.67 1.24 Allowed Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 118.525 -1.27 . . . . 0.0 111.166 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.72 -33.54 93.01 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.319 1.346 . . . . 0.0 112.011 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -67.01 -30.63 70.79 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -74.81 -30.09 61.3 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.669 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.566 HD11 ' CZ ' ' A' ' 65' ' ' PHE . 4.3 mt -69.74 -33.1 71.99 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 177.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -68.09 -45.06 74.79 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.418 1.104 . . . . 0.0 109.357 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.2 tp -60.45 -45.64 92.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.108 -1.86 . . . . 0.0 111.355 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 93.0 mmm -79.29 -26.35 42.32 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.898 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . -70.45 -37.49 74.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.221 0.534 . . . . 0.0 110.514 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.6 mmm-85 -76.26 -36.82 58.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.62 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.565 ' C ' ' H ' ' A' ' 77' ' ' LYS . 19.5 tptp -63.36 -42.12 98.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.806 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 38.4 mmm -62.92 11.39 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.305 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.565 ' H ' ' C ' ' A' ' 75' ' ' LYS . 64.8 tttm -49.18 -35.86 18.11 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.18 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 77' ' ' LYS . 45.5 t0 -31.32 92.03 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.516 0.51 . . . . 0.0 111.455 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 77' ' ' LYS . 10.2 m . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.652 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.513 ' CG ' ' H ' ' A' ' 3' ' ' GLN . 32.0 t70 58.03 -176.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.789 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.513 ' H ' ' CG ' ' A' ' 2' ' ' ASP . 4.9 tp-100 29.74 82.88 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 O-C-N 122.986 0.179 . . . . 0.0 111.285 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.557 ' H ' ' CD2' ' A' ' 4' ' ' LEU . 4.0 mm? -33.88 146.66 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 O-C-N 122.912 0.132 . . . . 0.0 110.958 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.722 HG22 ' N ' ' A' ' 6' ' ' ASP . 32.5 m -82.49 171.68 13.86 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.109 0.48 . . . . 0.0 111.417 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.722 ' N ' HG22 ' A' ' 5' ' ' THR . 97.7 m-20 -70.53 -42.02 71.78 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.826 178.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.51 ' CG ' ' N ' ' A' ' 8' ' ' GLN . 7.2 pt-20 -43.98 -41.84 5.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.634 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.534 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 38.1 tp60 -62.94 -23.57 67.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.475 0.655 . . . . 0.0 109.327 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.559 ' N ' ' O ' ' A' ' 6' ' ' ASP . 24.7 mt -81.29 -51.1 15.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.08 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 39.4 t -56.93 -42.8 80.66 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.652 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -63.56 -42.5 98.34 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.6 m-30 -55.1 -46.24 75.51 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -62.59 -40.34 96.58 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.886 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -62.06 -44.86 95.78 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.549 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -57.9 -43.32 86.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.262 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -70.78 -49.38 47.18 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.7 t -59.1 -35.55 73.61 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.8 tp -61.86 -44.52 96.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.281 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.549 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.7 m-30 -59.03 -25.19 63.48 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.965 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -83.27 101.99 11.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.841 0.353 . . . . 0.0 111.432 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -65.44 -30.7 71.53 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.822 0.344 . . . . 0.0 111.725 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -103.21 -10.77 18.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.404 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 61.52 45.77 95.68 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -97.49 18.73 14.69 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.645 0.26 . . . . 0.0 111.256 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.9 7.71 50.42 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 31.5 m -141.77 146.91 36.51 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.991 0.424 . . . . 0.0 110.945 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 92.1 mt -113.17 129.43 68.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 81.5 p -91.47 161.88 14.79 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 33' ' ' GLY . 71.9 p -56.22 -32.75 64.72 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.587 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -64.27 -48.47 75.58 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.229 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.07 -46.21 91.61 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.851 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.1 tp -62.62 -43.31 99.14 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -59.69 -49.18 81.32 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 178.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.9 m -48.14 -48.28 34.28 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 122.369 1.081 . . . . 0.0 108.607 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.422 HG11 ' CE2' ' A' ' 19' ' ' PHE . 67.3 t -68.11 -52.71 35.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 113.195 -1.821 . . . . 0.0 111.295 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.401 ' CE ' ' OE1' ' A' ' 41' ' ' GLN . 35.8 mmm -61.86 -42.29 98.88 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.678 0.751 . . . . 0.0 109.756 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.5 tpt85 -54.37 -51.6 64.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.539 -1.209 . . . . 0.0 110.137 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.412 ' C ' ' H ' ' A' ' 40' ' ' GLY . 47.0 m -62.14 -32.86 73.51 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.98 -1.464 . . . . 0.0 111.702 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.537 ' C ' ' H ' ' A' ' 41' ' ' GLN . 76.2 mt -73.84 33.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.782 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 38' ' ' SER . . . 62.49 -6.71 0.29 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.538 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.537 ' H ' ' C ' ' A' ' 39' ' ' LEU . 42.5 tt0 -81.41 141.73 33.65 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 42' ' ' ASN . 19.1 p-10 -124.88 72.99 63.92 Favored Pre-proline 0 N--CA 1.47 0.529 0 C-N-CA 121.376 -0.13 . . . . 0.0 111.288 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.407 ' CG ' HD21 ' A' ' 48' ' ' LEU . 94.3 Cg_endo -81.2 142.76 13.66 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.023 1.816 . . . . 0.0 111.845 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.415 ' OG1' ' N ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -87.43 175.11 8.12 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.393 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.415 ' N ' ' OG1' ' A' ' 44' ' ' THR . 52.8 mt-10 -57.2 -46.99 82.38 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.806 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.76 -49.51 72.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.525 0.679 . . . . 0.0 109.594 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -52.53 -47.08 66.94 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.946 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.407 HD21 ' CG ' ' A' ' 43' ' ' PRO . 95.4 mt -65.41 -46.78 78.66 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.195 0.522 . . . . 0.0 111.78 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.448 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 86.6 mt-30 -60.58 -44.54 96.09 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.598 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -67.12 -35.22 79.27 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.436 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.2 tpp -66.64 -50.94 61.33 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.45 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 56' ' ' ASP . 7.9 tt -71.36 -40.69 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.305 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 49' ' ' GLN . 22.9 t-20 -60.03 -39.57 86.34 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -77.43 -13.68 59.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.56 0.695 . . . . 0.0 109.999 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.441 ' O ' ' OE1' ' A' ' 67' ' ' GLU . 38.2 t -103.44 -22.78 4.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.549 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 52' ' ' ILE . 45.9 t0 -76.5 52.71 0.81 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.332 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.67 -27.39 0.1 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.642 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.449 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 37.8 m-20 -80.79 -34.75 33.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.515 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 87.16 10.13 72.08 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 51.3 p-10 -69.64 -27.26 64.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.394 0.14 . . . . 0.0 111.291 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 96.53 -7.25 65.81 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.9 p -129.16 167.08 18.12 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.6 mt -104.0 123.57 57.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.783 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -88.63 -175.86 5.07 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 176.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.417 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 38.2 t80 -67.95 -55.84 12.64 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 117.955 -1.498 . . . . 0.0 112.019 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.1 Cg_endo -56.08 -33.63 90.44 Favored 'Trans proline' 0 N--CA 1.505 2.163 0 C-N-CA 121.517 1.478 . . . . 0.0 112.047 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.449 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 68.7 mm-40 -57.35 -56.04 26.93 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -60.46 -36.49 78.37 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.707 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.48 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -60.94 -48.72 80.53 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.204 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -55.01 -50.04 70.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.591 1.186 . . . . 0.0 109.009 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 tp -53.37 -46.25 69.52 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 112.574 -2.103 . . . . 0.0 110.599 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.2 tpt -67.48 -46.74 72.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.759 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.18 -40.12 96.6 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.129 0.49 . . . . 0.0 109.979 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.2 mmt85 -62.38 -44.34 96.7 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.54 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.516 ' C ' ' H ' ' A' ' 77' ' ' LYS . 24.9 mmtp -65.26 -33.38 75.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.38 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.1 ttm -62.4 5.76 0.1 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.328 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 75' ' ' LYS . 51.6 pttt -58.95 -38.93 80.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.28 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.5 p-10 -113.74 13.95 18.64 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.717 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.5 m . . . . . 0 C--O 1.22 -0.5 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.629 -179.733 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 54.63 81.11 0.11 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.413 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -82.45 -5.13 58.49 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.811 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.458 HD12 ' N ' ' A' ' 4' ' ' LEU . 7.9 mp -75.55 160.66 29.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.707 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.692 HG22 ' N ' ' A' ' 6' ' ' ASP . 27.1 m -104.57 174.42 5.88 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.101 0.477 . . . . 0.0 111.062 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.692 ' N ' HG22 ' A' ' 5' ' ' THR . 1.8 p30 -73.21 -41.96 63.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.165 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.522 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 12.4 pt-20 -64.47 -40.76 96.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.576 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.559 ' O ' ' CD2' ' A' ' 12' ' ' PHE . 95.6 mt-30 -69.8 -35.03 74.51 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.273 0.559 . . . . 0.0 110.498 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.6 mt -72.95 -57.11 7.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.296 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.0 t -57.48 -46.66 83.44 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.089 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -49.27 -46.04 45.77 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 8' ' ' GLN . 20.3 m-30 -66.94 -47.07 72.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.382 0.611 . . . . 0.0 110.101 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -62.54 -45.79 91.35 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.774 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -66.06 -41.97 90.09 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.517 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.37 -45.71 93.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.512 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.42 ' C ' ' CD1' ' A' ' 16' ' ' PHE . 26.3 t80 -67.72 -43.95 78.8 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.3 m -63.88 -35.82 81.89 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 39.0 tp -64.21 -39.74 94.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.445 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.517 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.5 m-30 -66.4 -15.81 63.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.43 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.54 ' CG ' ' H ' ' A' ' 23' ' ' GLY . 65.7 t0 -92.24 89.59 6.93 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.209 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -50.28 -41.55 50.8 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.787 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -82.94 -27.11 30.79 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.048 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.54 ' H ' ' CG ' ' A' ' 20' ' ' ASP . . . 72.15 31.85 63.57 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.479 ' OD2' ' SG ' ' A' ' 26' ' ' CYS . 35.7 p-10 -81.69 -3.88 54.76 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.23 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.87 3.9 57.99 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.479 ' SG ' ' OD2' ' A' ' 24' ' ' ASP . 15.3 p -141.73 146.38 35.96 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.0 0.429 . . . . 0.0 111.034 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.4 HD11 ' CD2' ' A' ' 16' ' ' PHE . 72.6 mt -108.98 125.11 66.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.0 p -90.0 169.76 10.93 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.471 ' H ' HG23 ' A' ' 29' ' ' THR . 2.9 p -59.54 -52.24 66.42 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.979 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -53.19 -40.18 64.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -66.21 -43.45 86.67 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.505 HD13 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -62.29 -46.6 88.03 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.294 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 37' ' ' ARG . . . -60.0 -41.52 97.95 Favored Glycine 0 C--O 1.223 -0.588 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.7 m -48.69 -52.23 24.47 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.42 HG11 ' CE2' ' A' ' 19' ' ' PHE . 78.2 t -65.74 -49.82 75.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.194 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.7 mmm -65.14 -39.15 92.63 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 33' ' ' GLY . 23.9 tpt180 -55.49 -50.21 70.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.538 0.685 . . . . 0.0 110.2 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.6 t -71.43 -19.51 62.23 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.328 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.91 36.12 0.44 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.717 0.294 . . . . 0.0 111.348 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.74 45.97 94.08 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.496 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -144.75 154.73 43.03 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 25.3 p30 -134.54 73.84 67.12 Favored Pre-proline 0 N--CA 1.467 0.413 0 C-N-CA 121.184 -0.206 . . . . 0.0 110.963 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.415 ' CG ' HD21 ' A' ' 48' ' ' LEU . 87.1 Cg_endo -78.26 149.14 24.65 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.963 1.776 . . . . 0.0 111.6 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.8 p -87.91 164.31 15.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -59.54 -42.72 92.97 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.952 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.14 80.68 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.52 -48.12 82.9 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.075 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.415 HD21 ' CG ' ' A' ' 43' ' ' PRO . 52.6 mt -64.64 -42.45 95.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.158 0.504 . . . . 0.0 111.067 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -61.96 -36.59 81.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.899 0.857 . . . . 0.0 109.287 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -75.65 -40.07 56.69 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.006 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 33.9 mtp -63.77 -45.97 87.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.32 0.581 . . . . 0.0 110.048 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.487 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 1.4 tp -65.79 -47.44 85.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.874 -178.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.487 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 18.0 t-20 -69.06 -20.27 64.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.861 -177.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -72.34 -48.74 39.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.182 0.515 . . . . 0.0 110.525 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 57' ' ' ALA . 12.0 p -86.2 -2.33 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.373 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.459 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 16.6 t70 -64.57 41.89 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.625 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -50.68 -26.75 5.84 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.862 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 25.8 p30 -71.71 -39.29 70.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.356 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.514 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 91.81 7.39 64.59 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 51.6 p-10 -85.9 -22.53 27.44 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 122.724 -0.28 . . . . 0.0 111.387 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 85.73 3.41 86.04 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.508 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 22.9 p -139.6 151.2 45.83 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.9 mm -85.35 127.6 39.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.333 -0.547 . . . . 0.0 112.359 -176.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -104.71 153.79 20.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.744 ' CZ ' HD23 ' A' ' 69' ' ' LEU . 34.8 t80 -45.89 -55.61 12.46 Favored Pre-proline 0 C--N 1.319 -0.719 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.418 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 11.9 Cg_endo -49.22 -50.31 13.21 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.97 1.78 . . . . 0.0 111.489 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -55.85 -53.38 57.47 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -54.71 -21.36 10.62 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.175 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.744 HD23 ' CZ ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -79.04 -44.22 22.64 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.305 0.574 . . . . 0.0 110.219 179.283 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -58.23 -42.12 85.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.7 tp -59.71 -64.19 1.03 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 112.785 -2.007 . . . . 0.0 109.456 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.85 -38.11 54.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.645 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.38 -41.36 76.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.153 0.501 . . . . 0.0 110.254 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -60.76 -42.3 97.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.276 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.441 ' C ' ' H ' ' A' ' 77' ' ' LYS . 48.7 mtpt -64.05 -39.73 94.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.479 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 26.0 ttm -56.72 -4.78 0.18 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.197 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.441 ' H ' ' C ' ' A' ' 75' ' ' LYS . 3.2 ttmp? -58.32 -46.87 85.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.337 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -100.27 -70.42 0.74 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.693 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.4 t . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.969 -179.869 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.547 ' C ' ' H ' ' A' ' 3' ' ' GLN . . . . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 69.81 -26.12 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.608 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.547 ' H ' ' C ' ' A' ' 1' ' ' ALA . 15.7 mm100 -56.87 135.74 55.78 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.732 0.301 . . . . 0.0 110.558 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 71.9 mt -110.97 159.63 17.56 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.34 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.1 p -104.49 175.17 5.58 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.242 0.544 . . . . 0.0 111.249 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -77.72 -29.41 51.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.385 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.442 ' OE1' ' N ' ' A' ' 7' ' ' GLU . 48.6 mp0 -68.37 -44.21 75.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.197 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.57 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 95.9 mt-30 -65.85 -29.74 70.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.278 0.561 . . . . 0.0 110.194 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.2 mt -77.44 -53.16 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.112 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.7 t -58.16 -46.56 85.48 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.845 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -54.6 -42.97 71.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.596 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.607 ' CE1' ' SD ' ' A' ' 72' ' ' MET . 16.3 m-30 -64.92 -46.73 80.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.163 0.506 . . . . 0.0 110.183 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -65.96 -43.01 89.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.743 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -67.08 -45.24 77.92 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.223 0.535 . . . . 0.0 110.073 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.554 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -62.74 -44.83 95.19 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.534 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.429 ' CD2' HD11 ' A' ' 27' ' ' ILE . 54.1 t80 -66.72 -43.99 82.77 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.8 m -63.35 -36.64 84.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.2 tp -63.74 -40.29 96.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.473 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.4 m-30 -63.29 -18.01 63.14 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.487 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.541 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 24.2 t0 -98.04 93.89 6.55 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.905 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.48 ' NZ ' HG21 ' A' ' 34' ' ' THR . 55.2 mttp -65.74 -19.69 65.99 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.662 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 24' ' ' ASP . 8.8 p30 -109.99 13.16 23.47 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.522 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 35.18 32.08 0.03 OUTLIER Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.541 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 97.5 m-20 -69.84 -8.96 52.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.568 0.223 . . . . 0.0 110.811 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.67 -7.61 65.63 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.8 m -143.64 149.66 37.61 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.748 0.309 . . . . 0.0 111.098 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.429 HD11 ' CD2' ' A' ' 16' ' ' PHE . 73.8 mt -96.22 125.14 49.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.1 p -84.28 -160.14 0.44 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.7 p -84.79 -58.15 2.83 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.439 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 34' ' ' THR . 21.7 pttp -54.21 -35.98 62.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.415 . . . . 0.0 109.959 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.438 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 95.6 mt-10 -62.37 -50.84 69.95 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.0 tt -63.34 -42.02 98.9 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.53 -39.34 97.2 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 30' ' ' LYS . 20.0 m -52.77 -49.36 65.69 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.539 ' O ' HD13 ' A' ' 39' ' ' LEU . 96.6 t -63.15 -47.86 90.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.807 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 84.6 mmm -63.64 -42.8 98.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.502 0.668 . . . . 0.0 110.416 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -53.26 -49.39 67.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.104 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.3 m -71.45 -27.08 63.01 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.513 -1.221 . . . . 0.0 112.018 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 35' ' ' VAL . 7.2 mp -84.05 31.56 0.49 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.44 -8.0 1.73 Allowed Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.461 ' H ' ' C ' ' A' ' 39' ' ' LEU . 90.4 mm-40 -85.71 146.77 26.66 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.6 p30 -135.79 64.91 58.58 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 121.249 -0.181 . . . . 0.0 111.155 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.27 154.76 41.47 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.441 2.094 . . . . 0.0 111.783 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.9 m -94.32 161.43 14.24 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.437 ' HG2' ' H ' ' A' ' 45' ' ' GLU . 2.6 pt-20 -54.66 -34.3 62.02 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.706 -178.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.63 -45.15 85.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.465 0.65 . . . . 0.0 109.394 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -63.83 -41.14 97.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.187 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.1 mt -62.28 -45.92 91.12 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.072 0.463 . . . . 0.0 111.091 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -67.27 -45.69 75.89 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.437 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.72 -43.12 99.64 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.288 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.3 ttm -61.39 -41.96 97.96 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 56' ' ' ASP . 34.1 mt -67.94 -44.93 84.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.583 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -58.37 -35.72 72.4 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -69.07 -21.2 64.09 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.121 0.486 . . . . 0.0 110.474 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.577 ' C ' ' H ' ' A' ' 57' ' ' ALA . 83.8 t -106.93 -23.48 4.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.301 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 59' ' ' GLY . 27.5 t0 -63.46 34.23 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.469 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.577 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -36.92 -27.01 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.381 0.61 . . . . 0.0 110.873 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 56' ' ' ASP . 19.3 p-10 -85.96 -37.04 19.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.178 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 87.12 62.41 1.5 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.515 ' H ' ' CG ' ' A' ' 56' ' ' ASP . 55.0 p30 -123.92 -18.17 6.06 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.637 0.219 . . . . 0.0 111.204 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 80.36 2.57 89.46 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.809 -0.516 . . . . 0.0 111.809 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.458 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 64.4 p -136.68 159.61 41.29 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.3 mt -100.05 121.06 50.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -86.99 145.67 26.42 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.422 ' CE2' HD12 ' A' ' 69' ' ' LEU . 34.1 t80 -46.4 -48.69 45.94 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 118.589 -1.244 . . . . 0.0 111.231 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -52.79 -49.07 18.83 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.24 1.294 . . . . 0.0 111.825 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.406 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 94.4 mt-10 -55.45 -52.83 62.3 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -53.07 -23.92 8.88 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.517 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.422 HD12 ' CE2' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -71.91 -46.1 58.87 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.051 0.453 . . . . 0.0 110.55 179.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -61.52 -42.41 98.76 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 122.427 1.108 . . . . 0.0 108.937 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.5 tp -62.05 -30.65 71.13 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 112.774 -2.012 . . . . 0.0 109.682 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.607 ' SD ' ' CE1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -82.5 -40.37 21.15 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.703 178.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.83 -36.54 72.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.006 0.431 . . . . 0.0 109.983 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -66.95 -43.56 82.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.391 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -64.32 -45.93 85.77 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.472 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.3 tpt -69.03 -5.2 20.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.692 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.8 tptt -78.72 -10.48 59.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.202 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 25.3 p-10 -39.89 -65.83 0.36 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.43 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.5 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 10.1 t . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.452 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.471 ' O ' ' O ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 1' ' ' ALA . 87.8 m-20 57.85 144.44 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 O-C-N 123.58 0.55 . . . . 0.0 109.95 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -137.05 16.58 3.02 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 121.186 -0.206 . . . . 0.0 111.41 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.511 ' N ' ' CD2' ' A' ' 4' ' ' LEU . 3.5 mm? -79.68 173.21 12.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.015 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 7' ' ' GLU . 4.8 m -114.34 150.7 34.16 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.237 0.541 . . . . 0.0 111.186 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 6' ' ' ASP . 5.4 p-10 -63.11 -34.47 77.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.406 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.454 ' H ' HG22 ' A' ' 5' ' ' THR . 97.6 mt-10 -61.64 -47.72 84.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.724 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.532 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -59.68 -36.02 75.63 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.3 mt -72.17 -55.24 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.977 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.2 t -55.38 -53.49 55.6 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.822 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -54.07 -44.3 71.02 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' A' ' 8' ' ' GLN . 4.7 m-30 -60.74 -51.22 70.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.455 0.645 . . . . 0.0 109.514 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -59.68 -42.7 93.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.5 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -62.33 -46.73 87.4 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.15 78.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.335 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.412 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 34.1 t80 -69.73 -50.94 38.67 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.0 p -57.79 -35.11 70.35 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 46.9 tp -61.27 -45.25 95.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.532 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.463 ' CD1' HG21 ' A' ' 35' ' ' VAL . 17.2 m-85 -61.26 -27.77 68.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.474 ' OD1' ' OD1' ' A' ' 22' ' ' ASP . 27.1 t0 -78.55 90.76 4.52 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.839 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -62.48 -36.02 81.18 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.795 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.474 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 28.8 p30 -96.64 -1.36 46.94 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.481 0.181 . . . . 0.0 111.296 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.31 40.47 37.9 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -88.93 3.93 49.79 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.718 0.294 . . . . 0.0 111.19 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.76 -6.05 84.03 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.4 m -133.1 158.92 41.57 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.836 0.35 . . . . 0.0 110.889 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.0 mt -119.96 126.85 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.5 p -90.4 157.47 17.59 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.554 ' O ' ' N ' ' A' ' 33' ' ' GLY . 66.7 p -55.13 -29.72 58.29 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.349 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.95 -48.83 77.2 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.229 0.538 . . . . 0.0 110.275 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -61.59 -45.11 95.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.842 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 tp -63.42 -38.89 92.9 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 177.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -62.89 -47.62 87.44 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.1 m -47.52 -48.68 27.37 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' A' ' 19' ' ' PHE . 56.8 t -63.72 -51.87 64.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 113.53 -1.668 . . . . 0.0 111.233 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.482 ' SD ' ' OE1' ' A' ' 41' ' ' GLN . 17.3 mmt -63.79 -45.52 89.34 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -47.8 -54.54 12.07 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.313 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 40' ' ' GLY . 37.5 m -62.06 -37.16 83.92 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.642 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 41' ' ' GLN . 69.8 mt -69.91 34.78 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.776 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 38' ' ' SER . . . 58.92 3.57 1.75 Allowed Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.482 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 87.0 mt-30 -97.43 149.09 22.53 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -147.54 67.01 10.28 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.269 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -65.52 157.6 57.47 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.288 1.992 . . . . 0.0 111.923 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.8 p -82.53 164.83 20.63 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 177.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -57.37 -40.62 78.53 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.436 -0.506 . . . . 0.0 112.051 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.3 -50.08 74.88 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.571 0.7 . . . . 0.0 109.803 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -54.11 -47.19 72.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.268 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.24 -47.33 71.08 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.905 0.384 . . . . 0.0 111.783 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.417 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 94.6 mm-40 -61.05 -40.03 92.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.54 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -74.22 -38.58 63.52 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.774 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 43.4 tpp -62.37 -48.89 77.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.493 0.663 . . . . 0.0 110.548 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 53' ' ' ASN . 19.7 tt -71.84 -41.84 69.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.195 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 49' ' ' GLN . 31.3 t30 -64.06 -38.75 92.19 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -60.58 -55.41 33.66 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.456 0.646 . . . . 0.0 110.958 -177.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.587 ' O ' HG22 ' A' ' 55' ' ' VAL . 7.1 p -67.67 -6.05 4.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.097 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.595 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.0 t0 -80.07 75.48 6.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.721 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.04 -24.66 1.14 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.259 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 12.0 p-10 -99.43 -44.68 6.1 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.22 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.595 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 93.57 29.11 10.35 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.76 HD22 ' N ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -71.41 -19.84 62.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.441 0.163 . . . . 0.0 111.242 179.493 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.76 ' N ' HD22 ' A' ' 60' ' ' ASN . . . 87.91 -9.45 74.34 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.403 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 68.3 p -132.1 167.27 20.02 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.3 mt -100.13 126.36 53.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.777 -177.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -96.3 -172.25 2.49 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.728 ' CE2' HD11 ' A' ' 69' ' ' LEU . 55.4 t80 -71.6 -56.01 5.31 Favored Pre-proline 0 C--N 1.319 -0.728 0 C-N-CA 118.114 -1.434 . . . . 0.0 111.865 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 32.5 Cg_endo -57.05 -39.3 92.23 Favored 'Trans proline' 0 N--CA 1.503 2.046 0 C-N-CA 121.488 1.459 . . . . 0.0 111.875 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.432 ' OE2' ' OD1' ' A' ' 58' ' ' ASP . 64.5 mm-40 -55.02 -49.06 72.49 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -57.22 -42.35 81.22 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 114.319 -1.309 . . . . 0.0 110.16 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.728 HD11 ' CE2' ' A' ' 65' ' ' PHE . 71.3 mt -61.95 -44.77 96.06 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.767 -0.583 . . . . 0.0 110.904 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.437 HD22 HG23 ' A' ' 55' ' ' VAL . 21.8 t30 -57.3 -47.86 80.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 122.533 1.158 . . . . 0.0 109.079 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.424 ' HB2' HG21 ' A' ' 55' ' ' VAL . 32.2 tp -59.5 -50.11 75.17 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 112.823 -1.989 . . . . 0.0 110.102 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.3 tpt -65.48 -42.87 91.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.647 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.28 -40.55 94.03 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.919 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.5 ttt180 -57.36 -43.44 83.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.146 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -60.47 -42.52 96.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.287 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 87.2 mmm -69.06 -7.59 37.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.302 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -70.04 -44.53 69.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.621 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.413 ' CG ' ' N ' ' A' ' 79' ' ' THR . 65.9 t0 -150.74 -111.67 0.06 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.816 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.413 ' N ' ' CG ' ' A' ' 78' ' ' ASP . 76.7 p . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.597 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.544 ' C ' ' H ' ' A' ' 4' ' ' LEU . 47.6 p-10 -83.93 174.96 9.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.678 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 67.55 -36.37 0.29 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.973 0.416 . . . . 0.0 111.394 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.544 ' H ' ' C ' ' A' ' 2' ' ' ASP . 32.5 mt -119.17 168.17 11.12 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.003 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.432 ' O ' HD13 ' A' ' 9' ' ' ILE . 43.7 p -117.1 161.66 19.07 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.814 0.34 . . . . 0.0 111.114 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -75.7 -18.12 59.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -66.44 -43.66 84.99 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.049 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.613 ' O ' ' CD2' ' A' ' 12' ' ' PHE . 84.3 mt-30 -67.39 -33.67 75.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.525 0.679 . . . . 0.0 110.383 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.529 ' N ' HD12 ' A' ' 9' ' ' ILE . 1.4 mp -74.11 -58.22 5.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.709 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.5 t -56.29 -46.51 79.73 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.72 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -47.11 -50.37 20.21 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.239 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.613 ' CD2' ' O ' ' A' ' 8' ' ' GLN . 17.7 m-85 -62.92 -48.83 77.23 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.491 0.663 . . . . 0.0 110.76 178.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -62.42 -47.33 84.57 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.725 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -62.15 -42.16 98.99 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.0 99.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.396 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 19.6 t80 -70.03 -47.66 61.15 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.8 p -66.21 -30.54 71.02 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.9 tp -61.04 -41.54 96.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.296 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.576 ' CD1' HG21 ' A' ' 35' ' ' VAL . 25.9 m-85 -73.23 -15.18 61.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.821 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.543 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 26.3 t0 -86.8 69.8 10.32 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.269 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -40.08 -46.14 2.1 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.704 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.459 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 26.4 p-10 -74.87 -19.78 60.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.443 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 64.72 30.34 77.67 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.543 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 54.9 p-10 -81.58 -3.87 54.49 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.744 0.307 . . . . 0.0 111.151 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.68 5.11 72.03 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.455 ' O ' ' OD1' ' A' ' 20' ' ' ASP . 15.7 m -136.08 150.19 49.04 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.904 0.383 . . . . 0.0 110.817 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.4 ' CD1' ' CD2' ' A' ' 16' ' ' PHE . 82.9 mt -117.36 130.23 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.6 p -104.61 166.49 10.36 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 33' ' ' GLY . 36.0 p -56.45 -24.88 48.46 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.532 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.449 ' O ' ' OG1' ' A' ' 34' ' ' THR . 65.7 tttm -68.08 -50.15 56.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.092 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.25 -49.15 68.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.626 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.2 tp -62.26 -41.85 98.82 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -64.13 -42.68 97.94 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 30' ' ' LYS . 23.6 m -49.19 -46.51 45.7 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 122.275 1.036 . . . . 0.0 108.412 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.576 HG21 ' CD1' ' A' ' 19' ' ' PHE . 74.1 t -68.94 -55.48 15.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 113.398 -1.728 . . . . 0.0 111.217 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.8 mmt -60.2 -41.05 92.16 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.529 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.416 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 71.6 ttp85 -57.56 -50.25 73.71 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.321 178.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -68.38 -18.12 64.39 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.592 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 35' ' ' VAL . 1.8 mm? -91.05 38.95 0.97 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.905 0.383 . . . . 0.0 111.476 -178.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.49 26.56 59.74 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.396 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.522 ' OE1' ' N ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -111.97 142.84 43.87 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.522 ' N ' ' OE1' ' A' ' 41' ' ' GLN . 10.9 m120 -128.31 75.11 79.34 Favored Pre-proline 0 N--CA 1.47 0.541 0 C-N-CA 121.288 -0.165 . . . . 0.0 111.361 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -81.11 143.88 14.47 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.254 1.969 . . . . 0.0 111.487 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.435 HG23 ' H ' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -89.11 172.22 9.25 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.257 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -63.2 -39.58 95.04 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.901 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.46 94.3 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.392 0.615 . . . . 0.0 109.434 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.435 ' H ' HG23 ' A' ' 44' ' ' THR . 51.3 tp10 -56.84 -51.08 70.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.046 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.1 mt -62.62 -42.51 99.63 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.135 0.493 . . . . 0.0 111.11 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -64.64 -37.96 89.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.79 0.805 . . . . 0.0 109.272 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -75.37 -35.32 61.12 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.1 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 32.9 ttm -63.86 -50.76 67.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.451 0.643 . . . . 0.0 110.146 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.415 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 1.3 tt -66.28 -39.5 84.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.635 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -63.71 -30.84 71.89 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.784 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -77.08 -30.31 55.38 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.592 0.711 . . . . 0.0 110.497 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.579 ' O ' ' N ' ' A' ' 57' ' ' ALA . 54.7 t -98.39 -4.71 9.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.474 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 52' ' ' ILE . 16.6 m-20 -64.74 45.01 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.449 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -45.81 -37.58 6.26 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.286 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 25.0 p-10 -77.65 -43.3 31.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.435 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.476 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 90.36 16.74 54.9 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.497 ' OD1' ' O ' ' A' ' 62' ' ' THR . 52.9 p-10 -94.34 -1.77 53.27 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 122.87 -0.194 . . . . 0.0 111.093 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.77 2.25 50.28 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.532 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.497 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 31.6 p -134.13 150.65 51.14 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.6 mm -91.34 133.3 33.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -101.26 -172.34 2.15 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -76.98 -47.45 2.75 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 118.091 -1.443 . . . . 0.0 111.658 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.96 -37.62 75.35 Favored 'Trans proline' 0 N--CA 1.505 2.176 0 C-N-CA 121.701 1.601 . . . . 0.0 111.934 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -64.22 -35.87 82.21 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -76.44 -23.07 53.93 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.305 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.6 tp -78.3 -32.55 49.45 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.209 0.528 . . . . 0.0 110.652 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -68.43 -42.21 79.22 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.615 1.198 . . . . 0.0 108.641 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.8 tp -62.95 -41.55 99.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 112.527 -2.124 . . . . 0.0 110.416 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.404 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . 1.2 mmt -81.02 -22.49 39.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.885 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.39 -37.55 27.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.127 0.489 . . . . 0.0 109.791 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -70.47 -42.86 70.88 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.15 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.445 ' C ' ' H ' ' A' ' 77' ' ' LYS . 65.4 tttm -65.68 -47.37 75.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.438 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.513 ' SD ' ' O ' ' A' ' 76' ' ' MET . 0.1 OUTLIER -65.29 4.67 0.47 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.51 -179.416 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.445 ' H ' ' C ' ' A' ' 75' ' ' LYS . 88.6 tttt -64.36 -36.23 83.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.221 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -142.59 -84.32 0.17 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.997 0.427 . . . . 0.0 110.743 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.6 m . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.637 -179.757 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -83.16 100.11 10.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.102 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -78.65 138.08 38.14 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.885 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.3 mt -83.54 157.57 22.29 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.933 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.54 HG22 ' N ' ' A' ' 6' ' ' ASP . 7.1 m -96.81 165.75 11.96 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.082 0.468 . . . . 0.0 111.341 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.54 ' N ' HG22 ' A' ' 5' ' ' THR . 98.8 m-20 -68.51 -40.87 80.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.654 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -61.86 -46.67 88.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.949 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.546 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 7.8 mp0 -64.29 -32.08 73.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 78.3 mt -76.45 -55.37 11.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.247 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 42.9 t -56.72 -47.77 79.23 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.032 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -59.98 -40.7 90.05 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.843 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.546 ' CG ' ' O ' ' A' ' 8' ' ' GLN . 3.9 m-30 -61.19 -49.78 75.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.326 0.584 . . . . 0.0 109.835 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -65.57 -39.65 91.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.012 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -61.81 -43.03 99.66 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.531 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.0 -45.92 92.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.576 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 31.7 t80 -66.55 -48.79 68.54 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.9 m -62.91 -35.62 80.68 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.954 0.883 . . . . 0.0 108.8 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.3 tp -60.98 -43.59 98.61 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.311 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 9.7 m-30 -63.15 -19.0 64.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.955 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -85.91 95.27 9.41 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.28 0.363 . . . . 0.0 111.493 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -76.13 -20.58 57.48 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.371 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.2 p30 -110.56 1.09 17.92 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.65 0.262 . . . . 0.0 111.322 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 47.07 40.83 13.69 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -81.73 -2.65 51.35 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.725 0.298 . . . . 0.0 111.162 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.87 -8.18 78.77 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.1 m -143.05 139.85 30.7 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.776 0.322 . . . . 0.0 111.074 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.7 mt -96.58 128.4 47.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.5 p -86.23 -159.54 0.48 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 33' ' ' GLY . 22.0 p -86.56 -31.42 21.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.097 0.475 . . . . 0.0 110.806 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -67.12 -46.89 72.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.346 0.593 . . . . 0.0 110.403 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -63.16 -47.02 84.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.92 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.4 tp -63.82 -42.48 97.64 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -60.59 -46.8 93.73 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 178.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.9 m -48.87 -47.91 42.51 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 122.247 1.023 . . . . 0.0 108.292 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.92 -50.32 65.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 113.401 -1.727 . . . . 0.0 111.521 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 75.7 mmm -62.88 -43.0 99.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.783 0.801 . . . . 0.0 109.634 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -55.77 -52.21 64.73 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.452 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.5 t -66.42 -21.19 66.21 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.864 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 36.4 mt -84.43 30.9 0.53 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.583 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.6 45.98 94.74 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.855 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -141.19 151.11 43.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -134.91 68.82 71.21 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-O 120.394 0.14 . . . . 0.0 111.252 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.41 150.33 41.09 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.029 1.819 . . . . 0.0 111.845 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.3 p -87.22 166.96 14.54 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -59.81 -37.21 78.53 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.866 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.37 -47.41 78.95 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.448 0.642 . . . . 0.0 109.354 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -61.08 -46.42 90.73 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.134 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.2 mt -62.69 -49.32 75.58 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.162 0.506 . . . . 0.0 111.513 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -61.71 -39.47 91.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.226 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -72.02 -32.57 67.27 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.56 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.0 mmt -67.1 -45.75 76.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.363 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 4.1 tt -75.57 -41.63 41.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.893 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.41 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 24.4 t-20 -65.42 -41.79 93.19 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -177.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.78 -11.64 61.07 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.002 0.906 . . . . 0.0 109.909 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.531 ' C ' ' H ' ' A' ' 57' ' ' ALA . 42.9 t -110.37 -14.27 10.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.699 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 44.1 t0 -66.04 42.97 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.711 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -50.29 -28.67 8.2 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.261 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 1.8 p30 -77.87 -37.46 48.11 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.447 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.481 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 89.5 7.54 69.16 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.545 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 57.1 p30 -75.12 -21.52 58.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.416 0.151 . . . . 0.0 111.282 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.545 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 84.78 -5.52 81.8 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.741 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.429 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 54.5 p -133.82 163.71 28.87 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.8 mt -96.02 115.66 35.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.601 -0.439 . . . . 0.0 112.091 -177.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 65' ' ' PHE . 64.8 t0 -82.62 -173.52 4.67 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 176.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.509 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 34.2 t80 -77.68 -48.17 2.28 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 117.954 -1.498 . . . . 0.0 111.738 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.56 -43.57 53.97 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 121.287 1.324 . . . . 0.0 111.606 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.433 ' OE1' ' OD2' ' A' ' 58' ' ' ASP . 76.3 tt0 -56.0 -52.37 64.45 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 122.344 1.069 . . . . 0.0 108.208 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -48.34 -40.78 26.46 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.192 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.5 HD11 ' CE2' ' A' ' 65' ' ' PHE . 42.0 mt -61.43 -43.52 98.72 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.419 179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -58.48 -46.45 86.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 122.379 1.085 . . . . 0.0 109.125 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.1 tp -59.18 -47.43 85.33 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 112.847 -1.979 . . . . 0.0 110.484 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.0 tpt -67.71 -44.35 77.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.346 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.65 -39.56 88.77 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.156 0.503 . . . . 0.0 110.138 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.22 -37.46 72.03 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.627 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.535 ' C ' ' H ' ' A' ' 77' ' ' LYS . 65.2 tttm -62.12 -35.35 78.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.365 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 75.8 mmm -64.85 11.69 0.05 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.729 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.535 ' H ' ' C ' ' A' ' 75' ' ' LYS . 88.5 tttt -54.56 -44.38 72.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.04 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -72.55 95.55 1.83 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.095 0.474 . . . . 0.0 110.997 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.5 m . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.745 -179.827 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 54.43 31.09 13.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.808 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -77.11 17.49 0.45 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 121.253 -0.179 . . . . 0.0 111.253 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.2 pp -112.02 154.51 25.23 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.76 0.314 . . . . 0.0 110.626 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -89.76 170.53 10.35 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.29 0.566 . . . . 0.0 111.353 -179.457 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.678 ' O ' ' N ' ' A' ' 9' ' ' ILE . 5.8 p-10 -76.02 -52.7 9.66 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.284 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -43.31 -33.82 1.08 Allowed 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.961 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.532 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 84.2 mm-40 -70.53 -22.1 62.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.423 0.63 . . . . 0.0 109.835 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 6' ' ' ASP . 73.4 mt -83.28 -55.62 7.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.518 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -43.45 92.74 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 120.149 -0.621 . . . . 0.0 109.937 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -61.88 -39.64 92.65 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.0 m-30 -63.96 -45.97 86.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.385 0.612 . . . . 0.0 109.675 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -65.7 -43.14 90.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.587 -1.188 . . . . 0.0 111.756 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -62.96 -40.34 97.4 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.521 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -62.75 -43.35 99.03 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.36 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.424 ' CD1' HD11 ' A' ' 27' ' ' ILE . 48.1 t80 -68.16 -45.29 73.92 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.7 t -63.34 -36.99 85.53 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.4 tp -60.67 -38.39 84.78 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.943 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.521 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.8 m-30 -68.41 -15.39 63.53 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.017 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 65.8 t0 -95.29 77.36 3.43 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -43.02 -36.64 1.64 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.088 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.429 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 46.3 m-20 -83.52 -22.17 32.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.338 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 66.84 30.55 76.32 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.519 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 24.3 p-10 -88.66 0.11 56.74 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.533 0.206 . . . . 0.0 111.157 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.472 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 82.1 18.09 68.03 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.7 m -145.33 130.56 18.53 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 111.007 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.424 HD11 ' CD1' ' A' ' 16' ' ' PHE . 58.4 mt -103.67 141.57 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.424 ' H ' ' HB2' ' A' ' 31' ' ' GLU . 6.2 p -119.72 174.28 6.51 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.465 ' CG2' HD12 ' A' ' 52' ' ' ILE . 79.7 p -56.5 -33.48 66.04 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.808 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -67.69 -49.62 61.81 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.309 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.429 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 90.4 mt-10 -69.08 -45.37 70.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.2 tp -60.45 -44.31 95.96 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -63.83 -39.26 97.22 Favored Glycine 0 C--O 1.216 -1.003 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.1 m -50.29 -45.78 54.72 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.292 1.044 . . . . 0.0 108.677 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.71 -54.07 23.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 113.057 -1.883 . . . . 0.0 111.25 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.1 mmt -57.11 -41.6 79.27 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.523 0.678 . . . . 0.0 109.93 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -55.85 -45.39 78.46 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.564 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 61.8 p -79.87 -10.58 59.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.818 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.75 38.13 1.41 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.549 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.48 5.74 2.82 Favored Glycine 0 N--CA 1.465 0.568 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.502 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -103.71 151.8 22.57 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -138.1 74.04 43.74 Favored Pre-proline 0 N--CA 1.47 0.569 0 O-C-N 122.957 0.161 . . . . 0.0 111.19 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.445 ' CG ' HD21 ' A' ' 48' ' ' LEU . 97.7 Cg_endo -80.2 155.35 22.37 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.992 1.794 . . . . 0.0 112.026 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.566 HG22 ' N ' ' A' ' 45' ' ' GLU . 26.7 m -94.01 169.75 10.04 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.566 ' N ' HG22 ' A' ' 44' ' ' THR . 98.6 mt-10 -62.07 -34.0 75.46 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.954 -178.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.48 -44.55 96.88 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.481 0.657 . . . . 0.0 109.963 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.55 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -60.77 -51.54 68.91 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.037 -178.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.445 HD21 ' CG ' ' A' ' 43' ' ' PRO . 85.3 mt -61.26 -41.38 96.82 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.01 0.433 . . . . 0.0 111.829 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -64.61 -45.61 86.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.746 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -65.81 -37.57 86.6 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.074 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.4 mmm -61.91 -43.22 99.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.437 0.637 . . . . 0.0 109.563 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.465 HD12 ' CG2' ' A' ' 29' ' ' THR . 22.9 mt -66.68 -43.56 90.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.864 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -64.2 -35.03 79.47 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -70.43 -33.26 71.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.525 0.678 . . . . 0.0 110.324 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 55' ' ' VAL . 79.8 t -98.1 -4.74 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.095 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 15.8 t70 -65.6 41.59 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.057 0.456 . . . . 0.0 111.023 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -53.66 -25.97 20.42 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.58 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.434 ' OD1' ' OE1' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -80.31 -43.29 21.49 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.369 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.27 43.55 4.62 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.68 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 46.8 p30 -123.63 -15.27 7.08 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.268 0.099 . . . . 0.0 111.268 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 78.57 5.49 88.1 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.76 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.433 ' O ' ' OE1' ' A' ' 67' ' ' GLU . 72.4 p -135.84 164.5 27.79 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.0 mt -99.57 121.77 50.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.459 ' H ' ' HB3' ' A' ' 67' ' ' GLU . 90.5 m-20 -99.43 157.71 16.23 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 177.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.459 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 41.1 t80 -44.45 -53.92 13.43 Favored Pre-proline 0 CA--C 1.556 1.184 0 CA-C-N 120.557 1.526 . . . . 0.0 111.78 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.8 Cg_endo -57.24 -40.45 82.42 Favored 'Trans proline' 0 N--CA 1.505 2.157 0 C-N-CA 121.254 1.303 . . . . 0.0 112.087 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.459 ' HB3' ' H ' ' A' ' 64' ' ' ASP . 77.4 tt0 -63.02 -32.02 73.29 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.459 ' HB3' ' O ' ' A' ' 65' ' ' PHE . 53.5 t80 -71.8 -26.1 62.27 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.764 -1.562 . . . . 0.0 109.7 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.452 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 6.0 mt -76.01 -34.0 59.69 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.401 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -61.47 -42.28 98.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.62 1.2 . . . . 0.0 108.641 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.8 tp -58.17 -63.79 1.14 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 112.317 -2.22 . . . . 0.0 110.285 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 67.1 mmm -63.94 -32.85 74.53 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.187 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -63.46 -48.32 78.18 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.439 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -57.08 -44.19 82.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.244 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -63.51 -42.37 98.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.207 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -70.72 -16.51 62.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.368 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -69.49 -38.9 77.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.607 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -39.45 130.12 1.79 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.208 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.8 p . . . . . 0 C--O 1.222 -0.377 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.683 -179.82 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 3' ' ' GLN . 38.5 p-10 -65.25 -33.99 77.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.379 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.429 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 1.6 pt20 175.18 4.09 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.157 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 77.9 mt -115.14 160.84 19.2 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.596 0.236 . . . . 0.0 110.611 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.0 p -93.66 171.17 9.05 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.257 0.551 . . . . 0.0 111.31 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 25.5 p-10 -73.95 -29.01 61.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.469 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.415 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 80.6 mm-40 -61.21 -45.98 92.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.026 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.606 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 53.8 tt0 -66.13 -26.54 67.49 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.0 mt -80.53 -54.6 10.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.086 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.0 t -57.62 -43.82 85.05 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.776 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -64.07 -40.2 95.74 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.606 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 2.7 m-85 -61.24 -47.49 85.81 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.623 0.725 . . . . 0.0 109.377 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -62.73 -44.35 96.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.836 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -61.02 -40.34 93.22 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.53 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -61.1 -42.0 97.72 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.273 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -68.18 -47.21 68.58 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.9 t -60.19 -36.12 76.91 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.4 tp -61.96 -41.98 98.6 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.444 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.53 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.5 m-30 -62.93 -24.97 68.12 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.315 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.481 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 47.4 t0 -83.21 94.54 7.9 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.346 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -59.67 -33.22 71.28 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.055 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -97.53 -3.03 40.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.609 0.242 . . . . 0.0 111.124 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.46 36.51 30.86 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.481 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 33.2 p-10 -95.46 15.92 18.36 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.672 0.273 . . . . 0.0 111.095 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.44 ' C ' ' SG ' ' A' ' 26' ' ' CYS . . . 69.61 22.24 76.58 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.44 ' SG ' ' C ' ' A' ' 25' ' ' GLY . 3.2 m -149.99 139.18 21.22 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.883 0.373 . . . . 0.0 111.218 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 6.0 mm -108.78 118.87 57.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.6 p -78.66 -162.76 0.39 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.499 ' OG1' ' N ' ' A' ' 30' ' ' LYS . 1.6 p -84.62 -60.11 2.16 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.863 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.499 ' N ' ' OG1' ' A' ' 29' ' ' THR . 20.3 pttp -50.0 -33.2 17.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.112 0.482 . . . . 0.0 110.081 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -67.8 -48.07 67.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.824 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.7 tp -64.52 -42.82 95.56 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.59 -43.26 98.25 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.1 m -48.65 -47.94 40.08 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.1 t -65.81 -50.16 72.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.648 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.2 mmt -63.5 -40.82 98.07 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -57.29 -48.86 77.84 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.369 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 86.8 p -69.67 -19.1 63.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.511 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.9 mt -92.13 30.62 1.4 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.469 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.71 43.96 98.56 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.835 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -133.26 144.31 49.66 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -123.34 69.48 41.4 Favored Pre-proline 0 N--CA 1.47 0.574 0 CA-C-O 120.452 0.167 . . . . 0.0 111.385 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.431 ' CG ' HD21 ' A' ' 48' ' ' LEU . 86.5 Cg_endo -78.8 142.58 17.88 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.044 1.829 . . . . 0.0 111.665 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.2 p -81.26 163.73 22.75 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -57.57 -45.94 84.58 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.957 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.77 -44.75 82.11 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -57.32 -40.97 79.04 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.199 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.431 HD21 ' CG ' ' A' ' 43' ' ' PRO . 95.4 mt -66.42 -44.52 82.71 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.174 0.511 . . . . 0.0 111.56 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -67.05 -43.88 81.61 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.643 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -61.96 -45.9 91.62 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.04 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 48.9 tpp -57.99 -39.18 77.58 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.449 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 0.6 OUTLIER -68.22 -42.55 84.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.242 179.326 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -58.68 -34.36 71.17 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.467 ' HB2' HH12 ' A' ' 74' ' ' ARG . 1.1 mt-10 -73.48 -50.17 22.94 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.88 0.848 . . . . 0.0 111.275 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.549 HG22 ' HG3' ' A' ' 67' ' ' GLU . 11.3 p -72.59 -18.48 18.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.297 -1.319 . . . . 0.0 111.054 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.2 t0 -79.7 48.71 0.96 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.501 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -44.76 -21.02 0.04 OUTLIER 'General case' 0 C--N 1.34 0.195 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.382 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.439 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 31.3 m-20 -80.5 -35.16 35.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.448 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.53 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 89.27 15.0 59.48 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 62' ' ' THR . 50.4 p-10 -77.32 -28.02 53.05 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.288 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 92.26 -2.73 75.26 Favored Glycine 0 N--CA 1.466 0.649 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.523 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 53.9 p -135.9 163.27 30.64 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.3 mm -95.78 118.64 42.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.855 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -89.31 -168.4 2.15 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.435 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 28.7 t80 -71.78 -55.51 5.46 Favored Pre-proline 0 C--N 1.317 -0.812 0 C-N-CA 118.002 -1.479 . . . . 0.0 111.91 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 38.3 Cg_endo -59.12 -35.11 98.59 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 121.392 1.395 . . . . 0.0 111.698 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.549 ' HG3' HG22 ' A' ' 55' ' ' VAL . 6.1 tp10 -58.79 -55.25 37.58 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.48 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 42.5 t80 -47.86 -40.52 21.72 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.401 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -57.97 -41.6 83.28 Favored 'General case' 0 C--N 1.313 -1.0 0 O-C-N 121.036 -1.04 . . . . 0.0 110.289 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -60.38 -47.85 84.31 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.703 1.24 . . . . 0.0 108.615 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.508 HD23 HG21 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -46.64 -64.16 0.83 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 112.85 -1.977 . . . . 0.0 110.58 179.357 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 73.0 mmm -62.78 -39.6 94.71 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.294 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.75 -47.05 77.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.047 0.451 . . . . 0.0 110.308 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.467 HH12 ' HB2' ' A' ' 54' ' ' GLU . 82.5 mtp180 -60.17 -43.45 95.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.272 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.459 ' HZ3' HD13 ' A' ' 71' ' ' LEU . 45.6 mttp -65.13 -41.17 95.09 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.45 178.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 89.7 mmm -76.26 -14.2 60.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.477 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -67.65 -46.39 72.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.147 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -165.68 82.79 0.32 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.605 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.7 p . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.796 179.837 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 3' ' ' GLN . 64.5 t0 -69.16 139.53 54.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.826 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.473 ' CD ' ' N ' ' A' ' 3' ' ' GLN . 2.6 pm0 -119.12 172.62 7.44 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.727 0.299 . . . . 0.0 111.01 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.517 HD12 ' N ' ' A' ' 4' ' ' LEU . 11.0 mp -80.35 169.7 17.39 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.792 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 p -102.37 176.58 5.14 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.252 0.549 . . . . 0.0 111.347 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 19.1 p-10 -78.68 -28.87 45.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.485 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.08 -43.91 97.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.805 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.584 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 99.0 mm-40 -70.31 -26.36 63.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.283 0.563 . . . . 0.0 109.831 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -81.96 -56.78 5.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.094 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.8 m -59.1 -44.24 91.94 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.182 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -61.06 -39.91 91.64 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.601 ' CG ' ' SD ' ' A' ' 72' ' ' MET . 4.3 m-30 -63.67 -46.43 85.63 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.36 0.6 . . . . 0.0 109.779 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.98 -44.23 96.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.652 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.25 -39.89 92.0 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.468 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.27 -45.36 91.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.539 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 34.7 t80 -68.17 -45.41 73.54 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.5 p -67.15 -31.95 72.73 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.5 tp -63.14 -41.87 99.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.564 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.484 ' CD1' HG21 ' A' ' 35' ' ' VAL . 29.9 m-85 -72.65 -14.26 61.55 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.873 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -91.4 80.83 5.46 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.45 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.506 ' NZ ' HG21 ' A' ' 34' ' ' THR . 97.4 mttt -49.4 -24.46 1.96 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.313 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -105.47 2.23 28.36 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.528 0.204 . . . . 0.0 111.427 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 40.74 31.09 0.39 Allowed Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.455 ' CG ' ' SG ' ' A' ' 26' ' ' CYS . 29.9 p30 -84.25 1.5 44.41 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.696 0.284 . . . . 0.0 111.133 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.39 24.53 56.57 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.455 ' SG ' ' CG ' ' A' ' 24' ' ' ASP . 17.8 p -153.72 127.78 9.0 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.99 0.424 . . . . 0.0 111.136 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.419 HD11 ' CD2' ' A' ' 16' ' ' PHE . 79.4 mt -100.45 120.13 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.1 p -90.19 170.16 10.53 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.8 p -65.38 -25.05 67.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.148 0.499 . . . . 0.0 110.562 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -66.54 -49.82 65.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.54 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -62.96 -41.36 99.5 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.92 -42.21 98.84 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.96 -43.41 99.44 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.506 HG21 ' NZ ' ' A' ' 21' ' ' LYS . 21.4 m -50.49 -46.1 56.79 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.569 ' O ' HD13 ' A' ' 39' ' ' LEU . 70.9 t -68.98 -54.23 21.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 113.49 -1.686 . . . . 0.0 111.019 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 60.9 mmm -57.21 -44.53 83.8 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.454 0.645 . . . . 0.0 109.444 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -54.96 -51.03 67.42 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.414 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.3 p -70.48 -14.99 62.75 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.707 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.569 HD13 ' O ' ' A' ' 35' ' ' VAL . 7.3 mp -97.36 38.04 1.3 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.92 0.39 . . . . 0.0 111.587 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.14 5.33 2.24 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.322 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.43 ' H ' ' C ' ' A' ' 39' ' ' LEU . 44.6 tp60 -97.01 147.18 24.27 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.06 72.27 40.05 Favored Pre-proline 0 N--CA 1.47 0.556 0 C-N-CA 121.309 -0.156 . . . . 0.0 111.238 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.465 ' CG ' HD21 ' A' ' 48' ' ' LEU . 83.2 Cg_endo -77.92 155.06 30.18 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.199 1.933 . . . . 0.0 111.599 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.442 ' OG1' ' OE2' ' A' ' 47' ' ' GLU . 16.1 p -93.15 169.76 10.15 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 176.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -60.54 -36.92 79.61 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.876 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.15 -45.39 93.24 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.526 0.679 . . . . 0.0 109.458 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -60.23 -49.08 79.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.172 -178.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.465 HD21 ' CG ' ' A' ' 43' ' ' PRO . 89.9 mt -64.26 -43.97 93.22 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.268 0.556 . . . . 0.0 111.253 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -60.95 -36.14 78.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.421 -0.808 . . . . 0.0 108.988 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -77.92 -29.28 49.95 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.106 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.443 ' SD ' ' C ' ' A' ' 51' ' ' MET . 1.8 tmm? -67.95 -48.73 65.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.552 0.692 . . . . 0.0 110.016 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 2.2 tp -65.71 -42.69 93.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.368 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.41 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 41.0 t30 -63.02 -39.52 95.01 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.246 -178.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -61.13 -43.66 98.54 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.53 0.681 . . . . 0.0 110.019 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.5 t -104.0 64.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.579 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 58' ' ' ASP . 1.0 OUTLIER -129.14 47.04 2.53 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -178.417 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 56' ' ' ASP . . . -33.52 -32.25 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.96 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 56' ' ' ASP . 6.2 m-20 -94.67 -37.84 11.12 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.497 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 83.41 17.99 65.28 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.2 p30 -80.0 -12.08 59.73 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 121.286 -0.166 . . . . 0.0 111.291 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.58 6.5 77.01 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 71.1 p -138.97 165.43 27.12 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.4 mt -103.69 120.47 53.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.736 -0.386 . . . . 0.0 112.033 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -83.43 -169.09 2.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 176.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.412 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 54.8 t80 -80.24 -43.94 1.41 Allowed Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 120.208 1.367 . . . . 0.0 112.181 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 52.1 Cg_exo -56.97 -37.26 98.88 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 121.54 1.493 . . . . 0.0 112.103 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.449 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 48.1 mt-10 -61.88 -61.9 2.17 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -51.21 -25.7 5.9 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.219 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.3 tp -77.11 -45.55 26.54 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.091 0.472 . . . . 0.0 110.769 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -59.3 -43.2 92.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.38 1.086 . . . . 0.0 108.541 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 tp -55.56 -66.65 0.38 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 112.876 -1.965 . . . . 0.0 109.904 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.601 ' SD ' ' CG ' ' A' ' 12' ' ' PHE . 5.0 ttt -56.93 -36.82 70.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.916 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.87 -45.47 67.63 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.054 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -55.69 -43.86 76.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.17 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.68 -42.19 98.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.475 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -58.72 -9.58 1.83 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.143 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.4 tttp -62.28 -45.7 92.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.062 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -133.68 -87.71 0.41 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.006 0.431 . . . . 0.0 110.735 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 36.4 p . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.771 -179.542 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 3' ' ' GLN . 51.7 p-10 -84.53 82.6 8.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.015 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.462 ' O ' ' O ' ' A' ' 2' ' ' ASP . 96.3 mm-40 53.51 164.94 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.232 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.98 167.98 16.67 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.329 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.0 p -98.39 167.24 10.96 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.037 0.446 . . . . 0.0 111.558 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -70.32 -38.63 74.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.947 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.462 ' CG ' ' N ' ' A' ' 8' ' ' GLN . 13.0 pt-20 -58.95 -43.14 91.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.761 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.487 HE21 ' CE ' ' A' ' 76' ' ' MET . 48.5 tt0 -59.71 -32.17 70.28 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.108 0.48 . . . . 0.0 110.234 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 80.7 mt -71.21 -51.05 37.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.575 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.3 t -55.08 -49.64 71.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.656 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -47.72 -49.08 29.12 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.438 ' CE1' ' HB3' ' A' ' 72' ' ' MET . 17.0 m-85 -62.84 -48.26 79.82 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.335 0.588 . . . . 0.0 110.275 178.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -61.62 -43.77 98.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.657 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -63.61 -42.42 98.22 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.26 -44.03 95.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.255 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.445 ' C ' ' CD1' ' A' ' 16' ' ' PHE . 26.3 t80 -68.86 -47.55 65.66 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -178.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.5 m -62.37 -34.06 75.97 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.28 -42.17 99.12 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.77 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.56 ' CD1' HG21 ' A' ' 35' ' ' VAL . 20.5 m-85 -65.57 -20.97 66.54 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.79 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -82.1 94.04 7.14 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.555 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -67.47 -29.98 69.57 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 120.734 0.302 . . . . 0.0 111.703 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -101.01 -0.86 35.71 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 122.335 -0.228 . . . . 0.0 111.422 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 48.57 33.29 11.85 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -73.8 -14.83 61.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.658 0.266 . . . . 0.0 111.29 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.95 -8.25 42.27 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.0 p -140.11 158.39 44.13 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.067 0.461 . . . . 0.0 110.74 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.407 HD12 ' CE2' ' A' ' 16' ' ' PHE . 75.4 mt -113.89 127.27 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.3 p -86.69 -162.48 0.78 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 33' ' ' GLY . 70.9 p -85.93 -25.2 26.24 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.625 -0.672 . . . . 0.0 111.104 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.421 ' HG2' ' H ' ' A' ' 30' ' ' LYS . 16.7 pttp -72.97 -46.11 54.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.312 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.97 -50.68 69.82 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.46 HD23 ' SD ' ' A' ' 36' ' ' MET . 0.4 OUTLIER -64.13 -40.39 96.07 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 176.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -58.07 -47.42 89.29 Favored Glycine 0 C--O 1.214 -1.116 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.1 m -55.62 -43.29 75.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.828 0.823 . . . . 0.0 109.082 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.56 HG21 ' CD1' ' A' ' 19' ' ' PHE . 67.1 t -69.78 -55.24 15.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.185 -1.371 . . . . 0.0 112.78 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.46 ' SD ' HD23 ' A' ' 32' ' ' LEU . 13.9 ptm -66.29 -42.03 88.97 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.136 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.49 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 60.8 ttm-85 -52.76 -51.3 61.17 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.625 0.726 . . . . 0.0 110.022 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.512 ' C ' ' H ' ' A' ' 40' ' ' GLY . 52.3 m -59.29 -35.85 74.51 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.379 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.454 HD23 ' O ' ' A' ' 35' ' ' VAL . 1.6 mm? -66.44 34.78 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.543 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 38' ' ' SER . . . 63.99 42.45 98.24 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.886 -0.674 . . . . 0.0 111.793 178.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.427 ' C ' HD22 ' A' ' 42' ' ' ASN . 98.1 mm-40 -136.62 148.91 47.72 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.427 HD22 ' C ' ' A' ' 41' ' ' GLN . 2.6 m-80 -137.3 67.21 53.72 Favored Pre-proline 0 N--CA 1.468 0.433 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.924 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.44 155.21 40.91 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.285 1.99 . . . . 0.0 111.534 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.593 HG22 ' N ' ' A' ' 45' ' ' GLU . 45.4 m -88.45 169.82 11.44 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.593 ' N ' HG22 ' A' ' 44' ' ' THR . 99.1 mt-10 -60.28 -37.07 79.37 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.908 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.48 -46.72 80.3 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.475 0.655 . . . . 0.0 109.441 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -60.43 -46.05 91.42 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.233 -179.058 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.05 -47.04 84.68 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.099 0.476 . . . . 0.0 111.224 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -63.64 -39.88 95.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.295 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -75.39 -38.34 60.0 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.945 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.439 ' N ' ' O ' ' A' ' 47' ' ' GLU . 5.7 mmm -62.83 -47.15 84.64 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.604 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 52' ' ' ILE . 15.0 tt -72.36 -40.85 65.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.586 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -65.25 -27.74 68.86 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -65.18 -51.46 60.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.45 0.643 . . . . 0.0 111.138 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.54 ' O ' HG22 ' A' ' 55' ' ' VAL . 9.2 p -80.55 -6.81 10.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.328 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 50.6 t0 -65.94 45.77 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.908 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -47.06 -25.33 0.81 Allowed 'General case' 0 CA--C 1.523 -0.077 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.846 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -80.53 -38.03 30.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.423 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.548 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 86.42 18.15 59.31 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 46.3 p30 -83.51 -26.27 30.33 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 122.812 -0.228 . . . . 0.0 111.36 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.527 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 89.91 -3.69 82.97 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.7 p -130.78 168.88 16.5 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.5 mt -108.97 124.89 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.1 p30 -90.98 -175.99 4.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.678 ' CZ ' HD23 ' A' ' 69' ' ' LEU . 32.3 t80 -77.11 -47.69 2.64 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.568 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.51 -47.3 27.58 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.157 1.238 . . . . 0.0 112.047 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -55.91 -50.33 70.99 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -56.97 -42.99 81.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.703 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.678 HD23 ' CZ ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -64.96 -50.62 65.69 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.084 178.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -56.44 -44.93 80.94 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 122.307 1.051 . . . . 0.0 108.712 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 tt -60.03 -46.56 89.13 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.001 -1.909 . . . . 0.0 110.138 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.438 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . 3.1 mmt -67.52 -45.68 75.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.912 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.26 -40.79 87.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.098 0.475 . . . . 0.0 109.844 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -46.02 86.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.237 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.501 ' C ' ' H ' ' A' ' 77' ' ' LYS . 21.7 tptp -64.71 -37.79 88.8 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.218 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.487 ' CE ' HE21 ' A' ' 8' ' ' GLN . 16.9 ttt -66.92 12.1 0.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.302 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.501 ' H ' ' C ' ' A' ' 75' ' ' LYS . 87.8 tttt -63.87 -45.24 90.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.363 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -81.83 -75.25 0.3 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.14 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 59.5 p . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.693 -179.547 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.435 ' O ' ' O ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.435 ' O ' ' O ' ' A' ' 1' ' ' ALA . 45.7 t0 59.83 125.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.151 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -96.21 158.58 15.38 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.78 0.324 . . . . 0.0 110.825 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.539 ' H ' HD23 ' A' ' 4' ' ' LEU . 0.2 OUTLIER -90.55 165.88 13.52 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.314 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.541 ' OG1' ' NE2' ' A' ' 8' ' ' GLN . 70.9 p -97.79 171.22 8.45 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.25 0.548 . . . . 0.0 111.589 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 18.6 p-10 -68.33 -25.16 64.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.455 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.74 -46.07 89.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.848 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.544 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -63.44 -31.54 72.73 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 87.5 mt -76.69 -53.66 14.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.956 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.2 t -57.0 -49.78 74.72 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.782 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -54.85 -43.86 73.45 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.544 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 2.9 m-85 -60.72 -48.14 83.15 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -59.99 -45.92 91.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.556 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -63.51 -44.13 95.21 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.55 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -57.68 -47.56 81.99 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.292 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.431 ' CD2' HD11 ' A' ' 27' ' ' ILE . 58.6 t80 -67.22 -47.57 70.42 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 t -58.47 -37.96 76.56 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.5 tp -61.45 -41.55 97.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.168 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.55 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.3 m-30 -63.69 -29.15 70.41 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.431 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 43.8 t0 -82.73 93.98 7.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.447 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -59.19 -32.25 69.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.174 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -97.08 -10.45 26.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.624 0.249 . . . . 0.0 111.341 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.477 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 58.42 39.82 93.42 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.417 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 37.0 p-10 -99.6 17.41 20.54 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.664 0.268 . . . . 0.0 111.069 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.483 ' O ' ' SG ' ' A' ' 26' ' ' CYS . . . 66.64 25.77 72.87 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 25' ' ' GLY . 39.5 m -154.01 135.02 13.87 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.832 0.348 . . . . 0.0 111.05 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.431 HD11 ' CD2' ' A' ' 16' ' ' PHE . 62.4 mt -107.1 128.46 61.99 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.0 p -94.9 164.21 13.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.557 ' O ' ' N ' ' A' ' 33' ' ' GLY . 68.1 p -54.76 -34.51 62.67 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.508 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -64.99 -47.8 76.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.465 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.27 -46.07 74.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.117 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.456 HD23 ' C ' ' A' ' 32' ' ' LEU . 8.3 tt -62.62 -43.48 98.71 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -62.5 -43.35 99.16 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 178.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.4 m -48.25 -48.09 35.6 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 68.8 t -66.65 -52.73 42.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 113.494 -1.685 . . . . 0.0 111.436 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 68.1 mmm -63.16 -40.45 97.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.317 0.579 . . . . 0.0 109.886 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -57.52 -50.53 72.78 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.197 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.3 t -68.23 -19.99 64.79 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.781 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.401 ' O ' ' CD2' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -85.83 35.98 0.65 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.556 -178.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.13 44.78 94.63 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.644 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -144.51 155.8 43.86 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -145.57 72.84 14.08 Favored Pre-proline 0 N--CA 1.466 0.363 0 C-N-CA 121.112 -0.235 . . . . 0.0 111.29 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.477 ' HB2' HD21 ' A' ' 48' ' ' LEU . 27.6 Cg_exo -67.08 151.11 82.25 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 122.548 2.165 . . . . 0.0 111.961 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.8 p -83.56 162.94 20.69 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.65 -41.54 86.29 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.491 -0.484 . . . . 0.0 112.071 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.4 -46.88 79.94 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.347 0.594 . . . . 0.0 109.446 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 51' ' ' MET . 81.2 mm-40 -60.1 -46.62 88.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.311 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.477 HD21 ' HB2' ' A' ' 43' ' ' PRO . 90.9 mt -63.93 -47.89 78.72 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.199 0.524 . . . . 0.0 111.568 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -62.07 -37.58 85.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.09 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -77.85 -38.0 47.14 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.517 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.489 ' N ' ' O ' ' A' ' 47' ' ' GLU . 56.8 tpp -62.4 -48.49 79.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.255 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 9.2 tt -70.41 -42.13 78.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.838 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.426 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 37.6 t30 -67.41 -21.78 65.56 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -73.6 -54.33 8.4 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.574 0.702 . . . . 0.0 110.221 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.553 ' O ' HG22 ' A' ' 55' ' ' VAL . 8.1 p -75.44 -6.83 9.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.469 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 15.9 t0 -65.24 48.98 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.752 -178.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -52.78 -28.82 24.18 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.222 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -75.05 -38.33 61.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.399 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.532 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 85.55 26.85 34.29 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.553 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 45.3 p30 -98.37 -22.6 15.99 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 122.847 -0.208 . . . . 0.0 111.169 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.553 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 90.77 -4.08 81.63 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.463 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 61.3 p -136.74 167.82 20.7 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.8 mm -96.3 118.53 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 C-N-CA 120.681 -0.408 . . . . 0.0 112.076 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -87.88 -172.14 3.71 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.538 ' CZ ' HD11 ' A' ' 69' ' ' LEU . 42.0 t80 -74.1 -54.28 3.52 Favored Pre-proline 0 C--N 1.318 -0.781 0 C-N-CA 118.236 -1.386 . . . . 0.0 112.357 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 23.4 Cg_endo -54.61 -40.39 84.26 Favored 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 121.365 1.377 . . . . 0.0 111.704 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.23 -53.66 55.58 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -48.15 -43.12 31.12 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.698 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.538 HD11 ' CZ ' ' A' ' 65' ' ' PHE . 9.9 mt -63.6 -44.86 92.76 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.741 -0.599 . . . . 0.0 110.579 177.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -63.55 -45.61 89.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 122.509 1.147 . . . . 0.0 109.027 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.424 HD12 HG11 ' A' ' 55' ' ' VAL . 8.1 tt -58.01 -58.33 8.9 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 112.731 -2.032 . . . . 0.0 110.267 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.52 ' O ' ' N ' ' A' ' 76' ' ' MET . 93.1 mmm -64.82 -37.46 87.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.81 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . -60.23 -40.74 91.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.214 0.531 . . . . 0.0 110.25 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.2 mmt-85 -74.2 -41.87 60.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.948 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -78.26 -6.03 53.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.08 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.52 ' N ' ' O ' ' A' ' 72' ' ' MET . 8.1 ttt -51.25 -47.1 62.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.142 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -56.5 -81.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.359 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 39.4 p-10 -168.01 117.4 0.77 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.705 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.4 ' OXT' ' O ' ' A' ' 78' ' ' ASP . 3.5 m . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.56 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -152.96 -114.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.11 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.421 ' C ' HD22 ' A' ' 4' ' ' LEU . 88.3 mt-30 -134.83 50.69 2.15 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.697 0.284 . . . . 0.0 111.433 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.458 ' N ' ' CD2' ' A' ' 4' ' ' LEU . 3.8 mm? -98.25 172.25 7.69 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.933 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 p -113.58 170.73 8.03 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.148 0.499 . . . . 0.0 111.34 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -78.92 -33.06 45.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.684 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -62.16 -43.3 99.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.139 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.588 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 1.0 OUTLIER -67.72 -30.93 70.54 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 88.5 mt -80.4 -53.53 12.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.239 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 p -58.8 -46.18 88.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.122 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -59.18 -41.21 87.91 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.59 ' CZ ' ' SD ' ' A' ' 72' ' ' MET . 6.4 m-30 -63.24 -46.59 86.21 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.271 0.558 . . . . 0.0 109.967 178.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.6 tttp -62.52 -43.25 99.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.445 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -62.74 -40.99 98.96 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.471 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -58.9 -48.18 82.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.474 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.412 ' CE1' ' OD2' ' A' ' 20' ' ' ASP . 48.2 t80 -65.78 -45.42 82.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.2 m -65.25 -34.81 79.23 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 62.7 tp -64.0 -43.19 96.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.698 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 30.9 m-85 -66.84 -17.17 64.75 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.706 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.412 ' OD2' ' CE1' ' A' ' 16' ' ' PHE . 43.6 m-20 -90.55 94.12 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.355 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -61.86 -22.48 65.57 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.319 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -110.65 7.4 22.3 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.082 -178.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 35.84 28.78 0.02 OUTLIER Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 22' ' ' ASP . 41.1 p30 -70.31 -14.07 62.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.656 0.265 . . . . 0.0 111.131 -178.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.28 0.25 37.93 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 5.0 p -145.23 139.71 27.35 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.059 0.429 . . . . 0.0 111.117 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.401 HD11 ' CD2' ' A' ' 16' ' ' PHE . 80.6 mt -95.09 122.48 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 77.3 p -86.43 173.39 9.69 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -70.79 -38.62 73.39 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.326 -178.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -54.95 -48.45 73.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.03 0.443 . . . . 0.0 109.832 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.412 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 92.6 mt-10 -62.48 -43.62 98.38 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.4 tp -62.08 -43.64 98.39 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -61.43 -42.26 99.73 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.2 m -50.54 -50.39 53.43 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.1 t -64.85 -49.84 78.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.598 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 58.0 mmm -63.31 -42.19 98.99 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -52.63 -52.13 56.94 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.31 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.8 p -66.47 -26.8 67.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.615 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.523 ' C ' ' H ' ' A' ' 41' ' ' GLN . 68.9 mt -83.11 38.98 0.62 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.734 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.94 -0.76 0.29 Allowed Glycine 0 N--CA 1.465 0.611 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.523 ' H ' ' C ' ' A' ' 39' ' ' LEU . 28.9 tp60 -88.06 146.68 25.34 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -137.21 66.41 52.81 Favored Pre-proline 0 N--CA 1.466 0.373 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.384 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.452 ' CG ' HD21 ' A' ' 48' ' ' LEU . 87.7 Cg_endo -77.98 156.91 30.67 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.186 1.924 . . . . 0.0 111.568 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.0 p -91.66 167.18 12.38 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.438 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 55.7 mp0 -61.13 -34.89 75.7 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.563 -0.455 . . . . 0.0 112.002 -178.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.24 -48.32 82.23 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -58.31 -47.29 84.15 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.248 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.452 HD21 ' CG ' ' A' ' 43' ' ' PRO . 89.6 mt -63.19 -44.77 94.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.268 0.556 . . . . 0.0 111.379 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -66.25 -41.67 89.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.219 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.43 ' O ' ' OE2' ' A' ' 54' ' ' GLU . 97.6 m-20 -63.82 -50.22 69.79 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.313 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 39.5 ttm -53.39 -41.77 66.28 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 56' ' ' ASP . 35.2 mt -65.07 -44.56 95.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.338 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -54.63 -33.25 60.26 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.435 ' N ' ' CD ' ' A' ' 54' ' ' GLU . 2.0 mm-40 -76.66 -41.23 46.44 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 121.798 0.808 . . . . 0.0 110.53 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.2 t -81.65 -24.9 9.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.462 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 58' ' ' ASP . 32.4 t70 -82.09 44.01 0.82 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.85 -177.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -39.07 -21.46 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.211 0.529 . . . . 0.0 110.358 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 56' ' ' ASP . 85.4 m-20 -74.0 -36.46 64.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.344 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 85.99 36.88 9.67 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.484 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 8.4 m120 -102.99 -20.18 14.31 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 122.784 -0.245 . . . . 0.0 111.12 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.26 1.31 88.32 Favored Glycine 0 N--CA 1.466 0.695 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.9 p -135.61 162.32 33.04 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.9 mt -96.86 116.85 40.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.868 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -82.17 -166.13 1.18 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 176.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.476 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 71.4 t80 -81.15 -53.1 0.79 Allowed Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.984 178.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 35.4 Cg_endo -56.86 -30.47 85.53 Favored 'Trans proline' 0 N--CA 1.506 2.244 0 C-N-CA 121.832 1.688 . . . . 0.0 111.893 -178.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -65.66 -63.19 1.15 Allowed 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -48.64 -29.43 4.34 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.91 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.4 tp -68.87 -45.68 70.37 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.901 0.381 . . . . 0.0 110.821 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -60.22 -42.74 95.84 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 122.453 1.121 . . . . 0.0 108.809 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.1 tp -62.05 -32.89 73.46 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.431 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.59 ' SD ' ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -78.67 -44.25 24.13 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.9 179.126 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.32 -33.04 73.6 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.147 0.499 . . . . 0.0 110.368 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -74.13 -42.5 59.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.891 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -79.96 -10.18 59.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.328 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.7 ttt -51.83 -51.27 57.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.278 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 79' ' ' THR . 17.0 tptm -95.6 -63.6 1.14 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.133 0.492 . . . . 0.0 110.671 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -41.18 91.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.813 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 77' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.654 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 3' ' ' GLN . 87.6 m-20 -73.55 -11.48 60.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.084 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.521 ' O ' ' O ' ' A' ' 2' ' ' ASP . 98.9 mm-40 50.52 119.68 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 O-C-N 123.673 0.608 . . . . 0.0 111.047 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.427 HD12 ' N ' ' A' ' 4' ' ' LEU . 11.1 mp -65.84 166.79 10.52 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.421 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.1 p -95.2 165.89 12.18 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.112 0.482 . . . . 0.0 111.238 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 17.1 p-10 -70.83 -29.61 65.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.637 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -62.78 -46.96 85.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.925 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.531 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 87.2 mt-30 -65.78 -29.85 70.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.997 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.4 mt -77.49 -57.09 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.197 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.6 m -56.47 -42.24 77.88 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.342 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -65.99 -39.88 90.69 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.631 -0.428 . . . . 0.0 109.955 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.531 ' CG ' ' O ' ' A' ' 8' ' ' GLN . 4.3 m-30 -61.65 -46.84 88.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -58.63 -47.36 84.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.296 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -60.55 -40.95 93.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.539 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -58.8 -48.51 81.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.622 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.415 ' CD2' HD11 ' A' ' 27' ' ' ILE . 32.9 t80 -67.67 -47.11 70.42 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.7 m -59.83 -36.75 77.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 43.4 tp -62.43 -41.19 98.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.324 178.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 5.0 m-30 -64.76 -26.59 68.42 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.64 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 23' ' ' GLY . 47.7 t0 -82.88 92.64 7.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.195 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -57.38 -34.06 68.47 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.931 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -91.45 -22.81 20.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.521 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.484 ' H ' ' CG ' ' A' ' 20' ' ' ASP . . . 66.68 37.73 92.66 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.413 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 36.4 p-10 -98.05 14.02 28.9 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.549 0.214 . . . . 0.0 111.135 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.35 17.87 80.09 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.0 m -147.59 138.52 23.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.793 0.33 . . . . 0.0 111.115 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.415 HD11 ' CD2' ' A' ' 16' ' ' PHE . 68.4 mt -112.15 125.2 69.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 47.2 p -88.82 162.15 16.34 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -57.67 -29.99 65.09 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -178.797 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -66.42 -47.09 74.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.023 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -67.56 -46.65 72.1 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.263 178.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.3 tt -62.3 -41.08 98.22 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -64.66 -42.93 97.04 Favored Glycine 0 C--O 1.226 -0.393 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 178.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.7 m -50.07 -48.99 52.76 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.417 ' O ' HD23 ' A' ' 39' ' ' LEU . 73.3 t -64.17 -51.1 73.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.241 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.1 mmm -64.06 -41.69 97.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.447 0.642 . . . . 0.0 109.643 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 45.3 ttm180 -56.21 -45.56 79.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.714 0.769 . . . . 0.0 110.395 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.3 m -71.72 -19.39 62.06 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.855 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 35' ' ' VAL . 1.7 mm? -87.5 31.6 0.74 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.897 0.38 . . . . 0.0 111.654 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 60.94 42.78 99.84 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.708 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -136.81 149.88 48.01 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -129.43 70.54 81.87 Favored Pre-proline 0 N--CA 1.469 0.491 0 C-N-CA 121.305 -0.158 . . . . 0.0 111.241 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.76 145.52 25.72 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.183 1.922 . . . . 0.0 111.381 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.4 m -86.42 160.05 19.16 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.438 ' HG2' ' H ' ' A' ' 45' ' ' GLU . 2.0 pt-20 -59.92 -33.31 71.71 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.54 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.9 -47.15 86.02 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.187 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -64.09 -42.76 96.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.764 -179.388 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.49 -46.59 85.44 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.293 0.568 . . . . 0.0 110.788 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -62.85 -46.21 88.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.439 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -64.1 -40.62 96.61 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.664 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.6 ttm -59.82 -43.94 94.29 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.468 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 11.1 mt -64.48 -46.88 91.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.733 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -56.5 -35.89 68.52 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -65.27 -50.97 63.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.218 0.532 . . . . 0.0 111.119 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 57' ' ' ALA . 6.5 p -74.58 -21.3 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.194 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.553 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.8 t0 -67.79 49.23 0.05 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.797 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -39.98 -26.88 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.267 0.556 . . . . 0.0 110.384 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 56' ' ' ASP . 24.0 m-20 -88.13 -36.24 16.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.08 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 56' ' ' ASP . . . 92.47 14.45 55.56 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -66.92 -31.56 72.22 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.819 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.553 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 99.2 -1.1 57.4 Favored Glycine 0 N--CA 1.47 0.922 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 65.9 p -137.23 160.72 38.2 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.4 mm -92.15 122.3 43.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -84.52 -176.3 6.18 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.466 ' CE2' HD11 ' A' ' 69' ' ' LEU . 43.2 t80 -76.86 -54.91 1.56 Allowed Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 118.336 -1.345 . . . . 0.0 111.868 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.7 Cg_endo -57.67 -41.03 74.92 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.103 1.202 . . . . 0.0 111.513 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.421 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 62.6 mt-10 -55.15 -42.17 72.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.655 0.741 . . . . 0.0 109.179 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -62.12 -38.85 90.5 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.743 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.466 HD11 ' CE2' ' A' ' 65' ' ' PHE . 74.3 mt -61.48 -42.12 98.3 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.792 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -60.83 -44.91 96.32 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 122.217 1.008 . . . . 0.0 108.75 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.5 tp -63.42 -46.9 84.23 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.29 -1.777 . . . . 0.0 110.733 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.401 ' SD ' ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -67.35 -45.57 75.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.355 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.84 -37.87 89.0 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.66 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -73.11 -46.08 53.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.312 178.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -70.08 -13.61 62.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.446 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.406 ' SD ' ' C ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -54.89 -71.91 0.07 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.3 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -97.38 30.7 2.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.654 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -134.19 88.0 2.42 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.731 0.301 . . . . 0.0 110.463 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.893 -1.051 . . . . 0.0 110.53 179.685 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 53.98 36.02 23.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.37 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -87.44 -5.84 58.66 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.639 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.424 ' H ' HD23 ' A' ' 4' ' ' LEU . 0.4 OUTLIER -72.73 163.84 27.48 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.91 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.747 HG22 ' H ' ' A' ' 6' ' ' ASP . 20.4 m -98.2 176.76 5.61 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.15 0.5 . . . . 0.0 111.455 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.747 ' H ' HG22 ' A' ' 5' ' ' THR . 98.0 m-20 -75.1 -40.73 59.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.444 178.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -49.4 -42.51 42.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.617 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.559 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 13.2 mp0 -70.35 -26.23 63.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.292 0.568 . . . . 0.0 109.771 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.4 mt -82.29 -57.19 4.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.059 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 t -58.3 -43.76 88.25 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.451 -0.499 . . . . 0.0 109.952 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -62.41 -39.93 94.88 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.559 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.4 m-30 -64.09 -46.07 85.89 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.647 0.737 . . . . 0.0 109.591 178.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -60.03 -47.44 85.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.328 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -62.8 -41.26 99.2 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.72 -47.78 83.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.689 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.465 ' CE1' ' OD2' ' A' ' 20' ' ' ASP . 51.6 t80 -67.82 -45.31 75.06 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.8 m -65.25 -34.09 77.54 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.2 tp -62.9 -40.22 96.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.709 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.504 ' CD1' HG21 ' A' ' 35' ' ' VAL . 21.9 m-85 -73.23 -14.12 61.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.043 179.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.465 ' OD2' ' CE1' ' A' ' 16' ' ' PHE . 55.5 m-20 -89.28 74.19 7.93 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.396 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -43.26 -43.5 4.87 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.497 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 18.6 p30 -83.42 -22.42 32.67 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.536 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 73.12 28.06 67.16 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.9 p30 -81.1 -4.17 54.42 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.591 0.234 . . . . 0.0 111.229 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.8 12.72 74.02 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 33.6 m -143.16 128.93 19.35 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.856 0.36 . . . . 0.0 110.976 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 79.9 mt -97.64 123.34 50.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.1 p -97.03 170.14 9.35 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.1 p -61.19 -27.61 68.54 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.742 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -64.46 -48.82 73.85 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.502 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.409 ' O ' HG23 ' A' ' 35' ' ' VAL . 94.3 mt-10 -66.94 -41.86 86.28 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.0 tt -61.1 -43.03 99.5 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.33 -43.99 94.23 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.0 m -49.77 -48.06 50.62 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.588 ' O ' HD13 ' A' ' 39' ' ' LEU . 74.1 t -65.28 -51.54 63.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 113.549 -1.659 . . . . 0.0 111.513 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.0 mmt -61.28 -46.02 92.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.513 0.673 . . . . 0.0 109.456 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.9 tpt85 -50.01 -50.95 45.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.947 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.7 t -74.15 -15.51 61.03 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.828 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.588 HD13 ' O ' ' A' ' 35' ' ' VAL . 6.0 mp -93.56 37.55 1.06 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.043 0.449 . . . . 0.0 111.754 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.29 4.45 6.44 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.596 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -100.74 149.32 23.93 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -140.72 68.18 29.89 Favored Pre-proline 0 N--CA 1.467 0.401 0 C-N-CA 121.198 -0.201 . . . . 0.0 111.266 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.401 ' CG ' HD21 ' A' ' 48' ' ' LEU . 91.4 Cg_endo -74.79 158.43 42.99 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.327 2.018 . . . . 0.0 111.566 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.9 p -93.58 166.31 12.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -60.68 -33.21 72.5 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.694 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.53 98.9 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -62.23 -47.54 83.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.141 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.401 HD21 ' CG ' ' A' ' 43' ' ' PRO . 56.4 mt -64.87 -41.72 95.42 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.148 0.499 . . . . 0.0 111.241 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -61.86 -39.88 93.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.757 0.789 . . . . 0.0 109.196 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -78.32 -24.4 46.61 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.165 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.615 ' O ' HG12 ' A' ' 55' ' ' VAL . 41.3 ttm -71.22 -46.99 59.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.505 0.669 . . . . 0.0 109.82 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 tp -67.55 -40.52 84.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.269 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -65.3 -37.08 86.05 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.634 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -64.34 -36.65 84.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.407 0.622 . . . . 0.0 109.533 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.704 HG13 ' O ' ' A' ' 55' ' ' VAL . 7.2 p -109.39 68.44 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.115 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 58' ' ' ASP . 3.8 t0 -135.29 47.74 2.3 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -34.67 -29.76 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.763 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 42.3 p-10 -97.68 -38.37 9.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.487 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.546 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 91.14 12.67 59.82 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 40.4 p-10 -70.15 -25.23 63.36 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.803 -0.234 . . . . 0.0 111.31 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 90.76 7.84 66.03 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 75.2 p -143.81 157.23 44.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.3 mm -93.84 124.33 46.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.433 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 85.5 m-20 -90.0 -162.86 0.93 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 176.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.672 ' CZ ' HD11 ' A' ' 69' ' ' LEU . 50.4 t80 -76.24 -56.86 1.48 Allowed Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 118.274 -1.371 . . . . 0.0 111.85 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.47 -26.31 62.69 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 CA-C-N 120.37 1.168 . . . . 0.0 111.637 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.459 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 99.3 mt-10 -65.43 -35.07 79.82 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -70.83 -31.14 67.77 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.147 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.672 HD11 ' CZ ' ' A' ' 65' ' ' PHE . 9.7 mp -70.71 -34.57 72.07 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.588 177.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -64.42 -43.62 93.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 122.41 1.1 . . . . 0.0 108.815 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.665 ' HB2' HG21 ' A' ' 55' ' ' VAL . 25.8 tp -63.67 -45.92 87.91 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 112.998 -1.91 . . . . 0.0 110.844 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.485 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . 97.5 mmm -78.96 -30.13 44.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.113 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . -72.2 -41.22 67.18 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.171 0.51 . . . . 0.0 110.094 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.1 tpp85 -65.22 -44.55 87.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -68.03 -42.41 80.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.742 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.519 ' SD ' ' O ' ' A' ' 76' ' ' MET . 13.0 tmm? -71.94 -8.23 53.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.269 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -64.68 -46.01 84.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.148 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -148.92 53.46 0.98 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.748 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.956 179.928 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -157.39 -178.75 7.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.924 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.408 ' CG ' ' H ' ' A' ' 4' ' ' LEU . 25.9 tp60 -120.35 -143.43 0.35 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.736 0.303 . . . . 0.0 110.883 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.408 ' H ' ' CG ' ' A' ' 3' ' ' GLN . 72.2 mt -116.17 154.74 29.5 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.514 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.428 ' OG1' ' OE1' ' A' ' 8' ' ' GLN . 77.0 p -99.06 -177.74 3.72 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.204 0.526 . . . . 0.0 111.302 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 19.3 p-10 -77.41 -30.16 53.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.644 178.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -64.9 -44.79 88.45 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.069 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.532 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 5.1 mp0 -70.53 -25.64 63.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.169 0.509 . . . . 0.0 109.884 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.0 mt -83.97 -56.82 5.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.906 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -58.46 -41.12 84.48 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.258 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -65.6 -38.07 88.41 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.0 m-30 -64.9 -46.88 79.88 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.526 0.679 . . . . 0.0 109.673 178.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -62.23 -45.59 92.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.661 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -59.69 -37.57 79.18 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.495 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.07 -44.42 97.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.353 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.409 ' CE2' ' CG1' ' A' ' 27' ' ' ILE . 52.4 t80 -67.43 -45.95 74.54 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -178.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.4 t -63.45 -35.44 80.45 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.21 -40.64 98.04 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.338 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.495 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 27.1 m-85 -73.55 -19.67 60.84 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.099 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -87.38 80.27 8.2 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 120.904 -0.319 . . . . 0.0 111.583 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -52.59 -26.51 13.62 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.116 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' A' ' 24' ' ' ASP . 36.7 m-20 -103.26 4.46 36.64 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.876 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 38.52 31.59 0.12 Allowed Glycine 0 CA--C 1.529 0.967 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 34.9 p-10 -86.64 -0.85 57.03 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.639 0.257 . . . . 0.0 111.146 -178.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.425 ' O ' ' SG ' ' A' ' 26' ' ' CYS . . . 82.23 26.79 46.8 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 25' ' ' GLY . 40.4 m -154.09 134.52 13.44 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.907 0.384 . . . . 0.0 111.236 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.409 ' CG1' ' CE2' ' A' ' 16' ' ' PHE . 5.9 mm -102.32 115.54 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.3 p -88.19 163.97 15.89 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.446 HG22 ' CD1' ' A' ' 52' ' ' ILE . 0.6 OUTLIER -61.45 -24.42 66.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.18 0.514 . . . . 0.0 110.195 -178.562 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -69.4 -49.08 58.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.401 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -64.29 -43.52 94.49 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.058 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.7 tp -61.93 -42.81 99.53 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.99 -44.51 97.28 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.6 m -51.23 -46.51 62.32 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.57 -51.8 53.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 113.498 -1.683 . . . . 0.0 111.428 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.501 ' SD ' ' OE1' ' A' ' 41' ' ' GLN . 17.7 mmt -60.17 -42.51 95.12 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 63.3 ttm-85 -54.68 -46.5 74.07 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.591 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.0 m -76.48 -17.08 59.48 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.313 -1.312 . . . . 0.0 111.79 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' A' ' 41' ' ' GLN . 55.5 mt -93.26 38.39 1.04 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.723 0.297 . . . . 0.0 111.788 -178.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.1 2.22 0.88 Allowed Glycine 0 N--CA 1.464 0.528 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.501 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 80.2 mt-30 -97.7 150.39 21.25 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -136.54 68.71 60.43 Favored Pre-proline 0 N--CA 1.468 0.468 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.334 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.542 ' CG ' HD21 ' A' ' 48' ' ' LEU . 93.8 Cg_endo -75.26 153.72 40.75 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.267 1.978 . . . . 0.0 111.725 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -92.73 174.74 7.11 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.255 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.408 ' N ' ' OG1' ' A' ' 44' ' ' THR . 97.5 mt-10 -60.34 -40.03 89.21 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.778 -178.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.35 -46.46 90.15 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.508 0.671 . . . . 0.0 109.437 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.409 ' H ' HG23 ' A' ' 44' ' ' THR . 49.3 tp10 -54.24 -53.13 57.81 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.016 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.542 HD21 ' CG ' ' A' ' 43' ' ' PRO . 90.4 mt -62.12 -41.97 98.77 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.227 0.537 . . . . 0.0 111.067 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -67.26 -40.73 86.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.586 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -64.29 -41.72 96.74 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.258 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 38.5 ttm -59.15 -41.81 89.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.667 0.746 . . . . 0.0 109.46 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.446 ' CD1' HG22 ' A' ' 29' ' ' THR . 78.4 mt -66.27 -40.33 86.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.11 178.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -60.12 -39.37 85.99 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.354 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.6 -36.7 84.49 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.782 0.801 . . . . 0.0 109.732 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.499 HG13 ' OD1' ' A' ' 70' ' ' ASN . 59.6 t -110.84 63.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.878 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 58' ' ' ASP . 0.4 OUTLIER -124.37 41.39 3.51 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.356 -178.146 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 56' ' ' ASP . . . -30.64 -36.06 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.159 0.504 . . . . 0.0 111.096 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 48.6 p-10 -99.26 -33.68 10.64 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.741 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.561 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 81.07 22.96 60.07 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.459 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 39.5 p-10 -76.13 -23.68 54.87 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.49 0.182 . . . . 0.0 111.49 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.01 5.72 62.32 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.459 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 59.8 p -138.41 162.78 33.58 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.2 mt -98.91 121.23 49.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.979 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -90.58 -162.72 0.93 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.723 ' CE2' HD11 ' A' ' 69' ' ' LEU . 57.1 t80 -76.72 -55.0 1.61 Allowed Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 118.347 -1.341 . . . . 0.0 112.027 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 48.8 Cg_endo -62.02 -26.59 78.61 Favored 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 121.315 1.344 . . . . 0.0 112.189 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.435 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 97.6 mt-10 -70.75 -30.38 66.88 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -76.1 -35.75 59.2 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 113.927 -1.488 . . . . 0.0 110.273 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.723 HD11 ' CE2' ' A' ' 65' ' ' PHE . 88.7 mt -67.46 -30.48 70.21 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.405 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.499 ' OD1' HG13 ' A' ' 55' ' ' VAL . 14.0 t-20 -68.18 -45.1 74.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.652 1.215 . . . . 0.0 109.102 178.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 tp -63.56 -44.17 94.93 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 112.53 -2.123 . . . . 0.0 110.644 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.441 ' CG ' ' CE2' ' A' ' 12' ' ' PHE . 3.3 tpt -77.36 -32.6 55.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.612 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . -67.55 -35.7 79.55 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.038 0.447 . . . . 0.0 109.996 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -77.3 -44.5 29.43 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.584 0.707 . . . . 0.0 109.672 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -67.01 -18.51 65.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.233 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 6.0 ttt -49.5 -75.5 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.09 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -59.12 -74.35 0.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.42 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.412 ' CG ' ' N ' ' A' ' 79' ' ' THR . 37.9 t70 -168.66 172.29 8.11 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.604 -179.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.412 ' N ' ' CG ' ' A' ' 78' ' ' ASP . 84.6 m . . . . . 0 C--N 1.325 -0.495 0 CA-C-O 117.861 -1.066 . . . . 0.0 110.615 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 2' ' ' ASP . 55.8 t0 -66.44 -10.12 40.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.085 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.43 ' HG3' ' H ' ' A' ' 4' ' ' LEU . 28.8 tp60 -112.49 167.08 10.74 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.835 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.43 ' H ' ' HG3' ' A' ' 3' ' ' GLN . 87.6 mt -66.09 149.47 50.23 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.978 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 p -93.15 170.89 9.29 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.083 0.468 . . . . 0.0 111.462 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 23.1 p-10 -73.3 -42.57 62.22 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.566 178.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.492 ' CG ' ' N ' ' A' ' 8' ' ' GLN . 13.6 pt-20 -53.85 -43.64 69.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.575 -179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.613 ' O ' ' CD2' ' A' ' 12' ' ' PHE . 85.4 mt-30 -69.87 -27.1 64.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.332 0.587 . . . . 0.0 109.881 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 77.5 mt -78.53 -58.58 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.405 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.3 t -56.8 -41.69 78.19 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.712 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -59.21 -41.69 89.17 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.613 ' CD2' ' O ' ' A' ' 8' ' ' GLN . 13.0 m-30 -65.72 -49.04 69.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.414 0.626 . . . . 0.0 110.149 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -61.23 -48.46 81.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.376 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -61.64 -40.58 95.39 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.52 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -63.44 -41.72 98.67 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.529 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.497 ' CD2' HD11 ' A' ' 27' ' ' ILE . 28.0 t80 -68.61 -47.59 66.28 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 m -64.17 -33.8 76.61 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.46 -40.73 97.57 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.284 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 31.8 m-85 -73.79 -16.33 61.16 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.916 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.542 ' OD2' ' N ' ' A' ' 25' ' ' GLY . 51.1 t0 -84.23 69.68 10.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.744 0.307 . . . . 0.0 111.442 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -43.04 -44.23 4.66 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.136 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -73.56 -23.89 60.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.744 0.307 . . . . 0.0 111.303 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 68.09 28.61 73.31 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 24.7 p-10 -89.93 5.4 46.54 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.764 0.316 . . . . 0.0 111.217 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.542 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 81.45 11.43 83.23 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.2 m -142.27 136.95 30.29 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 122.611 -0.347 . . . . 0.0 111.082 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.497 HD11 ' CD2' ' A' ' 16' ' ' PHE . 67.7 mt -101.41 126.9 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.0 p -99.04 160.3 14.36 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 33' ' ' GLY . 46.8 p -57.0 -25.71 58.99 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.589 -179.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.02 -49.35 72.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.243 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.9 -45.12 87.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.026 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.0 tp -61.84 -42.44 99.04 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -61.42 -44.32 98.19 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 178.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.1 m -49.1 -44.28 42.09 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.416 1.103 . . . . 0.0 108.25 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.1 t -73.83 -59.11 3.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 113.206 -1.816 . . . . 0.0 111.328 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 72.5 mtp -53.63 -44.46 69.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.512 0.672 . . . . 0.0 109.694 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 78.8 ttt-85 -58.83 -45.08 90.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.129 178.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.1 m -79.28 0.65 27.88 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.635 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 mp -106.48 35.47 2.95 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.477 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.5 37.01 91.51 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.702 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -137.74 153.45 49.74 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -136.72 78.66 42.19 Favored Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 121.324 -0.15 . . . . 0.0 111.304 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.72 150.82 21.65 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.234 1.956 . . . . 0.0 111.713 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.1 m -86.17 163.31 17.9 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -64.78 -34.11 77.57 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.832 -178.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.66 -41.31 97.35 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.397 0.618 . . . . 0.0 109.541 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.485 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -62.24 -49.77 74.39 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.258 -179.09 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.6 mt -62.26 -41.24 98.27 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.06 0.457 . . . . 0.0 111.549 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.434 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 55.7 tt0 -65.21 -36.54 84.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.732 0.777 . . . . 0.0 109.429 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -80.17 -35.25 36.72 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.227 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.472 ' SD ' ' C ' ' A' ' 51' ' ' MET . 9.1 tmm? -70.38 -51.3 30.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.093 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 7.6 tp -59.15 -46.54 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.734 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.485 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 96.5 m-20 -69.57 -31.72 70.07 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.4 -36.66 84.88 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.639 0.733 . . . . 0.0 110.497 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.691 ' O ' HG22 ' A' ' 55' ' ' VAL . 14.6 p -98.31 18.25 2.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.8 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.719 ' CG ' ' H ' ' A' ' 59' ' ' GLY . 65.1 t0 -99.32 69.74 1.7 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.889 -177.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -37.74 -25.25 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.651 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 56' ' ' ASP . 17.4 m-20 -94.52 -40.87 9.64 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.615 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.719 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 92.03 7.65 63.98 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.408 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 15.7 m120 -66.99 -28.14 68.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.578 0.228 . . . . 0.0 111.16 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.593 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 99.91 8.26 51.51 Favored Glycine 0 N--CA 1.464 0.52 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 76.7 p -137.87 166.28 24.42 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.428 ' CG1' HD11 ' A' ' 52' ' ' ILE . 4.8 mt -104.11 125.22 58.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -176.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -97.79 158.09 15.71 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 176.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.549 ' CE2' HD11 ' A' ' 69' ' ' LEU . 58.3 t80 -49.93 -48.36 78.42 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 118.0 -1.48 . . . . 0.0 111.408 -178.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.35 -44.35 43.63 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 121.219 1.279 . . . . 0.0 112.31 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.432 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 73.3 mt-10 -61.22 -34.49 75.2 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 122.285 1.04 . . . . 0.0 108.297 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 65' ' ' PHE . 89.5 t80 -68.42 -25.91 65.26 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.356 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.549 HD11 ' CE2' ' A' ' 65' ' ' PHE . 25.2 mt -74.98 -32.71 61.75 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.925 0.393 . . . . 0.0 110.492 177.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -64.2 -42.61 96.55 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 122.745 1.26 . . . . 0.0 108.541 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.423 ' HB2' HG21 ' A' ' 55' ' ' VAL . 43.2 tp -63.02 -45.67 91.24 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.532 -2.122 . . . . 0.0 110.448 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.546 ' SD ' ' CE1' ' A' ' 12' ' ' PHE . 7.6 mmt -78.48 -28.26 46.41 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.97 178.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . -75.31 -42.95 53.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.145 0.498 . . . . 0.0 110.081 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.8 mmm-85 -66.53 -38.1 86.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.136 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.87 -43.7 98.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.346 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 9.8 mmt -67.43 -1.77 5.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.355 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -63.18 -35.61 80.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.097 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -58.34 -66.43 0.49 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.165 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.621 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -129.5 96.29 4.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -173.66 118.91 0.28 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.99 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.555 HD22 ' N ' ' A' ' 4' ' ' LEU . 3.4 mm? -87.55 156.88 19.32 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.868 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.2 p -98.38 175.29 6.1 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.379 0.609 . . . . 0.0 111.397 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -77.52 -34.45 54.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.587 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.472 ' OE1' ' N ' ' A' ' 7' ' ' GLU . 57.6 mp0 -65.1 -44.72 87.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.209 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.548 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 38.5 mt-30 -67.35 -24.13 65.68 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.07 0.462 . . . . 0.0 110.199 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 90.0 mt -83.63 -53.58 10.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.192 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.9 t -59.15 -45.12 91.81 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.251 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 11' ' ' GLU . 0.3 OUTLIER -62.86 -38.93 92.79 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.293 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.548 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 2.9 m-30 -62.44 -45.2 94.17 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 121.442 0.639 . . . . 0.0 109.861 178.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -63.54 -41.78 98.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.829 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -64.62 -41.78 95.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.54 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . -59.39 -49.56 77.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.566 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.455 ' CD2' HD11 ' A' ' 27' ' ' ILE . 51.3 t80 -66.47 -44.27 83.15 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.1 p -64.8 -35.39 80.95 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 41.2 tp -63.8 -39.43 94.23 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.493 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.54 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 4.6 m-30 -66.52 -16.27 64.02 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.318 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.463 ' OD2' ' N ' ' A' ' 24' ' ' ASP . 38.6 t0 -94.78 88.21 5.27 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.384 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -47.95 -40.88 23.51 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.537 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 3.4 p30 -91.98 -24.59 19.19 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.667 -178.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.411 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 76.76 33.12 47.76 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.041 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.463 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 80.0 m-20 -73.45 -7.39 51.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.782 0.325 . . . . 0.0 111.036 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.01 2.69 64.3 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.2 p -143.43 138.01 29.03 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.945 0.402 . . . . 0.0 111.096 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.455 HD11 ' CD2' ' A' ' 16' ' ' PHE . 76.9 mt -96.67 126.65 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.8 p -90.85 170.35 10.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.558 ' O ' ' N ' ' A' ' 33' ' ' GLY . 27.3 p -61.63 -49.29 77.15 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.917 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.493 ' CG ' ' N ' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -56.57 -43.03 79.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.152 0.501 . . . . 0.0 110.332 179.557 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.493 ' N ' ' CG ' ' A' ' 30' ' ' LYS . 89.6 mt-10 -61.55 -49.1 78.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.69 178.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.2 tt -63.25 -41.47 99.07 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -61.79 -40.7 99.16 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 30' ' ' LYS . 20.7 m -53.79 -48.62 69.63 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.08 -47.7 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.377 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 17.3 mmt -64.22 -44.28 92.4 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -50.62 -51.29 50.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.634 0.731 . . . . 0.0 110.676 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -68.34 -27.0 65.89 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.705 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 41' ' ' GLN . 46.6 mt -78.2 37.56 0.26 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -178.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.75 -6.91 0.77 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.138 -0.553 . . . . 0.0 111.75 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.487 ' H ' ' C ' ' A' ' 39' ' ' LEU . 76.6 mt-30 -89.5 149.85 22.72 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -133.95 65.21 69.35 Favored Pre-proline 0 N--CA 1.469 0.476 0 C-N-CA 121.321 -0.151 . . . . 0.0 111.384 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.2 155.6 33.15 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.147 1.898 . . . . 0.0 111.503 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 m -93.38 159.51 15.22 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.431 ' HG2' ' H ' ' A' ' 45' ' ' GLU . 0.8 OUTLIER -59.53 -33.26 71.16 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.665 -178.62 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.3 -39.4 82.93 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -69.31 -45.55 69.29 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.103 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.5 mt -63.7 -43.38 96.79 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.144 0.497 . . . . 0.0 110.957 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -60.75 -49.09 78.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.432 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -65.93 -33.22 75.34 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.106 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 34.8 ttm -65.75 -42.41 90.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.722 0.773 . . . . 0.0 109.994 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 1.1 tp -65.62 -47.35 86.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.724 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.416 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 77.7 m-20 -65.48 -28.53 69.28 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 124.009 0.818 . . . . 0.0 112.903 -177.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -68.21 -45.51 73.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.602 0.715 . . . . 0.0 110.969 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.541 ' O ' HG22 ' A' ' 55' ' ' VAL . 12.4 p -89.03 -3.47 9.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.719 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 37.5 t0 -64.67 41.57 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.233 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -40.67 -32.57 0.22 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.189 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -74.6 -38.31 62.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.675 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.542 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 91.08 16.57 53.73 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 42.7 p30 -87.64 -25.42 23.55 Favored 'General case' 0 CA--C 1.53 0.173 0 O-C-N 122.685 -0.303 . . . . 0.0 111.334 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.555 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 91.58 5.18 67.12 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.5 p -142.57 168.39 19.83 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.0 mt -97.86 119.62 46.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.307 -0.557 . . . . 0.0 112.194 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -90.62 148.72 22.47 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 176.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.565 ' CE2' HD11 ' A' ' 69' ' ' LEU . 46.6 t80 -48.03 -52.1 43.18 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 118.145 -1.422 . . . . 0.0 111.464 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.23 -50.61 12.47 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 CA-C-N 119.901 1.0 . . . . 0.0 111.603 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.441 ' OE2' ' O ' ' A' ' 55' ' ' VAL . 32.9 tt0 -55.17 -52.75 62.32 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -47.26 -25.35 0.93 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.941 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.565 HD11 ' CE2' ' A' ' 65' ' ' PHE . 83.7 mt -79.07 -41.74 28.04 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.781 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -60.96 -41.12 95.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 122.348 1.071 . . . . 0.0 108.466 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.7 tp -57.91 -64.43 0.91 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.821 -1.99 . . . . 0.0 110.318 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.7 mmm -63.45 -36.35 83.45 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.58 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.12 -49.08 73.6 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 121.116 0.484 . . . . 0.0 110.062 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -61.33 -43.08 99.47 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.442 ' C ' ' H ' ' A' ' 77' ' ' LYS . 49.8 tttp -65.91 -38.6 89.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.25 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 7.0 ttm -60.78 -1.18 0.36 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.367 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.442 ' H ' ' C ' ' A' ' 75' ' ' LYS . 61.8 pttt -54.83 -15.48 1.96 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.236 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 40.5 p-10 -74.71 108.16 7.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.086 0.47 . . . . 0.0 111.225 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.0 p . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.61 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.8 t0 52.8 77.88 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.034 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -132.43 179.13 6.31 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.067 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.591 HD22 ' N ' ' A' ' 4' ' ' LEU . 3.1 mm? -73.71 171.02 14.05 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.211 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.511 ' HG1' ' CD ' ' A' ' 8' ' ' GLN . 16.2 p -98.71 176.99 5.44 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.19 0.519 . . . . 0.0 111.392 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.436 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 24.9 p-10 -80.03 -26.36 39.82 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.339 177.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.412 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 97.6 mt-10 -63.15 -44.79 94.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.901 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.586 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 5.1 mp0 -69.91 -23.21 63.19 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.522 0.677 . . . . 0.0 110.124 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -83.9 -56.55 5.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.429 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 61.6 m -58.25 -40.69 82.43 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.151 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -65.73 -37.42 86.33 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.046 0.451 . . . . 0.0 109.873 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.586 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 2.4 m-85 -62.59 -45.28 93.63 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.468 0.652 . . . . 0.0 109.995 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -63.2 -42.21 99.28 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.064 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -63.31 -41.78 98.96 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.85 -46.99 86.43 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.292 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.439 ' CE2' ' CG1' ' A' ' 27' ' ' ILE . 48.1 t80 -67.9 -45.6 73.99 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.3 p -63.71 -33.78 76.41 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.1 tp -62.9 -39.92 95.96 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.242 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.531 ' CD1' HG21 ' A' ' 35' ' ' VAL . 21.2 m-85 -73.97 -18.97 60.8 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.033 179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 25' ' ' GLY . 29.2 t0 -86.57 74.1 9.95 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.749 0.309 . . . . 0.0 111.338 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -44.9 -36.55 3.38 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.735 0.303 . . . . 0.0 111.255 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -87.94 -23.86 23.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.708 0.289 . . . . 0.0 111.427 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.51 21.48 76.17 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.0 p-10 -80.13 -1.23 39.32 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.679 0.276 . . . . 0.0 111.11 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.433 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 82.97 26.41 45.08 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 32.2 m -151.03 132.15 14.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.992 0.425 . . . . 0.0 111.057 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.439 ' CG1' ' CE2' ' A' ' 16' ' ' PHE . 4.3 mm -101.64 147.79 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 p -126.94 167.98 15.14 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 33' ' ' GLY . 58.0 p -58.78 -30.49 67.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.959 0.409 . . . . 0.0 110.818 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HG3' ' H ' ' A' ' 31' ' ' GLU . 38.9 pttt -67.18 -49.47 64.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.79 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.46 ' H ' ' HG3' ' A' ' 30' ' ' LYS . 88.7 mt-10 -67.12 -48.52 67.87 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.189 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.99 -43.7 98.48 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -62.65 -41.21 99.85 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 178.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.3 m -50.29 -46.04 54.98 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.411 1.101 . . . . 0.0 108.231 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.531 HG21 ' CD1' ' A' ' 19' ' ' PHE . 58.5 t -69.76 -55.89 13.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 113.345 -1.752 . . . . 0.0 111.424 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 83.0 mmm -54.41 -44.74 72.64 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.868 0.842 . . . . 0.0 109.943 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -54.08 -46.95 72.17 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.461 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.1 t -79.07 -9.39 59.53 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.069 -1.423 . . . . 0.0 111.728 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.405 ' O ' ' CD2' ' A' ' 39' ' ' LEU . 0.9 OUTLIER -94.05 34.62 1.23 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.502 -178.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.37 2.1 6.74 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.548 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -102.47 152.42 21.16 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -134.61 65.16 66.34 Favored Pre-proline 0 N--CA 1.47 0.531 0 CA-C-O 120.405 0.145 . . . . 0.0 111.271 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.403 ' CG ' HD21 ' A' ' 48' ' ' LEU . 85.4 Cg_endo -76.47 156.04 36.43 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.146 1.898 . . . . 0.0 111.629 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.5 p -92.79 168.88 10.89 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -60.02 -31.77 70.27 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.881 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.11 -44.7 96.09 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.585 0.707 . . . . 0.0 109.593 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -60.79 -49.18 78.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.316 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.403 HD21 ' CG ' ' A' ' 43' ' ' PRO . 73.7 mt -62.94 -41.82 99.61 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.954 0.407 . . . . 0.0 111.576 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -66.11 -41.52 90.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.41 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -64.71 -37.26 86.98 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.956 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.6 ttm -61.88 -41.78 98.28 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.479 HD12 ' CG2' ' A' ' 29' ' ' THR . 25.2 mt -65.59 -43.24 94.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.292 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -63.72 -39.91 95.46 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.492 ' OE2' ' CZ ' ' A' ' 74' ' ' ARG . 69.1 tt0 -61.85 -37.69 85.43 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 122.028 0.918 . . . . 0.0 110.089 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.0 t -109.18 67.54 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.389 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 58' ' ' ASP . 2.8 t0 -131.9 45.2 2.81 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.128 0.489 . . . . 0.0 109.794 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -38.67 -23.15 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.06 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 56' ' ' ASP . 29.1 p-10 -102.28 -43.09 5.8 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.68 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.467 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 90.88 29.69 12.65 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.436 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 48.1 p30 -87.36 -11.88 48.01 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 111.392 0.145 . . . . 0.0 111.392 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.03 6.13 85.66 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.686 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.8 p -138.85 163.99 30.81 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.6 mt -99.76 122.65 51.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.824 -177.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -91.97 -165.2 1.3 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 176.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.471 ' CE2' HD11 ' A' ' 69' ' ' LEU . 59.5 t80 -77.48 -47.02 2.52 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 117.823 -1.551 . . . . 0.0 111.841 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -65.26 -31.22 53.72 Favored 'Trans proline' 0 N--CA 1.507 2.319 0 C-N-CA 121.439 1.426 . . . . 0.0 112.06 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -66.59 -31.07 71.53 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 122.808 1.289 . . . . 0.0 108.149 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -75.58 -30.98 59.81 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.456 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 73' ' ' ALA . 4.8 mt -69.7 -34.31 73.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.531 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -65.06 -44.13 89.98 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.47 1.129 . . . . 0.0 109.292 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.6 tp -61.66 -45.84 92.31 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 112.545 -2.116 . . . . 0.0 110.79 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.455 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . 99.5 mmm -80.12 -31.29 39.11 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.102 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . -72.1 -40.66 68.02 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.31 0.576 . . . . 0.0 109.812 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.492 ' CZ ' ' OE2' ' A' ' 54' ' ' GLU . 63.0 ttt180 -66.45 -42.25 87.89 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.245 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -62.83 -42.67 99.83 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.242 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 82.6 mmm -72.42 -5.28 35.44 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.398 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -63.72 -45.89 87.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.182 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -109.97 -100.0 0.39 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.12 0.486 . . . . 0.0 111.045 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 31.3 p . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.74 -179.617 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.227 -0.656 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -144.73 124.38 13.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.871 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -148.66 -127.3 0.05 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.593 0.235 . . . . 0.0 110.805 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 77.2 mt -99.01 162.76 12.9 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.458 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.6 m -106.15 158.26 16.96 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.151 0.501 . . . . 0.0 111.221 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -65.3 -33.64 76.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.223 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.94 -45.79 92.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.933 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.543 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -63.84 -36.23 83.23 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.88 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 74.7 mt -74.92 -54.34 14.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.078 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.0 t -55.83 -49.7 72.56 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.004 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -56.55 -41.68 77.27 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.883 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.543 ' CD1' ' O ' ' A' ' 8' ' ' GLN . 3.0 m-85 -61.73 -48.79 79.13 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -60.78 -44.33 96.93 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.725 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -62.64 -44.94 95.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.39 -49.49 77.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.602 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' A' ' 16' ' ' PHE . 38.2 t80 -65.51 -49.15 70.06 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.3 t -60.67 -37.74 82.57 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.7 tp -61.97 -43.92 97.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.064 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.544 ' CD1' HG21 ' A' ' 35' ' ' VAL . 19.5 m-85 -66.26 -24.54 66.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.841 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -86.88 85.24 7.26 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.534 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -67.46 -16.85 64.45 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.207 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 17.4 t0 -96.65 -0.46 48.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.202 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 38.01 53.86 2.02 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 26' ' ' CYS . 31.6 p-10 -111.84 9.15 20.7 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.695 0.283 . . . . 0.0 111.003 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.1 3.15 88.14 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 36.1 m -142.48 146.37 34.68 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.983 0.421 . . . . 0.0 110.887 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.9 mt -110.74 125.76 68.05 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 57.2 p -86.69 160.74 18.76 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 33' ' ' GLY . 34.0 p -58.44 -29.69 66.33 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.311 -178.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -65.04 -48.19 74.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.29 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -60.85 -47.11 87.84 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.3 tp -63.65 -40.6 97.27 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 29' ' ' THR . . . -60.88 -46.67 94.07 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.0 m -48.57 -49.7 35.5 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.544 HG21 ' CD1' ' A' ' 19' ' ' PHE . 53.0 t -63.75 -51.07 74.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.587 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.2 mmt -62.83 -45.16 93.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 61.6 ttt85 -54.07 -50.24 67.22 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.405 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.3 t -66.85 -21.02 66.03 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.47 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.6 mt -86.83 29.89 0.78 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.73 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.58 39.98 98.56 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.87 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -128.04 142.54 51.19 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -129.64 62.69 64.73 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 121.351 -0.139 . . . . 0.0 111.315 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.35 152.33 34.52 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.222 1.948 . . . . 0.0 111.538 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.8 p -83.85 160.93 21.05 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -60.23 -33.82 72.81 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.849 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.78 -47.15 85.72 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.427 0.632 . . . . 0.0 109.342 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.42 -43.58 83.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.846 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.4 mt -65.19 -45.59 84.17 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.107 0.479 . . . . 0.0 111.632 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.441 ' O ' HG22 ' A' ' 52' ' ' ILE . 58.4 tt0 -66.54 -33.96 76.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 122.203 1.002 . . . . 0.0 109.233 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.467 ' O ' ' OE2' ' A' ' 54' ' ' GLU . 96.2 m-20 -76.37 -39.98 52.33 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.524 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 39.2 ttm -58.66 -45.12 90.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.328 0.585 . . . . 0.0 110.498 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.441 HG22 ' O ' ' A' ' 49' ' ' GLN . 6.6 tt -70.66 -33.22 52.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.399 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -60.46 -39.0 86.02 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.562 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.467 ' OE2' ' O ' ' A' ' 50' ' ' ASP . 4.9 mm-40 -65.28 -16.43 63.55 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.364 0.602 . . . . 0.0 110.833 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 57' ' ' ALA . 3.0 t -110.2 -19.12 7.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.759 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -65.55 48.51 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.043 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -57.7 -23.34 51.19 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.964 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 17.6 p-10 -88.67 -44.88 10.27 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.318 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 93.05 50.31 2.47 Favored Glycine 0 N--CA 1.471 1.006 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.67 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 55.6 p30 -109.88 -21.61 12.27 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.692 -0.299 . . . . 0.0 110.999 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.544 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 84.7 -4.71 84.15 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 51.1 p -131.42 169.43 16.05 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.9 mt -104.14 119.29 52.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -91.54 -175.93 4.35 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 175.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.451 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 75.6 t80 -69.44 -55.61 9.37 Favored Pre-proline 0 C--N 1.318 -0.796 0 C-N-CA 118.63 -1.228 . . . . 0.0 112.242 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 14.3 Cg_endo -50.45 -43.08 46.34 Favored 'Trans proline' 0 N--CA 1.504 2.109 0 C-N-CA 121.885 1.724 . . . . 0.0 111.373 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.401 ' OE2' ' CG ' ' A' ' 58' ' ' ASP . 95.2 mt-10 -58.86 -52.63 64.89 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -57.33 -41.71 80.5 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.648 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.4 tp -61.36 -44.73 96.68 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.163 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -64.24 -52.5 58.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 122.619 1.199 . . . . 0.0 108.953 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.8 tt -51.95 -59.43 4.35 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.078 -1.874 . . . . 0.0 110.62 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.465 ' O ' ' N ' ' A' ' 76' ' ' MET . 1.2 tpt -61.6 -39.29 90.68 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.757 178.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.86 -37.54 87.26 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.197 0.522 . . . . 0.0 110.499 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -80.57 -34.97 34.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.593 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -82.79 -7.45 59.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.347 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.465 ' N ' ' O ' ' A' ' 72' ' ' MET . 24.5 tpp -57.84 -47.58 82.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.438 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -54.0 -81.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.954 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 55.76 78.81 0.18 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.068 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.674 -179.958 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_